Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 A20140416_SF113_02 A20140416_SF113_02 TB373172.[MT7]-DAGVVC[CAM]TNETR.2y9_1.heavy 683.331 / 1035.49 10404.0 20.68939971923828 44 14 10 10 10 2.5557136389978656 33.505522513711234 0.0 3 0.9475442461271624 5.364741997960755 10404.0 95.3461668918604 0.0 - - - - - - - 182.30769230769232 20 13 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 3 1 A20140416_SF113_02 A20140416_SF113_02 TB373172.[MT7]-DAGVVC[CAM]TNETR.2y6_1.heavy 683.331 / 780.331 17763.0 20.68939971923828 44 14 10 10 10 2.5557136389978656 33.505522513711234 0.0 3 0.9475442461271624 5.364741997960755 17763.0 162.43093672832316 0.0 - - - - - - - 162.84615384615384 35 13 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 5 1 A20140416_SF113_02 A20140416_SF113_02 TB373172.[MT7]-DAGVVC[CAM]TNETR.2y10_1.heavy 683.331 / 1106.53 21147.0 20.68939971923828 44 14 10 10 10 2.5557136389978656 33.505522513711234 0.0 3 0.9475442461271624 5.364741997960755 21147.0 298.27354020187954 0.0 - - - - - - - 169.27272727272728 42 11 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 7 1 A20140416_SF113_02 A20140416_SF113_02 TB373172.[MT7]-DAGVVC[CAM]TNETR.2y7_1.heavy 683.331 / 879.399 23431.0 20.68939971923828 44 14 10 10 10 2.5557136389978656 33.505522513711234 0.0 3 0.9475442461271624 5.364741997960755 23431.0 325.33857866341805 0.0 - - - - - - - 169.25 46 12 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 9 2 A20140416_SF113_02 A20140416_SF113_02 TB235744.[MT7]-GLQLLSK[MT7].2y4_1.heavy 523.844 / 604.415 8922.0 30.51337480545044 39 20 6 5 8 5.270949905412599 15.250833970653005 0.04030036926269531 4 0.9905498574344571 12.685295353757349 8922.0 5.040032196647621 2.0 - - - - - - - 628.0 17 1 CYFIP2 cytoplasmic FMR1 interacting protein 2 11 2 A20140416_SF113_02 A20140416_SF113_02 TB235744.[MT7]-GLQLLSK[MT7].2y5_1.heavy 523.844 / 732.474 5278.0 30.51337480545044 39 20 6 5 8 5.270949905412599 15.250833970653005 0.04030036926269531 4 0.9905498574344571 12.685295353757349 5278.0 4.850454803865833 1.0 - - - - - - - 728.9 34 10 CYFIP2 cytoplasmic FMR1 interacting protein 2 13 2 A20140416_SF113_02 A20140416_SF113_02 TB235744.[MT7]-GLQLLSK[MT7].2b4_1.heavy 523.844 / 556.357 11561.0 30.51337480545044 39 20 6 5 8 5.270949905412599 15.250833970653005 0.04030036926269531 4 0.9905498574344571 12.685295353757349 11561.0 5.028639714658743 0.0 - - - - - - - 1319.5 23 2 CYFIP2 cytoplasmic FMR1 interacting protein 2 15 2 A20140416_SF113_02 A20140416_SF113_02 TB235744.[MT7]-GLQLLSK[MT7].2y6_1.heavy 523.844 / 845.558 3770.0 30.51337480545044 39 20 6 5 8 5.270949905412599 15.250833970653005 0.04030036926269531 4 0.9905498574344571 12.685295353757349 3770.0 8.763057324840764 0.0 - - - - - - - 586.5555555555555 7 9 CYFIP2 cytoplasmic FMR1 interacting protein 2 17 3 A20140416_SF113_02 A20140416_SF113_02 TB235747.[MT7]-WSQLTK[MT7].2y4_1.heavy 525.813 / 633.405 9384.0 27.294099807739258 48 20 10 10 8 9.03957610209475 11.062465636726802 0.0 4 0.9972020292882499 23.325957165474044 9384.0 4.439002873357506 1.0 - - - - - - - 2663.714285714286 18 7 FBXL5 F-box and leucine-rich repeat protein 5 19 3 A20140416_SF113_02 A20140416_SF113_02 TB235747.[MT7]-WSQLTK[MT7].2b3_1.heavy 525.813 / 546.279 12888.0 27.294099807739258 48 20 10 10 8 9.03957610209475 11.062465636726802 0.0 4 0.9972020292882499 23.325957165474044 12888.0 4.552473830930803 1.0 - - - - - - - 1251.0 69 3 FBXL5 F-box and leucine-rich repeat protein 5 21 3 A20140416_SF113_02 A20140416_SF113_02 TB235747.[MT7]-WSQLTK[MT7].2y5_1.heavy 525.813 / 720.437 47172.0 27.294099807739258 48 20 10 10 8 9.03957610209475 11.062465636726802 0.0 4 0.9972020292882499 23.325957165474044 47172.0 50.374710275030544 0.0 - - - - - - - 312.5 94 2 FBXL5 F-box and leucine-rich repeat protein 5 23 3 A20140416_SF113_02 A20140416_SF113_02 TB235747.[MT7]-WSQLTK[MT7].2y3_1.heavy 525.813 / 505.347 20020.0 27.294099807739258 48 20 10 10 8 9.03957610209475 11.062465636726802 0.0 4 0.9972020292882499 23.325957165474044 20020.0 5.391048278060476 1.0 - - - - - - - 3504.0 40 1 FBXL5 F-box and leucine-rich repeat protein 5 25 4 A20140416_SF113_02 A20140416_SF113_02 TB495391.[MT7]-YAPLHLVPLIER.3b4_1.heavy 522.316 / 589.347 137081.0 35.762699127197266 45 15 10 10 10 3.441973106623023 20.542028393895556 0.0 3 0.9561787423324718 5.873826432918289 137081.0 111.2216526191311 0.0 - - - - - - - 1324.2857142857142 274 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 27 4 A20140416_SF113_02 A20140416_SF113_02 TB495391.[MT7]-YAPLHLVPLIER.3y4_1.heavy 522.316 / 530.33 14513.0 35.762699127197266 45 15 10 10 10 3.441973106623023 20.542028393895556 0.0 3 0.9561787423324718 5.873826432918289 14513.0 5.200097268603498 0.0 - - - - - - - 488.0 29 1 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 29 4 A20140416_SF113_02 A20140416_SF113_02 TB495391.[MT7]-YAPLHLVPLIER.3y8_1.heavy 522.316 / 976.594 2805.0 35.762699127197266 45 15 10 10 10 3.441973106623023 20.542028393895556 0.0 3 0.9561787423324718 5.873826432918289 2805.0 10.691188524590164 0.0 - - - - - - - 257.55555555555554 5 9 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 31 4 A20140416_SF113_02 A20140416_SF113_02 TB495391.[MT7]-YAPLHLVPLIER.3y5_1.heavy 522.316 / 627.382 191230.0 35.762699127197266 45 15 10 10 10 3.441973106623023 20.542028393895556 0.0 3 0.9561787423324718 5.873826432918289 191230.0 113.80654116539294 0.0 - - - - - - - 915.0 382 2 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 33 5 A20140416_SF113_02 A20140416_SF113_02 TB373441.[MT7]-WLQDNAENVYVWK[MT7].3b4_1.heavy 651.675 / 687.358 20152.0 36.275901794433594 41 11 10 10 10 1.0457291643577795 59.3437619469969 0.0 3 0.8745878012742075 3.4478275879216733 20152.0 18.788364370875705 0.0 - - - - - - - 371.0 40 2 GP1BA glycoprotein Ib (platelet), alpha polypeptide 35 5 A20140416_SF113_02 A20140416_SF113_02 TB373441.[MT7]-WLQDNAENVYVWK[MT7].3b5_1.heavy 651.675 / 801.401 19534.0 36.275901794433594 41 11 10 10 10 1.0457291643577795 59.3437619469969 0.0 3 0.8745878012742075 3.4478275879216733 19534.0 24.910219398438983 0.0 - - - - - - - 772.5833333333334 39 12 GP1BA glycoprotein Ib (platelet), alpha polypeptide 37 5 A20140416_SF113_02 A20140416_SF113_02 TB373441.[MT7]-WLQDNAENVYVWK[MT7].3b3_1.heavy 651.675 / 572.331 27199.0 36.275901794433594 41 11 10 10 10 1.0457291643577795 59.3437619469969 0.0 3 0.8745878012742075 3.4478275879216733 27199.0 20.26319710515113 0.0 - - - - - - - 890.0 54 5 GP1BA glycoprotein Ib (platelet), alpha polypeptide 39 5 A20140416_SF113_02 A20140416_SF113_02 TB373441.[MT7]-WLQDNAENVYVWK[MT7].3y4_1.heavy 651.675 / 739.426 63423.0 36.275901794433594 41 11 10 10 10 1.0457291643577795 59.3437619469969 0.0 3 0.8745878012742075 3.4478275879216733 63423.0 50.274578772086855 0.0 - - - - - - - 2313.714285714286 126 7 GP1BA glycoprotein Ib (platelet), alpha polypeptide 41 6 A20140416_SF113_02 A20140416_SF113_02 TB373576.[MT7]-GQWGTVC[CAM]DNLWDLTDASVVC[CAM]R.3y7_1.heavy 866.073 / 806.383 10309.0 40.3671989440918 46 16 10 10 10 5.791964638575553 17.26529877858396 0.0 3 0.9670847256621412 6.783676549016682 10309.0 32.63660044150111 0.0 - - - - - - - 679.625 20 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 43 6 A20140416_SF113_02 A20140416_SF113_02 TB373576.[MT7]-GQWGTVC[CAM]DNLWDLTDASVVC[CAM]R.3y6_1.heavy 866.073 / 691.356 10422.0 40.3671989440918 46 16 10 10 10 5.791964638575553 17.26529877858396 0.0 3 0.9670847256621412 6.783676549016682 10422.0 41.38147058823529 0.0 - - - - - - - 249.4 20 10 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 45 6 A20140416_SF113_02 A20140416_SF113_02 TB373576.[MT7]-GQWGTVC[CAM]DNLWDLTDASVVC[CAM]R.3b4_1.heavy 866.073 / 573.29 4305.0 40.3671989440918 46 16 10 10 10 5.791964638575553 17.26529877858396 0.0 3 0.9670847256621412 6.783676549016682 4305.0 4.767611590983468 0.0 - - - - - - - 663.4285714285714 8 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 47 6 A20140416_SF113_02 A20140416_SF113_02 TB373576.[MT7]-GQWGTVC[CAM]DNLWDLTDASVVC[CAM]R.3y10_1.heavy 866.073 / 1135.54 8950.0 40.3671989440918 46 16 10 10 10 5.791964638575553 17.26529877858396 0.0 3 0.9670847256621412 6.783676549016682 8950.0 46.44633184545516 0.0 - - - - - - - 283.3333333333333 17 12 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 49 7 A20140416_SF113_02 A20140416_SF113_02 TB372937.[MT7]-TEDGWK[MT7].2y4_1.heavy 512.271 / 649.343 7321.0 22.863500595092773 50 20 10 10 10 11.278790242703245 8.866199108959801 0.0 3 0.9969596716555008 22.376493472341334 7321.0 11.272291109493992 0.0 - - - - - - - 653.4285714285714 14 7 FBXO25 F-box protein 25 51 7 A20140416_SF113_02 A20140416_SF113_02 TB372937.[MT7]-TEDGWK[MT7].2y5_1.heavy 512.271 / 778.385 9037.0 22.863500595092773 50 20 10 10 10 11.278790242703245 8.866199108959801 0.0 3 0.9969596716555008 22.376493472341334 9037.0 23.305438457717145 0.0 - - - - - - - 653.7142857142857 18 7 FBXO25 F-box protein 25 53 7 A20140416_SF113_02 A20140416_SF113_02 TB372937.[MT7]-TEDGWK[MT7].2b4_1.heavy 512.271 / 547.248 3317.0 22.863500595092773 50 20 10 10 10 11.278790242703245 8.866199108959801 0.0 3 0.9969596716555008 22.376493472341334 3317.0 1.3928332063401052 10.0 - - - - - - - 1225.5714285714287 7 7 FBXO25 F-box protein 25 55 7 A20140416_SF113_02 A20140416_SF113_02 TB372937.[MT7]-TEDGWK[MT7].2y3_1.heavy 512.271 / 534.316 24822.0 22.863500595092773 50 20 10 10 10 11.278790242703245 8.866199108959801 0.0 3 0.9969596716555008 22.376493472341334 24822.0 20.995168290725665 0.0 - - - - - - - 343.5 49 2 FBXO25 F-box protein 25 57 8 A20140416_SF113_02 A20140416_SF113_02 TB373575.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].3y3_1.heavy 863.771 / 534.316 6532.0 45.60599899291992 44 14 10 10 10 2.28410243564075 34.83263437029016 0.0 3 0.9487338009618982 5.427173872696967 6532.0 26.27244323276384 0.0 - - - - - - - 314.55555555555554 13 9 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 59 8 A20140416_SF113_02 A20140416_SF113_02 TB373575.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].3b4_1.heavy 863.771 / 573.355 3778.0 45.60599899291992 44 14 10 10 10 2.28410243564075 34.83263437029016 0.0 3 0.9487338009618982 5.427173872696967 3778.0 10.728099269436632 0.0 - - - - - - - 262.25 7 12 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 61 8 A20140416_SF113_02 A20140416_SF113_02 TB373575.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].3b8_1.heavy 863.771 / 1032.53 5194.0 45.60599899291992 44 14 10 10 10 2.28410243564075 34.83263437029016 0.0 3 0.9487338009618982 5.427173872696967 5194.0 38.94892547410846 0.0 - - - - - - - 257.3636363636364 10 11 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 63 8 A20140416_SF113_02 A20140416_SF113_02 TB373575.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].3b7_1.heavy 863.771 / 919.45 7162.0 45.60599899291992 44 14 10 10 10 2.28410243564075 34.83263437029016 0.0 3 0.9487338009618982 5.427173872696967 7162.0 46.26404278259369 0.0 - - - - - - - 209.75 14 12 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 65 9 A20140416_SF113_02 A20140416_SF113_02 TB373447.[MT7]-YQILNNEVFAILNK[MT7].3y3_1.heavy 656.378 / 518.342 20562.0 41.24489974975586 44 14 10 10 10 2.182821493581709 35.95303780426256 0.0 3 0.9460736091514191 5.2904235631477725 20562.0 23.777079004528634 0.0 - - - - - - - 779.1875 41 16 CYFIP2 cytoplasmic FMR1 interacting protein 2 67 9 A20140416_SF113_02 A20140416_SF113_02 TB373447.[MT7]-YQILNNEVFAILNK[MT7].3b5_1.heavy 656.378 / 776.442 4475.0 41.24489974975586 44 14 10 10 10 2.182821493581709 35.95303780426256 0.0 3 0.9460736091514191 5.2904235631477725 4475.0 13.9712441314554 0.0 - - - - - - - 291.26666666666665 8 15 CYFIP2 cytoplasmic FMR1 interacting protein 2 69 9 A20140416_SF113_02 A20140416_SF113_02 TB373447.[MT7]-YQILNNEVFAILNK[MT7].3b3_1.heavy 656.378 / 549.315 13743.0 41.24489974975586 44 14 10 10 10 2.182821493581709 35.95303780426256 0.0 3 0.9460736091514191 5.2904235631477725 13743.0 25.422535091092627 0.0 - - - - - - - 765.0909090909091 27 11 CYFIP2 cytoplasmic FMR1 interacting protein 2 71 9 A20140416_SF113_02 A20140416_SF113_02 TB373447.[MT7]-YQILNNEVFAILNK[MT7].3b7_1.heavy 656.378 / 1019.53 8843.0 41.24489974975586 44 14 10 10 10 2.182821493581709 35.95303780426256 0.0 3 0.9460736091514191 5.2904235631477725 8843.0 31.334001224356772 0.0 - - - - - - - 167.71428571428572 17 14 CYFIP2 cytoplasmic FMR1 interacting protein 2 73 10 A20140416_SF113_02 A20140416_SF113_02 TB373574.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].4b7_1.heavy 648.08 / 919.45 4879.0 45.60599899291992 34 10 4 10 10 0.8375458953691062 71.77882965246924 0.0 3 0.8368990765602599 3.0133283090563894 4879.0 21.63482048130418 0.0 - - - - - - - 224.71428571428572 9 14 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 75 10 A20140416_SF113_02 A20140416_SF113_02 TB373574.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].4b4_1.heavy 648.08 / 573.355 4014.0 45.60599899291992 34 10 4 10 10 0.8375458953691062 71.77882965246924 0.0 3 0.8368990765602599 3.0133283090563894 4014.0 4.4014489573211755 1.0 - - - - - - - 250.1818181818182 8 11 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 77 10 A20140416_SF113_02 A20140416_SF113_02 TB373574.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].4b5_1.heavy 648.08 / 733.386 1259.0 45.60599899291992 34 10 4 10 10 0.8375458953691062 71.77882965246924 0.0 3 0.8368990765602599 3.0133283090563894 1259.0 3.560203949386238 1.0 - - - - - - - 209.8 37 15 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 79 10 A20140416_SF113_02 A20140416_SF113_02 TB373574.[MT7]-ALMLC[CAM]EGLFVADVTDFEGWK[MT7].4y3_1.heavy 648.08 / 534.316 10703.0 45.60599899291992 34 10 4 10 10 0.8375458953691062 71.77882965246924 0.0 3 0.8368990765602599 3.0133283090563894 10703.0 20.30305857706414 0.0 - - - - - - - 708.3333333333334 21 9 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 81 11 A20140416_SF113_02 A20140416_SF113_02 TB372938.[MT7]-SESAQSK[MT7].2y5_1.heavy 512.779 / 664.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100509582;LOC100510495;LOC100510519;LOC100510687;HLA-DRB1;HLA-DRB3;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 4 83 11 A20140416_SF113_02 A20140416_SF113_02 TB372938.[MT7]-SESAQSK[MT7].2y3_1.heavy 512.779 / 506.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100509582;LOC100510495;LOC100510519;LOC100510687;HLA-DRB1;HLA-DRB3;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 4 85 11 A20140416_SF113_02 A20140416_SF113_02 TB372938.[MT7]-SESAQSK[MT7].2y6_1.heavy 512.779 / 793.417 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100509582;LOC100510495;LOC100510519;LOC100510687;HLA-DRB1;HLA-DRB3;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 4 87 11 A20140416_SF113_02 A20140416_SF113_02 TB372938.[MT7]-SESAQSK[MT7].2b5_1.heavy 512.779 / 647.312 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100509582;LOC100510495;LOC100510519;LOC100510687;HLA-DRB1;HLA-DRB3;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 4 89 12 A20140416_SF113_02 A20140416_SF113_02 TB235843.[MT7]-LFGGDMEK[MT7].2y3_1.heavy 592.815 / 551.298 11183.0 29.9060001373291 42 16 10 6 10 1.8865000437041701 41.23680190335068 0.039798736572265625 3 0.9647787801992816 6.556576958519102 11183.0 2.7351909953589404 4.0 - - - - - - - 1675.6666666666667 22 3 ARHGAP4 Rho GTPase activating protein 4 91 12 A20140416_SF113_02 A20140416_SF113_02 TB235843.[MT7]-LFGGDMEK[MT7].2y6_1.heavy 592.815 / 780.368 8670.0 29.9060001373291 42 16 10 6 10 1.8865000437041701 41.23680190335068 0.039798736572265625 3 0.9647787801992816 6.556576958519102 8670.0 5.639699662524649 1.0 - - - - - - - 314.0 17 4 ARHGAP4 Rho GTPase activating protein 4 93 12 A20140416_SF113_02 A20140416_SF113_02 TB235843.[MT7]-LFGGDMEK[MT7].2b5_1.heavy 592.815 / 634.332 13948.0 29.9060001373291 42 16 10 6 10 1.8865000437041701 41.23680190335068 0.039798736572265625 3 0.9647787801992816 6.556576958519102 13948.0 9.097713913162188 0.0 - - - - - - - 377.0 27 1 ARHGAP4 Rho GTPase activating protein 4 95 12 A20140416_SF113_02 A20140416_SF113_02 TB235843.[MT7]-LFGGDMEK[MT7].2y7_1.heavy 592.815 / 927.436 30031.0 29.9060001373291 42 16 10 6 10 1.8865000437041701 41.23680190335068 0.039798736572265625 3 0.9647787801992816 6.556576958519102 30031.0 42.904911680859385 1.0 - - - - - - - 282.5 90 8 ARHGAP4 Rho GTPase activating protein 4 97 13 A20140416_SF113_02 A20140416_SF113_02 TB373571.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].3y7_1.heavy 860.111 / 965.529 6225.0 36.83209991455078 41 11 10 10 10 1.3095844062130642 45.27136492243676 0.0 3 0.8571301529233405 3.2253765106660426 6225.0 8.87827868852459 0.0 - - - - - - - 292.8 12 15 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 99 13 A20140416_SF113_02 A20140416_SF113_02 TB373571.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].3b4_1.heavy 860.111 / 609.336 7079.0 36.83209991455078 41 11 10 10 10 1.3095844062130642 45.27136492243676 0.0 3 0.8571301529233405 3.2253765106660426 7079.0 11.987471637061802 0.0 - - - - - - - 686.25 14 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 101 13 A20140416_SF113_02 A20140416_SF113_02 TB373571.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].3y9_2.heavy 860.111 / 591.305 10252.0 36.83209991455078 41 11 10 10 10 1.3095844062130642 45.27136492243676 0.0 3 0.8571301529233405 3.2253765106660426 10252.0 14.877459995523973 1.0 - - - - - - - 1168.0 20 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 103 13 A20140416_SF113_02 A20140416_SF113_02 TB373571.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].3y9_1.heavy 860.111 / 1181.6 9032.0 36.83209991455078 41 11 10 10 10 1.3095844062130642 45.27136492243676 0.0 3 0.8571301529233405 3.2253765106660426 9032.0 40.12577049180327 0.0 - - - - - - - 215.84615384615384 18 13 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 105 14 A20140416_SF113_02 A20140416_SF113_02 TB495192.[MT7]-LQEYLSGR.2b3_1.heavy 555.307 / 515.295 34832.0 29.80660057067871 50 20 10 10 10 14.199028084736774 7.042735559308799 0.0 3 0.9983211147338654 30.115569567840982 34832.0 19.459716096960157 0.0 - - - - - - - 1194.5 69 2 ARHGAP4 Rho GTPase activating protein 4 107 14 A20140416_SF113_02 A20140416_SF113_02 TB495192.[MT7]-LQEYLSGR.2y5_1.heavy 555.307 / 595.32 35335.0 29.80660057067871 50 20 10 10 10 14.199028084736774 7.042735559308799 0.0 3 0.9983211147338654 30.115569567840982 35335.0 40.81018302762725 0.0 - - - - - - - 1634.5714285714287 70 7 ARHGAP4 Rho GTPase activating protein 4 109 14 A20140416_SF113_02 A20140416_SF113_02 TB495192.[MT7]-LQEYLSGR.2y6_1.heavy 555.307 / 724.362 35084.0 29.80660057067871 50 20 10 10 10 14.199028084736774 7.042735559308799 0.0 3 0.9983211147338654 30.115569567840982 35084.0 27.787947503550022 0.0 - - - - - - - 377.0 70 1 ARHGAP4 Rho GTPase activating protein 4 111 14 A20140416_SF113_02 A20140416_SF113_02 TB495192.[MT7]-LQEYLSGR.2y7_1.heavy 555.307 / 852.421 81988.0 29.80660057067871 50 20 10 10 10 14.199028084736774 7.042735559308799 0.0 3 0.9983211147338654 30.115569567840982 81988.0 91.82303839436268 0.0 - - - - - - - 646.5714285714286 163 7 ARHGAP4 Rho GTPase activating protein 4 113 15 A20140416_SF113_02 A20140416_SF113_02 TB372870.[MT7]-C[CAM]LDTER.2y4_1.heavy 469.23 / 520.236 8959.0 19.3152494430542 41 15 10 6 10 2.367080857695859 42.24612761954445 0.03669929504394531 3 0.95573500560207 5.844091376242461 8959.0 12.694478723404256 0.0 - - - - - - - 1196.875 17 8 DEFB125 defensin, beta 125 115 15 A20140416_SF113_02 A20140416_SF113_02 TB372870.[MT7]-C[CAM]LDTER.2b3_1.heavy 469.23 / 533.251 41989.0 19.3152494430542 41 15 10 6 10 2.367080857695859 42.24612761954445 0.03669929504394531 3 0.95573500560207 5.844091376242461 41989.0 22.19428140165547 0.0 - - - - - - - 957.0 83 2 DEFB125 defensin, beta 125 117 15 A20140416_SF113_02 A20140416_SF113_02 TB372870.[MT7]-C[CAM]LDTER.2y5_1.heavy 469.23 / 633.32 19969.0 19.3152494430542 41 15 10 6 10 2.367080857695859 42.24612761954445 0.03669929504394531 3 0.95573500560207 5.844091376242461 19969.0 28.91799416884056 0.0 - - - - - - - 717.9166666666666 39 12 DEFB125 defensin, beta 125 119 15 A20140416_SF113_02 A20140416_SF113_02 TB372870.[MT7]-C[CAM]LDTER.2b5_1.heavy 469.23 / 763.341 12720.0 19.3152494430542 41 15 10 6 10 2.367080857695859 42.24612761954445 0.03669929504394531 3 0.95573500560207 5.844091376242461 12720.0 19.894082261601376 0.0 - - - - - - - 668.4444444444445 25 9 DEFB125 defensin, beta 125 121 16 A20140416_SF113_02 A20140416_SF113_02 TB372871.[MT7]-DFLEDR.2b3_1.heavy 469.739 / 520.289 31485.0 27.747400283813477 45 15 10 10 10 2.834981974378303 35.27359288481172 0.0 3 0.9516804254451171 5.591603578423221 31485.0 12.507152164156501 0.0 - - - - - - - 1249.5 62 2 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 123 16 A20140416_SF113_02 A20140416_SF113_02 TB372871.[MT7]-DFLEDR.2y4_1.heavy 469.739 / 532.273 22989.0 27.747400283813477 45 15 10 10 10 2.834981974378303 35.27359288481172 0.0 3 0.9516804254451171 5.591603578423221 22989.0 5.745418721272403 1.0 - - - - - - - 1999.0 142 1 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 125 16 A20140416_SF113_02 A20140416_SF113_02 TB372871.[MT7]-DFLEDR.2y5_1.heavy 469.739 / 679.341 76838.0 27.747400283813477 45 15 10 10 10 2.834981974378303 35.27359288481172 0.0 3 0.9516804254451171 5.591603578423221 76838.0 99.10741669714113 0.0 - - - - - - - 656.25 153 4 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 127 16 A20140416_SF113_02 A20140416_SF113_02 TB372871.[MT7]-DFLEDR.2b5_1.heavy 469.739 / 764.358 43229.0 27.747400283813477 45 15 10 10 10 2.834981974378303 35.27359288481172 0.0 3 0.9516804254451171 5.591603578423221 43229.0 35.401861897697614 0.0 - - - - - - - 687.5 86 10 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 129 17 A20140416_SF113_02 A20140416_SF113_02 TB373177.[MT7]-YITLPAGTEK[MT7].2b3_1.heavy 690.902 / 522.304 10433.0 29.925899505615234 46 18 10 10 8 1.0960608411288084 52.41491910926702 0.0 4 0.9831754023968727 9.50121700543954 10433.0 18.327332350678063 0.0 - - - - - - - 729.2 20 10 ARHGAP4 Rho GTPase activating protein 4 131 17 A20140416_SF113_02 A20140416_SF113_02 TB373177.[MT7]-YITLPAGTEK[MT7].2y4_1.heavy 690.902 / 578.327 4902.0 29.925899505615234 46 18 10 10 8 1.0960608411288084 52.41491910926702 0.0 4 0.9831754023968727 9.50121700543954 4902.0 1.5361275970895065 3.0 - - - - - - - 251.0 11 1 ARHGAP4 Rho GTPase activating protein 4 133 17 A20140416_SF113_02 A20140416_SF113_02 TB373177.[MT7]-YITLPAGTEK[MT7].2y5_1.heavy 690.902 / 649.364 3143.0 29.925899505615234 46 18 10 10 8 1.0960608411288084 52.41491910926702 0.0 4 0.9831754023968727 9.50121700543954 3143.0 1.269620563035496 11.0 - - - - - - - 251.5 29 2 ARHGAP4 Rho GTPase activating protein 4 135 17 A20140416_SF113_02 A20140416_SF113_02 TB373177.[MT7]-YITLPAGTEK[MT7].2y6_1.heavy 690.902 / 746.417 41859.0 29.925899505615234 46 18 10 10 8 1.0960608411288084 52.41491910926702 0.0 4 0.9831754023968727 9.50121700543954 41859.0 68.83973474801061 0.0 - - - - - - - 644.375 83 8 ARHGAP4 Rho GTPase activating protein 4 137 18 A20140416_SF113_02 A20140416_SF113_02 TB373015.[MT7]-SWDIFFR.2y4_1.heavy 557.794 / 582.34 41738.0 39.516998291015625 50 20 10 10 10 5.888776731353595 16.981455497806586 0.0 3 0.9928928828036258 14.630463341720414 41738.0 75.78742105263157 0.0 - - - - - - - 684.0 83 8 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 139 18 A20140416_SF113_02 A20140416_SF113_02 TB373015.[MT7]-SWDIFFR.2b3_1.heavy 557.794 / 533.248 50405.0 39.516998291015625 50 20 10 10 10 5.888776731353595 16.981455497806586 0.0 3 0.9928928828036258 14.630463341720414 50405.0 111.48474310776942 0.0 - - - - - - - 760.0 100 9 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 141 18 A20140416_SF113_02 A20140416_SF113_02 TB373015.[MT7]-SWDIFFR.2b4_1.heavy 557.794 / 646.332 14939.0 39.516998291015625 50 20 10 10 10 5.888776731353595 16.981455497806586 0.0 3 0.9928928828036258 14.630463341720414 14939.0 48.22414035087719 0.0 - - - - - - - 294.5 29 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 143 18 A20140416_SF113_02 A20140416_SF113_02 TB373015.[MT7]-SWDIFFR.2y6_1.heavy 557.794 / 883.446 20413.0 39.516998291015625 50 20 10 10 10 5.888776731353595 16.981455497806586 0.0 3 0.9928928828036258 14.630463341720414 20413.0 134.59448830409355 0.0 - - - - - - - 212.8 40 15 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 145 19 A20140416_SF113_02 A20140416_SF113_02 TB236338.[MT7]-NFPVTDAMVASVLGPGTSLQAELEK[MT7].4y5_1.heavy 716.384 / 733.421 15889.0 42.18280029296875 42 12 10 10 10 1.6655451438902422 54.63180051776941 0.0 3 0.8871515372353355 3.6386744308904997 15889.0 26.232251314941294 0.0 - - - - - - - 273.6 31 5 ALOX15B arachidonate 15-lipoxygenase, type B 147 19 A20140416_SF113_02 A20140416_SF113_02 TB236338.[MT7]-NFPVTDAMVASVLGPGTSLQAELEK[MT7].4b8_1.heavy 716.384 / 1020.49 14100.0 42.18280029296875 42 12 10 10 10 1.6655451438902422 54.63180051776941 0.0 3 0.8871515372353355 3.6386744308904997 14100.0 26.49573711339471 1.0 - - - - - - - 285.57142857142856 31 7 ALOX15B arachidonate 15-lipoxygenase, type B 149 19 A20140416_SF113_02 A20140416_SF113_02 TB236338.[MT7]-NFPVTDAMVASVLGPGTSLQAELEK[MT7].4b7_1.heavy 716.384 / 889.454 15994.0 42.18280029296875 42 12 10 10 10 1.6655451438902422 54.63180051776941 0.0 3 0.8871515372353355 3.6386744308904997 15994.0 59.90148288973384 0.0 - - - - - - - 298.1666666666667 31 6 ALOX15B arachidonate 15-lipoxygenase, type B 151 19 A20140416_SF113_02 A20140416_SF113_02 TB236338.[MT7]-NFPVTDAMVASVLGPGTSLQAELEK[MT7].4b6_1.heavy 716.384 / 818.417 6734.0 42.18280029296875 42 12 10 10 10 1.6655451438902422 54.63180051776941 0.0 3 0.8871515372353355 3.6386744308904997 6734.0 2.6247791376003224 1.0 - - - - - - - 210.14285714285714 13 7 ALOX15B arachidonate 15-lipoxygenase, type B 153 20 A20140416_SF113_02 A20140416_SF113_02 TB373022.[MT7]-SQLVYQSR.2y4_1.heavy 562.813 / 553.273 N/A 22.78260040283203 48 18 10 10 10 4.261853844269436 23.46396747848633 0.0 3 0.986100310928973 10.455757297301291 48873.0 20.08634497089176 0.0 - - - - - - - 2352.0 97 2 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 155 20 A20140416_SF113_02 A20140416_SF113_02 TB373022.[MT7]-SQLVYQSR.2y5_1.heavy 562.813 / 652.341 34762.0 22.78260040283203 48 18 10 10 10 4.261853844269436 23.46396747848633 0.0 3 0.986100310928973 10.455757297301291 34762.0 54.98303267973857 0.0 - - - - - - - 280.3333333333333 69 9 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 157 20 A20140416_SF113_02 A20140416_SF113_02 TB373022.[MT7]-SQLVYQSR.2y6_1.heavy 562.813 / 765.425 29370.0 22.78260040283203 48 18 10 10 10 4.261853844269436 23.46396747848633 0.0 3 0.986100310928973 10.455757297301291 29370.0 40.669657693585904 0.0 - - - - - - - 267.55555555555554 58 9 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 159 20 A20140416_SF113_02 A20140416_SF113_02 TB373022.[MT7]-SQLVYQSR.2y7_1.heavy 562.813 / 893.484 29485.0 22.78260040283203 48 18 10 10 10 4.261853844269436 23.46396747848633 0.0 3 0.986100310928973 10.455757297301291 29485.0 138.81082959669655 0.0 - - - - - - - 215.0625 58 16 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 161 21 A20140416_SF113_02 A20140416_SF113_02 TB373021.[MT7]-THLAPGVER.3y6_1.heavy 375.216 / 628.341 26785.0 20.317100524902344 43 13 10 10 10 0.88806706075406 71.8725406241589 0.0 3 0.9083840903011918 4.045797012261189 26785.0 51.19457186544343 0.0 - - - - - - - 705.0833333333334 53 12 PLA2G4F phospholipase A2, group IVF 163 21 A20140416_SF113_02 A20140416_SF113_02 TB373021.[MT7]-THLAPGVER.3y4_1.heavy 375.216 / 460.251 187931.0 20.317100524902344 43 13 10 10 10 0.88806706075406 71.8725406241589 0.0 3 0.9083840903011918 4.045797012261189 187931.0 54.441208902296296 0.0 - - - - - - - 2414.0 375 3 PLA2G4F phospholipase A2, group IVF 165 21 A20140416_SF113_02 A20140416_SF113_02 TB373021.[MT7]-THLAPGVER.3y5_1.heavy 375.216 / 557.304 379788.0 20.317100524902344 43 13 10 10 10 0.88806706075406 71.8725406241589 0.0 3 0.9083840903011918 4.045797012261189 379788.0 148.83323981693803 0.0 - - - - - - - 261.6666666666667 759 3 PLA2G4F phospholipase A2, group IVF 167 21 A20140416_SF113_02 A20140416_SF113_02 TB373021.[MT7]-THLAPGVER.3y5_2.heavy 375.216 / 279.156 256246.0 20.317100524902344 43 13 10 10 10 0.88806706075406 71.8725406241589 0.0 3 0.9083840903011918 4.045797012261189 256246.0 259.2820129813313 0.0 - - - - - - - 1315.9166666666667 512 12 PLA2G4F phospholipase A2, group IVF 169 22 A20140416_SF113_02 A20140416_SF113_02 TB373184.[MT7]-RAEVELEYSR.3b5_1.heavy 465.916 / 729.401 87956.0 24.520200729370117 43 13 10 10 10 2.6941931493569338 37.1168637348323 0.0 3 0.9003877172675927 3.877333247200662 87956.0 78.51674618723725 0.0 - - - - - - - 382.0 175 1 ARHGAP4 Rho GTPase activating protein 4 171 22 A20140416_SF113_02 A20140416_SF113_02 TB373184.[MT7]-RAEVELEYSR.3b3_1.heavy 465.916 / 501.29 45253.0 24.520200729370117 43 13 10 10 10 2.6941931493569338 37.1168637348323 0.0 3 0.9003877172675927 3.877333247200662 45253.0 16.471145453824104 0.0 - - - - - - - 2040.0 90 1 ARHGAP4 Rho GTPase activating protein 4 173 22 A20140416_SF113_02 A20140416_SF113_02 TB373184.[MT7]-RAEVELEYSR.3y4_1.heavy 465.916 / 554.257 178844.0 24.520200729370117 43 13 10 10 10 2.6941931493569338 37.1168637348323 0.0 3 0.9003877172675927 3.877333247200662 178844.0 116.9480988746412 0.0 - - - - - - - 1402.0 357 1 ARHGAP4 Rho GTPase activating protein 4 175 22 A20140416_SF113_02 A20140416_SF113_02 TB373184.[MT7]-RAEVELEYSR.3y5_1.heavy 465.916 / 667.341 82857.0 24.520200729370117 43 13 10 10 10 2.6941931493569338 37.1168637348323 0.0 3 0.9003877172675927 3.877333247200662 82857.0 125.39737468246408 0.0 - - - - - - - 318.5 165 2 ARHGAP4 Rho GTPase activating protein 4 177 23 A20140416_SF113_02 A20140416_SF113_02 TB373433.[MT7]-SEWGSLLEELVAEGK[MT7].3b6_1.heavy 645.682 / 804.401 26091.0 42.659400939941406 41 11 10 10 10 2.005148631446292 49.87161471809254 0.0 3 0.873669923253765 3.43500374330797 26091.0 158.80622762148337 0.0 - - - - - - - 263.8 52 10 PFKL phosphofructokinase, liver 179 23 A20140416_SF113_02 A20140416_SF113_02 TB373433.[MT7]-SEWGSLLEELVAEGK[MT7].3b5_1.heavy 645.682 / 691.317 14853.0 42.659400939941406 41 11 10 10 10 2.005148631446292 49.87161471809254 0.0 3 0.873669923253765 3.43500374330797 14853.0 39.96603328341626 0.0 - - - - - - - 330.7692307692308 29 13 PFKL phosphofructokinase, liver 181 23 A20140416_SF113_02 A20140416_SF113_02 TB373433.[MT7]-SEWGSLLEELVAEGK[MT7].3y4_1.heavy 645.682 / 548.316 79249.0 42.659400939941406 41 11 10 10 10 2.005148631446292 49.87161471809254 0.0 3 0.873669923253765 3.43500374330797 79249.0 160.80335930982176 0.0 - - - - - - - 349.14285714285717 158 7 PFKL phosphofructokinase, liver 183 23 A20140416_SF113_02 A20140416_SF113_02 TB373433.[MT7]-SEWGSLLEELVAEGK[MT7].3b7_1.heavy 645.682 / 917.485 13680.0 42.659400939941406 41 11 10 10 10 2.005148631446292 49.87161471809254 0.0 3 0.873669923253765 3.43500374330797 13680.0 46.51135074017462 0.0 - - - - - - - 278.0769230769231 27 13 PFKL phosphofructokinase, liver 185 24 A20140416_SF113_02 A20140416_SF113_02 TB235955.[MT7]-DLIYFGSEK[MT7].2y4_1.heavy 680.374 / 564.311 11984.0 33.09322643280029 40 14 10 6 10 1.648944740228916 42.09359625269295 0.039699554443359375 3 0.936703298781188 4.879260333878719 11984.0 6.098071596574348 2.0 - - - - - - - 382.0 23 1 FBXL5 F-box and leucine-rich repeat protein 5 187 24 A20140416_SF113_02 A20140416_SF113_02 TB235955.[MT7]-DLIYFGSEK[MT7].2y5_1.heavy 680.374 / 711.379 9434.0 33.09322643280029 40 14 10 6 10 1.648944740228916 42.09359625269295 0.039699554443359375 3 0.936703298781188 4.879260333878719 9434.0 2.3999558341479093 1.0 - - - - - - - 739.2 21 5 FBXL5 F-box and leucine-rich repeat protein 5 189 24 A20140416_SF113_02 A20140416_SF113_02 TB235955.[MT7]-DLIYFGSEK[MT7].2y3_1.heavy 680.374 / 507.289 3570.0 33.09322643280029 40 14 10 6 10 1.648944740228916 42.09359625269295 0.039699554443359375 3 0.936703298781188 4.879260333878719 3570.0 0.33714450624409686 5.0 - - - - - - - 1183.5714285714287 11 7 FBXL5 F-box and leucine-rich repeat protein 5 191 24 A20140416_SF113_02 A20140416_SF113_02 TB235955.[MT7]-DLIYFGSEK[MT7].2y6_1.heavy 680.374 / 874.443 17975.0 33.09322643280029 40 14 10 6 10 1.648944740228916 42.09359625269295 0.039699554443359375 3 0.936703298781188 4.879260333878719 17975.0 26.21290359891897 0.0 - - - - - - - 623.2222222222222 35 9 FBXL5 F-box and leucine-rich repeat protein 5 193 25 A20140416_SF113_02 A20140416_SF113_02 TB372927.[MT7]-RLDAAYR.2y6_1.heavy 504.789 / 708.367 3406.0 20.823549270629883 26 12 6 6 2 1.5589348844859396 50.14402009123232 0.038299560546875 12 0.8873857404035256 3.642530302724633 3406.0 6.728235117387012 0.0 - - - - - - - 713.5 6 8 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 195 25 A20140416_SF113_02 A20140416_SF113_02 TB372927.[MT7]-RLDAAYR.2b3_1.heavy 504.789 / 529.321 6352.0 20.823549270629883 26 12 6 6 2 1.5589348844859396 50.14402009123232 0.038299560546875 12 0.8873857404035256 3.642530302724633 6352.0 12.404752438114551 0.0 - - - - - - - 726.3333333333334 12 9 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 197 25 A20140416_SF113_02 A20140416_SF113_02 TB372927.[MT7]-RLDAAYR.2b5_1.heavy 504.789 / 671.396 1473.0 20.823549270629883 26 12 6 6 2 1.5589348844859396 50.14402009123232 0.038299560546875 12 0.8873857404035256 3.642530302724633 1473.0 5.335025174385063 6.0 - - - - - - - 316.25 18 16 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 199 25 A20140416_SF113_02 A20140416_SF113_02 TB372927.[MT7]-RLDAAYR.2b4_1.heavy 504.789 / 600.359 1565.0 20.823549270629883 26 12 6 6 2 1.5589348844859396 50.14402009123232 0.038299560546875 12 0.8873857404035256 3.642530302724633 1565.0 4.292647926376025 17.0 - - - - - - - 329.6666666666667 4 12 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 201 26 A20140416_SF113_02 A20140416_SF113_02 TB373587.[MT7]-GDWYSGPATELDTEPDDEWVK[MT7].3y7_1.heavy 900.085 / 1032.51 22755.0 35.54609966278076 42 17 10 5 10 7.619794567025742 13.123713391532196 0.043598175048828125 3 0.9722148907930275 7.386616931078708 22755.0 19.708297305202343 0.0 - - - - - - - 811.1111111111111 45 9 FBXL5 F-box and leucine-rich repeat protein 5 203 26 A20140416_SF113_02 A20140416_SF113_02 TB373587.[MT7]-GDWYSGPATELDTEPDDEWVK[MT7].3b4_1.heavy 900.085 / 666.3 9491.0 35.54609966278076 42 17 10 5 10 7.619794567025742 13.123713391532196 0.043598175048828125 3 0.9722148907930275 7.386616931078708 9491.0 18.43575539568345 0.0 - - - - - - - 780.5833333333334 18 12 FBXL5 F-box and leucine-rich repeat protein 5 205 26 A20140416_SF113_02 A20140416_SF113_02 TB373587.[MT7]-GDWYSGPATELDTEPDDEWVK[MT7].3b5_1.heavy 900.085 / 753.332 5354.0 35.54609966278076 42 17 10 5 10 7.619794567025742 13.123713391532196 0.043598175048828125 3 0.9722148907930275 7.386616931078708 5354.0 10.41366589750228 0.0 - - - - - - - 324.55555555555554 10 9 FBXL5 F-box and leucine-rich repeat protein 5 207 26 A20140416_SF113_02 A20140416_SF113_02 TB373587.[MT7]-GDWYSGPATELDTEPDDEWVK[MT7].3b3_1.heavy 900.085 / 503.237 4746.0 35.54609966278076 42 17 10 5 10 7.619794567025742 13.123713391532196 0.043598175048828125 3 0.9722148907930275 7.386616931078708 4746.0 1.9766616878267365 1.0 - - - - - - - 446.3333333333333 12 3 FBXL5 F-box and leucine-rich repeat protein 5 209 27 A20140416_SF113_02 A20140416_SF113_02 TB495385.[MT7]-GLGELQELYLK[MT7].2b4_1.heavy 775.955 / 501.279 23364.0 36.47679901123047 48 18 10 10 10 5.82307581812824 17.173054777800203 0.0 3 0.9871529882977301 10.87665271673109 23364.0 31.81550688643035 0.0 - - - - - - - 853.0 46 10 GP1BA glycoprotein Ib (platelet), alpha polypeptide 211 27 A20140416_SF113_02 A20140416_SF113_02 TB495385.[MT7]-GLGELQELYLK[MT7].2y3_1.heavy 775.955 / 567.362 14711.0 36.47679901123047 48 18 10 10 10 5.82307581812824 17.173054777800203 0.0 3 0.9871529882977301 10.87665271673109 14711.0 11.439527725889322 0.0 - - - - - - - 401.5 29 4 GP1BA glycoprotein Ib (platelet), alpha polypeptide 213 27 A20140416_SF113_02 A20140416_SF113_02 TB495385.[MT7]-GLGELQELYLK[MT7].2b7_1.heavy 775.955 / 871.464 9890.0 36.47679901123047 48 18 10 10 10 5.82307581812824 17.173054777800203 0.0 3 0.9871529882977301 10.87665271673109 9890.0 21.48599205216067 0.0 - - - - - - - 284.5 19 10 GP1BA glycoprotein Ib (platelet), alpha polypeptide 215 27 A20140416_SF113_02 A20140416_SF113_02 TB495385.[MT7]-GLGELQELYLK[MT7].2b5_1.heavy 775.955 / 614.363 12238.0 36.47679901123047 48 18 10 10 10 5.82307581812824 17.173054777800203 0.0 3 0.9871529882977301 10.87665271673109 12238.0 12.51535125788 0.0 - - - - - - - 1298.0 24 12 GP1BA glycoprotein Ib (platelet), alpha polypeptide 217 28 A20140416_SF113_02 A20140416_SF113_02 TB235950.[MT7]-VAFPDTK[MT7]K[MT7].3y3_1.heavy 446.61 / 664.46 21115.0 24.692899703979492 39 9 10 10 10 0.6587694322644814 79.66794296086557 0.0 3 0.8180510649233177 2.848205276639929 21115.0 12.955834959644399 1.0 - - - - - - - 389.0 55 1 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 219 28 A20140416_SF113_02 A20140416_SF113_02 TB235950.[MT7]-VAFPDTK[MT7]K[MT7].3b5_1.heavy 446.61 / 674.363 123194.0 24.692899703979492 39 9 10 10 10 0.6587694322644814 79.66794296086557 0.0 3 0.8180510649233177 2.848205276639929 123194.0 105.39686324105804 0.0 - - - - - - - 1202.7142857142858 246 7 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 221 28 A20140416_SF113_02 A20140416_SF113_02 TB235950.[MT7]-VAFPDTK[MT7]K[MT7].3b3_1.heavy 446.61 / 462.283 108556.0 24.692899703979492 39 9 10 10 10 0.6587694322644814 79.66794296086557 0.0 3 0.8180510649233177 2.848205276639929 108556.0 44.55559895643751 0.0 - - - - - - - 1425.0 217 1 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 223 28 A20140416_SF113_02 A20140416_SF113_02 TB235950.[MT7]-VAFPDTK[MT7]K[MT7].3y5_1.heavy 446.61 / 876.539 40288.0 24.692899703979492 39 9 10 10 10 0.6587694322644814 79.66794296086557 0.0 3 0.8180510649233177 2.848205276639929 40288.0 203.7348739215406 0.0 - - - - - - - 162.25 80 8 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 225 29 A20140416_SF113_02 A20140416_SF113_02 TB495388.[MT7]-EILVTGTC[CAM]HLK[MT7].3y3_1.heavy 520.3 / 541.358 21023.0 27.333599090576172 42 12 10 10 10 1.0060255263658662 58.70330973635872 0.0 3 0.8884387568560461 3.6600156830492994 21023.0 9.98788749006178 0.0 - - - - - - - 1259.0 42 1 SRRD SRR1 domain containing 227 29 A20140416_SF113_02 A20140416_SF113_02 TB495388.[MT7]-EILVTGTC[CAM]HLK[MT7].3b6_1.heavy 520.3 / 757.458 11833.0 27.333599090576172 42 12 10 10 10 1.0060255263658662 58.70330973635872 0.0 3 0.8884387568560461 3.6600156830492994 11833.0 1.9446179129005752 2.0 - - - - - - - 755.1666666666666 23 6 SRRD SRR1 domain containing 229 29 A20140416_SF113_02 A20140416_SF113_02 TB495388.[MT7]-EILVTGTC[CAM]HLK[MT7].3y4_1.heavy 520.3 / 701.388 7679.0 27.333599090576172 42 12 10 10 10 1.0060255263658662 58.70330973635872 0.0 3 0.8884387568560461 3.6600156830492994 7679.0 6.634629221262084 0.0 - - - - - - - 1223.0 15 7 SRRD SRR1 domain containing 231 29 A20140416_SF113_02 A20140416_SF113_02 TB495388.[MT7]-EILVTGTC[CAM]HLK[MT7].3b3_1.heavy 520.3 / 500.32 N/A 27.333599090576172 42 12 10 10 10 1.0060255263658662 58.70330973635872 0.0 3 0.8884387568560461 3.6600156830492994 31345.0 9.058138448005412 0.0 - - - - - - - 3147.0 62 1 SRRD SRR1 domain containing 233 30 A20140416_SF113_02 A20140416_SF113_02 TB235656.[MT7]-LLESAK[MT7].2b3_1.heavy 474.802 / 500.32 17566.0 25.12980079650879 48 18 10 10 10 3.589632243509127 27.85800695344844 0.0 3 0.9879919733634221 11.250996862513825 17566.0 7.595246260487832 0.0 - - - - - - - 1292.0 35 1 TTC39A tetratricopeptide repeat domain 39A 235 30 A20140416_SF113_02 A20140416_SF113_02 TB235656.[MT7]-LLESAK[MT7].2y4_1.heavy 474.802 / 578.327 26220.0 25.12980079650879 48 18 10 10 10 3.589632243509127 27.85800695344844 0.0 3 0.9879919733634221 11.250996862513825 26220.0 5.520184744723127 1.0 - - - - - - - 2647.5 52 2 TTC39A tetratricopeptide repeat domain 39A 237 30 A20140416_SF113_02 A20140416_SF113_02 TB235656.[MT7]-LLESAK[MT7].2y5_1.heavy 474.802 / 691.411 46240.0 25.12980079650879 48 18 10 10 10 3.589632243509127 27.85800695344844 0.0 3 0.9879919733634221 11.250996862513825 46240.0 23.10906610468566 0.0 - - - - - - - 732.0 92 3 TTC39A tetratricopeptide repeat domain 39A 239 30 A20140416_SF113_02 A20140416_SF113_02 TB235656.[MT7]-LLESAK[MT7].2b4_1.heavy 474.802 / 587.352 5812.0 25.12980079650879 48 18 10 10 10 3.589632243509127 27.85800695344844 0.0 3 0.9879919733634221 11.250996862513825 5812.0 4.757511057664306 5.0 - - - - - - - 2306.5714285714284 20 7 TTC39A tetratricopeptide repeat domain 39A 241 31 A20140416_SF113_02 A20140416_SF113_02 TB495188.[MT7]-AAVDTYC[CAM]R.2y4_1.heavy 550.27 / 599.261 124812.0 21.19860076904297 48 18 10 10 10 3.6956552277431385 23.49321694746741 0.0 3 0.9822621653665076 9.252690116823537 124812.0 340.77119396087573 0.0 - - - - - - - 718.7777777777778 249 9 LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 243 31 A20140416_SF113_02 A20140416_SF113_02 TB495188.[MT7]-AAVDTYC[CAM]R.2y5_1.heavy 550.27 / 714.288 64068.0 21.19860076904297 48 18 10 10 10 3.6956552277431385 23.49321694746741 0.0 3 0.9822621653665076 9.252690116823537 64068.0 198.1682237492291 0.0 - - - - - - - 651.5 128 8 LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 245 31 A20140416_SF113_02 A20140416_SF113_02 TB495188.[MT7]-AAVDTYC[CAM]R.2b4_1.heavy 550.27 / 501.279 124632.0 21.19860076904297 48 18 10 10 10 3.6956552277431385 23.49321694746741 0.0 3 0.9822621653665076 9.252690116823537 124632.0 28.023447336451333 0.0 - - - - - - - 2381.0 249 2 LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 247 31 A20140416_SF113_02 A20140416_SF113_02 TB495188.[MT7]-AAVDTYC[CAM]R.2y7_1.heavy 550.27 / 884.393 97855.0 21.19860076904297 48 18 10 10 10 3.6956552277431385 23.49321694746741 0.0 3 0.9822621653665076 9.252690116823537 97855.0 391.13534384800687 0.0 - - - - - - - 325.75 195 8 LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 249 32 A20140416_SF113_02 A20140416_SF113_02 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 3309820.0 28.314800262451172 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 3309820.0 1118.273892913289 0.0 - - - - - - - 497.0 6619 1 251 32 A20140416_SF113_02 A20140416_SF113_02 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 1111430.0 28.314800262451172 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1111430.0 351.6138403871338 0.0 - - - - - - - 828.6666666666666 2222 3 253 32 A20140416_SF113_02 A20140416_SF113_02 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 849417.0 28.314800262451172 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 849417.0 311.8133079103661 0.0 - - - - - - - 1492.0 1698 1 255 33 A20140416_SF113_02 A20140416_SF113_02 TB373027.[MT7]-EAAAEARK[MT7].3y6_1.heavy 378.555 / 789.47 340.0 16.396049976348877 40 14 10 6 10 1.8996085384718329 35.26262526404909 0.03899955749511719 3 0.9476444224331697 5.369917658556123 340.0 5.483870967741935 0.0 - - - - - - - 0.0 0 0 NTHL1 nth endonuclease III-like 1 (E. coli) 257 33 A20140416_SF113_02 A20140416_SF113_02 TB373027.[MT7]-EAAAEARK[MT7].3b4_1.heavy 378.555 / 487.263 75347.0 16.396049976348877 40 14 10 6 10 1.8996085384718329 35.26262526404909 0.03899955749511719 3 0.9476444224331697 5.369917658556123 75347.0 24.210225683118537 0.0 - - - - - - - 1298.0 150 2 NTHL1 nth endonuclease III-like 1 (E. coli) 259 33 A20140416_SF113_02 A20140416_SF113_02 TB373027.[MT7]-EAAAEARK[MT7].3b5_1.heavy 378.555 / 616.306 68703.0 16.396049976348877 40 14 10 6 10 1.8996085384718329 35.26262526404909 0.03899955749511719 3 0.9476444224331697 5.369917658556123 68703.0 84.87495117075956 0.0 - - - - - - - 663.0 137 11 NTHL1 nth endonuclease III-like 1 (E. coli) 261 33 A20140416_SF113_02 A20140416_SF113_02 TB373027.[MT7]-EAAAEARK[MT7].3b3_1.heavy 378.555 / 416.226 56495.0 16.396049976348877 40 14 10 6 10 1.8996085384718329 35.26262526404909 0.03899955749511719 3 0.9476444224331697 5.369917658556123 56495.0 26.017175939640637 1.0 - - - - - - - 1711.25 112 8 NTHL1 nth endonuclease III-like 1 (E. coli) 263 34 A20140416_SF113_02 A20140416_SF113_02 TB372869.[MT7]-TFQQIR.2y4_1.heavy 468.773 / 544.32 40919.0 24.120800018310547 47 17 10 10 10 4.328206573975487 23.104257685221647 0.0 3 0.976860200849569 8.097324508450102 40919.0 18.97734007787815 0.0 - - - - - - - 1657.0 81 1 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 265 34 A20140416_SF113_02 A20140416_SF113_02 TB372869.[MT7]-TFQQIR.2b3_1.heavy 468.773 / 521.284 32888.0 24.120800018310547 47 17 10 10 10 4.328206573975487 23.104257685221647 0.0 3 0.976860200849569 8.097324508450102 32888.0 5.334959961047666 1.0 - - - - - - - 1020.0 67 1 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 267 34 A20140416_SF113_02 A20140416_SF113_02 TB372869.[MT7]-TFQQIR.2y5_1.heavy 468.773 / 691.389 149653.0 24.120800018310547 47 17 10 10 10 4.328206573975487 23.104257685221647 0.0 3 0.976860200849569 8.097324508450102 149653.0 201.70355845969402 0.0 - - - - - - - 255.0 299 2 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 269 34 A20140416_SF113_02 A20140416_SF113_02 TB372869.[MT7]-TFQQIR.2b4_1.heavy 468.773 / 649.343 68580.0 24.120800018310547 47 17 10 10 10 4.328206573975487 23.104257685221647 0.0 3 0.976860200849569 8.097324508450102 68580.0 81.22248240808449 0.0 - - - - - - - 655.5714285714286 137 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 271 35 A20140416_SF113_02 A20140416_SF113_02 TB373024.[MT7]-TIAYENK[MT7].2y4_1.heavy 563.821 / 697.364 26255.0 22.372800827026367 48 18 10 10 10 4.560380558509172 21.927994542782386 0.0 3 0.9898590792100492 12.244920733616627 26255.0 19.03619410826668 0.0 - - - - - - - 1760.5714285714287 52 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 273 35 A20140416_SF113_02 A20140416_SF113_02 TB373024.[MT7]-TIAYENK[MT7].2y5_1.heavy 563.821 / 768.401 26040.0 22.372800827026367 48 18 10 10 10 4.560380558509172 21.927994542782386 0.0 3 0.9898590792100492 12.244920733616627 26040.0 110.26719960465692 0.0 - - - - - - - 290.64285714285717 52 14 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 275 35 A20140416_SF113_02 A20140416_SF113_02 TB373024.[MT7]-TIAYENK[MT7].2y3_1.heavy 563.821 / 534.3 18325.0 22.372800827026367 48 18 10 10 10 4.560380558509172 21.927994542782386 0.0 3 0.9898590792100492 12.244920733616627 18325.0 12.349932029177719 0.0 - - - - - - - 536.0 36 1 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 277 35 A20140416_SF113_02 A20140416_SF113_02 TB373024.[MT7]-TIAYENK[MT7].2y6_1.heavy 563.821 / 881.485 17682.0 22.372800827026367 48 18 10 10 10 4.560380558509172 21.927994542782386 0.0 3 0.9898590792100492 12.244920733616627 17682.0 96.02954034395141 0.0 - - - - - - - 235.4 35 10 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 279 36 A20140416_SF113_02 A20140416_SF113_02 TB236336.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].3b9_1.heavy 943.157 / 1057.58 8293.0 40.67817401885986 36 13 10 3 10 2.3883458027299613 41.86998377106722 0.07670211791992188 3 0.9075097048107291 4.026323818028678 8293.0 15.550930093009299 0.0 - - - - - - - 730.4285714285714 16 7 ARHGAP4 Rho GTPase activating protein 4 281 36 A20140416_SF113_02 A20140416_SF113_02 TB236336.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].3b5_1.heavy 943.157 / 660.343 5566.0 40.67817401885986 36 13 10 3 10 2.3883458027299613 41.86998377106722 0.07670211791992188 3 0.9075097048107291 4.026323818028678 5566.0 8.162487577884692 0.0 - - - - - - - 302.8333333333333 11 6 ARHGAP4 Rho GTPase activating protein 4 283 36 A20140416_SF113_02 A20140416_SF113_02 TB236336.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].3y4_1.heavy 943.157 / 560.316 13518.0 40.67817401885986 36 13 10 3 10 2.3883458027299613 41.86998377106722 0.07670211791992188 3 0.9075097048107291 4.026323818028678 13518.0 14.313228154366957 0.0 - - - - - - - 340.6666666666667 27 6 ARHGAP4 Rho GTPase activating protein 4 285 36 A20140416_SF113_02 A20140416_SF113_02 TB236336.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].3y5_1.heavy 943.157 / 657.369 65207.0 40.67817401885986 36 13 10 3 10 2.3883458027299613 41.86998377106722 0.07670211791992188 3 0.9075097048107291 4.026323818028678 65207.0 44.81749295536251 0.0 - - - - - - - 727.2 130 5 ARHGAP4 Rho GTPase activating protein 4 287 37 A20140416_SF113_02 A20140416_SF113_02 TB235928.[MT7]-ATASALDLLK[MT7].3b4_1.heavy 430.934 / 475.263 52439.0 33.580101013183594 40 14 10 6 10 1.3303530864514141 44.26272312209059 0.03820037841796875 3 0.945105185607758 5.243118789132076 52439.0 39.03679499922495 1.0 - - - - - - - 1134.5 104 8 CAGE1 cancer antigen 1 289 37 A20140416_SF113_02 A20140416_SF113_02 TB235928.[MT7]-ATASALDLLK[MT7].3b5_1.heavy 430.934 / 546.3 112946.0 33.580101013183594 40 14 10 6 10 1.3303530864514141 44.26272312209059 0.03820037841796875 3 0.945105185607758 5.243118789132076 112946.0 184.09700440528633 0.0 - - - - - - - 644.0 225 9 CAGE1 cancer antigen 1 291 37 A20140416_SF113_02 A20140416_SF113_02 TB235928.[MT7]-ATASALDLLK[MT7].3y4_1.heavy 430.934 / 632.41 58490.0 33.580101013183594 40 14 10 6 10 1.3303530864514141 44.26272312209059 0.03820037841796875 3 0.945105185607758 5.243118789132076 58490.0 89.22171626211217 0.0 - - - - - - - 680.4 116 10 CAGE1 cancer antigen 1 293 37 A20140416_SF113_02 A20140416_SF113_02 TB235928.[MT7]-ATASALDLLK[MT7].3b7_1.heavy 430.934 / 774.411 53448.0 33.580101013183594 40 14 10 6 10 1.3303530864514141 44.26272312209059 0.03820037841796875 3 0.945105185607758 5.243118789132076 53448.0 90.10310258023915 0.0 - - - - - - - 270.0 106 7 CAGE1 cancer antigen 1 295 38 A20140416_SF113_02 A20140416_SF113_02 TB373320.[MT7]-TILEMTQILK[MT7]R.3y6_1.heavy 545.335 / 902.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXO25 F-box protein 25 297 38 A20140416_SF113_02 A20140416_SF113_02 TB373320.[MT7]-TILEMTQILK[MT7]R.3b4_1.heavy 545.335 / 601.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXO25 F-box protein 25 299 38 A20140416_SF113_02 A20140416_SF113_02 TB373320.[MT7]-TILEMTQILK[MT7]R.3y4_1.heavy 545.335 / 673.484 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXO25 F-box protein 25 301 38 A20140416_SF113_02 A20140416_SF113_02 TB373320.[MT7]-TILEMTQILK[MT7]R.3y8_1.heavy 545.335 / 1162.67 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXO25 F-box protein 25 303 39 A20140416_SF113_02 A20140416_SF113_02 TB495590.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].4y9_2.heavy 645.335 / 591.305 87893.0 36.83209991455078 41 11 10 10 10 1.453485932602881 68.800115471996 0.0 3 0.8594858921349968 3.252974857599432 87893.0 84.43567573404538 0.0 - - - - - - - 1746.125 175 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 305 39 A20140416_SF113_02 A20140416_SF113_02 TB495590.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].4y9_1.heavy 645.335 / 1181.6 11744.0 36.83209991455078 41 11 10 10 10 1.453485932602881 68.800115471996 0.0 3 0.8594858921349968 3.252974857599432 11744.0 73.1806898960027 0.0 - - - - - - - 185.625 23 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 307 39 A20140416_SF113_02 A20140416_SF113_02 TB495590.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].4b4_1.heavy 645.335 / 609.336 29669.0 36.83209991455078 41 11 10 10 10 1.453485932602881 68.800115471996 0.0 3 0.8594858921349968 3.252974857599432 29669.0 34.724737416821206 0.0 - - - - - - - 370.6666666666667 59 3 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 309 39 A20140416_SF113_02 A20140416_SF113_02 TB495590.[MT7]-IYTSPTWSAFVTDSSWSARK[MT7].4y7_1.heavy 645.335 / 965.529 8159.0 36.83209991455078 41 11 10 10 10 1.453485932602881 68.800115471996 0.0 3 0.8594858921349968 3.252974857599432 8159.0 30.91956229470628 0.0 - - - - - - - 266.3076923076923 16 13 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 311 40 A20140416_SF113_02 A20140416_SF113_02 TB373325.[MT7]-NVLISVLQAIRK[MT7].3y6_1.heavy 548.025 / 872.58 9769.0 41.02040100097656 50 20 10 10 10 48.92454259425475 2.043963922756083 0.0 3 0.9998800966905339 112.7048084111626 9769.0 90.16049552552751 0.0 - - - - - - - 217.3 19 10 CYFIP2 cytoplasmic FMR1 interacting protein 2 313 40 A20140416_SF113_02 A20140416_SF113_02 TB373325.[MT7]-NVLISVLQAIRK[MT7].3y8_1.heavy 548.025 / 1058.68 19430.0 41.02040100097656 50 20 10 10 10 48.92454259425475 2.043963922756083 0.0 3 0.9998800966905339 112.7048084111626 19430.0 178.42092080824 0.0 - - - - - - - 145.16666666666666 38 6 CYFIP2 cytoplasmic FMR1 interacting protein 2 315 40 A20140416_SF113_02 A20140416_SF113_02 TB373325.[MT7]-NVLISVLQAIRK[MT7].3y5_1.heavy 548.025 / 759.496 8358.0 41.02040100097656 50 20 10 10 10 48.92454259425475 2.043963922756083 0.0 3 0.9998800966905339 112.7048084111626 8358.0 52.95967741935483 0.0 - - - - - - - 262.5 16 12 CYFIP2 cytoplasmic FMR1 interacting protein 2 317 40 A20140416_SF113_02 A20140416_SF113_02 TB373325.[MT7]-NVLISVLQAIRK[MT7].3y9_1.heavy 548.025 / 1171.76 N/A 41.02040100097656 50 20 10 10 10 48.92454259425475 2.043963922756083 0.0 3 0.9998800966905339 112.7048084111626 0.0 0.0 4.0 - - - - - - - 0.0 0 0 CYFIP2 cytoplasmic FMR1 interacting protein 2 319 41 A20140416_SF113_02 A20140416_SF113_02 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 1836720.0 17.487199783325195 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1836720.0 3001.3081445913976 0.0 - - - - - - - 361.3333333333333 3673 3 321 41 A20140416_SF113_02 A20140416_SF113_02 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 3668810.0 17.487199783325195 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 3668810.0 8457.375713974145 0.0 - - - - - - - 299.0 7337 3 323 41 A20140416_SF113_02 A20140416_SF113_02 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 1334280.0 17.487199783325195 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1334280.0 1932.5079688642998 0.0 - - - - - - - 299.0 2668 1 325 42 A20140416_SF113_02 A20140416_SF113_02 TB373423.[MT7]-YQVLLSLMLSSQTK[MT7].3b4_1.heavy 633.7 / 648.384 11583.0 42.142601013183594 40 10 10 10 10 0.6811319294432967 75.5136443342167 0.0 3 0.8365683672884808 3.0101896941979436 11583.0 12.853843969959946 1.0 - - - - - - - 699.0 23 7 NTHL1 nth endonuclease III-like 1 (E. coli) 327 42 A20140416_SF113_02 A20140416_SF113_02 TB373423.[MT7]-YQVLLSLMLSSQTK[MT7].3b5_1.heavy 633.7 / 761.468 8188.0 42.142601013183594 40 10 10 10 10 0.6811319294432967 75.5136443342167 0.0 3 0.8365683672884808 3.0101896941979436 8188.0 17.398138432915136 0.0 - - - - - - - 262.125 16 8 NTHL1 nth endonuclease III-like 1 (E. coli) 329 42 A20140416_SF113_02 A20140416_SF113_02 TB373423.[MT7]-YQVLLSLMLSSQTK[MT7].3b3_1.heavy 633.7 / 535.3 15278.0 42.142601013183594 40 10 10 10 10 0.6811319294432967 75.5136443342167 0.0 3 0.8365683672884808 3.0101896941979436 15278.0 30.482758145014582 0.0 - - - - - - - 719.0 30 10 NTHL1 nth endonuclease III-like 1 (E. coli) 331 42 A20140416_SF113_02 A20140416_SF113_02 TB373423.[MT7]-YQVLLSLMLSSQTK[MT7].3y5_1.heavy 633.7 / 694.385 23965.0 42.142601013183594 40 10 10 10 10 0.6811319294432967 75.5136443342167 0.0 3 0.8365683672884808 3.0101896941979436 23965.0 35.051270678118755 0.0 - - - - - - - 249.75 47 8 NTHL1 nth endonuclease III-like 1 (E. coli) 333 43 A20140416_SF113_02 A20140416_SF113_02 TB373295.[MT7]-LREAERQEEK[MT7].3y3_1.heavy 525.961 / 549.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 335 43 A20140416_SF113_02 A20140416_SF113_02 TB373295.[MT7]-LREAERQEEK[MT7].3y7_2.heavy 525.961 / 517.273 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 337 43 A20140416_SF113_02 A20140416_SF113_02 TB373295.[MT7]-LREAERQEEK[MT7].3b5_1.heavy 525.961 / 743.417 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 339 43 A20140416_SF113_02 A20140416_SF113_02 TB373295.[MT7]-LREAERQEEK[MT7].3y4_1.heavy 525.961 / 677.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 341 44 A20140416_SF113_02 A20140416_SF113_02 TB235729.[MT7]-FMYFQR.2y4_1.heavy 518.264 / 613.309 11231.0 32.49470138549805 42 17 9 10 6 4.179413158967194 23.926804122115495 0.0 5 0.9795339871783152 8.611965159864276 11231.0 3.6339700127278065 3.0 - - - - - - - 645.0 43 1 CYFIP2 cytoplasmic FMR1 interacting protein 2 343 44 A20140416_SF113_02 A20140416_SF113_02 TB235729.[MT7]-FMYFQR.2b3_1.heavy 518.264 / 586.282 11231.0 32.49470138549805 42 17 9 10 6 4.179413158967194 23.926804122115495 0.0 5 0.9795339871783152 8.611965159864276 11231.0 6.277770391307476 1.0 - - - - - - - 2305.5714285714284 24 7 CYFIP2 cytoplasmic FMR1 interacting protein 2 345 44 A20140416_SF113_02 A20140416_SF113_02 TB235729.[MT7]-FMYFQR.2y5_1.heavy 518.264 / 744.35 18589.0 32.49470138549805 42 17 9 10 6 4.179413158967194 23.926804122115495 0.0 5 0.9795339871783152 8.611965159864276 18589.0 36.78456672033757 0.0 - - - - - - - 682.4285714285714 37 7 CYFIP2 cytoplasmic FMR1 interacting protein 2 347 44 A20140416_SF113_02 A20140416_SF113_02 TB235729.[MT7]-FMYFQR.2b4_1.heavy 518.264 / 733.35 4905.0 32.49470138549805 42 17 9 10 6 4.179413158967194 23.926804122115495 0.0 5 0.9795339871783152 8.611965159864276 4905.0 9.000597001363017 2.0 - - - - - - - 645.2727272727273 10 11 CYFIP2 cytoplasmic FMR1 interacting protein 2 349 45 A20140416_SF113_02 A20140416_SF113_02 TB373296.[MT7]-ATNIRGTDLLSK[MT7].3y7_1.heavy 526.314 / 877.511 3796.0 26.930500030517578 44 18 10 10 6 3.7151076978960305 26.917120076123986 0.0 5 0.9827256705671731 9.376367108219227 3796.0 8.602266139657445 1.0 - - - - - - - 632.5833333333334 9 12 PLA2G4F phospholipase A2, group IVF 351 45 A20140416_SF113_02 A20140416_SF113_02 TB373296.[MT7]-ATNIRGTDLLSK[MT7].3b4_1.heavy 526.314 / 544.321 6706.0 26.930500030517578 44 18 10 10 6 3.7151076978960305 26.917120076123986 0.0 5 0.9827256705671731 9.376367108219227 6706.0 2.640091040079075 4.0 - - - - - - - 1202.0 18 2 PLA2G4F phospholipase A2, group IVF 353 45 A20140416_SF113_02 A20140416_SF113_02 TB373296.[MT7]-ATNIRGTDLLSK[MT7].3y4_1.heavy 526.314 / 604.415 19993.0 26.930500030517578 44 18 10 10 6 3.7151076978960305 26.917120076123986 0.0 5 0.9827256705671731 9.376367108219227 19993.0 6.912867374660411 0.0 - - - - - - - 2151.285714285714 39 7 PLA2G4F phospholipase A2, group IVF 355 45 A20140416_SF113_02 A20140416_SF113_02 TB373296.[MT7]-ATNIRGTDLLSK[MT7].3b8_1.heavy 526.314 / 973.518 3796.0 26.930500030517578 44 18 10 10 6 3.7151076978960305 26.917120076123986 0.0 5 0.9827256705671731 9.376367108219227 3796.0 36.88868794032325 0.0 - - - - - - - 239.33333333333334 7 9 PLA2G4F phospholipase A2, group IVF 357 46 A20140416_SF113_02 A20140416_SF113_02 TB235861.[MT7]-QFETVC[CAM]K[MT7].2b3_1.heavy 600.32 / 549.279 5807.0 23.882299423217773 44 14 10 10 10 7.295370036743696 13.70732389122721 0.0 3 0.9461673236567097 5.295068659808767 5807.0 5.1441173096050745 2.0 - - - - - - - 379.0 11 1 CAGE1 cancer antigen 1 359 46 A20140416_SF113_02 A20140416_SF113_02 TB235861.[MT7]-QFETVC[CAM]K[MT7].2y4_1.heavy 600.32 / 651.362 6438.0 23.882299423217773 44 14 10 10 10 7.295370036743696 13.70732389122721 0.0 3 0.9461673236567097 5.295068659808767 6438.0 17.36054692179918 0.0 - - - - - - - 224.22222222222223 12 9 CAGE1 cancer antigen 1 361 46 A20140416_SF113_02 A20140416_SF113_02 TB235861.[MT7]-QFETVC[CAM]K[MT7].2y3_1.heavy 600.32 / 550.314 4040.0 23.882299423217773 44 14 10 10 10 7.295370036743696 13.70732389122721 0.0 3 0.9461673236567097 5.295068659808767 4040.0 4.062793595358768 8.0 - - - - - - - 1751.5 10 8 CAGE1 cancer antigen 1 363 46 A20140416_SF113_02 A20140416_SF113_02 TB235861.[MT7]-QFETVC[CAM]K[MT7].2y6_1.heavy 600.32 / 927.473 10983.0 23.882299423217773 44 14 10 10 10 7.295370036743696 13.70732389122721 0.0 3 0.9461673236567097 5.295068659808767 10983.0 71.54681398416886 0.0 - - - - - - - 286.8181818181818 21 11 CAGE1 cancer antigen 1 365 47 A20140416_SF113_02 A20140416_SF113_02 TB235720.[MT7]-SSLENSSR.2b5_1.heavy 512.263 / 675.343 930.0 17.2096004486084 48 20 10 10 8 29.72325125419461 3.3643695013306383 0.0 4 0.9957844247178507 19.001210108922372 930.0 2.9303713468585215 5.0 - - - - - - - 0.0 1 0 TTC39A tetratricopeptide repeat domain 39A 367 47 A20140416_SF113_02 A20140416_SF113_02 TB235720.[MT7]-SSLENSSR.2y5_1.heavy 512.263 / 592.268 1752.0 17.2096004486084 48 20 10 10 8 29.72325125419461 3.3643695013306383 0.0 4 0.9957844247178507 19.001210108922372 1752.0 5.19063452748369 1.0 - - - - - - - 715.1428571428571 4 7 TTC39A tetratricopeptide repeat domain 39A 369 47 A20140416_SF113_02 A20140416_SF113_02 TB235720.[MT7]-SSLENSSR.2b4_1.heavy 512.263 / 561.3 2360.0 17.2096004486084 48 20 10 10 8 29.72325125419461 3.3643695013306383 0.0 4 0.9957844247178507 19.001210108922372 2360.0 5.343024511003325 0.0 - - - - - - - 585.375 4 8 TTC39A tetratricopeptide repeat domain 39A 371 47 A20140416_SF113_02 A20140416_SF113_02 TB235720.[MT7]-SSLENSSR.2y7_1.heavy 512.263 / 792.385 6223.0 17.2096004486084 48 20 10 10 8 29.72325125419461 3.3643695013306383 0.0 4 0.9957844247178507 19.001210108922372 6223.0 27.25238825174825 0.0 - - - - - - - 207.1578947368421 12 19 TTC39A tetratricopeptide repeat domain 39A 373 48 A20140416_SF113_02 A20140416_SF113_02 TB495582.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].4b4_1.heavy 605.077 / 617.414 38625.0 41.47050094604492 45 15 10 10 10 2.3320362790840456 42.88097955288973 0.0 3 0.9535955938351016 5.706750102931117 38625.0 40.632594370110624 0.0 - - - - - - - 1196.0 77 7 PFKL phosphofructokinase, liver 375 48 A20140416_SF113_02 A20140416_SF113_02 TB495582.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].4y3_1.heavy 605.077 / 518.342 25341.0 41.47050094604492 45 15 10 10 10 2.3320362790840456 42.88097955288973 0.0 3 0.9535955938351016 5.706750102931117 25341.0 28.02109066610675 0.0 - - - - - - - 759.0 50 10 PFKL phosphofructokinase, liver 377 48 A20140416_SF113_02 A20140416_SF113_02 TB495582.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].4y6_1.heavy 605.077 / 761.427 20094.0 41.47050094604492 45 15 10 10 10 2.3320362790840456 42.88097955288973 0.0 3 0.9535955938351016 5.706750102931117 20094.0 58.01114743450963 1.0 - - - - - - - 325.0 52 11 PFKL phosphofructokinase, liver 379 48 A20140416_SF113_02 A20140416_SF113_02 TB495582.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].4b3_1.heavy 605.077 / 504.33 57045.0 41.47050094604492 45 15 10 10 10 2.3320362790840456 42.88097955288973 0.0 3 0.9535955938351016 5.706750102931117 57045.0 32.46210467745506 0.0 - - - - - - - 335.0 114 1 PFKL phosphofructokinase, liver 381 49 A20140416_SF113_02 A20140416_SF113_02 TB372942.[MT7]-SYTAAESR.2y5_1.heavy 514.76 / 533.268 7781.0 18.42942476272583 37 11 10 6 10 1.0925079673502407 71.81043722662116 0.03230094909667969 3 0.8701201164366468 3.3866850017671255 7781.0 9.869880657855308 0.0 - - - - - - - 702.0833333333334 15 12 ARHGAP4 Rho GTPase activating protein 4 383 49 A20140416_SF113_02 A20140416_SF113_02 TB372942.[MT7]-SYTAAESR.2b4_1.heavy 514.76 / 567.289 6988.0 18.42942476272583 37 11 10 6 10 1.0925079673502407 71.81043722662116 0.03230094909667969 3 0.8701201164366468 3.3866850017671255 6988.0 38.29282828282828 0.0 - - - - - - - 289.0 13 18 ARHGAP4 Rho GTPase activating protein 4 385 49 A20140416_SF113_02 A20140416_SF113_02 TB372942.[MT7]-SYTAAESR.2b6_1.heavy 514.76 / 767.369 18982.0 18.42942476272583 37 11 10 6 10 1.0925079673502407 71.81043722662116 0.03230094909667969 3 0.8701201164366468 3.3866850017671255 18982.0 125.44672120479689 0.0 - - - - - - - 195.75 37 20 ARHGAP4 Rho GTPase activating protein 4 387 49 A20140416_SF113_02 A20140416_SF113_02 TB372942.[MT7]-SYTAAESR.2y7_1.heavy 514.76 / 797.379 20023.0 18.42942476272583 37 11 10 6 10 1.0925079673502407 71.81043722662116 0.03230094909667969 3 0.8701201164366468 3.3866850017671255 20023.0 83.57807276897415 0.0 - - - - - - - 209.94117647058823 40 17 ARHGAP4 Rho GTPase activating protein 4 389 50 A20140416_SF113_02 A20140416_SF113_02 TB495581.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].3y6_1.heavy 806.433 / 761.427 77821.0 41.47050094604492 44 14 10 10 10 1.1807762569339766 50.58962644985996 0.0 3 0.9441228020659918 5.196390204469854 77821.0 66.22623389763302 0.0 - - - - - - - 448.0 155 1 PFKL phosphofructokinase, liver 391 50 A20140416_SF113_02 A20140416_SF113_02 TB495581.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].3b4_1.heavy 806.433 / 617.414 72894.0 41.47050094604492 44 14 10 10 10 1.1807762569339766 50.58962644985996 0.0 3 0.9441228020659918 5.196390204469854 72894.0 72.62759236950842 0.0 - - - - - - - 448.0 145 1 PFKL phosphofructokinase, liver 393 50 A20140416_SF113_02 A20140416_SF113_02 TB495581.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].3b3_1.heavy 806.433 / 504.33 76253.0 41.47050094604492 44 14 10 10 10 1.1807762569339766 50.58962644985996 0.0 3 0.9441228020659918 5.196390204469854 76253.0 69.15752812534174 0.0 - - - - - - - 336.0 152 2 PFKL phosphofructokinase, liver 395 50 A20140416_SF113_02 A20140416_SF113_02 TB495581.[MT7]-VFLIYEGYEGLVEGGENIK[MT7].3b7_1.heavy 806.433 / 966.542 39750.0 41.47050094604492 44 14 10 10 10 1.1807762569339766 50.58962644985996 0.0 3 0.9441228020659918 5.196390204469854 39750.0 38.3114055998613 0.0 - - - - - - - 1248.0 79 7 PFKL phosphofructokinase, liver 397 51 A20140416_SF113_02 A20140416_SF113_02 TB235939.[MT7]-ESALNPSQPPSFLC[CAM]K[MT7].3y7_1.heavy 655.011 / 992.536 34048.0 31.785600662231445 45 15 10 10 10 3.3621550920815353 29.742827817645157 0.0 3 0.9592339315086397 6.091530590021877 34048.0 99.52200161895651 0.0 - - - - - - - 338.6666666666667 68 3 CAGE1 cancer antigen 1 399 51 A20140416_SF113_02 A20140416_SF113_02 TB235939.[MT7]-ESALNPSQPPSFLC[CAM]K[MT7].3y6_1.heavy 655.011 / 895.483 17278.0 31.785600662231445 45 15 10 10 10 3.3621550920815353 29.742827817645157 0.0 3 0.9592339315086397 6.091530590021877 17278.0 27.43405259259948 0.0 - - - - - - - 682.625 34 8 CAGE1 cancer antigen 1 401 51 A20140416_SF113_02 A20140416_SF113_02 TB235939.[MT7]-ESALNPSQPPSFLC[CAM]K[MT7].3b4_1.heavy 655.011 / 545.305 32651.0 31.785600662231445 45 15 10 10 10 3.3621550920815353 29.742827817645157 0.0 3 0.9592339315086397 6.091530590021877 32651.0 7.103134454954126 0.0 - - - - - - - 1397.0 65 1 CAGE1 cancer antigen 1 403 51 A20140416_SF113_02 A20140416_SF113_02 TB235939.[MT7]-ESALNPSQPPSFLC[CAM]K[MT7].3b5_1.heavy 655.011 / 659.348 68858.0 31.785600662231445 45 15 10 10 10 3.3621550920815353 29.742827817645157 0.0 3 0.9592339315086397 6.091530590021877 68858.0 32.59691351701967 0.0 - - - - - - - 635.0 137 1 CAGE1 cancer antigen 1 405 52 A20140416_SF113_02 A20140416_SF113_02 TB373044.[MT7]-NYPYIAK[MT7].2y4_1.heavy 578.834 / 638.399 5715.0 26.613499641418457 43 18 10 5 10 10.71303374004597 9.33442406945793 0.04419898986816406 3 0.9883469336182488 11.421407244144687 5715.0 1.7285714285714286 1.0 - - - - - - - 1285.875 11 8 SRRD SRR1 domain containing 407 52 A20140416_SF113_02 A20140416_SF113_02 TB373044.[MT7]-NYPYIAK[MT7].2y5_1.heavy 578.834 / 735.452 59566.0 26.613499641418457 43 18 10 5 10 10.71303374004597 9.33442406945793 0.04419898986816406 3 0.9883469336182488 11.421407244144687 59566.0 62.95339282589677 0.0 - - - - - - - 254.0 119 1 SRRD SRR1 domain containing 409 52 A20140416_SF113_02 A20140416_SF113_02 TB373044.[MT7]-NYPYIAK[MT7].2b4_1.heavy 578.834 / 682.332 6096.0 26.613499641418457 43 18 10 5 10 10.71303374004597 9.33442406945793 0.04419898986816406 3 0.9883469336182488 11.421407244144687 6096.0 6.0090756302521005 1.0 - - - - - - - 1666.875 12 8 SRRD SRR1 domain containing 411 52 A20140416_SF113_02 A20140416_SF113_02 TB373044.[MT7]-NYPYIAK[MT7].2y6_1.heavy 578.834 / 898.516 15241.0 26.613499641418457 43 18 10 5 10 10.71303374004597 9.33442406945793 0.04419898986816406 3 0.9883469336182488 11.421407244144687 15241.0 72.77620359955004 0.0 - - - - - - - 254.0 30 8 SRRD SRR1 domain containing 413 53 A20140416_SF113_02 A20140416_SF113_02 TB373419.[MT7]-TLQNLEEVLANTQK[MT7].2b8_1.heavy 945.033 / 1071.58 3934.0 37.134626388549805 40 14 10 6 10 3.2500775014943093 24.583964288982244 0.03730010986328125 3 0.9417998049805558 5.090623433244579 3934.0 6.8213089594968785 0.0 - - - - - - - 248.25 7 12 CAGE1 cancer antigen 1 415 53 A20140416_SF113_02 A20140416_SF113_02 TB373419.[MT7]-TLQNLEEVLANTQK[MT7].2y5_1.heavy 945.033 / 705.401 4173.0 37.134626388549805 40 14 10 6 10 3.2500775014943093 24.583964288982244 0.03730010986328125 3 0.9417998049805558 5.090623433244579 4173.0 8.868825614636936 0.0 - - - - - - - 244.94444444444446 8 18 CAGE1 cancer antigen 1 417 53 A20140416_SF113_02 A20140416_SF113_02 TB373419.[MT7]-TLQNLEEVLANTQK[MT7].2b4_1.heavy 945.033 / 601.343 3934.0 37.134626388549805 40 14 10 6 10 3.2500775014943093 24.583964288982244 0.03730010986328125 3 0.9417998049805558 5.090623433244579 3934.0 14.730190469048779 0.0 - - - - - - - 318.0 7 15 CAGE1 cancer antigen 1 419 53 A20140416_SF113_02 A20140416_SF113_02 TB373419.[MT7]-TLQNLEEVLANTQK[MT7].2y6_1.heavy 945.033 / 818.485 6080.0 37.134626388549805 40 14 10 6 10 3.2500775014943093 24.583964288982244 0.03730010986328125 3 0.9417998049805558 5.090623433244579 6080.0 50.06373019006261 0.0 - - - - - - - 278.0833333333333 12 12 CAGE1 cancer antigen 1 421 54 A20140416_SF113_02 A20140416_SF113_02 TB373316.[MT7]-GESPPLPLDNLGK[MT7].3b6_1.heavy 542.31 / 725.395 55472.0 32.22999954223633 47 17 10 10 10 3.897951248162075 25.654502489519604 0.0 3 0.9777685388172483 8.26172020335048 55472.0 45.145924783583155 0.0 - - - - - - - 774.0 110 5 ALOX15B arachidonate 15-lipoxygenase, type B 423 54 A20140416_SF113_02 A20140416_SF113_02 TB373316.[MT7]-GESPPLPLDNLGK[MT7].3b4_1.heavy 542.31 / 515.258 18319.0 32.22999954223633 47 17 10 10 10 3.897951248162075 25.654502489519604 0.0 3 0.9777685388172483 8.26172020335048 18319.0 4.433840936195587 3.0 - - - - - - - 1806.0 36 1 ALOX15B arachidonate 15-lipoxygenase, type B 425 54 A20140416_SF113_02 A20140416_SF113_02 TB373316.[MT7]-GESPPLPLDNLGK[MT7].3y4_1.heavy 542.31 / 575.363 26704.0 32.22999954223633 47 17 10 10 10 3.897951248162075 25.654502489519604 0.0 3 0.9777685388172483 8.26172020335048 26704.0 27.447009966777408 0.0 - - - - - - - 774.0 53 1 ALOX15B arachidonate 15-lipoxygenase, type B 427 54 A20140416_SF113_02 A20140416_SF113_02 TB373316.[MT7]-GESPPLPLDNLGK[MT7].3y5_1.heavy 542.31 / 690.39 33413.0 32.22999954223633 47 17 10 10 10 3.897951248162075 25.654502489519604 0.0 3 0.9777685388172483 8.26172020335048 33413.0 17.073692419814684 1.0 - - - - - - - 825.6 68 5 ALOX15B arachidonate 15-lipoxygenase, type B 429 55 A20140416_SF113_02 A20140416_SF113_02 TB372949.[MT7]-SISANEK[MT7].2y4_1.heavy 518.797 / 605.338 4457.0 19.04509925842285 38 20 2 10 6 6.55691428500981 15.251076291879631 0.0 5 0.9903590836856058 12.558960035867027 4457.0 8.390808416389813 1.0 - - - - - - - 717.0909090909091 8 11 TTC39A tetratricopeptide repeat domain 39A 431 55 A20140416_SF113_02 A20140416_SF113_02 TB372949.[MT7]-SISANEK[MT7].2y5_1.heavy 518.797 / 692.37 8492.0 19.04509925842285 38 20 2 10 6 6.55691428500981 15.251076291879631 0.0 5 0.9903590836856058 12.558960035867027 8492.0 30.303402489626556 0.0 - - - - - - - 286.0 16 16 TTC39A tetratricopeptide repeat domain 39A 433 55 A20140416_SF113_02 A20140416_SF113_02 TB372949.[MT7]-SISANEK[MT7].2y3_1.heavy 518.797 / 534.3 3674.0 19.04509925842285 38 20 2 10 6 6.55691428500981 15.251076291879631 0.0 5 0.9903590836856058 12.558960035867027 3674.0 4.681609110542551 2.0 - - - - - - - 676.3076923076923 48 13 TTC39A tetratricopeptide repeat domain 39A 435 55 A20140416_SF113_02 A20140416_SF113_02 TB372949.[MT7]-SISANEK[MT7].2y6_1.heavy 518.797 / 805.454 6504.0 19.04509925842285 38 20 2 10 6 6.55691428500981 15.251076291879631 0.0 5 0.9903590836856058 12.558960035867027 6504.0 23.47917012448133 3.0 - - - - - - - 255.8125 14 16 TTC39A tetratricopeptide repeat domain 39A 437 56 A20140416_SF113_02 A20140416_SF113_02 TB235937.[MT7]-AQVHVC[CAM]SSK[MT7].3y3_1.heavy 435.239 / 465.279 58393.0 18.768199920654297 47 17 10 10 10 4.266436228809461 19.023087873581638 0.0 3 0.973287798093981 7.534180299410883 58393.0 78.34017801122046 0.0 - - - - - - - 1221.111111111111 116 9 PLA2G4F phospholipase A2, group IVF 439 56 A20140416_SF113_02 A20140416_SF113_02 TB235937.[MT7]-AQVHVC[CAM]SSK[MT7].3b4_1.heavy 435.239 / 580.332 56916.0 18.768199920654297 47 17 10 10 10 4.266436228809461 19.023087873581638 0.0 3 0.973287798093981 7.534180299410883 56916.0 14.8011691633175 2.0 - - - - - - - 2679.0 121 1 PLA2G4F phospholipase A2, group IVF 441 56 A20140416_SF113_02 A20140416_SF113_02 TB235937.[MT7]-AQVHVC[CAM]SSK[MT7].3y4_1.heavy 435.239 / 625.31 84746.0 18.768199920654297 47 17 10 10 10 4.266436228809461 19.023087873581638 0.0 3 0.973287798093981 7.534180299410883 84746.0 120.56513922299575 0.0 - - - - - - - 1249.857142857143 169 7 PLA2G4F phospholipase A2, group IVF 443 56 A20140416_SF113_02 A20140416_SF113_02 TB235937.[MT7]-AQVHVC[CAM]SSK[MT7].3b3_1.heavy 435.239 / 443.273 64407.0 18.768199920654297 47 17 10 10 10 4.266436228809461 19.023087873581638 0.0 3 0.973287798093981 7.534180299410883 64407.0 29.351165325824617 0.0 - - - - - - - 1718.2857142857142 128 7 PLA2G4F phospholipase A2, group IVF 445 57 A20140416_SF113_02 A20140416_SF113_02 TB235935.[MT7]-QEMYQWK[MT7].3b4_1.heavy 434.225 / 696.314 36830.0 28.276199340820312 50 20 10 10 10 20.273138176697582 4.932635447379446 0.0 2 0.9962964820500969 20.273139880365477 36830.0 53.29099678456592 0.0 - - - - - - - 793.25 73 8 ALOX15B arachidonate 15-lipoxygenase, type B 447 57 A20140416_SF113_02 A20140416_SF113_02 TB235935.[MT7]-QEMYQWK[MT7].3b3_1.heavy 434.225 / 533.251 189499.0 28.276199340820312 50 20 10 10 10 20.273138176697582 4.932635447379446 0.0 2 0.9962964820500969 20.273139880365477 189499.0 89.27103146297969 0.0 - - - - - - - 995.0 378 1 ALOX15B arachidonate 15-lipoxygenase, type B 449 58 A20140416_SF113_02 A20140416_SF113_02 TB372943.[MT7]-YSVDEK[MT7].2y4_1.heavy 514.779 / 634.353 5243.0 21.69659996032715 42 17 10 5 10 3.584062686634847 21.567552136095813 0.041599273681640625 3 0.9714999554257345 7.292941284245276 5243.0 2.416246127752993 1.0 - - - - - - - 1171.142857142857 10 7 FBXL5 F-box and leucine-rich repeat protein 5 451 58 A20140416_SF113_02 A20140416_SF113_02 TB372943.[MT7]-YSVDEK[MT7].2y5_1.heavy 514.779 / 721.385 23735.0 21.69659996032715 42 17 10 5 10 3.584062686634847 21.567552136095813 0.041599273681640625 3 0.9714999554257345 7.292941284245276 23735.0 65.47586206896551 0.0 - - - - - - - 699.1111111111111 47 9 FBXL5 F-box and leucine-rich repeat protein 5 453 58 A20140416_SF113_02 A20140416_SF113_02 TB372943.[MT7]-YSVDEK[MT7].2b4_1.heavy 514.779 / 609.3 29264.0 21.69659996032715 42 17 10 5 10 3.584062686634847 21.567552136095813 0.041599273681640625 3 0.9714999554257345 7.292941284245276 29264.0 23.822865780336745 0.0 - - - - - - - 796.6428571428571 58 14 FBXL5 F-box and leucine-rich repeat protein 5 455 58 A20140416_SF113_02 A20140416_SF113_02 TB372943.[MT7]-YSVDEK[MT7].2y3_1.heavy 514.779 / 535.284 9627.0 21.69659996032715 42 17 10 5 10 3.584062686634847 21.567552136095813 0.041599273681640625 3 0.9714999554257345 7.292941284245276 9627.0 13.016752973304069 0.0 - - - - - - - 752.0 19 9 FBXL5 F-box and leucine-rich repeat protein 5 457 59 A20140416_SF113_02 A20140416_SF113_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 2710800.0 19.785999298095703 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2710800.0 8430.07853568337 0.0 - - - - - - - 472.0 5421 1 459 59 A20140416_SF113_02 A20140416_SF113_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 1819460.0 19.785999298095703 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1819460.0 2189.195246684862 0.0 - - - - - - - 314.3333333333333 3638 3 461 59 A20140416_SF113_02 A20140416_SF113_02 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 1765220.0 19.785999298095703 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1765220.0 6909.479951757198 0.0 - - - - - - - 741.1428571428571 3530 7 463 60 A20140416_SF113_02 A20140416_SF113_02 TB372977.[MT7]-VAFPDTK[MT7].2y4_1.heavy 533.313 / 604.342 129588.0 27.013200759887695 46 16 10 10 10 1.4120708460798597 45.7999592001593 0.0 3 0.9616060581192711 6.2781488690367135 129588.0 76.2361332651752 0.0 - - - - - - - 1385.0 259 2 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 465 60 A20140416_SF113_02 A20140416_SF113_02 TB372977.[MT7]-VAFPDTK[MT7].2y5_1.heavy 533.313 / 751.411 29343.0 27.013200759887695 46 16 10 10 10 1.4120708460798597 45.7999592001593 0.0 3 0.9616060581192711 6.2781488690367135 29343.0 39.25686062805194 1.0 - - - - - - - 720.0 77 7 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 467 60 A20140416_SF113_02 A20140416_SF113_02 TB372977.[MT7]-VAFPDTK[MT7].2y6_1.heavy 533.313 / 822.448 50626.0 27.013200759887695 46 16 10 10 10 1.4120708460798597 45.7999592001593 0.0 3 0.9616060581192711 6.2781488690367135 50626.0 76.86476455847074 0.0 - - - - - - - 220.5 101 4 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 469 60 A20140416_SF113_02 A20140416_SF113_02 TB372977.[MT7]-VAFPDTK[MT7].2b5_1.heavy 533.313 / 674.363 60701.0 27.013200759887695 46 16 10 10 10 1.4120708460798597 45.7999592001593 0.0 3 0.9616060581192711 6.2781488690367135 60701.0 61.302288590461146 0.0 - - - - - - - 378.0 121 2 FAM108B1;FAM108A1 family with sequence similarity 108, member B1;family with sequence similarity 108, member A1 471 61 A20140416_SF113_02 A20140416_SF113_02 TB495156.[MT7]-ELQAWVR.2y4_1.heavy 523.299 / 531.304 608783.0 21.841899871826172 46 16 10 10 10 3.232187213830127 24.929180361475776 0.0 3 0.9623583712307285 6.340979808142271 608783.0 746.0719790264426 0.0 - - - - - - - 399.0 1217 1 ALOX15B arachidonate 15-lipoxygenase, type B 473 61 A20140416_SF113_02 A20140416_SF113_02 TB495156.[MT7]-ELQAWVR.2b3_1.heavy 523.299 / 515.295 953558.0 21.841899871826172 46 16 10 10 10 3.232187213830127 24.929180361475776 0.0 3 0.9623583712307285 6.340979808142271 953558.0 192.97732235468033 0.0 - - - - - - - 949.0 1907 2 ALOX15B arachidonate 15-lipoxygenase, type B 475 61 A20140416_SF113_02 A20140416_SF113_02 TB495156.[MT7]-ELQAWVR.2y5_1.heavy 523.299 / 659.362 979004.0 21.841899871826172 46 16 10 10 10 3.232187213830127 24.929180361475776 0.0 3 0.9623583712307285 6.340979808142271 979004.0 921.8960154546033 0.0 - - - - - - - 499.0 1958 1 ALOX15B arachidonate 15-lipoxygenase, type B 477 61 A20140416_SF113_02 A20140416_SF113_02 TB495156.[MT7]-ELQAWVR.2b6_1.heavy 523.299 / 871.479 365057.0 21.841899871826172 46 16 10 10 10 3.232187213830127 24.929180361475776 0.0 3 0.9623583712307285 6.340979808142271 365057.0 507.3829989359697 0.0 - - - - - - - 727.5714285714286 730 7 ALOX15B arachidonate 15-lipoxygenase, type B 479 62 A20140416_SF113_02 A20140416_SF113_02 TB236207.[MT7]-LTQLNLDRC[CAM]ELTK[MT7].3y3_1.heavy 631.355 / 505.347 14959.0 30.30270004272461 43 13 10 10 10 2.940630040608003 34.00631790435089 0.0 3 0.9296143529780381 4.624230255925797 14959.0 11.84453055526565 0.0 - - - - - - - 1221.142857142857 29 7 GP1BA glycoprotein Ib (platelet), alpha polypeptide 481 62 A20140416_SF113_02 A20140416_SF113_02 TB236207.[MT7]-LTQLNLDRC[CAM]ELTK[MT7].3b5_1.heavy 631.355 / 714.427 5908.0 30.30270004272461 43 13 10 10 10 2.940630040608003 34.00631790435089 0.0 3 0.9296143529780381 4.624230255925797 5908.0 4.542607158638974 3.0 - - - - - - - 1206.7 18 10 GP1BA glycoprotein Ib (platelet), alpha polypeptide 483 62 A20140416_SF113_02 A20140416_SF113_02 TB236207.[MT7]-LTQLNLDRC[CAM]ELTK[MT7].3y12_2.heavy 631.355 / 817.936 47894.0 30.30270004272461 43 13 10 10 10 2.940630040608003 34.00631790435089 0.0 3 0.9296143529780381 4.624230255925797 47894.0 86.9752199681782 0.0 - - - - - - - 1131.4285714285713 95 7 GP1BA glycoprotein Ib (platelet), alpha polypeptide 485 62 A20140416_SF113_02 A20140416_SF113_02 TB236207.[MT7]-LTQLNLDRC[CAM]ELTK[MT7].3y5_1.heavy 631.355 / 794.42 7920.0 30.30270004272461 43 13 10 10 10 2.940630040608003 34.00631790435089 0.0 3 0.9296143529780381 4.624230255925797 7920.0 21.42718838751874 0.0 - - - - - - - 712.4444444444445 15 9 GP1BA glycoprotein Ib (platelet), alpha polypeptide 487 63 A20140416_SF113_02 A20140416_SF113_02 TB235889.[MT7]-SSPYPTDVAR.2y8_1.heavy 618.821 / 918.468 8265.0 23.398099899291992 44 14 10 10 10 1.3535903929729214 42.40941510675712 0.0 3 0.9341858965502897 4.784006055005925 8265.0 49.48796296296297 0.0 - - - - - - - 261.9230769230769 16 13 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 489 63 A20140416_SF113_02 A20140416_SF113_02 TB235889.[MT7]-SSPYPTDVAR.2b4_1.heavy 618.821 / 579.289 8386.0 23.398099899291992 44 14 10 10 10 1.3535903929729214 42.40941510675712 0.0 3 0.9341858965502897 4.784006055005925 8386.0 18.03334900117509 0.0 - - - - - - - 401.1 16 10 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 491 63 A20140416_SF113_02 A20140416_SF113_02 TB235889.[MT7]-SSPYPTDVAR.2y9_1.heavy 618.821 / 1005.5 4375.0 23.398099899291992 44 14 10 10 10 1.3535903929729214 42.40941510675712 0.0 3 0.9341858965502897 4.784006055005925 4375.0 -0.35599974377730104 2.0 - - - - - - - 197.75 10 8 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 493 63 A20140416_SF113_02 A20140416_SF113_02 TB235889.[MT7]-SSPYPTDVAR.2y6_1.heavy 618.821 / 658.352 5469.0 23.398099899291992 44 14 10 10 10 1.3535903929729214 42.40941510675712 0.0 3 0.9341858965502897 4.784006055005925 5469.0 18.18434624727655 0.0 - - - - - - - 288.875 10 8 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 495 64 A20140416_SF113_02 A20140416_SF113_02 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 2161260.0 34.159400939941406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2161260.0 651.8597149718395 0.0 - - - - - - - 314.0 4322 6 497 64 A20140416_SF113_02 A20140416_SF113_02 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 1033730.0 34.159400939941406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1033730.0 337.51093748815794 0.0 - - - - - - - 209.33333333333334 2067 3 499 64 A20140416_SF113_02 A20140416_SF113_02 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 1518730.0 34.159400939941406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1518730.0 358.83985124447406 0.0 - - - - - - - 251.0 3037 1 501 65 A20140416_SF113_02 A20140416_SF113_02 TB235905.[MT7]-C[CAM]LELQGELR.2b3_1.heavy 631.338 / 547.267 6662.0 29.52280044555664 43 17 8 10 8 2.924025011180318 27.72736076273502 0.0 4 0.9767345272582549 8.075339852829744 6662.0 4.039936356404136 2.0 - - - - - - - 1162.75 24 8 ARHGAP4 Rho GTPase activating protein 4 503 65 A20140416_SF113_02 A20140416_SF113_02 TB235905.[MT7]-C[CAM]LELQGELR.2y8_1.heavy 631.338 / 957.536 7291.0 29.52280044555664 43 17 8 10 8 2.924025011180318 27.72736076273502 0.0 4 0.9767345272582549 8.075339852829744 7291.0 9.496707758434937 1.0 - - - - - - - 682.4285714285714 17 7 ARHGAP4 Rho GTPase activating protein 4 505 65 A20140416_SF113_02 A20140416_SF113_02 TB235905.[MT7]-C[CAM]LELQGELR.2y6_1.heavy 631.338 / 715.41 5028.0 29.52280044555664 43 17 8 10 8 2.924025011180318 27.72736076273502 0.0 4 0.9767345272582549 8.075339852829744 5028.0 4.871435457437578 0.0 - - - - - - - 1178.5 10 8 ARHGAP4 Rho GTPase activating protein 4 507 65 A20140416_SF113_02 A20140416_SF113_02 TB235905.[MT7]-C[CAM]LELQGELR.2y7_1.heavy 631.338 / 844.452 4148.0 29.52280044555664 43 17 8 10 8 2.924025011180318 27.72736076273502 0.0 4 0.9767345272582549 8.075339852829744 4148.0 8.097146969015952 0.0 - - - - - - - 691.5 8 8 ARHGAP4 Rho GTPase activating protein 4 509 66 A20140416_SF113_02 A20140416_SF113_02 TB372973.[MT7]-IWEAEK[MT7].2b3_1.heavy 532.305 / 573.315 11450.0 27.333599090576172 45 17 10 10 8 3.1764302748145563 31.481881026284483 0.0 4 0.975801819500667 7.9175595986925495 11450.0 8.95503973232957 1.0 - - - - - - - 2249.25 22 8 SRRD SRR1 domain containing 511 66 A20140416_SF113_02 A20140416_SF113_02 TB372973.[MT7]-IWEAEK[MT7].2y4_1.heavy 532.305 / 620.337 14092.0 27.333599090576172 45 17 10 10 8 3.1764302748145563 31.481881026284483 0.0 4 0.975801819500667 7.9175595986925495 14092.0 6.689503973691423 1.0 - - - - - - - 1698.5 29 4 SRRD SRR1 domain containing 513 66 A20140416_SF113_02 A20140416_SF113_02 TB372973.[MT7]-IWEAEK[MT7].2y5_1.heavy 532.305 / 806.417 45296.0 27.333599090576172 45 17 10 10 8 3.1764302748145563 31.481881026284483 0.0 4 0.975801819500667 7.9175595986925495 45296.0 100.89210818162603 0.0 - - - - - - - 168.0 90 3 SRRD SRR1 domain containing 515 66 A20140416_SF113_02 A20140416_SF113_02 TB372973.[MT7]-IWEAEK[MT7].2b4_1.heavy 532.305 / 644.352 5033.0 27.333599090576172 45 17 10 10 8 3.1764302748145563 31.481881026284483 0.0 4 0.975801819500667 7.9175595986925495 5033.0 2.5140006884314428 6.0 - - - - - - - 2696.0 11 7 SRRD SRR1 domain containing 517 67 A20140416_SF113_02 A20140416_SF113_02 TB235782.[MT7]-FVEGLLK[MT7].2y4_1.heavy 547.347 / 574.404 12007.0 33.46394920349121 36 20 4 6 6 14.51996059024829 6.887071034280955 0.039699554443359375 6 0.9946014083211069 16.78906668364588 12007.0 7.573963965105836 0.0 - - - - - - - 1264.0 24 2 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 519 67 A20140416_SF113_02 A20140416_SF113_02 TB235782.[MT7]-FVEGLLK[MT7].2y5_1.heavy 547.347 / 703.447 8595.0 33.46394920349121 36 20 4 6 6 14.51996059024829 6.887071034280955 0.039699554443359375 6 0.9946014083211069 16.78906668364588 8595.0 10.102510244968581 2.0 - - - - - - - 1169.0 20 4 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 521 67 A20140416_SF113_02 A20140416_SF113_02 TB235782.[MT7]-FVEGLLK[MT7].2b4_1.heavy 547.347 / 577.31 6699.0 33.46394920349121 36 20 4 6 6 14.51996059024829 6.887071034280955 0.039699554443359375 6 0.9946014083211069 16.78906668364588 6699.0 3.758459191444093 5.0 - - - - - - - 2149.0 41 2 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 523 67 A20140416_SF113_02 A20140416_SF113_02 TB235782.[MT7]-FVEGLLK[MT7].2y6_1.heavy 547.347 / 802.516 9479.0 33.46394920349121 36 20 4 6 6 14.51996059024829 6.887071034280955 0.039699554443359375 6 0.9946014083211069 16.78906668364588 9479.0 10.311862897953024 3.0 - - - - - - - 316.0 30 2 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 525 68 A20140416_SF113_02 A20140416_SF113_02 TB495576.[MT7]-K[MT7]TLQALEFHTVPFQLLAR.4b7_1.heavy 600.856 / 1072.66 4797.0 37.052398681640625 44 14 10 10 10 1.7398786623459337 57.475272364779066 0.0 3 0.9383276572731086 4.943783868602757 4797.0 21.9635 0.0 - - - - - - - 232.33333333333334 9 18 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 527 68 A20140416_SF113_02 A20140416_SF113_02 TB495576.[MT7]-K[MT7]TLQALEFHTVPFQLLAR.4b7_2.heavy 600.856 / 536.834 58547.0 37.052398681640625 44 14 10 10 10 1.7398786623459337 57.475272364779066 0.0 3 0.9383276572731086 4.943783868602757 58547.0 57.47601829268292 0.0 - - - - - - - 843.4285714285714 117 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 529 68 A20140416_SF113_02 A20140416_SF113_02 TB495576.[MT7]-K[MT7]TLQALEFHTVPFQLLAR.4b5_1.heavy 600.856 / 830.534 7995.0 37.052398681640625 44 14 10 10 10 1.7398786623459337 57.475272364779066 0.0 3 0.9383276572731086 4.943783868602757 7995.0 22.1 0.0 - - - - - - - 768.75 15 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 531 68 A20140416_SF113_02 A20140416_SF113_02 TB495576.[MT7]-K[MT7]TLQALEFHTVPFQLLAR.4y7_1.heavy 600.856 / 844.504 99014.0 37.052398681640625 44 14 10 10 10 1.7398786623459337 57.475272364779066 0.0 3 0.9383276572731086 4.943783868602757 99014.0 213.50173261065942 0.0 - - - - - - - 808.2857142857143 198 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 533 69 A20140416_SF113_02 A20140416_SF113_02 TB373208.[MT7]-FTSAQSFNFTR.2y8_1.heavy 725.366 / 970.474 4546.0 31.657100677490234 50 20 10 10 10 5.358499796246285 18.661939685068496 0.0 3 0.9924699502816089 14.213156868777801 4546.0 14.996966482927975 0.0 - - - - - - - 647.25 9 8 PLA2G4F phospholipase A2, group IVF 535 69 A20140416_SF113_02 A20140416_SF113_02 TB373208.[MT7]-FTSAQSFNFTR.2y9_1.heavy 725.366 / 1057.51 8461.0 31.657100677490234 50 20 10 10 10 5.358499796246285 18.661939685068496 0.0 3 0.9924699502816089 14.213156868777801 8461.0 14.404410982523054 0.0 - - - - - - - 275.72727272727275 16 11 PLA2G4F phospholipase A2, group IVF 537 69 A20140416_SF113_02 A20140416_SF113_02 TB373208.[MT7]-FTSAQSFNFTR.2y10_1.heavy 725.366 / 1158.55 16669.0 31.657100677490234 50 20 10 10 10 5.358499796246285 18.661939685068496 0.0 3 0.9924699502816089 14.213156868777801 16669.0 41.65128288789611 0.0 - - - - - - - 241.27272727272728 33 11 PLA2G4F phospholipase A2, group IVF 539 69 A20140416_SF113_02 A20140416_SF113_02 TB373208.[MT7]-FTSAQSFNFTR.2y7_1.heavy 725.366 / 899.437 7703.0 31.657100677490234 50 20 10 10 10 5.358499796246285 18.661939685068496 0.0 3 0.9924699502816089 14.213156868777801 7703.0 10.330339578263603 0.0 - - - - - - - 606.0 15 10 PLA2G4F phospholipase A2, group IVF 541 70 A20140416_SF113_02 A20140416_SF113_02 TB495575.[MT7]-GSLAAVAHAQSLVEAQPNVDK[MT7].4y5_1.heavy 599.081 / 716.406 30702.0 30.709299087524414 31 3 10 10 8 0.3837516223063768 120.71152531617193 0.0 4 0.5650852157885152 1.7988267386146273 30702.0 33.965100481599904 0.0 - - - - - - - 377.0 61 1 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 543 70 A20140416_SF113_02 A20140416_SF113_02 TB495575.[MT7]-GSLAAVAHAQSLVEAQPNVDK[MT7].4b7_1.heavy 599.081 / 714.427 5159.0 30.709299087524414 31 3 10 10 8 0.3837516223063768 120.71152531617193 0.0 4 0.5650852157885152 1.7988267386146273 5159.0 2.733762301286904 1.0 - - - - - - - 1150.4285714285713 20 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 545 70 A20140416_SF113_02 A20140416_SF113_02 TB495575.[MT7]-GSLAAVAHAQSLVEAQPNVDK[MT7].4b5_1.heavy 599.081 / 544.321 5914.0 30.709299087524414 31 3 10 10 8 0.3837516223063768 120.71152531617193 0.0 4 0.5650852157885152 1.7988267386146273 5914.0 0.8926481842615113 8.0 - - - - - - - 1594.0 13 3 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 547 70 A20140416_SF113_02 A20140416_SF113_02 TB495575.[MT7]-GSLAAVAHAQSLVEAQPNVDK[MT7].4b6_1.heavy 599.081 / 643.39 8053.0 30.709299087524414 31 3 10 10 8 0.3837516223063768 120.71152531617193 0.0 4 0.5650852157885152 1.7988267386146273 8053.0 5.54734148250315 0.0 - - - - - - - 1223.909090909091 16 11 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 549 71 A20140416_SF113_02 A20140416_SF113_02 TB495400.[MT7]-MLPLLGAVLLQK[MT7].3y3_1.heavy 528.677 / 532.357 139680.0 44.25412559509277 36 10 10 6 10 1.1647715611992286 68.3676424962107 0.03569793701171875 3 0.8466687584673225 3.110533376509815 139680.0 269.55105312649334 0.0 - - - - - - - 304.3333333333333 279 3 PLA2G4F phospholipase A2, group IVF 551 71 A20140416_SF113_02 A20140416_SF113_02 TB495400.[MT7]-MLPLLGAVLLQK[MT7].3b6_1.heavy 528.677 / 769.476 51706.0 44.25412559509277 36 10 10 6 10 1.1647715611992286 68.3676424962107 0.03569793701171875 3 0.8466687584673225 3.110533376509815 51706.0 658.7776562124006 0.0 - - - - - - - 292.0 103 5 PLA2G4F phospholipase A2, group IVF 553 71 A20140416_SF113_02 A20140416_SF113_02 TB495400.[MT7]-MLPLLGAVLLQK[MT7].3b4_1.heavy 528.677 / 599.371 61298.0 44.25412559509277 36 10 10 6 10 1.1647715611992286 68.3676424962107 0.03569793701171875 3 0.8466687584673225 3.110533376509815 61298.0 324.91289617486336 1.0 - - - - - - - 182.75 122 8 PLA2G4F phospholipase A2, group IVF 555 71 A20140416_SF113_02 A20140416_SF113_02 TB495400.[MT7]-MLPLLGAVLLQK[MT7].3b7_1.heavy 528.677 / 840.513 52711.0 44.25412559509277 36 10 10 6 10 1.1647715611992286 68.3676424962107 0.03569793701171875 3 0.8466687584673225 3.110533376509815 52711.0 363.11751763770235 0.0 - - - - - - - 219.4 105 5 PLA2G4F phospholipase A2, group IVF 557 72 A20140416_SF113_02 A20140416_SF113_02 TB235783.[MT7]-DFLEDRR.3b4_1.heavy 365.529 / 649.331 51657.0 24.78030014038086 43 13 10 10 10 2.1139180871930283 47.30552267178207 0.0 3 0.9010999510420353 3.8915093396468183 51657.0 133.8529674233082 0.0 - - - - - - - 732.125 103 8 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 559 72 A20140416_SF113_02 A20140416_SF113_02 TB235783.[MT7]-DFLEDRR.3b5_1.heavy 365.529 / 764.358 N/A 24.78030014038086 43 13 10 10 10 2.1139180871930283 47.30552267178207 0.0 3 0.9010999510420353 3.8915093396468183 0.0 0.0 3.0 - - - - - - - 0.0 0 0 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 561 72 A20140416_SF113_02 A20140416_SF113_02 TB235783.[MT7]-DFLEDRR.3b3_1.heavy 365.529 / 520.289 90043.0 24.78030014038086 43 13 10 10 10 2.1139180871930283 47.30552267178207 0.0 3 0.9010999510420353 3.8915093396468183 90043.0 60.88361827571467 0.0 - - - - - - - 130.0 180 1 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 563 72 A20140416_SF113_02 A20140416_SF113_02 TB235783.[MT7]-DFLEDRR.3y3_2.heavy 365.529 / 223.627 341433.0 24.78030014038086 43 13 10 10 10 2.1139180871930283 47.30552267178207 0.0 3 0.9010999510420353 3.8915093396468183 341433.0 406.832402306214 0.0 - - - - - - - 390.0 682 1 HLA-DRB5 major histocompatibility complex, class II, DR beta 5 565 73 A20140416_SF113_02 A20140416_SF113_02 TB495405.[MT7]-YNVLNNVETLK[MT7].3b6_1.heavy 532.306 / 862.454 24908.0 33.12300109863281 43 13 10 10 10 2.115902908605159 47.26114775555642 0.0 3 0.9276512797971097 4.560296876063485 24908.0 26.443256350688294 1.0 - - - - - - - 232.2 89 5 PLA2G4F phospholipase A2, group IVF 567 73 A20140416_SF113_02 A20140416_SF113_02 TB495405.[MT7]-YNVLNNVETLK[MT7].3y3_1.heavy 532.306 / 505.347 74596.0 33.12300109863281 43 13 10 10 10 2.115902908605159 47.26114775555642 0.0 3 0.9276512797971097 4.560296876063485 74596.0 13.856180311372267 0.0 - - - - - - - 1291.0 149 1 PLA2G4F phospholipase A2, group IVF 569 73 A20140416_SF113_02 A20140416_SF113_02 TB495405.[MT7]-YNVLNNVETLK[MT7].3b5_1.heavy 532.306 / 748.411 29683.0 33.12300109863281 43 13 10 10 10 2.115902908605159 47.26114775555642 0.0 3 0.9276512797971097 4.560296876063485 29683.0 43.93697074010328 0.0 - - - - - - - 1217.142857142857 59 7 PLA2G4F phospholipase A2, group IVF 571 73 A20140416_SF113_02 A20140416_SF113_02 TB495405.[MT7]-YNVLNNVETLK[MT7].3b3_1.heavy 532.306 / 521.284 83372.0 33.12300109863281 43 13 10 10 10 2.115902908605159 47.26114775555642 0.0 3 0.9276512797971097 4.560296876063485 83372.0 25.661379150422487 0.0 - - - - - - - 2267.714285714286 166 7 PLA2G4F phospholipase A2, group IVF 573 74 A20140416_SF113_02 A20140416_SF113_02 TB495579.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.2y12_1.heavy 1203.11 / 1225.65 5301.0 37.67390060424805 46 16 10 10 10 2.048365741390202 39.52381447828081 0.0 3 0.9623981376232805 6.344353238400269 5301.0 52.12677966101695 0.0 - - - - - - - 147.5 10 4 PLA2G4F phospholipase A2, group IVF 575 74 A20140416_SF113_02 A20140416_SF113_02 TB495579.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.2b4_1.heavy 1203.11 / 654.267 6244.0 37.67390060424805 46 16 10 10 10 2.048365741390202 39.52381447828081 0.0 3 0.9623981376232805 6.344353238400269 6244.0 57.3088238315357 0.0 - - - - - - - 168.42857142857142 12 7 PLA2G4F phospholipase A2, group IVF 577 74 A20140416_SF113_02 A20140416_SF113_02 TB495579.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.2b6_1.heavy 1203.11 / 881.394 12016.0 37.67390060424805 46 16 10 10 10 2.048365741390202 39.52381447828081 0.0 3 0.9623981376232805 6.344353238400269 12016.0 148.1633898305085 0.0 - - - - - - - 141.6 24 10 PLA2G4F phospholipase A2, group IVF 579 74 A20140416_SF113_02 A20140416_SF113_02 TB495579.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.2y11_1.heavy 1203.11 / 1112.57 24974.0 37.67390060424805 46 16 10 10 10 2.048365741390202 39.52381447828081 0.0 3 0.9623981376232805 6.344353238400269 24974.0 98.5269214181475 0.0 - - - - - - - 309.125 49 8 PLA2G4F phospholipase A2, group IVF 581 75 A20140416_SF113_02 A20140416_SF113_02 TB495292.[MT7]-GC[CAM]REEPGPLR.3y4_1.heavy 438.895 / 442.277 41513.0 20.28179931640625 48 18 10 10 10 2.7921956422323393 35.814109329406 0.0 3 0.983764385693389 9.672498334556158 41513.0 27.84147772637133 0.0 - - - - - - - 1429.0 83 1 NTHL1 nth endonuclease III-like 1 (E. coli) 583 75 A20140416_SF113_02 A20140416_SF113_02 TB495292.[MT7]-GC[CAM]REEPGPLR.3b7_1.heavy 438.895 / 930.422 N/A 20.28179931640625 48 18 10 10 10 2.7921956422323393 35.814109329406 0.0 3 0.983764385693389 9.672498334556158 84.0 1.0 6.0 - - - - - - - 0.0 0 0 NTHL1 nth endonuclease III-like 1 (E. coli) 585 75 A20140416_SF113_02 A20140416_SF113_02 TB495292.[MT7]-GC[CAM]REEPGPLR.3y5_1.heavy 438.895 / 539.33 186640.0 20.28179931640625 48 18 10 10 10 2.7921956422323393 35.814109329406 0.0 3 0.983764385693389 9.672498334556158 186640.0 126.5606790078223 0.0 - - - - - - - 252.0 373 1 NTHL1 nth endonuclease III-like 1 (E. coli) 587 75 A20140416_SF113_02 A20140416_SF113_02 TB495292.[MT7]-GC[CAM]REEPGPLR.3b7_2.heavy 438.895 / 465.715 98320.0 20.28179931640625 48 18 10 10 10 2.7921956422323393 35.814109329406 0.0 3 0.983764385693389 9.672498334556158 98320.0 64.59803792119374 0.0 - - - - - - - 672.0 196 2 NTHL1 nth endonuclease III-like 1 (E. coli) 589 76 A20140416_SF113_02 A20140416_SF113_02 TB235606.[MT7]-DEILPR.2y5_1.heavy 443.759 / 627.382 4099.0 27.45439910888672 18 2 2 10 4 0.29382021527670893 127.23235589293336 0.0 9 0.49714058885949913 1.661433221474647 4099.0 6.41977823977824 2.0 - - - - - - - 711.7777777777778 37 9 ARHGAP4 Rho GTPase activating protein 4 591 76 A20140416_SF113_02 A20140416_SF113_02 TB235606.[MT7]-DEILPR.2b4_1.heavy 443.759 / 615.347 35230.0 27.45439910888672 18 2 2 10 4 0.29382021527670893 127.23235589293336 0.0 9 0.49714058885949913 1.661433221474647 35230.0 7.031324759762332 1.0 - - - - - - - 1922.0 163 2 ARHGAP4 Rho GTPase activating protein 4 593 76 A20140416_SF113_02 A20140416_SF113_02 TB235606.[MT7]-DEILPR.2b4_2.heavy 443.759 / 308.177 11402.0 27.45439910888672 18 2 2 10 4 0.29382021527670893 127.23235589293336 0.0 9 0.49714058885949913 1.661433221474647 11402.0 1.3422579857310617 6.0 - - - - - - - 1537.0 168 1 ARHGAP4 Rho GTPase activating protein 4 595 77 A20140416_SF113_02 A20140416_SF113_02 TB235884.[MT7]-IQAATLQAK[MT7].3b4_1.heavy 411.259 / 528.326 233850.0 25.33240032196045 43 18 10 5 10 4.135953712130776 24.178220299395377 0.04580116271972656 3 0.987654911852012 11.096026207879085 233850.0 103.21814069361558 0.0 - - - - - - - 2335.0 467 1 TTC39A tetratricopeptide repeat domain 39A 597 77 A20140416_SF113_02 A20140416_SF113_02 TB235884.[MT7]-IQAATLQAK[MT7].3b5_1.heavy 411.259 / 629.374 148507.0 25.33240032196045 43 18 10 5 10 4.135953712130776 24.178220299395377 0.04580116271972656 3 0.987654911852012 11.096026207879085 148507.0 146.5604934464148 0.0 - - - - - - - 864.6666666666666 297 3 TTC39A tetratricopeptide repeat domain 39A 599 77 A20140416_SF113_02 A20140416_SF113_02 TB235884.[MT7]-IQAATLQAK[MT7].3y4_1.heavy 411.259 / 603.395 33463.0 25.33240032196045 43 18 10 5 10 4.135953712130776 24.178220299395377 0.04580116271972656 3 0.987654911852012 11.096026207879085 33463.0 22.465773020439293 1.0 - - - - - - - 389.0 94 1 TTC39A tetratricopeptide repeat domain 39A 601 77 A20140416_SF113_02 A20140416_SF113_02 TB235884.[MT7]-IQAATLQAK[MT7].3b3_1.heavy 411.259 / 457.289 200647.0 25.33240032196045 43 18 10 5 10 4.135953712130776 24.178220299395377 0.04580116271972656 3 0.987654911852012 11.096026207879085 200647.0 26.919965155952816 0.0 - - - - - - - 2594.0 401 1 TTC39A tetratricopeptide repeat domain 39A 603 78 A20140416_SF113_02 A20140416_SF113_02 TB372832.[MT7]-TAVPSK[MT7].2b3_1.heavy 445.781 / 416.263 55788.0 19.333599090576172 44 14 10 10 10 2.514072203553418 39.77610502143052 0.0 3 0.9315831641447129 4.691083167173418 55788.0 18.264114507952556 0.0 - - - - - - - 2201.0 111 3 CAGE1 cancer antigen 1 605 78 A20140416_SF113_02 A20140416_SF113_02 TB372832.[MT7]-TAVPSK[MT7].2y4_1.heavy 445.781 / 574.368 11050.0 19.333599090576172 44 14 10 10 10 2.514072203553418 39.77610502143052 0.0 3 0.9315831641447129 4.691083167173418 11050.0 4.9783548779482105 3.0 - - - - - - - 1665.142857142857 91 7 CAGE1 cancer antigen 1 607 78 A20140416_SF113_02 A20140416_SF113_02 TB372832.[MT7]-TAVPSK[MT7].2y5_1.heavy 445.781 / 645.405 12330.0 19.333599090576172 44 14 10 10 10 2.514072203553418 39.77610502143052 0.0 3 0.9315831641447129 4.691083167173418 12330.0 7.656658505251584 1.0 - - - - - - - 1212.7142857142858 24 7 CAGE1 cancer antigen 1 609 78 A20140416_SF113_02 A20140416_SF113_02 TB372832.[MT7]-TAVPSK[MT7].2y3_1.heavy 445.781 / 475.3 94463.0 19.333599090576172 44 14 10 10 10 2.514072203553418 39.77610502143052 0.0 3 0.9315831641447129 4.691083167173418 94463.0 77.20277993758123 0.0 - - - - - - - 1291.3333333333333 188 6 CAGE1 cancer antigen 1 611 79 A20140416_SF113_02 A20140416_SF113_02 TB235880.[MT7]-DFDWNLK[MT7].3y3_1.heavy 409.22 / 518.342 27490.0 32.836299896240234 50 20 10 10 10 9.734015440119967 10.273252658695963 0.0 3 0.9976562872533452 25.487387421005522 27490.0 53.20645161290322 1.0 - - - - - - - 680.9 54 10 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 613 79 A20140416_SF113_02 A20140416_SF113_02 TB235880.[MT7]-DFDWNLK[MT7].3b4_1.heavy 409.22 / 708.311 10790.0 32.836299896240234 50 20 10 10 10 9.734015440119967 10.273252658695963 0.0 3 0.9976562872533452 25.487387421005522 10790.0 144.99062500000002 0.0 - - - - - - - 183.14285714285714 21 7 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 615 79 A20140416_SF113_02 A20140416_SF113_02 TB235880.[MT7]-DFDWNLK[MT7].3b5_1.heavy 409.22 / 822.354 5524.0 32.836299896240234 50 20 10 10 10 9.734015440119967 10.273252658695963 0.0 3 0.9976562872533452 25.487387421005522 5524.0 56.899080739299606 1.0 - - - - - - - 192.5 32 2 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 617 79 A20140416_SF113_02 A20140416_SF113_02 TB235880.[MT7]-DFDWNLK[MT7].3b3_1.heavy 409.22 / 522.232 172388.0 32.836299896240234 50 20 10 10 10 9.734015440119967 10.273252658695963 0.0 3 0.9976562872533452 25.487387421005522 172388.0 334.70584108107937 0.0 - - - - - - - 256.5 344 2 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 619 80 A20140416_SF113_02 A20140416_SF113_02 TB372967.[MT7]-FC[CAM]SEVK[MT7].2y4_1.heavy 529.283 / 606.358 6293.0 23.690099716186523 43 13 10 10 10 1.8694881673261625 48.94310125045473 0.0 3 0.9149481434628045 4.201391836916472 6293.0 7.198259794507835 2.0 - - - - - - - 494.0 12 4 CYFIP2 cytoplasmic FMR1 interacting protein 2 621 80 A20140416_SF113_02 A20140416_SF113_02 TB372967.[MT7]-FC[CAM]SEVK[MT7].2y5_1.heavy 529.283 / 766.389 6663.0 23.690099716186523 43 13 10 10 10 1.8694881673261625 48.94310125045473 0.0 3 0.9149481434628045 4.201391836916472 6663.0 6.5820182346189275 1.0 - - - - - - - 781.3333333333334 19 9 CYFIP2 cytoplasmic FMR1 interacting protein 2 623 80 A20140416_SF113_02 A20140416_SF113_02 TB372967.[MT7]-FC[CAM]SEVK[MT7].2b4_1.heavy 529.283 / 668.283 4689.0 23.690099716186523 43 13 10 10 10 1.8694881673261625 48.94310125045473 0.0 3 0.9149481434628045 4.201391836916472 4689.0 7.533354605618584 1.0 - - - - - - - 802.125 9 8 CYFIP2 cytoplasmic FMR1 interacting protein 2 625 80 A20140416_SF113_02 A20140416_SF113_02 TB372967.[MT7]-FC[CAM]SEVK[MT7].2b5_1.heavy 529.283 / 767.351 2715.0 23.690099716186523 43 13 10 10 10 1.8694881673261625 48.94310125045473 0.0 3 0.9149481434628045 4.201391836916472 2715.0 7.4824538963598926 3.0 - - - - - - - 709.375 7 8 CYFIP2 cytoplasmic FMR1 interacting protein 2 627 81 A20140416_SF113_02 A20140416_SF113_02 TB372968.[MT7]-FNYVVK[MT7].2y4_1.heavy 529.318 / 652.415 12189.0 28.285849571228027 25 13 2 6 4 0.8996918908167695 68.16045982646847 0.038600921630859375 7 0.9089334459397016 4.0581739688361615 12189.0 5.492690381456892 2.0 - - - - - - - 953.6666666666666 63 3 FBXO25 F-box protein 25 629 81 A20140416_SF113_02 A20140416_SF113_02 TB372968.[MT7]-FNYVVK[MT7].2b3_1.heavy 529.318 / 569.284 5348.0 28.285849571228027 25 13 2 6 4 0.8996918908167695 68.16045982646847 0.038600921630859375 7 0.9089334459397016 4.0581739688361615 5348.0 2.9724051142589776 2.0 - - - - - - - 1293.4 28 5 FBXO25 F-box protein 25 631 81 A20140416_SF113_02 A20140416_SF113_02 TB372968.[MT7]-FNYVVK[MT7].2y5_1.heavy 529.318 / 766.458 10572.0 28.285849571228027 25 13 2 6 4 0.8996918908167695 68.16045982646847 0.038600921630859375 7 0.9089334459397016 4.0581739688361615 10572.0 9.919293247694386 1.0 - - - - - - - 331.6666666666667 23 3 FBXO25 F-box protein 25 633 81 A20140416_SF113_02 A20140416_SF113_02 TB372968.[MT7]-FNYVVK[MT7].2b4_1.heavy 529.318 / 668.352 5224.0 28.285849571228027 25 13 2 6 4 0.8996918908167695 68.16045982646847 0.038600921630859375 7 0.9089334459397016 4.0581739688361615 5224.0 4.333402610676945 1.0 - - - - - - - 1318.5 10 10 FBXO25 F-box protein 25 635 82 A20140416_SF113_02 A20140416_SF113_02 TB372966.[MT7]-SIATFQSR.2y5_1.heavy 527.294 / 638.326 18458.0 25.263599395751953 50 20 10 10 10 21.441083104023292 4.663943491792893 0.0 3 0.9989957039545423 38.93992763257674 18458.0 12.420854700854703 1.0 - - - - - - - 1227.7777777777778 36 9 ALOX15B arachidonate 15-lipoxygenase, type B 637 82 A20140416_SF113_02 A20140416_SF113_02 TB372966.[MT7]-SIATFQSR.2b4_1.heavy 527.294 / 517.31 12478.0 25.263599395751953 50 20 10 10 10 21.441083104023292 4.663943491792893 0.0 3 0.9989957039545423 38.93992763257674 12478.0 4.082678964633448 3.0 - - - - - - - 2340.0 29 2 ALOX15B arachidonate 15-lipoxygenase, type B 639 82 A20140416_SF113_02 A20140416_SF113_02 TB372966.[MT7]-SIATFQSR.2y6_1.heavy 527.294 / 709.363 43544.0 25.263599395751953 50 20 10 10 10 21.441083104023292 4.663943491792893 0.0 3 0.9989957039545423 38.93992763257674 43544.0 15.923411127847652 2.0 - - - - - - - 1170.0 87 1 ALOX15B arachidonate 15-lipoxygenase, type B 641 82 A20140416_SF113_02 A20140416_SF113_02 TB372966.[MT7]-SIATFQSR.2y7_1.heavy 527.294 / 822.447 33666.0 25.263599395751953 50 20 10 10 10 21.441083104023292 4.663943491792893 0.0 3 0.9989957039545423 38.93992763257674 33666.0 80.33931818181819 0.0 - - - - - - - 211.25 67 8 ALOX15B arachidonate 15-lipoxygenase, type B 643 83 A20140416_SF113_02 A20140416_SF113_02 TB235799.[MT7]-LTQLNLDR.2y5_1.heavy 558.828 / 630.357 6035.0 29.52280044555664 44 20 10 10 4 7.114478060062024 14.055844877976643 0.0 7 0.9972487320586664 23.523194740273183 6035.0 2.5983708352760257 5.0 - - - - - - - 2227.1428571428573 18 7 GP1BA glycoprotein Ib (platelet), alpha polypeptide 645 83 A20140416_SF113_02 A20140416_SF113_02 TB235799.[MT7]-LTQLNLDR.2b4_1.heavy 558.828 / 600.384 N/A 29.52280044555664 44 20 10 10 4 7.114478060062024 14.055844877976643 0.0 7 0.9972487320586664 23.523194740273183 4400.0 1.8258713794796269 19.0 - - - - - - - 3215.0 13 7 GP1BA glycoprotein Ib (platelet), alpha polypeptide 647 83 A20140416_SF113_02 A20140416_SF113_02 TB235799.[MT7]-LTQLNLDR.2b5_1.heavy 558.828 / 714.427 5281.0 29.52280044555664 44 20 10 10 4 7.114478060062024 14.055844877976643 0.0 7 0.9972487320586664 23.523194740273183 5281.0 2.548714542564592 6.0 - - - - - - - 1215.4444444444443 17 9 GP1BA glycoprotein Ib (platelet), alpha polypeptide 649 83 A20140416_SF113_02 A20140416_SF113_02 TB235799.[MT7]-LTQLNLDR.2y7_1.heavy 558.828 / 859.463 15087.0 29.52280044555664 44 20 10 10 4 7.114478060062024 14.055844877976643 0.0 7 0.9972487320586664 23.523194740273183 15087.0 3.276725455721734 1.0 - - - - - - - 377.0 33 2 GP1BA glycoprotein Ib (platelet), alpha polypeptide 651 84 A20140416_SF113_02 A20140416_SF113_02 TB495560.[MT7]-SNFSLAILNVGAPAAGMNAAVR.3b5_1.heavy 763.415 / 693.369 12479.0 39.0724983215332 48 18 10 10 10 7.184627374475893 13.918606322613195 0.0 3 0.9864440750837611 10.587805710748606 12479.0 19.50087024329382 0.0 - - - - - - - 830.0 24 8 PFKL phosphofructokinase, liver 653 84 A20140416_SF113_02 A20140416_SF113_02 TB495560.[MT7]-SNFSLAILNVGAPAAGMNAAVR.3y12_1.heavy 763.415 / 1085.55 17173.0 39.0724983215332 48 18 10 10 10 7.184627374475893 13.918606322613195 0.0 3 0.9864440750837611 10.587805710748606 17173.0 68.61700873362446 0.0 - - - - - - - 374.54545454545456 34 11 PFKL phosphofructokinase, liver 655 84 A20140416_SF113_02 A20140416_SF113_02 TB495560.[MT7]-SNFSLAILNVGAPAAGMNAAVR.3b7_1.heavy 763.415 / 877.49 20722.0 39.0724983215332 48 18 10 10 10 7.184627374475893 13.918606322613195 0.0 3 0.9864440750837611 10.587805710748606 20722.0 35.52453922986482 0.0 - - - - - - - 768.4285714285714 41 7 PFKL phosphofructokinase, liver 657 84 A20140416_SF113_02 A20140416_SF113_02 TB495560.[MT7]-SNFSLAILNVGAPAAGMNAAVR.3y10_1.heavy 763.415 / 957.494 33659.0 39.0724983215332 48 18 10 10 10 7.184627374475893 13.918606322613195 0.0 3 0.9864440750837611 10.587805710748606 33659.0 66.23132015112114 0.0 - - - - - - - 317.77777777777777 67 9 PFKL phosphofructokinase, liver 659 85 A20140416_SF113_02 A20140416_SF113_02 TB372964.[MT7]-GGTPSAFDR.2y8_1.heavy 526.268 / 850.405 21268.0 22.548500061035156 50 20 10 10 10 5.689670231823373 17.57571105627205 0.0 3 0.9931486089730653 14.901319286416406 21268.0 117.87006294416244 0.0 - - - - - - - 787.8571428571429 42 7 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 661 85 A20140416_SF113_02 A20140416_SF113_02 TB372964.[MT7]-GGTPSAFDR.2b6_1.heavy 526.268 / 615.322 14516.0 22.548500061035156 50 20 10 10 10 5.689670231823373 17.57571105627205 0.0 3 0.9931486089730653 14.901319286416406 14516.0 14.407238965802147 0.0 - - - - - - - 262.6666666666667 29 3 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 663 85 A20140416_SF113_02 A20140416_SF113_02 TB372964.[MT7]-GGTPSAFDR.2y6_1.heavy 526.268 / 692.336 64142.0 22.548500061035156 50 20 10 10 10 5.689670231823373 17.57571105627205 0.0 3 0.9931486089730653 14.901319286416406 64142.0 79.22724814814815 0.0 - - - - - - - 187.66666666666666 128 3 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 665 85 A20140416_SF113_02 A20140416_SF113_02 TB372964.[MT7]-GGTPSAFDR.2b5_1.heavy 526.268 / 544.285 7877.0 22.548500061035156 50 20 10 10 10 5.689670231823373 17.57571105627205 0.0 3 0.9931486089730653 14.901319286416406 7877.0 11.795907284297785 0.0 - - - - - - - 1137.6666666666667 22 9 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 667 86 A20140416_SF113_02 A20140416_SF113_02 TB372961.[MT7]-LSGQDVER.2b4_1.heavy 524.281 / 530.305 4209.0 21.28030014038086 46 18 10 10 8 5.076564791457644 19.698359837398392 0.0 4 0.9877578053493599 11.14265468914082 4209.0 7.868037907876822 1.0 - - - - - - - 1239.5 8 8 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 669 86 A20140416_SF113_02 A20140416_SF113_02 TB372961.[MT7]-LSGQDVER.2y6_1.heavy 524.281 / 703.337 7951.0 21.28030014038086 46 18 10 10 8 5.076564791457644 19.698359837398392 0.0 4 0.9877578053493599 11.14265468914082 7951.0 23.06507782418819 0.0 - - - - - - - 297.8181818181818 35 11 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 671 86 A20140416_SF113_02 A20140416_SF113_02 TB372961.[MT7]-LSGQDVER.2b5_1.heavy 524.281 / 645.332 22636.0 21.28030014038086 46 18 10 10 8 5.076564791457644 19.698359837398392 0.0 4 0.9877578053493599 11.14265468914082 22636.0 18.206659297014035 1.0 - - - - - - - 717.0 77 3 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 673 86 A20140416_SF113_02 A20140416_SF113_02 TB372961.[MT7]-LSGQDVER.2y7_1.heavy 524.281 / 790.369 42091.0 21.28030014038086 46 18 10 10 8 5.076564791457644 19.698359837398392 0.0 4 0.9877578053493599 11.14265468914082 42091.0 92.5727259994907 0.0 - - - - - - - 794.875 84 8 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 675 87 A20140416_SF113_02 A20140416_SF113_02 TB495412.[MT7]-QANWLSVSNIIQLGGTIIGSAR.3b4_1.heavy 814.791 / 644.327 17782.0 47.127750396728516 43 17 10 6 10 13.59293573081604 7.356762511080937 0.0399017333984375 3 0.971247405016673 7.260687181728668 17782.0 46.799688235716474 0.0 - - - - - - - 783.5 35 8 PFKL phosphofructokinase, liver 677 87 A20140416_SF113_02 A20140416_SF113_02 TB495412.[MT7]-QANWLSVSNIIQLGGTIIGSAR.3b5_1.heavy 814.791 / 757.411 20030.0 47.127750396728516 43 17 10 6 10 13.59293573081604 7.356762511080937 0.0399017333984375 3 0.971247405016673 7.260687181728668 20030.0 85.0588877137001 0.0 - - - - - - - 191.9090909090909 40 11 PFKL phosphofructokinase, liver 679 87 A20140416_SF113_02 A20140416_SF113_02 TB495412.[MT7]-QANWLSVSNIIQLGGTIIGSAR.3y10_1.heavy 814.791 / 944.552 19008.0 47.127750396728516 43 17 10 6 10 13.59293573081604 7.356762511080937 0.0399017333984375 3 0.971247405016673 7.260687181728668 19008.0 149.71860310715707 0.0 - - - - - - - 817.5714285714286 38 7 PFKL phosphofructokinase, liver 681 87 A20140416_SF113_02 A20140416_SF113_02 TB495412.[MT7]-QANWLSVSNIIQLGGTIIGSAR.3y9_1.heavy 814.791 / 831.468 45374.0 47.127750396728516 43 17 10 6 10 13.59293573081604 7.356762511080937 0.0399017333984375 3 0.971247405016673 7.260687181728668 45374.0 177.90097079614878 0.0 - - - - - - - 242.11111111111111 90 9 PFKL phosphofructokinase, liver 683 88 A20140416_SF113_02 A20140416_SF113_02 TB495286.[MT7]-LIYPVGFWR.2b3_1.heavy 647.875 / 534.341 140648.0 39.765899658203125 47 17 10 10 10 15.156175567963732 6.597970546829396 0.0 3 0.9722974663779732 7.397669165550974 140648.0 88.85013381811441 1.0 - - - - - - - 1242.625 313 8 NTHL1 nth endonuclease III-like 1 (E. coli) 685 88 A20140416_SF113_02 A20140416_SF113_02 TB495286.[MT7]-LIYPVGFWR.2y8_1.heavy 647.875 / 1037.56 163842.0 39.765899658203125 47 17 10 10 10 15.156175567963732 6.597970546829396 0.0 3 0.9722974663779732 7.397669165550974 163842.0 257.40181486484073 0.0 - - - - - - - 314.25 327 4 NTHL1 nth endonuclease III-like 1 (E. coli) 687 88 A20140416_SF113_02 A20140416_SF113_02 TB495286.[MT7]-LIYPVGFWR.2y6_1.heavy 647.875 / 761.409 281182.0 39.765899658203125 47 17 10 10 10 15.156175567963732 6.597970546829396 0.0 3 0.9722974663779732 7.397669165550974 281182.0 510.37301750547044 0.0 - - - - - - - 767.2857142857143 562 7 NTHL1 nth endonuclease III-like 1 (E. coli) 689 88 A20140416_SF113_02 A20140416_SF113_02 TB495286.[MT7]-LIYPVGFWR.2y7_1.heavy 647.875 / 924.473 166013.0 39.765899658203125 47 17 10 10 10 15.156175567963732 6.597970546829396 0.0 3 0.9722974663779732 7.397669165550974 166013.0 316.6719165572575 0.0 - - - - - - - 320.1 332 10 NTHL1 nth endonuclease III-like 1 (E. coli) 691 89 A20140416_SF113_02 A20140416_SF113_02 TB235794.[MT7]-FLWQPK[MT7].2y4_1.heavy 553.834 / 702.406 39645.0 33.37532424926758 46 20 10 6 10 4.620414528636018 17.293881005339536 0.039703369140625 3 0.9934171065919194 15.202514537527883 39645.0 38.988853159426675 0.0 - - - - - - - 823.5 79 2 HLA-DRB1 major histocompatibility complex, class II, DR beta 1 693 89 A20140416_SF113_02 A20140416_SF113_02 TB235794.[MT7]-FLWQPK[MT7].2b3_1.heavy 553.834 / 591.341 30272.0 33.37532424926758 46 20 10 6 10 4.620414528636018 17.293881005339536 0.039703369140625 3 0.9934171065919194 15.202514537527883 30272.0 10.846295966581422 1.0 - - - - - - - 760.0 62 3 HLA-DRB1 major histocompatibility complex, class II, DR beta 1 695 89 A20140416_SF113_02 A20140416_SF113_02 TB235794.[MT7]-FLWQPK[MT7].2y5_1.heavy 553.834 / 815.49 27992.0 33.37532424926758 46 20 10 6 10 4.620414528636018 17.293881005339536 0.039703369140625 3 0.9934171065919194 15.202514537527883 27992.0 51.97446531774758 0.0 - - - - - - - 760.1111111111111 55 9 HLA-DRB1 major histocompatibility complex, class II, DR beta 1 697 89 A20140416_SF113_02 A20140416_SF113_02 TB235794.[MT7]-FLWQPK[MT7].2b4_1.heavy 553.834 / 719.4 42305.0 33.37532424926758 46 20 10 6 10 4.620414528636018 17.293881005339536 0.039703369140625 3 0.9934171065919194 15.202514537527883 42305.0 63.594504632111935 0.0 - - - - - - - 253.0 84 1 HLA-DRB1 major histocompatibility complex, class II, DR beta 1 699 90 A20140416_SF113_02 A20140416_SF113_02 TB495416.[MT7]-LVEDHLAVQSLIR.3y7_1.heavy 546.322 / 786.483 76131.0 33.40510177612305 45 17 10 10 8 3.134375219583302 31.90428490348212 0.0 4 0.9774644775356447 8.205585511827588 76131.0 109.11170102558035 0.0 - - - - - - - 642.1 152 10 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 701 90 A20140416_SF113_02 A20140416_SF113_02 TB495416.[MT7]-LVEDHLAVQSLIR.3y6_1.heavy 546.322 / 715.446 46860.0 33.40510177612305 45 17 10 10 8 3.134375219583302 31.90428490348212 0.0 4 0.9774644775356447 8.205585511827588 46860.0 59.032797234014026 0.0 - - - - - - - 385.0 93 1 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 703 90 A20140416_SF113_02 A20140416_SF113_02 TB495416.[MT7]-LVEDHLAVQSLIR.3b4_1.heavy 546.322 / 601.331 97571.0 33.40510177612305 45 17 10 10 8 3.134375219583302 31.90428490348212 0.0 4 0.9774644775356447 8.205585511827588 97571.0 92.78376674006539 0.0 - - - - - - - 256.5 195 2 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 705 90 A20140416_SF113_02 A20140416_SF113_02 TB495416.[MT7]-LVEDHLAVQSLIR.3y5_1.heavy 546.322 / 616.378 50069.0 33.40510177612305 45 17 10 10 8 3.134375219583302 31.90428490348212 0.0 4 0.9774644775356447 8.205585511827588 50069.0 32.376692334510814 1.0 - - - - - - - 719.2 133 5 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 707 91 A20140416_SF113_02 A20140416_SF113_02 TB495280.[MT7]-RFDEATQLR.3y6_1.heavy 427.234 / 717.389 113997.0 24.166200637817383 43 13 10 10 10 3.4011443843112015 29.401868518513943 0.0 3 0.9299810529919862 4.636468783140028 113997.0 263.17434106069794 0.0 - - - - - - - 776.1111111111111 227 9 PFKL phosphofructokinase, liver 709 91 A20140416_SF113_02 A20140416_SF113_02 TB495280.[MT7]-RFDEATQLR.3b4_1.heavy 427.234 / 692.348 55502.0 24.166200637817383 43 13 10 10 10 3.4011443843112015 29.401868518513943 0.0 3 0.9299810529919862 4.636468783140028 55502.0 54.61202623906706 0.0 - - - - - - - 873.0 111 3 PFKL phosphofructokinase, liver 711 91 A20140416_SF113_02 A20140416_SF113_02 TB495280.[MT7]-RFDEATQLR.3b3_1.heavy 427.234 / 563.306 46646.0 24.166200637817383 43 13 10 10 10 3.4011443843112015 29.401868518513943 0.0 3 0.9299810529919862 4.636468783140028 46646.0 47.13980811984216 0.0 - - - - - - - 1289.0 93 3 PFKL phosphofructokinase, liver 713 91 A20140416_SF113_02 A20140416_SF113_02 TB495280.[MT7]-RFDEATQLR.3y4_1.heavy 427.234 / 517.309 191325.0 24.166200637817383 43 13 10 10 10 3.4011443843112015 29.401868518513943 0.0 3 0.9299810529919862 4.636468783140028 191325.0 56.41670547261275 0.0 - - - - - - - 2245.0 382 4 PFKL phosphofructokinase, liver 715 92 A20140416_SF113_02 A20140416_SF113_02 TB495414.[MT7]-RTILEMTQILK[MT7].3b6_1.heavy 545.335 / 888.509 12979.0 35.11949920654297 48 18 10 10 10 5.07230643334049 19.714897219674203 0.0 3 0.981330569311827 9.018178736942634 12979.0 47.377709772700534 0.0 - - - - - - - 256.9 25 10 FBXO25 F-box protein 25 717 92 A20140416_SF113_02 A20140416_SF113_02 TB495414.[MT7]-RTILEMTQILK[MT7].3y3_1.heavy 545.335 / 517.383 N/A 35.11949920654297 48 18 10 10 10 5.07230643334049 19.714897219674203 0.0 3 0.981330569311827 9.018178736942634 92934.0 23.21302028325836 0.0 - - - - - - - 2816.0 185 1 FBXO25 F-box protein 25 719 92 A20140416_SF113_02 A20140416_SF113_02 TB495414.[MT7]-RTILEMTQILK[MT7].3b4_1.heavy 545.335 / 628.426 38080.0 35.11949920654297 48 18 10 10 10 5.07230643334049 19.714897219674203 0.0 3 0.981330569311827 9.018178736942634 38080.0 24.994742974361106 0.0 - - - - - - - 367.0 76 1 FBXO25 F-box protein 25 721 92 A20140416_SF113_02 A20140416_SF113_02 TB495414.[MT7]-RTILEMTQILK[MT7].3b5_1.heavy 545.335 / 757.469 45304.0 35.11949920654297 48 18 10 10 10 5.07230643334049 19.714897219674203 0.0 3 0.981330569311827 9.018178736942634 45304.0 45.40642578722361 0.0 - - - - - - - 830.0 90 9 FBXO25 F-box protein 25 723 93 A20140416_SF113_02 A20140416_SF113_02 TB495413.[MT7]-TAGSGLSFLEWYR.3y3_1.heavy 544.283 / 524.262 45553.0 39.845298767089844 44 14 10 10 10 1.5292413959173858 43.705287835254815 0.0 3 0.939263284950792 4.982114342601307 45553.0 117.19391528995023 0.0 - - - - - - - 343.3333333333333 91 6 PLA2G4F phospholipase A2, group IVF 725 93 A20140416_SF113_02 A20140416_SF113_02 TB495413.[MT7]-TAGSGLSFLEWYR.3b5_1.heavy 544.283 / 518.269 40402.0 39.845298767089844 44 14 10 10 10 1.5292413959173858 43.705287835254815 0.0 3 0.939263284950792 4.982114342601307 40402.0 75.99825551272855 0.0 - - - - - - - 182.8 80 5 PLA2G4F phospholipase A2, group IVF 727 93 A20140416_SF113_02 A20140416_SF113_02 TB495413.[MT7]-TAGSGLSFLEWYR.3y4_1.heavy 544.283 / 653.304 67528.0 39.845298767089844 44 14 10 10 10 1.5292413959173858 43.705287835254815 0.0 3 0.939263284950792 4.982114342601307 67528.0 385.2129367575656 0.0 - - - - - - - 251.6 135 10 PLA2G4F phospholipase A2, group IVF 729 93 A20140416_SF113_02 A20140416_SF113_02 TB495413.[MT7]-TAGSGLSFLEWYR.3y5_1.heavy 544.283 / 766.388 35824.0 39.845298767089844 44 14 10 10 10 1.5292413959173858 43.705287835254815 0.0 3 0.939263284950792 4.982114342601307 35824.0 176.40402205049207 0.0 - - - - - - - 254.33333333333334 71 9 PLA2G4F phospholipase A2, group IVF 731 94 A20140416_SF113_02 A20140416_SF113_02 TB495140.[MT7]-QEELQAR.2b3_1.heavy 509.276 / 531.253 22289.0 19.260299682617188 43 13 10 10 10 1.219356252984218 55.00569299832259 0.0 3 0.9058294461042156 3.9896632947822672 22289.0 36.499643955632784 0.0 - - - - - - - 709.6666666666666 44 12 ALOX15B arachidonate 15-lipoxygenase, type B 733 94 A20140416_SF113_02 A20140416_SF113_02 TB495140.[MT7]-QEELQAR.2y5_1.heavy 509.276 / 616.341 19760.0 19.260299682617188 43 13 10 10 10 1.219356252984218 55.00569299832259 0.0 3 0.9058294461042156 3.9896632947822672 19760.0 39.68952084892445 0.0 - - - - - - - 818.3 39 10 ALOX15B arachidonate 15-lipoxygenase, type B 735 94 A20140416_SF113_02 A20140416_SF113_02 TB495140.[MT7]-QEELQAR.2b4_1.heavy 509.276 / 644.337 13905.0 19.260299682617188 43 13 10 10 10 1.219356252984218 55.00569299832259 0.0 3 0.9058294461042156 3.9896632947822672 13905.0 59.679981203007515 0.0 - - - - - - - 615.25 27 8 ALOX15B arachidonate 15-lipoxygenase, type B 737 94 A20140416_SF113_02 A20140416_SF113_02 TB495140.[MT7]-QEELQAR.2y6_1.heavy 509.276 / 745.384 51364.0 19.260299682617188 43 13 10 10 10 1.219356252984218 55.00569299832259 0.0 3 0.9058294461042156 3.9896632947822672 51364.0 154.08147470998736 0.0 - - - - - - - 817.2857142857143 102 7 ALOX15B arachidonate 15-lipoxygenase, type B 739 95 A20140416_SF113_02 A20140416_SF113_02 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 993487.0 32.007999420166016 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 993487.0 104.63341688792754 0.0 - - - - - - - 1142.0 1986 1 741 95 A20140416_SF113_02 A20140416_SF113_02 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 244670.0 32.007999420166016 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 244670.0 108.01325468958748 0.0 - - - - - - - 635.0 489 1 743 95 A20140416_SF113_02 A20140416_SF113_02 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 322970.0 32.007999420166016 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 322970.0 74.45902726330627 0.0 - - - - - - - 761.0 645 1 745 96 A20140416_SF113_02 A20140416_SF113_02 TB235891.[MT7]-LSHIAEDVGR.3y3_1.heavy 414.23 / 331.209 181757.0 25.627700805664062 45 15 10 10 10 3.295299688151634 24.093878180769735 0.0 3 0.9539682089957789 5.729981859385636 181757.0 50.16143099610825 0.0 - - - - - - - 2442.0 363 1 ARHGAP4 Rho GTPase activating protein 4 747 96 A20140416_SF113_02 A20140416_SF113_02 TB235891.[MT7]-LSHIAEDVGR.3y6_1.heavy 414.23 / 646.315 309142.0 25.627700805664062 45 15 10 10 10 3.295299688151634 24.093878180769735 0.0 3 0.9539682089957789 5.729981859385636 309142.0 55.901137035267496 0.0 - - - - - - - 321.5 618 2 ARHGAP4 Rho GTPase activating protein 4 749 96 A20140416_SF113_02 A20140416_SF113_02 TB235891.[MT7]-LSHIAEDVGR.3b3_1.heavy 414.23 / 482.284 339092.0 25.627700805664062 45 15 10 10 10 3.295299688151634 24.093878180769735 0.0 3 0.9539682089957789 5.729981859385636 339092.0 45.23136546807539 1.0 - - - - - - - 1285.0 678 1 ARHGAP4 Rho GTPase activating protein 4 751 96 A20140416_SF113_02 A20140416_SF113_02 TB235891.[MT7]-LSHIAEDVGR.3y5_1.heavy 414.23 / 575.278 205537.0 25.627700805664062 45 15 10 10 10 3.295299688151634 24.093878180769735 0.0 3 0.9539682089957789 5.729981859385636 205537.0 63.29433240386562 0.0 - - - - - - - 835.5 411 2 ARHGAP4 Rho GTPase activating protein 4 753 97 A20140416_SF113_02 A20140416_SF113_02 TB372808.[MT7]-RALSLR.2y5_2.heavy 430.283 / 280.182 N/A N/A - - - - - - - - - 0.0 - - - - - - - C11orf86;ZGPAT chromosome 11 open reading frame 86;zinc finger, CCCH-type with G patch domain 755 97 A20140416_SF113_02 A20140416_SF113_02 TB372808.[MT7]-RALSLR.2y5_1.heavy 430.283 / 559.356 N/A N/A - - - - - - - - - 0.0 - - - - - - - C11orf86;ZGPAT chromosome 11 open reading frame 86;zinc finger, CCCH-type with G patch domain 757 97 A20140416_SF113_02 A20140416_SF113_02 TB372808.[MT7]-RALSLR.2b4_1.heavy 430.283 / 572.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - C11orf86;ZGPAT chromosome 11 open reading frame 86;zinc finger, CCCH-type with G patch domain 759 97 A20140416_SF113_02 A20140416_SF113_02 TB372808.[MT7]-RALSLR.2b5_1.heavy 430.283 / 685.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - C11orf86;ZGPAT chromosome 11 open reading frame 86;zinc finger, CCCH-type with G patch domain 761 98 A20140416_SF113_02 A20140416_SF113_02 TB372994.[MT7]-NAFVTGIAR.2y8_1.heavy 546.818 / 834.483 41182.0 28.49915075302124 39 18 9 6 6 2.838500355890609 28.43725071002382 0.03940010070800781 5 0.9832207882829872 9.514094398058027 41182.0 97.01157478596765 0.0 - - - - - - - 341.0 82 8 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 763 98 A20140416_SF113_02 A20140416_SF113_02 TB372994.[MT7]-NAFVTGIAR.2y5_1.heavy 546.818 / 517.309 28530.0 28.49915075302124 39 18 9 6 6 2.838500355890609 28.43725071002382 0.03940010070800781 5 0.9832207882829872 9.514094398058027 28530.0 10.176685626174258 1.0 - - - - - - - 2233.0 99 1 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 765 98 A20140416_SF113_02 A20140416_SF113_02 TB372994.[MT7]-NAFVTGIAR.2y6_1.heavy 546.818 / 616.378 26297.0 28.49915075302124 39 18 9 6 6 2.838500355890609 28.43725071002382 0.03940010070800781 5 0.9832207882829872 9.514094398058027 26297.0 15.935123437994385 1.0 - - - - - - - 992.0 56 1 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 767 98 A20140416_SF113_02 A20140416_SF113_02 TB372994.[MT7]-NAFVTGIAR.2y7_1.heavy 546.818 / 763.446 25677.0 28.49915075302124 39 18 9 6 6 2.838500355890609 28.43725071002382 0.03940010070800781 5 0.9832207882829872 9.514094398058027 25677.0 44.157555509007125 0.0 - - - - - - - 716.4444444444445 51 9 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 769 99 A20140416_SF113_02 A20140416_SF113_02 TB372809.[MT7]-EAAAEAR.2y5_1.heavy 431.231 / 517.273 N/A N/A - - - - - - - - - 0.0 - - - - - - - NTHL1 nth endonuclease III-like 1 (E. coli) 771 99 A20140416_SF113_02 A20140416_SF113_02 TB372809.[MT7]-EAAAEAR.2b4_1.heavy 431.231 / 487.263 N/A N/A - - - - - - - - - 0.0 - - - - - - - NTHL1 nth endonuclease III-like 1 (E. coli) 773 99 A20140416_SF113_02 A20140416_SF113_02 TB372809.[MT7]-EAAAEAR.2y6_1.heavy 431.231 / 588.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - NTHL1 nth endonuclease III-like 1 (E. coli) 775 99 A20140416_SF113_02 A20140416_SF113_02 TB372809.[MT7]-EAAAEAR.2b5_1.heavy 431.231 / 616.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - NTHL1 nth endonuclease III-like 1 (E. coli) 777 100 A20140416_SF113_02 A20140416_SF113_02 TB495551.[MT7]-LLTPQGPFSQAVLDIFTSR.3y6_1.heavy 745.415 / 738.378 N/A 46.4541015625 46 20 10 10 6 6.161382163433157 16.230124564173995 0.0 6 0.9938662933073995 15.749930116757026 0.0 0.0 37.0 - - - - - - - 0.0 19 0 PLA2G4F phospholipase A2, group IVF 779 100 A20140416_SF113_02 A20140416_SF113_02 TB495551.[MT7]-LLTPQGPFSQAVLDIFTSR.3b6_1.heavy 745.415 / 754.458 9424.0 46.4541015625 46 20 10 10 6 6.161382163433157 16.230124564173995 0.0 6 0.9938662933073995 15.749930116757026 9424.0 1.7012691975517253 1.0 - - - - - - - 0.0 19 0 PLA2G4F phospholipase A2, group IVF 781 100 A20140416_SF113_02 A20140416_SF113_02 TB495551.[MT7]-LLTPQGPFSQAVLDIFTSR.3y8_1.heavy 745.415 / 950.531 6150.0 46.4541015625 46 20 10 10 6 6.161382163433157 16.230124564173995 0.0 6 0.9938662933073995 15.749930116757026 6150.0 -0.2844248227607441 3.0 - - - - - - - 0.0 19 0 PLA2G4F phospholipase A2, group IVF 783 100 A20140416_SF113_02 A20140416_SF113_02 TB495551.[MT7]-LLTPQGPFSQAVLDIFTSR.3y5_1.heavy 745.415 / 623.351 11261.0 46.4541015625 46 20 10 10 6 6.161382163433157 16.230124564173995 0.0 6 0.9938662933073995 15.749930116757026 11261.0 3.5991903915731998 1.0 - - - - - - - 0.0 22 0 PLA2G4F phospholipase A2, group IVF 785 101 A20140416_SF113_02 A20140416_SF113_02 TB236127.[MT7]-RELLQELAEFMR.3b6_1.heavy 560.307 / 913.522 9284.0 41.273624420166016 40 14 10 6 10 1.934382072011105 41.19330192773498 0.038299560546875 3 0.9426126815182673 5.126905162274584 9284.0 63.814530338548764 0.0 - - - - - - - 199.2 18 10 ARHGAP4 Rho GTPase activating protein 4 787 101 A20140416_SF113_02 A20140416_SF113_02 TB236127.[MT7]-RELLQELAEFMR.3b4_1.heavy 560.307 / 656.421 10721.0 41.273624420166016 40 14 10 6 10 1.934382072011105 41.19330192773498 0.038299560546875 3 0.9426126815182673 5.126905162274584 10721.0 24.249388497199714 0.0 - - - - - - - 284.2857142857143 21 14 ARHGAP4 Rho GTPase activating protein 4 789 101 A20140416_SF113_02 A20140416_SF113_02 TB236127.[MT7]-RELLQELAEFMR.3y4_1.heavy 560.307 / 582.27 22436.0 41.273624420166016 40 14 10 6 10 1.934382072011105 41.19330192773498 0.038299560546875 3 0.9426126815182673 5.126905162274584 22436.0 129.94606334841626 0.0 - - - - - - - 302.2 44 15 ARHGAP4 Rho GTPase activating protein 4 791 101 A20140416_SF113_02 A20140416_SF113_02 TB236127.[MT7]-RELLQELAEFMR.3y5_1.heavy 560.307 / 653.308 36030.0 41.273624420166016 40 14 10 6 10 1.934382072011105 41.19330192773498 0.038299560546875 3 0.9426126815182673 5.126905162274584 36030.0 362.1653173535526 0.0 - - - - - - - 233.55555555555554 72 9 ARHGAP4 Rho GTPase activating protein 4 793 102 A20140416_SF113_02 A20140416_SF113_02 TB372997.[MT7]-ITSTAWK[MT7].2y4_1.heavy 547.826 / 649.379 13211.0 27.35374927520752 38 17 10 5 6 1.395051467042088 43.84332371909317 0.04030036926269531 5 0.9728239061567369 7.469308205420344 13211.0 3.1308084406686767 1.0 - - - - - - - 818.0 26 2 FBXL5 F-box and leucine-rich repeat protein 5 795 102 A20140416_SF113_02 A20140416_SF113_02 TB372997.[MT7]-ITSTAWK[MT7].2y5_1.heavy 547.826 / 736.411 14595.0 27.35374927520752 38 17 10 5 6 1.395051467042088 43.84332371909317 0.04030036926269531 5 0.9728239061567369 7.469308205420344 14595.0 8.062567056349799 0.0 - - - - - - - 1258.0 29 7 FBXL5 F-box and leucine-rich repeat protein 5 797 102 A20140416_SF113_02 A20140416_SF113_02 TB372997.[MT7]-ITSTAWK[MT7].2y6_1.heavy 547.826 / 837.459 44415.0 27.35374927520752 38 17 10 5 6 1.395051467042088 43.84332371909317 0.04030036926269531 5 0.9728239061567369 7.469308205420344 44415.0 49.953300733496334 0.0 - - - - - - - 644.75 88 8 FBXL5 F-box and leucine-rich repeat protein 5 799 102 A20140416_SF113_02 A20140416_SF113_02 TB372997.[MT7]-ITSTAWK[MT7].2b5_1.heavy 547.826 / 618.358 16734.0 27.35374927520752 38 17 10 5 6 1.395051467042088 43.84332371909317 0.04030036926269531 5 0.9728239061567369 7.469308205420344 16734.0 6.660002481466005 2.0 - - - - - - - 755.0 41 1 FBXL5 F-box and leucine-rich repeat protein 5 801 103 A20140416_SF113_02 A20140416_SF113_02 TB235765.[MT7]-AREPSVGGR.3y3_1.heavy 358.204 / 289.162 59332.0 17.69930076599121 38 18 2 10 8 5.124997462281351 19.512204783704583 0.0 4 0.9819814789764401 9.180123470110729 59332.0 33.254792725499385 0.0 - - - - - - - 1387.0 118 2 AQP8 aquaporin 8 803 103 A20140416_SF113_02 A20140416_SF113_02 TB235765.[MT7]-AREPSVGGR.3y6_1.heavy 358.204 / 572.315 48318.0 17.69930076599121 38 18 2 10 8 5.124997462281351 19.512204783704583 0.0 4 0.9819814789764401 9.180123470110729 48318.0 37.59170461401808 0.0 - - - - - - - 730.3333333333334 96 6 AQP8 aquaporin 8 805 103 A20140416_SF113_02 A20140416_SF113_02 TB235765.[MT7]-AREPSVGGR.3y4_1.heavy 358.204 / 388.23 42972.0 17.69930076599121 38 18 2 10 8 5.124997462281351 19.512204783704583 0.0 4 0.9819814789764401 9.180123470110729 42972.0 7.354616218776762 2.0 - - - - - - - 2372.0 181 1 AQP8 aquaporin 8 807 103 A20140416_SF113_02 A20140416_SF113_02 TB235765.[MT7]-AREPSVGGR.3y5_1.heavy 358.204 / 475.262 22993.0 17.69930076599121 38 18 2 10 8 5.124997462281351 19.512204783704583 0.0 4 0.9819814789764401 9.180123470110729 22993.0 21.22038918939833 1.0 - - - - - - - 1213.2727272727273 253 11 AQP8 aquaporin 8 809 104 A20140416_SF113_02 A20140416_SF113_02 TB495559.[MT7]-VPVWEPQDWQQQLVNIR.3y7_1.heavy 760.407 / 870.516 18896.0 39.66254997253418 38 17 8 5 8 4.217970866156247 23.708082197146137 0.041500091552734375 4 0.9730280157681155 7.497645619934399 18896.0 39.4017029181396 0.0 - - - - - - - 673.0 37 8 NTHL1 nth endonuclease III-like 1 (E. coli) 811 104 A20140416_SF113_02 A20140416_SF113_02 TB495559.[MT7]-VPVWEPQDWQQQLVNIR.3y6_1.heavy 760.407 / 742.457 14201.0 39.66254997253418 38 17 8 5 8 4.217970866156247 23.708082197146137 0.041500091552734375 4 0.9730280157681155 7.497645619934399 14201.0 14.98501384534622 1.0 - - - - - - - 1832.375 89 8 NTHL1 nth endonuclease III-like 1 (E. coli) 813 104 A20140416_SF113_02 A20140416_SF113_02 TB495559.[MT7]-VPVWEPQDWQQQLVNIR.3b5_1.heavy 760.407 / 755.421 33555.0 39.66254997253418 38 17 8 5 8 4.217970866156247 23.708082197146137 0.041500091552734375 4 0.9730280157681155 7.497645619934399 33555.0 83.83312266267764 0.0 - - - - - - - 327.42857142857144 67 7 NTHL1 nth endonuclease III-like 1 (E. coli) 815 104 A20140416_SF113_02 A20140416_SF113_02 TB495559.[MT7]-VPVWEPQDWQQQLVNIR.3y8_1.heavy 760.407 / 998.574 12827.0 39.66254997253418 38 17 8 5 8 4.217970866156247 23.708082197146137 0.041500091552734375 4 0.9730280157681155 7.497645619934399 12827.0 68.8067160700868 0.0 - - - - - - - 253.78571428571428 25 14 NTHL1 nth endonuclease III-like 1 (E. coli) 817 105 A20140416_SF113_02 A20140416_SF113_02 TB495270.[MT7]-ARSESAQSK[MT7].3y3_1.heavy 417.901 / 506.306 11659.0 14.138299942016602 40 12 10 10 8 0.9854447996645294 60.63986766077451 0.0 4 0.8813129104090234 3.546243507900696 11659.0 42.420022321428576 0.0 - - - - - - - 247.5 23 36 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100510495;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 819 105 A20140416_SF113_02 A20140416_SF113_02 TB495270.[MT7]-ARSESAQSK[MT7].3b6_1.heavy 417.901 / 746.391 8351.0 14.138299942016602 40 12 10 10 8 0.9854447996645294 60.63986766077451 0.0 4 0.8813129104090234 3.546243507900696 8351.0 178.84941920374706 0.0 - - - - - - - 117.58823529411765 16 34 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100510495;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 821 105 A20140416_SF113_02 A20140416_SF113_02 TB495270.[MT7]-ARSESAQSK[MT7].3b4_1.heavy 417.901 / 588.322 2334.0 14.138299942016602 40 12 10 10 8 0.9854447996645294 60.63986766077451 0.0 4 0.8813129104090234 3.546243507900696 2334.0 18.151714215912484 1.0 - - - - - - - 140.825 4 40 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100510495;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 823 105 A20140416_SF113_02 A20140416_SF113_02 TB495270.[MT7]-ARSESAQSK[MT7].3b5_1.heavy 417.901 / 675.354 4973.0 14.138299942016602 40 12 10 10 8 0.9854447996645294 60.63986766077451 0.0 4 0.8813129104090234 3.546243507900696 4973.0 30.60515725550621 1.0 - - - - - - - 101.725 15 40 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100509246;LOC100510495;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 825 106 A20140416_SF113_02 A20140416_SF113_02 TB495556.[MT7]-AVTELGRPDAEYWNSQK[MT7].3y3_1.heavy 751.39 / 506.306 N/A 29.124000549316406 48 18 10 10 10 3.4988898072770698 28.580494244779516 0.0 3 0.9816839196806595 9.105021629490365 19776.0 8.58286481065254 1.0 - - - - - - - 456.5 39 6 LOC100133811;LOC100290966;LOC100294276;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 827 106 A20140416_SF113_02 A20140416_SF113_02 TB495556.[MT7]-AVTELGRPDAEYWNSQK[MT7].3b4_1.heavy 751.39 / 545.305 13930.0 29.124000549316406 48 18 10 10 10 3.4988898072770698 28.580494244779516 0.0 3 0.9816839196806595 9.105021629490365 13930.0 5.332875059985527 0.0 - - - - - - - 311.25 27 4 LOC100133811;LOC100290966;LOC100294276;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 829 106 A20140416_SF113_02 A20140416_SF113_02 TB495556.[MT7]-AVTELGRPDAEYWNSQK[MT7].3y4_1.heavy 751.39 / 620.348 16666.0 29.124000549316406 48 18 10 10 10 3.4988898072770698 28.580494244779516 0.0 3 0.9816839196806595 9.105021629490365 16666.0 13.88778185375962 0.0 - - - - - - - 1340.5555555555557 33 9 LOC100133811;LOC100290966;LOC100294276;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 831 106 A20140416_SF113_02 A20140416_SF113_02 TB495556.[MT7]-AVTELGRPDAEYWNSQK[MT7].3y8_1.heavy 751.39 / 1169.57 7214.0 29.124000549316406 48 18 10 10 10 3.4988898072770698 28.580494244779516 0.0 3 0.9816839196806595 9.105021629490365 7214.0 70.53973103865778 0.0 - - - - - - - 279.8125 14 16 LOC100133811;LOC100290966;LOC100294276;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 833 107 A20140416_SF113_02 A20140416_SF113_02 TB236320.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].3y7_1.heavy 841.818 / 900.527 17789.0 34.2484016418457 46 16 10 10 10 3.201974553548144 31.230729141550754 0.0 3 0.962765973250801 6.375812369789742 17789.0 33.64866301430261 0.0 - - - - - - - 298.75 35 12 ALOX15B arachidonate 15-lipoxygenase, type B 835 107 A20140416_SF113_02 A20140416_SF113_02 TB236320.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].3b4_1.heavy 841.818 / 517.31 10995.0 34.2484016418457 46 16 10 10 10 3.201974553548144 31.230729141550754 0.0 3 0.962765973250801 6.375812369789742 10995.0 12.802522552398944 0.0 - - - - - - - 792.5833333333334 21 12 ALOX15B arachidonate 15-lipoxygenase, type B 837 107 A20140416_SF113_02 A20140416_SF113_02 TB236320.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].3y4_1.heavy 841.818 / 575.363 15689.0 34.2484016418457 46 16 10 10 10 3.201974553548144 31.230729141550754 0.0 3 0.962765973250801 6.375812369789742 15689.0 28.294612716763005 0.0 - - - - - - - 794.2857142857143 31 7 ALOX15B arachidonate 15-lipoxygenase, type B 839 107 A20140416_SF113_02 A20140416_SF113_02 TB236320.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].3y5_1.heavy 841.818 / 690.39 6547.0 34.2484016418457 46 16 10 10 10 3.201974553548144 31.230729141550754 0.0 3 0.962765973250801 6.375812369789742 6547.0 5.127461920970973 1.0 - - - - - - - 823.5555555555555 15 9 ALOX15B arachidonate 15-lipoxygenase, type B 841 108 A20140416_SF113_02 A20140416_SF113_02 TB495553.[MT7]-LLTPQGPFSQAVLDIFTSR.2y4_1.heavy 1117.62 / 510.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 843 108 A20140416_SF113_02 A20140416_SF113_02 TB495553.[MT7]-LLTPQGPFSQAVLDIFTSR.2y5_1.heavy 1117.62 / 623.351 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 845 108 A20140416_SF113_02 A20140416_SF113_02 TB495553.[MT7]-LLTPQGPFSQAVLDIFTSR.2y9_1.heavy 1117.62 / 1021.57 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 847 108 A20140416_SF113_02 A20140416_SF113_02 TB495553.[MT7]-LLTPQGPFSQAVLDIFTSR.2y11_1.heavy 1117.62 / 1236.66 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 849 109 A20140416_SF113_02 A20140416_SF113_02 TB495273.[MT7]-VQEAEENFR.2b3_1.heavy 633.316 / 501.279 26420.0 24.78030014038086 48 18 10 10 10 3.4372815507109404 22.24055092428096 0.0 3 0.9890256513461515 11.769960802800538 26420.0 34.103033875447665 0.0 - - - - - - - 765.7777777777778 52 9 TTC39A tetratricopeptide repeat domain 39A 851 109 A20140416_SF113_02 A20140416_SF113_02 TB495273.[MT7]-VQEAEENFR.2y8_1.heavy 633.316 / 1022.45 89852.0 24.78030014038086 48 18 10 10 10 3.4372815507109404 22.24055092428096 0.0 3 0.9890256513461515 11.769960802800538 89852.0 64.14777997971267 0.0 - - - - - - - 191.5 179 6 TTC39A tetratricopeptide repeat domain 39A 853 109 A20140416_SF113_02 A20140416_SF113_02 TB495273.[MT7]-VQEAEENFR.2y6_1.heavy 633.316 / 765.353 25654.0 24.78030014038086 48 18 10 10 10 3.4372815507109404 22.24055092428096 0.0 3 0.9890256513461515 11.769960802800538 25654.0 107.27582654994114 0.0 - - - - - - - 601.8571428571429 51 7 TTC39A tetratricopeptide repeat domain 39A 855 109 A20140416_SF113_02 A20140416_SF113_02 TB495273.[MT7]-VQEAEENFR.2y7_1.heavy 633.316 / 894.395 25016.0 24.78030014038086 48 18 10 10 10 3.4372815507109404 22.24055092428096 0.0 3 0.9890256513461515 11.769960802800538 25016.0 112.34339425587467 0.0 - - - - - - - 217.2 50 10 TTC39A tetratricopeptide repeat domain 39A 857 110 A20140416_SF113_02 A20140416_SF113_02 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 1164460.0 22.863500595092773 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1164460.0 522.5200137205246 0.0 - - - - - - - 1479.0 2328 1 859 110 A20140416_SF113_02 A20140416_SF113_02 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 2026010.0 22.863500595092773 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2026010.0 632.2010619794514 0.0 - - - - - - - 363.8 4052 5 861 110 A20140416_SF113_02 A20140416_SF113_02 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 5566960.0 22.863500595092773 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 5566960.0 628.7642278804392 0.0 - - - - - - - 455.0 11133 1 863 111 A20140416_SF113_02 A20140416_SF113_02 TB235628.[MT7]-HLQESR.2y5_1.heavy 457.252 / 632.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAGE1 cancer antigen 1 865 112 A20140416_SF113_02 A20140416_SF113_02 TB372810.[MT7]-SIDLNR.2y4_1.heavy 431.249 / 517.273 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 867 112 A20140416_SF113_02 A20140416_SF113_02 TB372810.[MT7]-SIDLNR.2b3_1.heavy 431.249 / 460.252 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 869 112 A20140416_SF113_02 A20140416_SF113_02 TB372810.[MT7]-SIDLNR.2y5_1.heavy 431.249 / 630.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 871 112 A20140416_SF113_02 A20140416_SF113_02 TB372810.[MT7]-SIDLNR.2b4_1.heavy 431.249 / 573.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 873 113 A20140416_SF113_02 A20140416_SF113_02 TB236113.[MT7]-SDLAVPSELALLK[MT7].3y3_1.heavy 548.666 / 517.383 42564.0 37.052398681640625 44 14 10 10 10 1.9579600815135365 44.28898963349065 0.0 3 0.9496001276984236 5.474021860859383 42564.0 26.432618200810122 0.0 - - - - - - - 1738.375 85 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 875 113 A20140416_SF113_02 A20140416_SF113_02 TB236113.[MT7]-SDLAVPSELALLK[MT7].3b4_1.heavy 548.666 / 531.289 62947.0 37.052398681640625 44 14 10 10 10 1.9579600815135365 44.28898963349065 0.0 3 0.9496001276984236 5.474021860859383 62947.0 29.905707065335744 0.0 - - - - - - - 839.0 125 3 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 877 113 A20140416_SF113_02 A20140416_SF113_02 TB236113.[MT7]-SDLAVPSELALLK[MT7].3b5_1.heavy 548.666 / 630.358 79972.0 37.052398681640625 44 14 10 10 10 1.9579600815135365 44.28898963349065 0.0 3 0.9496001276984236 5.474021860859383 79972.0 119.88423978442015 0.0 - - - - - - - 753.2857142857143 159 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 879 113 A20140416_SF113_02 A20140416_SF113_02 TB236113.[MT7]-SDLAVPSELALLK[MT7].3y4_1.heavy 548.666 / 588.42 39327.0 37.052398681640625 44 14 10 10 10 1.9579600815135365 44.28898963349065 0.0 3 0.9496001276984236 5.474021860859383 39327.0 37.70366179505432 0.0 - - - - - - - 770.4285714285714 78 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 881 114 A20140416_SF113_02 A20140416_SF113_02 TB236319.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].4y5_1.heavy 631.615 / 690.39 63948.0 34.22570037841797 41 16 10 5 10 5.0634596812690775 19.749342602632623 0.04540252685546875 3 0.9638725657688385 6.473327321099741 63948.0 34.185108661186234 0.0 - - - - - - - 371.0 127 1 ALOX15B arachidonate 15-lipoxygenase, type B 883 114 A20140416_SF113_02 A20140416_SF113_02 TB236319.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].4b12_2.heavy 631.615 / 658.868 153252.0 34.22570037841797 41 16 10 5 10 5.0634596812690775 19.749342602632623 0.04540252685546875 3 0.9638725657688385 6.473327321099741 153252.0 163.69802568686168 0.0 - - - - - - - 928.0 306 2 ALOX15B arachidonate 15-lipoxygenase, type B 885 114 A20140416_SF113_02 A20140416_SF113_02 TB236319.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].4b4_1.heavy 631.615 / 517.31 22512.0 34.22570037841797 41 16 10 5 10 5.0634596812690775 19.749342602632623 0.04540252685546875 3 0.9638725657688385 6.473327321099741 22512.0 7.285744822099793 1.0 - - - - - - - 2432.6666666666665 45 3 ALOX15B arachidonate 15-lipoxygenase, type B 887 114 A20140416_SF113_02 A20140416_SF113_02 TB236319.[MT7]-VSVSIVGTRGESPPLPLDNLGK[MT7].4y7_1.heavy 631.615 / 900.527 42302.0 34.22570037841797 41 16 10 5 10 5.0634596812690775 19.749342602632623 0.04540252685546875 3 0.9638725657688385 6.473327321099741 42302.0 74.60951159683414 0.0 - - - - - - - 742.0 84 7 ALOX15B arachidonate 15-lipoxygenase, type B 889 115 A20140416_SF113_02 A20140416_SF113_02 TB372986.[MT7]-VTVYPSK[MT7].2y4_1.heavy 541.328 / 638.363 99339.0 24.234149932861328 42 17 10 5 10 2.492157849703169 40.125869238945114 0.045299530029296875 3 0.9770235469591165 8.126168177176794 99339.0 137.78785021548333 0.0 - - - - - - - 734.375 198 8 LOC100290966;LOC100294276;LOC100509246;LOC100509301;LOC100509582;LOC100510519;HLA-DRB1;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 4 891 115 A20140416_SF113_02 A20140416_SF113_02 TB372986.[MT7]-VTVYPSK[MT7].2b4_1.heavy 541.328 / 607.357 64992.0 24.234149932861328 42 17 10 5 10 2.492157849703169 40.125869238945114 0.045299530029296875 3 0.9770235469591165 8.126168177176794 64992.0 72.88267362924282 0.0 - - - - - - - 332.0 129 5 LOC100290966;LOC100294276;LOC100509246;LOC100509301;LOC100509582;LOC100510519;HLA-DRB1;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 4 893 115 A20140416_SF113_02 A20140416_SF113_02 TB372986.[MT7]-VTVYPSK[MT7].2y3_1.heavy 541.328 / 475.3 199700.0 24.234149932861328 42 17 10 5 10 2.492157849703169 40.125869238945114 0.045299530029296875 3 0.9770235469591165 8.126168177176794 199700.0 120.19291238849088 0.0 - - - - - - - 1149.0 399 1 LOC100290966;LOC100294276;LOC100509246;LOC100509301;LOC100509582;LOC100510519;HLA-DRB1;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 4 895 115 A20140416_SF113_02 A20140416_SF113_02 TB372986.[MT7]-VTVYPSK[MT7].2y6_1.heavy 541.328 / 838.479 64864.0 24.234149932861328 42 17 10 5 10 2.492157849703169 40.125869238945114 0.045299530029296875 3 0.9770235469591165 8.126168177176794 64864.0 109.22776072346454 0.0 - - - - - - - 303.25 129 8 LOC100290966;LOC100294276;LOC100509246;LOC100509301;LOC100509582;LOC100510519;HLA-DRB1;HLA-DRB4 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;HLA class II histocompatibility antigen, DR beta 4 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 4 897 116 A20140416_SF113_02 A20140416_SF113_02 TB495268.[MT7]-AAVDTY[MT7]C[CAM]R.3y3_1.heavy 415.216 / 642.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 899 116 A20140416_SF113_02 A20140416_SF113_02 TB495268.[MT7]-AAVDTY[MT7]C[CAM]R.3b4_1.heavy 415.216 / 501.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 901 116 A20140416_SF113_02 A20140416_SF113_02 TB495268.[MT7]-AAVDTY[MT7]C[CAM]R.3y7_2.heavy 415.216 / 514.751 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 903 116 A20140416_SF113_02 A20140416_SF113_02 TB495268.[MT7]-AAVDTY[MT7]C[CAM]R.3y5_1.heavy 415.216 / 858.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - LOC100133811;LOC100290966;LOC100509246;HLA-DRB1;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-10 beta chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 5 905 117 A20140416_SF113_02 A20140416_SF113_02 TB495540.[MT7]-TLQALEFHTVPFQLLAR.4y5_1.heavy 532.806 / 600.383 34006.0 39.80609893798828 37 7 10 10 10 0.45507572870799673 98.10653118720657 0.0 3 0.7271799396128843 2.306831495497764 34006.0 58.28539301310043 0.0 - - - - - - - 701.125 68 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 907 117 A20140416_SF113_02 A20140416_SF113_02 TB495540.[MT7]-TLQALEFHTVPFQLLAR.4b4_1.heavy 532.806 / 558.337 17175.0 39.80609893798828 37 7 10 10 10 0.45507572870799673 98.10653118720657 0.0 3 0.7271799396128843 2.306831495497764 17175.0 33.60936329588015 0.0 - - - - - - - 712.2222222222222 34 9 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 909 117 A20140416_SF113_02 A20140416_SF113_02 TB495540.[MT7]-TLQALEFHTVPFQLLAR.4b5_1.heavy 532.806 / 671.421 8358.0 39.80609893798828 37 7 10 10 10 0.45507572870799673 98.10653118720657 0.0 3 0.7271799396128843 2.306831495497764 8358.0 25.639716157205243 0.0 - - - - - - - 281.61538461538464 16 13 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 911 117 A20140416_SF113_02 A20140416_SF113_02 TB495540.[MT7]-TLQALEFHTVPFQLLAR.4b6_1.heavy 532.806 / 800.463 15572.0 39.80609893798828 37 7 10 10 10 0.45507572870799673 98.10653118720657 0.0 3 0.7271799396128843 2.306831495497764 15572.0 72.1394752186589 0.0 - - - - - - - 257.4166666666667 31 12 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 913 118 A20140416_SF113_02 A20140416_SF113_02 TB373000.[MT7]-TAQELSFR.2y4_1.heavy 548.299 / 522.304 N/A 27.121300379435223 31 18 0 5 8 4.453494359811278 22.454277904202314 0.04020118713378906 4 0.9864436227970615 10.587628685681485 17634.0 5.611130912693014 3.0 - - - - - - - 2267.0 346 1 ARHGAP4 Rho GTPase activating protein 4 915 118 A20140416_SF113_02 A20140416_SF113_02 TB373000.[MT7]-TAQELSFR.2y5_1.heavy 548.299 / 651.346 8565.0 27.121300379435223 31 18 0 5 8 4.453494359811278 22.454277904202314 0.04020118713378906 4 0.9864436227970615 10.587628685681485 8565.0 6.380362501114762 0.0 - - - - - - - 738.0 17 7 ARHGAP4 Rho GTPase activating protein 4 917 118 A20140416_SF113_02 A20140416_SF113_02 TB373000.[MT7]-TAQELSFR.2b4_1.heavy 548.299 / 574.295 12848.0 27.121300379435223 31 18 0 5 8 4.453494359811278 22.454277904202314 0.04020118713378906 4 0.9864436227970615 10.587628685681485 12848.0 10.777534351982789 1.0 - - - - - - - 756.0 27 1 ARHGAP4 Rho GTPase activating protein 4 919 118 A20140416_SF113_02 A20140416_SF113_02 TB373000.[MT7]-TAQELSFR.2y7_1.heavy 548.299 / 850.442 23176.0 27.121300379435223 31 18 0 5 8 4.453494359811278 22.454277904202314 0.04020118713378906 4 0.9864436227970615 10.587628685681485 23176.0 56.713756613756615 1.0 - - - - - - - 738.0 46 7 ARHGAP4 Rho GTPase activating protein 4 921 119 A20140416_SF113_02 A20140416_SF113_02 TB495546.[MT7]-DLFISDFWSSALETINR.3y7_1.heavy 720.036 / 816.457 18673.0 47.32709884643555 46 16 10 10 10 2.370487597188969 37.131427724096774 0.0 3 0.9692870412284219 7.0239868537399115 18673.0 36.60384291886674 0.0 - - - - - - - 584.5714285714286 37 7 SRRD SRR1 domain containing 923 119 A20140416_SF113_02 A20140416_SF113_02 TB495546.[MT7]-DLFISDFWSSALETINR.3y6_1.heavy 720.036 / 745.42 37609.0 47.32709884643555 46 16 10 10 10 2.370487597188969 37.131427724096774 0.0 3 0.9692870412284219 7.0239868537399115 37609.0 94.23647949055095 0.0 - - - - - - - 773.1428571428571 75 7 SRRD SRR1 domain containing 925 119 A20140416_SF113_02 A20140416_SF113_02 TB495546.[MT7]-DLFISDFWSSALETINR.3b6_1.heavy 720.036 / 835.432 61230.0 47.32709884643555 46 16 10 10 10 2.370487597188969 37.131427724096774 0.0 3 0.9692870412284219 7.0239868537399115 61230.0 264.4022727272727 0.0 - - - - - - - 754.2857142857143 122 7 SRRD SRR1 domain containing 927 119 A20140416_SF113_02 A20140416_SF113_02 TB495546.[MT7]-DLFISDFWSSALETINR.3b3_1.heavy 720.036 / 520.289 48694.0 47.32709884643555 46 16 10 10 10 2.370487597188969 37.131427724096774 0.0 3 0.9692870412284219 7.0239868537399115 48694.0 143.60132191480017 0.0 - - - - - - - 762.6666666666666 97 9 SRRD SRR1 domain containing 929 120 A20140416_SF113_02 A20140416_SF113_02 TB495541.[MT7]-TLQALEFHTVPFQLLAR.3y7_1.heavy 710.073 / 844.504 334867.0 39.80609893798828 47 17 10 10 10 13.365161579993426 7.482139246987629 0.0 3 0.9778759541475934 8.281826562040617 334867.0 379.3647291471068 0.0 - - - - - - - 344.0 669 1 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 931 120 A20140416_SF113_02 A20140416_SF113_02 TB495541.[MT7]-TLQALEFHTVPFQLLAR.3b6_1.heavy 710.073 / 800.463 133878.0 39.80609893798828 47 17 10 10 10 13.365161579993426 7.482139246987629 0.0 3 0.9778759541475934 8.281826562040617 133878.0 218.79941801889726 0.0 - - - - - - - 1259.857142857143 267 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 933 120 A20140416_SF113_02 A20140416_SF113_02 TB495541.[MT7]-TLQALEFHTVPFQLLAR.3b4_1.heavy 710.073 / 558.337 91848.0 39.80609893798828 47 17 10 10 10 13.365161579993426 7.482139246987629 0.0 3 0.9778759541475934 8.281826562040617 91848.0 145.68661315803962 0.0 - - - - - - - 1210.7142857142858 183 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 935 120 A20140416_SF113_02 A20140416_SF113_02 TB495541.[MT7]-TLQALEFHTVPFQLLAR.3y9_1.heavy 710.073 / 1044.62 119333.0 39.80609893798828 47 17 10 10 10 13.365161579993426 7.482139246987629 0.0 3 0.9778759541475934 8.281826562040617 119333.0 244.91925764192143 0.0 - - - - - - - 755.9 238 10 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 937 121 A20140416_SF113_02 A20140416_SF113_02 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 1180230.0 29.967199325561523 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1180230.0 1482.880677627687 0.0 - - - - - - - 251.0 2360 1 939 121 A20140416_SF113_02 A20140416_SF113_02 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 1267200.0 29.967199325561523 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1267200.0 1488.9588032564666 0.0 - - - - - - - 1185.142857142857 2534 7 941 121 A20140416_SF113_02 A20140416_SF113_02 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 2171410.0 29.967199325561523 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2171410.0 1799.8756093227944 0.0 - - - - - - - 1006.0 4342 1 943 122 A20140416_SF113_02 A20140416_SF113_02 TB495160.[MT7]-HLEQLK[MT7].2y4_1.heavy 528.326 / 661.4 9004.0 21.83127498626709 34 17 4 5 8 3.6747147106554845 20.987810828049913 0.042499542236328125 4 0.9777687282562311 8.261755535005955 9004.0 15.346624990516652 0.0 - - - - - - - 734.6 18 10 SRRD SRR1 domain containing 945 122 A20140416_SF113_02 A20140416_SF113_02 TB495160.[MT7]-HLEQLK[MT7].2y5_1.heavy 528.326 / 774.484 13868.0 21.83127498626709 34 17 4 5 8 3.6747147106554845 20.987810828049913 0.042499542236328125 4 0.9777687282562311 8.261755535005955 13868.0 56.48040206736767 0.0 - - - - - - - 241.25 27 12 SRRD SRR1 domain containing 947 122 A20140416_SF113_02 A20140416_SF113_02 TB495160.[MT7]-HLEQLK[MT7].2b4_1.heavy 528.326 / 652.354 3001.0 21.83127498626709 34 17 4 5 8 3.6747147106554845 20.987810828049913 0.042499542236328125 4 0.9777687282562311 8.261755535005955 3001.0 1.3765383301615186 3.0 - - - - - - - 1202.875 16 8 SRRD SRR1 domain containing 949 122 A20140416_SF113_02 A20140416_SF113_02 TB495160.[MT7]-HLEQLK[MT7].2y3_1.heavy 528.326 / 532.357 4243.0 21.83127498626709 34 17 4 5 8 3.6747147106554845 20.987810828049913 0.042499542236328125 4 0.9777687282562311 8.261755535005955 4243.0 4.952554848786243 5.0 - - - - - - - 1256.7142857142858 49 7 SRRD SRR1 domain containing 951 123 A20140416_SF113_02 A20140416_SF113_02 TB495162.[MT7]-VSVSIVGTR.2y8_1.heavy 531.325 / 818.473 87390.0 27.917400360107422 46 20 6 10 10 10.49754068624348 9.526040716474208 0.0 3 0.997167397634241 23.182859032383114 87390.0 65.69655321191463 0.0 - - - - - - - 1758.142857142857 174 7 ALOX15B arachidonate 15-lipoxygenase, type B 953 123 A20140416_SF113_02 A20140416_SF113_02 TB495162.[MT7]-VSVSIVGTR.2b4_1.heavy 531.325 / 517.31 N/A 27.917400360107422 46 20 6 10 10 10.49754068624348 9.526040716474208 0.0 3 0.997167397634241 23.182859032383114 16036.0 3.6248751413531517 6.0 - - - - - - - 3397.6666666666665 273 3 ALOX15B arachidonate 15-lipoxygenase, type B 955 123 A20140416_SF113_02 A20140416_SF113_02 TB495162.[MT7]-VSVSIVGTR.2y6_1.heavy 531.325 / 632.373 31948.0 27.917400360107422 46 20 6 10 10 10.49754068624348 9.526040716474208 0.0 3 0.997167397634241 23.182859032383114 31948.0 23.91749427610289 0.0 - - - - - - - 497.0 63 1 ALOX15B arachidonate 15-lipoxygenase, type B 957 123 A20140416_SF113_02 A20140416_SF113_02 TB495162.[MT7]-VSVSIVGTR.2y7_1.heavy 531.325 / 731.441 16658.0 27.917400360107422 46 20 6 10 10 10.49754068624348 9.526040716474208 0.0 3 0.997167397634241 23.182859032383114 16658.0 13.170320145285306 0.0 - - - - - - - 373.0 33 3 ALOX15B arachidonate 15-lipoxygenase, type B 959 124 A20140416_SF113_02 A20140416_SF113_02 TB495538.[MT7]-GLYADYLFNAIAGNWER.3y6_1.heavy 706.357 / 732.342 121388.0 45.208099365234375 38 13 10 5 10 1.1426901549573334 55.22778353412875 0.040802001953125 3 0.9084525239913018 4.0473327762556 121388.0 163.5881404820246 0.0 - - - - - - - 332.2857142857143 242 7 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 961 124 A20140416_SF113_02 A20140416_SF113_02 TB495538.[MT7]-GLYADYLFNAIAGNWER.3b6_1.heavy 706.357 / 827.406 95536.0 45.208099365234375 38 13 10 5 10 1.1426901549573334 55.22778353412875 0.040802001953125 3 0.9084525239913018 4.0473327762556 95536.0 289.2616856934661 0.0 - - - - - - - 234.625 191 8 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 963 124 A20140416_SF113_02 A20140416_SF113_02 TB495538.[MT7]-GLYADYLFNAIAGNWER.3b5_1.heavy 706.357 / 664.342 99025.0 45.208099365234375 38 13 10 5 10 1.1426901549573334 55.22778353412875 0.040802001953125 3 0.9084525239913018 4.0473327762556 99025.0 200.28719903637457 0.0 - - - - - - - 297.8333333333333 198 6 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 965 124 A20140416_SF113_02 A20140416_SF113_02 TB495538.[MT7]-GLYADYLFNAIAGNWER.3b7_1.heavy 706.357 / 940.49 50720.0 45.208099365234375 38 13 10 5 10 1.1426901549573334 55.22778353412875 0.040802001953125 3 0.9084525239913018 4.0473327762556 50720.0 152.98345936772225 0.0 - - - - - - - 178.625 101 8 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 967 125 A20140416_SF113_02 A20140416_SF113_02 TB495306.[MT7]-TVVK[MT7]FPTK[MT7].3y6_2.heavy 451.294 / 504.328 60386.0 25.75909996032715 44 14 10 10 10 3.214841944541791 31.105728283090734 0.0 3 0.9378001430244703 4.922553782061472 60386.0 16.194539740171965 0.0 - - - - - - - 1548.0 120 1 GP1BA glycoprotein Ib (platelet), alpha polypeptide 969 125 A20140416_SF113_02 A20140416_SF113_02 TB495306.[MT7]-TVVK[MT7]FPTK[MT7].3y3_1.heavy 451.294 / 489.315 139352.0 25.75909996032715 44 14 10 10 10 3.214841944541791 31.105728283090734 0.0 3 0.9378001430244703 4.922553782061472 139352.0 53.89821530453327 0.0 - - - - - - - 1612.5 278 2 GP1BA glycoprotein Ib (platelet), alpha polypeptide 971 125 A20140416_SF113_02 A20140416_SF113_02 TB495306.[MT7]-TVVK[MT7]FPTK[MT7].3y7_2.heavy 451.294 / 553.862 57805.0 25.75909996032715 44 14 10 10 10 3.214841944541791 31.105728283090734 0.0 3 0.9378001430244703 4.922553782061472 57805.0 21.08649734301095 0.0 - - - - - - - 1419.0 115 1 GP1BA glycoprotein Ib (platelet), alpha polypeptide 973 125 A20140416_SF113_02 A20140416_SF113_02 TB495306.[MT7]-TVVK[MT7]FPTK[MT7].3y4_1.heavy 451.294 / 636.384 47612.0 25.75909996032715 44 14 10 10 10 3.214841944541791 31.105728283090734 0.0 3 0.9378001430244703 4.922553782061472 47612.0 81.15144106539455 0.0 - - - - - - - 722.4 95 10 GP1BA glycoprotein Ib (platelet), alpha polypeptide 975 126 A20140416_SF113_02 A20140416_SF113_02 TB373245.[MT7]-EALVQYVTMVIFTC[CAM]SAK[MT7].3y6_1.heavy 750.07 / 857.431 13130.0 46.40909957885742 44 14 10 10 10 2.766874715057091 36.141860509913485 0.0 3 0.9426663957049195 5.129329678615782 13130.0 49.19171236171236 0.0 - - - - - - - 245.14285714285714 26 14 ALOX15B arachidonate 15-lipoxygenase, type B 977 126 A20140416_SF113_02 A20140416_SF113_02 TB373245.[MT7]-EALVQYVTMVIFTC[CAM]SAK[MT7].3b4_1.heavy 750.07 / 557.341 8446.0 46.40909957885742 44 14 10 10 10 2.766874715057091 36.141860509913485 0.0 3 0.9426663957049195 5.129329678615782 8446.0 19.40622816399287 0.0 - - - - - - - 618.75 16 8 ALOX15B arachidonate 15-lipoxygenase, type B 979 126 A20140416_SF113_02 A20140416_SF113_02 TB373245.[MT7]-EALVQYVTMVIFTC[CAM]SAK[MT7].3b5_1.heavy 750.07 / 685.4 18079.0 46.40909957885742 44 14 10 10 10 2.766874715057091 36.141860509913485 0.0 3 0.9426663957049195 5.129329678615782 18079.0 45.408210955710956 0.0 - - - - - - - 726.0 36 8 ALOX15B arachidonate 15-lipoxygenase, type B 981 126 A20140416_SF113_02 A20140416_SF113_02 TB373245.[MT7]-EALVQYVTMVIFTC[CAM]SAK[MT7].3y5_1.heavy 750.07 / 710.362 12470.0 46.40909957885742 44 14 10 10 10 2.766874715057091 36.141860509913485 0.0 3 0.9426663957049195 5.129329678615782 12470.0 69.19905303030302 0.0 - - - - - - - 270.0 24 11 ALOX15B arachidonate 15-lipoxygenase, type B 983 127 A20140416_SF113_02 A20140416_SF113_02 TB495302.[MT7]-YTLHINTLAR.3y6_1.heavy 449.262 / 687.415 135548.0 29.243099212646484 50 20 10 10 10 6.862362330623559 14.572241333534098 0.0 3 0.992670128456517 14.406170612423892 135548.0 192.5074686708687 0.0 - - - - - - - 373.0 271 3 ALOX15B arachidonate 15-lipoxygenase, type B 985 127 A20140416_SF113_02 A20140416_SF113_02 TB495302.[MT7]-YTLHINTLAR.3b4_1.heavy 449.262 / 659.363 77723.0 29.243099212646484 50 20 10 10 10 6.862362330623559 14.572241333534098 0.0 3 0.992670128456517 14.406170612423892 77723.0 60.8309258062161 0.0 - - - - - - - 124.0 155 1 ALOX15B arachidonate 15-lipoxygenase, type B 987 127 A20140416_SF113_02 A20140416_SF113_02 TB495302.[MT7]-YTLHINTLAR.3b3_1.heavy 449.262 / 522.304 283781.0 29.243099212646484 50 20 10 10 10 6.862362330623559 14.572241333534098 0.0 3 0.992670128456517 14.406170612423892 283781.0 142.63218737434659 0.0 - - - - - - - 870.0 567 1 ALOX15B arachidonate 15-lipoxygenase, type B 989 127 A20140416_SF113_02 A20140416_SF113_02 TB495302.[MT7]-YTLHINTLAR.3y5_1.heavy 449.262 / 574.331 404406.0 29.243099212646484 50 20 10 10 10 6.862362330623559 14.572241333534098 0.0 3 0.992670128456517 14.406170612423892 404406.0 282.60154200984255 0.0 - - - - - - - 1350.2857142857142 808 7 ALOX15B arachidonate 15-lipoxygenase, type B 991 128 A20140416_SF113_02 A20140416_SF113_02 TB373249.[MT7]-LRPLTASQTVK[MT7].3b6_1.heavy 501.315 / 796.516 42804.0 25.04010009765625 50 20 10 10 10 22.355847954997138 4.473102527862169 0.0 3 0.9993317147910603 47.737234527076545 42804.0 80.3091335948836 0.0 - - - - - - - 743.7142857142857 85 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 993 128 A20140416_SF113_02 A20140416_SF113_02 TB373249.[MT7]-LRPLTASQTVK[MT7].3b5_1.heavy 501.315 / 725.479 27192.0 25.04010009765625 50 20 10 10 10 22.355847954997138 4.473102527862169 0.0 3 0.9993317147910603 47.737234527076545 27192.0 30.409432766931666 0.0 - - - - - - - 780.875 54 8 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 995 128 A20140416_SF113_02 A20140416_SF113_02 TB373249.[MT7]-LRPLTASQTVK[MT7].3b7_1.heavy 501.315 / 883.548 37990.0 25.04010009765625 50 20 10 10 10 22.355847954997138 4.473102527862169 0.0 3 0.9993317147910603 47.737234527076545 37990.0 208.57971153846154 0.0 - - - - - - - 260.0 75 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 997 128 A20140416_SF113_02 A20140416_SF113_02 TB373249.[MT7]-LRPLTASQTVK[MT7].3b8_2.heavy 501.315 / 506.307 N/A 25.04010009765625 50 20 10 10 10 22.355847954997138 4.473102527862169 0.0 3 0.9993317147910603 47.737234527076545 128413.0 45.70350683576913 1.0 - - - - - - - 1431.0 265 2 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 999 129 A20140416_SF113_02 A20140416_SF113_02 TB495530.[MT7]-QLQVVPLFGDMQIELAR.3b4_1.heavy 701.058 / 613.379 36907.0 42.659400939941406 46 16 10 10 10 2.138684780601165 37.4799517575301 0.0 3 0.9683587990605144 6.9196488475634705 36907.0 36.13857151598141 1.0 - - - - - - - 336.6666666666667 80 6 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1001 129 A20140416_SF113_02 A20140416_SF113_02 TB495530.[MT7]-QLQVVPLFGDMQIELAR.3b5_1.heavy 701.058 / 712.447 33470.0 42.659400939941406 46 16 10 10 10 2.138684780601165 37.4799517575301 0.0 3 0.9683587990605144 6.9196488475634705 33470.0 93.41629583287998 0.0 - - - - - - - 303.0 66 5 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1003 129 A20140416_SF113_02 A20140416_SF113_02 TB495530.[MT7]-QLQVVPLFGDMQIELAR.3b3_1.heavy 701.058 / 514.311 29728.0 42.659400939941406 46 16 10 10 10 2.138684780601165 37.4799517575301 0.0 3 0.9683587990605144 6.9196488475634705 29728.0 48.48936062701205 0.0 - - - - - - - 722.4285714285714 59 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1005 129 A20140416_SF113_02 A20140416_SF113_02 TB495530.[MT7]-QLQVVPLFGDMQIELAR.3y9_1.heavy 701.058 / 1032.51 14662.0 42.659400939941406 46 16 10 10 10 2.138684780601165 37.4799517575301 0.0 3 0.9683587990605144 6.9196488475634705 14662.0 27.388557845121504 0.0 - - - - - - - 202.0 29 12 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1007 130 A20140416_SF113_02 A20140416_SF113_02 TB373104.[MT7]-FDSDVGEYR.2y8_1.heavy 616.289 / 940.401 10716.0 26.76409912109375 46 16 10 10 10 6.356051122186342 15.733038969894597 0.0 3 0.9690457303296499 6.99641245428591 10716.0 25.108484336764928 0.0 - - - - - - - 637.75 21 8 LOC100133811;LOC100294036;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB3;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 5 1009 130 A20140416_SF113_02 A20140416_SF113_02 TB373104.[MT7]-FDSDVGEYR.2y5_1.heavy 616.289 / 623.315 25515.0 26.76409912109375 46 16 10 10 10 6.356051122186342 15.733038969894597 0.0 3 0.9690457303296499 6.99641245428591 25515.0 46.91129983465969 0.0 - - - - - - - 751.1111111111111 51 9 LOC100133811;LOC100294036;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB3;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 5 1011 130 A20140416_SF113_02 A20140416_SF113_02 TB373104.[MT7]-FDSDVGEYR.2b4_1.heavy 616.289 / 609.264 19392.0 26.76409912109375 46 16 10 10 10 6.356051122186342 15.733038969894597 0.0 3 0.9690457303296499 6.99641245428591 19392.0 22.57207434375733 0.0 - - - - - - - 1330.142857142857 38 7 LOC100133811;LOC100294036;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB3;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 5 1013 130 A20140416_SF113_02 A20140416_SF113_02 TB373104.[MT7]-FDSDVGEYR.2y7_1.heavy 616.289 / 825.374 10461.0 26.76409912109375 46 16 10 10 10 6.356051122186342 15.733038969894597 0.0 3 0.9690457303296499 6.99641245428591 10461.0 39.587705882352935 0.0 - - - - - - - 601.2857142857143 20 7 LOC100133811;LOC100294036;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB3;HLA-DRB5 HLA class II histocompatibility antigen, DRB1-4 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 3;major histocompatibility complex, class II, DR beta 5 1015 131 A20140416_SF113_02 A20140416_SF113_02 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 817988.0 25.71500015258789 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 817988.0 703.3771287747095 0.0 - - - - - - - 10838.0 1635 2 1017 131 A20140416_SF113_02 A20140416_SF113_02 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 1120430.0 25.71500015258789 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1120430.0 703.8147824032555 0.0 - - - - - - - 16516.0 2240 1 1019 131 A20140416_SF113_02 A20140416_SF113_02 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 1341470.0 25.71500015258789 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1341470.0 1111.2632999294826 0.0 - - - - - - - 16774.0 2682 1 1021 132 A20140416_SF113_02 A20140416_SF113_02 TB373105.[MT7]-IQAATLQAK[MT7].2y8_1.heavy 616.384 / 974.575 22999.0 25.309499740600586 47 17 10 10 10 2.495088472263849 32.15845773932739 0.0 3 0.9754053964528124 7.853229824841862 22999.0 58.82436538461538 0.0 - - - - - - - 650.0 45 8 TTC39A tetratricopeptide repeat domain 39A 1023 132 A20140416_SF113_02 A20140416_SF113_02 TB373105.[MT7]-IQAATLQAK[MT7].2y5_1.heavy 616.384 / 704.442 13124.0 25.309499740600586 47 17 10 10 10 2.495088472263849 32.15845773932739 0.0 3 0.9754053964528124 7.853229824841862 13124.0 13.265157789132314 0.0 - - - - - - - 624.0 26 10 TTC39A tetratricopeptide repeat domain 39A 1025 132 A20140416_SF113_02 A20140416_SF113_02 TB373105.[MT7]-IQAATLQAK[MT7].2b4_1.heavy 616.384 / 528.326 15982.0 25.309499740600586 47 17 10 10 10 2.495088472263849 32.15845773932739 0.0 3 0.9754053964528124 7.853229824841862 15982.0 12.305291781871531 0.0 - - - - - - - 260.0 31 1 TTC39A tetratricopeptide repeat domain 39A 1027 132 A20140416_SF113_02 A20140416_SF113_02 TB373105.[MT7]-IQAATLQAK[MT7].2y7_1.heavy 616.384 / 846.516 13254.0 25.309499740600586 47 17 10 10 10 2.495088472263849 32.15845773932739 0.0 3 0.9754053964528124 7.853229824841862 13254.0 16.123717786097604 1.0 - - - - - - - 594.2857142857143 28 7 TTC39A tetratricopeptide repeat domain 39A 1029 133 A20140416_SF113_02 A20140416_SF113_02 TB495442.[MT7]-FINMFAVLDELK[MT7].3b4_1.heavy 576.66 / 650.345 82023.0 46.66510009765625 42 12 10 10 10 0.7775497923987669 73.74325102957746 0.0 3 0.8807736847739499 3.5380488287733898 82023.0 545.3618133333333 0.0 - - - - - - - 184.6153846153846 164 13 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1031 133 A20140416_SF113_02 A20140416_SF113_02 TB495442.[MT7]-FINMFAVLDELK[MT7].3b5_1.heavy 576.66 / 797.414 41386.0 46.66510009765625 42 12 10 10 10 0.7775497923987669 73.74325102957746 0.0 3 0.8807736847739499 3.5380488287733898 41386.0 232.2871365079365 0.0 - - - - - - - 170.45454545454547 82 11 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1033 133 A20140416_SF113_02 A20140416_SF113_02 TB495442.[MT7]-FINMFAVLDELK[MT7].3y4_1.heavy 576.66 / 648.369 102641.0 46.66510009765625 42 12 10 10 10 0.7775497923987669 73.74325102957746 0.0 3 0.8807736847739499 3.5380488287733898 102641.0 71.85555832558438 0.0 - - - - - - - 168.75 205 4 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1035 133 A20140416_SF113_02 A20140416_SF113_02 TB495442.[MT7]-FINMFAVLDELK[MT7].3b3_1.heavy 576.66 / 519.305 48434.0 46.66510009765625 42 12 10 10 10 0.7775497923987669 73.74325102957746 0.0 3 0.8807736847739499 3.5380488287733898 48434.0 224.30323555555555 0.0 - - - - - - - 268.75 96 12 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1037 134 A20140416_SF113_02 A20140416_SF113_02 TB495443.[MT7]-FINMFAVLDELK[MT7].2b3_1.heavy 864.486 / 519.305 8674.0 46.644100189208984 39 14 10 5 10 2.499635106424652 40.00583914947282 0.04199981689453125 3 0.9379929615500385 4.9302825567542605 8674.0 46.24218543046358 0.0 - - - - - - - 193.85714285714286 17 14 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1039 134 A20140416_SF113_02 A20140416_SF113_02 TB495443.[MT7]-FINMFAVLDELK[MT7].2y8_1.heavy 864.486 / 1078.63 6336.0 46.644100189208984 39 14 10 5 10 2.499635106424652 40.00583914947282 0.04199981689453125 3 0.9379929615500385 4.9302825567542605 6336.0 31.205721854304638 0.0 - - - - - - - 197.875 12 16 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1041 134 A20140416_SF113_02 A20140416_SF113_02 TB495443.[MT7]-FINMFAVLDELK[MT7].2b4_1.heavy 864.486 / 650.345 8146.0 46.644100189208984 39 14 10 5 10 2.499635106424652 40.00583914947282 0.04199981689453125 3 0.9379929615500385 4.9302825567542605 8146.0 60.31801969173065 0.0 - - - - - - - 188.5 16 12 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1043 134 A20140416_SF113_02 A20140416_SF113_02 TB495443.[MT7]-FINMFAVLDELK[MT7].2y3_1.heavy 864.486 / 533.341 6034.0 46.644100189208984 39 14 10 5 10 2.499635106424652 40.00583914947282 0.04199981689453125 3 0.9379929615500385 4.9302825567542605 6034.0 16.563252676013867 0.0 - - - - - - - 188.375 12 16 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1045 135 A20140416_SF113_02 A20140416_SF113_02 TB495309.[MT7]-TFSQNRPAAAR.3b4_1.heavy 454.917 / 608.316 37269.0 19.115999221801758 50 20 10 10 10 41.836362736975154 2.390265153514877 0.0 3 0.9995453946908206 57.88001886198771 37269.0 32.221336429017306 0.0 - - - - - - - 710.4545454545455 74 11 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1047 135 A20140416_SF113_02 A20140416_SF113_02 TB495309.[MT7]-TFSQNRPAAAR.3b5_1.heavy 454.917 / 722.359 22324.0 19.115999221801758 50 20 10 10 10 41.836362736975154 2.390265153514877 0.0 3 0.9995453946908206 57.88001886198771 22324.0 70.84804910834814 0.0 - - - - - - - 555.6666666666666 44 9 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1049 135 A20140416_SF113_02 A20140416_SF113_02 TB495309.[MT7]-TFSQNRPAAAR.3b3_1.heavy 454.917 / 480.258 38332.0 19.115999221801758 50 20 10 10 10 41.836362736975154 2.390265153514877 0.0 3 0.9995453946908206 57.88001886198771 38332.0 34.62464558318082 0.0 - - - - - - - 1215.888888888889 76 9 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1051 135 A20140416_SF113_02 A20140416_SF113_02 TB495309.[MT7]-TFSQNRPAAAR.3y5_1.heavy 454.917 / 485.283 396077.0 19.115999221801758 50 20 10 10 10 41.836362736975154 2.390265153514877 0.0 3 0.9995453946908206 57.88001886198771 396077.0 121.53872082910584 0.0 - - - - - - - 1354.6666666666667 792 3 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1053 136 A20140416_SF113_02 A20140416_SF113_02 TB495534.[MT7]-ASFLSDQPEPYLPFLSR.3b6_1.heavy 704.369 / 765.39 17118.0 40.93459987640381 44 18 10 6 10 3.5986369896388677 27.788298816445852 0.037998199462890625 3 0.9817176242934016 9.11343635091171 17118.0 49.772763641746856 0.0 - - - - - - - 276.3636363636364 34 11 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 1055 136 A20140416_SF113_02 A20140416_SF113_02 TB495534.[MT7]-ASFLSDQPEPYLPFLSR.3b4_1.heavy 704.369 / 563.331 24213.0 40.93459987640381 44 18 10 6 10 3.5986369896388677 27.788298816445852 0.037998199462890625 3 0.9817176242934016 9.11343635091171 24213.0 21.48494595355461 0.0 - - - - - - - 253.25 48 4 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 1057 136 A20140416_SF113_02 A20140416_SF113_02 TB495534.[MT7]-ASFLSDQPEPYLPFLSR.3y8_1.heavy 704.369 / 992.556 43245.0 40.93459987640381 44 18 10 6 10 3.5986369896388677 27.788298816445852 0.037998199462890625 3 0.9817176242934016 9.11343635091171 43245.0 88.17008238330017 0.0 - - - - - - - 262.6666666666667 86 6 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 1059 136 A20140416_SF113_02 A20140416_SF113_02 TB495534.[MT7]-ASFLSDQPEPYLPFLSR.3y5_1.heavy 704.369 / 619.356 31758.0 40.93459987640381 44 18 10 6 10 3.5986369896388677 27.788298816445852 0.037998199462890625 3 0.9817176242934016 9.11343635091171 31758.0 36.040443100307215 0.0 - - - - - - - 405.2 63 5 DENND5B;DENND5A DENN/MADD domain containing 5B;DENN/MADD domain containing 5A 1061 137 A20140416_SF113_02 A20140416_SF113_02 TB495449.[MT7]-MLPLLGAVLLQK[MT7]R.3b4_1.heavy 580.711 / 599.371 6674.0 41.357675552368164 37 14 10 3 10 1.8058274086414252 37.41542109808515 0.0735015869140625 3 0.9343995053102119 4.791875991326867 6674.0 22.536867086873116 0.0 - - - - - - - 272.8181818181818 13 11 PLA2G4F phospholipase A2, group IVF 1063 137 A20140416_SF113_02 A20140416_SF113_02 TB495449.[MT7]-MLPLLGAVLLQK[MT7]R.3y8_1.heavy 580.711 / 1028.67 5784.0 41.357675552368164 37 14 10 3 10 1.8058274086414252 37.41542109808515 0.0735015869140625 3 0.9343995053102119 4.791875991326867 5784.0 25.923783783783783 1.0 - - - - - - - 222.25 11 8 PLA2G4F phospholipase A2, group IVF 1065 137 A20140416_SF113_02 A20140416_SF113_02 TB495449.[MT7]-MLPLLGAVLLQK[MT7]R.3y5_1.heavy 580.711 / 801.543 6341.0 41.357675552368164 37 14 10 3 10 1.8058274086414252 37.41542109808515 0.0735015869140625 3 0.9343995053102119 4.791875991326867 6341.0 13.821955056179775 0.0 - - - - - - - 244.5 12 10 PLA2G4F phospholipase A2, group IVF 1067 137 A20140416_SF113_02 A20140416_SF113_02 TB495449.[MT7]-MLPLLGAVLLQK[MT7]R.3y9_1.heavy 580.711 / 1141.75 2558.0 41.357675552368164 37 14 10 3 10 1.8058274086414252 37.41542109808515 0.0735015869140625 3 0.9343995053102119 4.791875991326867 2558.0 22.966755407294656 0.0 - - - - - - - 208.5 5 8 PLA2G4F phospholipase A2, group IVF 1069 138 A20140416_SF113_02 A20140416_SF113_02 TB236018.[MT7]-QTIETEEVNK[MT7].3b6_1.heavy 493.603 / 846.432 21666.0 22.78260040283203 32 14 0 10 8 2.1319604137335113 37.22894154733953 0.0 4 0.9440096811371071 5.1910882830189315 21666.0 75.7521342031687 0.0 - - - - - - - 635.2857142857143 43 7 ARHGAP4 Rho GTPase activating protein 4 1071 138 A20140416_SF113_02 A20140416_SF113_02 TB236018.[MT7]-QTIETEEVNK[MT7].3y3_1.heavy 493.603 / 504.326 78441.0 22.78260040283203 32 14 0 10 8 2.1319604137335113 37.22894154733953 0.0 4 0.9440096811371071 5.1910882830189315 78441.0 53.24970772316479 0.0 - - - - - - - 1750.0 156 4 ARHGAP4 Rho GTPase activating protein 4 1073 138 A20140416_SF113_02 A20140416_SF113_02 TB236018.[MT7]-QTIETEEVNK[MT7].3b4_1.heavy 493.603 / 616.342 70330.0 22.78260040283203 32 14 0 10 8 2.1319604137335113 37.22894154733953 0.0 4 0.9440096811371071 5.1910882830189315 70330.0 24.473526798393774 1.0 - - - - - - - 2222.0 1035 1 ARHGAP4 Rho GTPase activating protein 4 1075 138 A20140416_SF113_02 A20140416_SF113_02 TB236018.[MT7]-QTIETEEVNK[MT7].3y4_1.heavy 493.603 / 633.369 41665.0 22.78260040283203 32 14 0 10 8 2.1319604137335113 37.22894154733953 0.0 4 0.9440096811371071 5.1910882830189315 41665.0 65.67074144847828 0.0 - - - - - - - 762.1428571428571 83 7 ARHGAP4 Rho GTPase activating protein 4 1077 139 A20140416_SF113_02 A20140416_SF113_02 TB495241.[MT7]-WQLSEQLR.2b3_1.heavy 602.334 / 572.331 26858.0 31.006399154663086 48 18 10 10 10 6.966304831214192 14.35481254738181 0.0 3 0.9872424275400136 10.914794220639346 26858.0 14.075881024343659 0.0 - - - - - - - 2343.0 53 3 ARHGAP4 Rho GTPase activating protein 4 1079 139 A20140416_SF113_02 A20140416_SF113_02 TB495241.[MT7]-WQLSEQLR.2y5_1.heavy 602.334 / 632.336 33259.0 31.006399154663086 48 18 10 10 10 6.966304831214192 14.35481254738181 0.0 3 0.9872424275400136 10.914794220639346 33259.0 32.146271514851065 0.0 - - - - - - - 627.6666666666666 66 3 ARHGAP4 Rho GTPase activating protein 4 1081 139 A20140416_SF113_02 A20140416_SF113_02 TB495241.[MT7]-WQLSEQLR.2y6_1.heavy 602.334 / 745.42 49825.0 31.006399154663086 48 18 10 10 10 6.966304831214192 14.35481254738181 0.0 3 0.9872424275400136 10.914794220639346 49825.0 49.711134544685294 0.0 - - - - - - - 314.0 99 2 ARHGAP4 Rho GTPase activating protein 4 1083 139 A20140416_SF113_02 A20140416_SF113_02 TB495241.[MT7]-WQLSEQLR.2y7_1.heavy 602.334 / 873.479 69404.0 31.006399154663086 48 18 10 10 10 6.966304831214192 14.35481254738181 0.0 3 0.9872424275400136 10.914794220639346 69404.0 59.73632688635921 0.0 - - - - - - - 753.2857142857143 138 7 ARHGAP4 Rho GTPase activating protein 4 1085 140 A20140416_SF113_02 A20140416_SF113_02 TB372885.[MT7]-DTAELLR.2y4_1.heavy 481.275 / 530.33 15821.0 26.349900245666504 40 17 10 5 8 2.8320585375825944 35.310004603703774 0.04300117492675781 4 0.9713705517222583 7.27636145132186 15821.0 7.150912285815005 1.0 - - - - - - - 1670.6 31 5 FBXL5 F-box and leucine-rich repeat protein 5 1087 140 A20140416_SF113_02 A20140416_SF113_02 TB372885.[MT7]-DTAELLR.2b4_1.heavy 481.275 / 561.264 52525.0 26.349900245666504 40 17 10 5 8 2.8320585375825944 35.310004603703774 0.04300117492675781 4 0.9713705517222583 7.27636145132186 52525.0 21.3615500813386 0.0 - - - - - - - 1645.0 105 1 FBXL5 F-box and leucine-rich repeat protein 5 1089 140 A20140416_SF113_02 A20140416_SF113_02 TB372885.[MT7]-DTAELLR.2y6_1.heavy 481.275 / 702.414 57335.0 26.349900245666504 40 17 10 5 8 2.8320585375825944 35.310004603703774 0.04300117492675781 4 0.9713705517222583 7.27636145132186 57335.0 39.24102975312627 0.0 - - - - - - - 316.5 114 2 FBXL5 F-box and leucine-rich repeat protein 5 1091 140 A20140416_SF113_02 A20140416_SF113_02 TB372885.[MT7]-DTAELLR.2b5_1.heavy 481.275 / 674.348 41261.0 26.349900245666504 40 17 10 5 8 2.8320585375825944 35.310004603703774 0.04300117492675781 4 0.9713705517222583 7.27636145132186 41261.0 14.31229142007347 1.0 - - - - - - - 380.0 121 1 FBXL5 F-box and leucine-rich repeat protein 5 1093 141 A20140416_SF113_02 A20140416_SF113_02 TB236017.[MT7]-TILEMTQILK[MT7].3b6_1.heavy 493.302 / 833.456 10811.0 38.47100067138672 44 14 10 10 10 2.4385061692840555 41.00871314562225 0.0 3 0.9334951570820383 4.758816373770277 10811.0 51.70478260869565 0.0 - - - - - - - 201.25 21 8 FBXO25 F-box protein 25 1095 141 A20140416_SF113_02 A20140416_SF113_02 TB236017.[MT7]-TILEMTQILK[MT7].3y3_1.heavy 493.302 / 517.383 138240.0 38.47100067138672 44 14 10 10 10 2.4385061692840555 41.00871314562225 0.0 3 0.9334951570820383 4.758816373770277 138240.0 384.66782608695655 0.0 - - - - - - - 391.0 276 5 FBXO25 F-box protein 25 1097 141 A20140416_SF113_02 A20140416_SF113_02 TB236017.[MT7]-TILEMTQILK[MT7].3b4_1.heavy 493.302 / 601.368 168258.0 38.47100067138672 44 14 10 10 10 2.4385061692840555 41.00871314562225 0.0 3 0.9334951570820383 4.758816373770277 168258.0 389.18806956521735 0.0 - - - - - - - 201.25 336 8 FBXO25 F-box protein 25 1099 141 A20140416_SF113_02 A20140416_SF113_02 TB236017.[MT7]-TILEMTQILK[MT7].3b5_1.heavy 493.302 / 732.408 48189.0 38.47100067138672 44 14 10 10 10 2.4385061692840555 41.00871314562225 0.0 3 0.9334951570820383 4.758816373770277 48189.0 584.5535217391304 0.0 - - - - - - - 166.11111111111111 96 9 FBXO25 F-box protein 25 1101 142 A20140416_SF113_02 A20140416_SF113_02 TB372887.[MT7]-SLPTEK[MT7].2y4_1.heavy 481.792 / 618.358 154110.0 21.799400329589844 42 16 10 10 6 0.9537905578597089 61.35536312274042 0.0 5 0.9683216630549843 6.91557010844771 154110.0 228.8429036719432 0.0 - - - - - - - 827.8333333333334 308 6 TTC39A;ZNF331 tetratricopeptide repeat domain 39A;zinc finger protein 331 1103 142 A20140416_SF113_02 A20140416_SF113_02 TB372887.[MT7]-SLPTEK[MT7].2y5_1.heavy 481.792 / 731.442 33762.0 21.799400329589844 42 16 10 10 6 0.9537905578597089 61.35536312274042 0.0 5 0.9683216630549843 6.91557010844771 33762.0 70.84554355477474 0.0 - - - - - - - 648.9 67 10 TTC39A;ZNF331 tetratricopeptide repeat domain 39A;zinc finger protein 331 1105 142 A20140416_SF113_02 A20140416_SF113_02 TB372887.[MT7]-SLPTEK[MT7].2y3_1.heavy 481.792 / 521.305 14701.0 21.799400329589844 42 16 10 10 6 0.9537905578597089 61.35536312274042 0.0 5 0.9683216630549843 6.91557010844771 14701.0 13.083413032299099 2.0 - - - - - - - 912.0 272 1 TTC39A;ZNF331 tetratricopeptide repeat domain 39A;zinc finger protein 331 1107 143 A20140416_SF113_02 A20140416_SF113_02 TB495245.[MT7]-RFNYVVK[MT7].2b3_1.heavy 607.368 / 562.322 N/A 27.575199127197266 43 13 10 10 10 3.0853613798641195 21.60740945995853 0.0 2 0.9297288733006124 4.628042098443318 3384.0 0.8224221981969855 26.0 - - - - - - - 1431.0 14 1 FBXO25 F-box protein 25 1109 143 A20140416_SF113_02 A20140416_SF113_02 TB495245.[MT7]-RFNYVVK[MT7].2b4_1.heavy 607.368 / 725.385 3384.0 27.575199127197266 43 13 10 10 10 3.0853613798641195 21.60740945995853 0.0 2 0.9297288733006124 4.628042098443318 3384.0 5.0447554476463985 1.0 - - - - - - - 260.0 6 6 FBXO25 F-box protein 25 1111 143 A20140416_SF113_02 A20140416_SF113_02 TB495245.[MT7]-RFNYVVK[MT7].2b6_1.heavy 607.368 / 923.522 N/A 27.575199127197266 43 13 10 10 10 3.0853613798641195 21.60740945995853 0.0 2 0.9297288733006124 4.628042098443318 651.0 0.8335467349551856 19.0 - - - - - - - 664.0 8 10 FBXO25 F-box protein 25 1113 143 A20140416_SF113_02 A20140416_SF113_02 TB495245.[MT7]-RFNYVVK[MT7].2b5_1.heavy 607.368 / 824.453 7027.0 27.575199127197266 43 13 10 10 10 3.0853613798641195 21.60740945995853 0.0 2 0.9297288733006124 4.628042098443318 7027.0 13.804672038941774 0.0 - - - - - - - 694.3333333333334 14 9 FBXO25 F-box protein 25 1115 144 A20140416_SF113_02 A20140416_SF113_02 TB372881.[MT7]-SLGPGAGPR.2y8_1.heavy 478.276 / 724.41 20013.0 20.718124389648438 31 15 2 6 8 2.195485808749189 36.17010984586452 0.038299560546875 4 0.9531697020557688 5.680536077316433 20013.0 93.07120967741935 0.0 - - - - - - - 317.75 40 12 NTHL1 nth endonuclease III-like 1 (E. coli) 1117 144 A20140416_SF113_02 A20140416_SF113_02 TB372881.[MT7]-SLGPGAGPR.2y6_1.heavy 478.276 / 554.305 11263.0 20.718124389648438 31 15 2 6 8 2.195485808749189 36.17010984586452 0.038299560546875 4 0.9531697020557688 5.680536077316433 11263.0 4.510488620636211 1.0 - - - - - - - 1795.142857142857 35 7 NTHL1 nth endonuclease III-like 1 (E. coli) 1119 144 A20140416_SF113_02 A20140416_SF113_02 TB372881.[MT7]-SLGPGAGPR.2b5_1.heavy 478.276 / 556.321 2979.0 20.718124389648438 31 15 2 6 8 2.195485808749189 36.17010984586452 0.038299560546875 4 0.9531697020557688 5.680536077316433 2979.0 0.2483189774937483 22.0 - - - - - - - 791.5 100 2 NTHL1 nth endonuclease III-like 1 (E. coli) 1121 144 A20140416_SF113_02 A20140416_SF113_02 TB372881.[MT7]-SLGPGAGPR.2y7_1.heavy 478.276 / 611.326 17686.0 20.718124389648438 31 15 2 6 8 2.195485808749189 36.17010984586452 0.038299560546875 4 0.9531697020557688 5.680536077316433 17686.0 16.71043981635505 0.0 - - - - - - - 763.4 35 10 NTHL1 nth endonuclease III-like 1 (E. coli) 1123 145 A20140416_SF113_02 A20140416_SF113_02 TB373633.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4y8_1.heavy 808.7 / 1192.71 2644.0 44.97679901123047 41 11 10 10 10 1.096194064978309 59.727893400191874 0.0 3 0.8597251390706918 3.2558162041400758 2644.0 14.047936138627437 1.0 - - - - - - - 190.46153846153845 5 13 ARHGAP4 Rho GTPase activating protein 4 1125 145 A20140416_SF113_02 A20140416_SF113_02 TB373633.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4b7_1.heavy 808.7 / 1001.51 3412.0 44.97679901123047 41 11 10 10 10 1.096194064978309 59.727893400191874 0.0 3 0.8597251390706918 3.2558162041400758 3412.0 34.319532163742686 0.0 - - - - - - - 177.66666666666666 6 12 ARHGAP4 Rho GTPase activating protein 4 1127 145 A20140416_SF113_02 A20140416_SF113_02 TB373633.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4y6_1.heavy 808.7 / 976.639 2133.0 44.97679901123047 41 11 10 10 10 1.096194064978309 59.727893400191874 0.0 3 0.8597251390706918 3.2558162041400758 2133.0 3.7418326172440026 0.0 - - - - - - - 234.58333333333334 4 12 ARHGAP4 Rho GTPase activating protein 4 1129 145 A20140416_SF113_02 A20140416_SF113_02 TB373633.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4b10_2.heavy 808.7 / 679.345 8530.0 44.97679901123047 41 11 10 10 10 1.096194064978309 59.727893400191874 0.0 3 0.8597251390706918 3.2558162041400758 8530.0 55.89826276345801 0.0 - - - - - - - 184.91666666666666 17 12 ARHGAP4 Rho GTPase activating protein 4 1131 146 A20140416_SF113_02 A20140416_SF113_02 TB372883.[MT7]-AQNIQSR.2y4_1.heavy 480.771 / 503.294 3955.0 16.64965009689331 46 20 10 6 10 19.107794597468377 5.233466347458496 0.03899955749511719 3 0.9986148305797433 33.15589674219315 3955.0 12.704044055649241 0.0 - - - - - - - 675.5 7 8 ARHGAP4 Rho GTPase activating protein 4 1133 146 A20140416_SF113_02 A20140416_SF113_02 TB372883.[MT7]-AQNIQSR.2y5_1.heavy 480.771 / 617.336 8437.0 16.64965009689331 46 20 10 6 10 19.107794597468377 5.233466347458496 0.03899955749511719 3 0.9986148305797433 33.15589674219315 8437.0 25.10881061816394 0.0 - - - - - - - 301.7692307692308 16 13 ARHGAP4 Rho GTPase activating protein 4 1135 146 A20140416_SF113_02 A20140416_SF113_02 TB372883.[MT7]-AQNIQSR.2b4_1.heavy 480.771 / 571.332 7877.0 16.64965009689331 46 20 10 6 10 19.107794597468377 5.233466347458496 0.03899955749511719 3 0.9986148305797433 33.15589674219315 7877.0 23.890758467023172 0.0 - - - - - - - 687.875 15 8 ARHGAP4 Rho GTPase activating protein 4 1137 146 A20140416_SF113_02 A20140416_SF113_02 TB372883.[MT7]-AQNIQSR.2y6_1.heavy 480.771 / 745.395 22378.0 16.64965009689331 46 20 10 6 10 19.107794597468377 5.233466347458496 0.03899955749511719 3 0.9986148305797433 33.15589674219315 22378.0 89.27047737650477 0.0 - - - - - - - 233.9090909090909 44 11 ARHGAP4 Rho GTPase activating protein 4 1139 147 A20140416_SF113_02 A20140416_SF113_02 TB495105.[MT7]-EEPGPLR.2b3_1.heavy 471.262 / 500.247 3854.0 22.013599395751953 45 17 10 10 8 1.798336160478775 42.196702636991965 0.0 4 0.9733181516965651 7.538483826982077 3854.0 0.5909568066433089 18.0 - - - - - - - 991.0 11 1 NTHL1 nth endonuclease III-like 1 (E. coli) 1141 147 A20140416_SF113_02 A20140416_SF113_02 TB495105.[MT7]-EEPGPLR.2y5_1.heavy 471.262 / 539.33 61001.0 22.013599395751953 45 17 10 10 8 1.798336160478775 42.196702636991965 0.0 4 0.9733181516965651 7.538483826982077 61001.0 38.45614091148555 0.0 - - - - - - - 1321.0 122 4 NTHL1 nth endonuclease III-like 1 (E. coli) 1143 147 A20140416_SF113_02 A20140416_SF113_02 TB495105.[MT7]-EEPGPLR.2b4_1.heavy 471.262 / 557.269 11892.0 22.013599395751953 45 17 10 10 8 1.798336160478775 42.196702636991965 0.0 4 0.9733181516965651 7.538483826982077 11892.0 13.9644494892168 1.0 - - - - - - - 440.0 23 2 NTHL1 nth endonuclease III-like 1 (E. coli) 1145 147 A20140416_SF113_02 A20140416_SF113_02 TB495105.[MT7]-EEPGPLR.2y6_1.heavy 471.262 / 668.373 19159.0 22.013599395751953 45 17 10 10 8 1.798336160478775 42.196702636991965 0.0 4 0.9733181516965651 7.538483826982077 19159.0 22.044638958049823 1.0 - - - - - - - 330.0 39 2 NTHL1 nth endonuclease III-like 1 (E. coli) 1147 148 A20140416_SF113_02 A20140416_SF113_02 TB495624.[MT7]-QTSAILQQHYGGDIPASVAELVALPGVGPK[MT7].4b14_2.heavy 826.959 / 828.927 52320.0 39.364749908447266 37 12 10 5 10 1.396380467765538 60.22797173021843 0.0438995361328125 3 0.8968834283306738 3.8097247369995473 52320.0 138.25356557578135 0.0 - - - - - - - 257.5 104 8 NTHL1 nth endonuclease III-like 1 (E. coli) 1149 148 A20140416_SF113_02 A20140416_SF113_02 TB495624.[MT7]-QTSAILQQHYGGDIPASVAELVALPGVGPK[MT7].4b13_2.heavy 826.959 / 772.385 22668.0 39.364749908447266 37 12 10 5 10 1.396380467765538 60.22797173021843 0.0438995361328125 3 0.8968834283306738 3.8097247369995473 22668.0 48.95206512061729 0.0 - - - - - - - 701.0 45 8 NTHL1 nth endonuclease III-like 1 (E. coli) 1151 148 A20140416_SF113_02 A20140416_SF113_02 TB495624.[MT7]-QTSAILQQHYGGDIPASVAELVALPGVGPK[MT7].4b5_1.heavy 826.959 / 645.369 5724.0 39.364749908447266 37 12 10 5 10 1.396380467765538 60.22797173021843 0.0438995361328125 3 0.8968834283306738 3.8097247369995473 5724.0 12.11831317573629 0.0 - - - - - - - 772.75 11 8 NTHL1 nth endonuclease III-like 1 (E. coli) 1153 148 A20140416_SF113_02 A20140416_SF113_02 TB495624.[MT7]-QTSAILQQHYGGDIPASVAELVALPGVGPK[MT7].4y6_1.heavy 826.959 / 698.432 100748.0 39.364749908447266 37 12 10 5 10 1.396380467765538 60.22797173021843 0.0438995361328125 3 0.8968834283306738 3.8097247369995473 100748.0 156.46700630761765 0.0 - - - - - - - 752.1428571428571 201 7 NTHL1 nth endonuclease III-like 1 (E. coli) 1155 149 A20140416_SF113_02 A20140416_SF113_02 TB373233.[MT7]-ELLIVPGQVVDR.2b3_1.heavy 741.444 / 500.32 167817.0 34.56340026855469 45 17 10 10 8 3.2154753214990803 31.099601148044016 0.0 4 0.9705108061198637 7.168987985758919 167817.0 118.89321873781313 1.0 - - - - - - - 811.3333333333334 367 6 ALOX15B arachidonate 15-lipoxygenase, type B 1157 149 A20140416_SF113_02 A20140416_SF113_02 TB373233.[MT7]-ELLIVPGQVVDR.2y8_1.heavy 741.444 / 869.484 85186.0 34.56340026855469 45 17 10 10 8 3.2154753214990803 31.099601148044016 0.0 4 0.9705108061198637 7.168987985758919 85186.0 137.914956884042 0.0 - - - - - - - 806.25 170 8 ALOX15B arachidonate 15-lipoxygenase, type B 1159 149 A20140416_SF113_02 A20140416_SF113_02 TB373233.[MT7]-ELLIVPGQVVDR.2y9_1.heavy 741.444 / 982.568 63890.0 34.56340026855469 45 17 10 10 8 3.2154753214990803 31.099601148044016 0.0 4 0.9705108061198637 7.168987985758919 63890.0 155.78246639655282 0.0 - - - - - - - 797.7777777777778 127 9 ALOX15B arachidonate 15-lipoxygenase, type B 1161 149 A20140416_SF113_02 A20140416_SF113_02 TB373233.[MT7]-ELLIVPGQVVDR.2y7_1.heavy 741.444 / 770.416 184124.0 34.56340026855469 45 17 10 10 8 3.2154753214990803 31.099601148044016 0.0 4 0.9705108061198637 7.168987985758919 184124.0 270.279768729652 0.0 - - - - - - - 811.3333333333334 368 9 ALOX15B arachidonate 15-lipoxygenase, type B 1163 150 A20140416_SF113_02 A20140416_SF113_02 TB373239.[MT7]-ALGFENATQALGR.3b6_1.heavy 497.939 / 776.406 165775.0 32.1416015625 45 15 10 10 10 2.253402922050493 30.823059522777953 0.0 3 0.9595088699234744 6.1123187853470045 165775.0 144.68219285726636 0.0 - - - - - - - 308.0 331 5 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1165 150 A20140416_SF113_02 A20140416_SF113_02 TB373239.[MT7]-ALGFENATQALGR.3b4_1.heavy 497.939 / 533.32 299063.0 32.1416015625 45 15 10 10 10 2.253402922050493 30.823059522777953 0.0 3 0.9595088699234744 6.1123187853470045 299063.0 108.01375798683304 0.0 - - - - - - - 1219.5 598 2 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1167 150 A20140416_SF113_02 A20140416_SF113_02 TB373239.[MT7]-ALGFENATQALGR.3b5_1.heavy 497.939 / 662.363 237941.0 32.1416015625 45 15 10 10 10 2.253402922050493 30.823059522777953 0.0 3 0.9595088699234744 6.1123187853470045 237941.0 78.87163574085713 0.0 - - - - - - - 642.3333333333334 475 3 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1169 150 A20140416_SF113_02 A20140416_SF113_02 TB373239.[MT7]-ALGFENATQALGR.3y5_1.heavy 497.939 / 544.32 362112.0 32.1416015625 45 15 10 10 10 2.253402922050493 30.823059522777953 0.0 3 0.9595088699234744 6.1123187853470045 362112.0 136.70498770898791 0.0 - - - - - - - 1284.0 724 1 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1171 151 A20140416_SF113_02 A20140416_SF113_02 TB495453.[MT7]-DFVSEAYLLTLGK[MT7].3b6_1.heavy 581.997 / 793.385 137128.0 40.792301177978516 47 17 10 10 10 2.5268571057247184 30.81471721006093 0.0 3 0.9767392676640362 8.076165883056504 137128.0 516.697758509506 0.0 - - - - - - - 708.875 274 8 CYFIP2 cytoplasmic FMR1 interacting protein 2 1173 151 A20140416_SF113_02 A20140416_SF113_02 TB495453.[MT7]-DFVSEAYLLTLGK[MT7].3b5_1.heavy 581.997 / 722.348 49339.0 40.792301177978516 47 17 10 10 10 2.5268571057247184 30.81471721006093 0.0 3 0.9767392676640362 8.076165883056504 49339.0 124.75408589383667 0.0 - - - - - - - 664.5714285714286 98 7 CYFIP2 cytoplasmic FMR1 interacting protein 2 1175 151 A20140416_SF113_02 A20140416_SF113_02 TB495453.[MT7]-DFVSEAYLLTLGK[MT7].3b3_1.heavy 581.997 / 506.273 41172.0 40.792301177978516 47 17 10 10 10 2.5268571057247184 30.81471721006093 0.0 3 0.9767392676640362 8.076165883056504 41172.0 67.40753619827453 0.0 - - - - - - - 742.3636363636364 82 11 CYFIP2 cytoplasmic FMR1 interacting protein 2 1177 151 A20140416_SF113_02 A20140416_SF113_02 TB495453.[MT7]-DFVSEAYLLTLGK[MT7].3b7_1.heavy 581.997 / 956.448 61929.0 40.792301177978516 47 17 10 10 10 2.5268571057247184 30.81471721006093 0.0 3 0.9767392676640362 8.076165883056504 61929.0 632.4478905305835 0.0 - - - - - - - 252.84615384615384 123 13 CYFIP2 cytoplasmic FMR1 interacting protein 2 1179 152 A20140416_SF113_02 A20140416_SF113_02 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 445226.0 33.914100646972656 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 445226.0 186.91056415314972 0.0 - - - - - - - 704.5555555555555 890 9 1181 152 A20140416_SF113_02 A20140416_SF113_02 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 1074650.0 33.914100646972656 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1074650.0 238.27059795901846 0.0 - - - - - - - 254.0 2149 1 1183 152 A20140416_SF113_02 A20140416_SF113_02 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 938291.0 33.914100646972656 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 938291.0 217.79817856716195 0.0 - - - - - - - 1204.5 1876 8 1185 153 A20140416_SF113_02 A20140416_SF113_02 TB373374.[MT7]-ALGILTSHQSGFLK[MT7].3y3_1.heavy 587.348 / 551.367 11913.0 33.2843017578125 50 20 10 10 10 3.299862861630592 22.95342303712084 0.0 3 0.9924030562865699 14.150363265160989 11913.0 5.481973030518098 1.0 - - - - - - - 1922.0 51 2 FBXL5 F-box and leucine-rich repeat protein 5 1187 153 A20140416_SF113_02 A20140416_SF113_02 TB373374.[MT7]-ALGILTSHQSGFLK[MT7].3b5_1.heavy 587.348 / 612.42 21137.0 33.2843017578125 50 20 10 10 10 3.299862861630592 22.95342303712084 0.0 3 0.9924030562865699 14.150363265160989 21137.0 14.655769524417085 0.0 - - - - - - - 769.0 42 1 FBXL5 F-box and leucine-rich repeat protein 5 1189 153 A20140416_SF113_02 A20140416_SF113_02 TB373374.[MT7]-ALGILTSHQSGFLK[MT7].3y4_1.heavy 587.348 / 608.389 28695.0 33.2843017578125 50 20 10 10 10 3.299862861630592 22.95342303712084 0.0 3 0.9924030562865699 14.150363265160989 28695.0 17.350672597381315 0.0 - - - - - - - 1720.142857142857 57 7 FBXL5 F-box and leucine-rich repeat protein 5 1191 153 A20140416_SF113_02 A20140416_SF113_02 TB373374.[MT7]-ALGILTSHQSGFLK[MT7].3y5_1.heavy 587.348 / 695.421 75708.0 33.2843017578125 50 20 10 10 10 3.299862861630592 22.95342303712084 0.0 3 0.9924030562865699 14.150363265160989 75708.0 37.085569367919945 0.0 - - - - - - - 170.66666666666666 151 3 FBXL5 F-box and leucine-rich repeat protein 5 1193 154 A20140416_SF113_02 A20140416_SF113_02 TB495522.[MT7]-NANFYLQAGSAFAEMK[MT7].3b4_1.heavy 684.015 / 591.301 44475.0 37.0880012512207 46 16 10 10 10 2.4951045476027107 40.07848091819628 0.0 3 0.961844251681162 6.297841361832507 44475.0 34.403200666136506 0.0 - - - - - - - 308.0 88 2 ALOX15B arachidonate 15-lipoxygenase, type B 1195 154 A20140416_SF113_02 A20140416_SF113_02 TB495522.[MT7]-NANFYLQAGSAFAEMK[MT7].3b5_1.heavy 684.015 / 754.364 40533.0 37.0880012512207 46 16 10 10 10 2.4951045476027107 40.07848091819628 0.0 3 0.961844251681162 6.297841361832507 40533.0 29.240875959924026 0.0 - - - - - - - 827.2857142857143 81 7 ALOX15B arachidonate 15-lipoxygenase, type B 1197 154 A20140416_SF113_02 A20140416_SF113_02 TB495522.[MT7]-NANFYLQAGSAFAEMK[MT7].3y4_1.heavy 684.015 / 622.335 31416.0 37.0880012512207 46 16 10 10 10 2.4951045476027107 40.07848091819628 0.0 3 0.961844251681162 6.297841361832507 31416.0 47.91840371948857 0.0 - - - - - - - 807.6666666666666 62 9 ALOX15B arachidonate 15-lipoxygenase, type B 1199 154 A20140416_SF113_02 A20140416_SF113_02 TB495522.[MT7]-NANFYLQAGSAFAEMK[MT7].3y5_1.heavy 684.015 / 769.404 22669.0 37.0880012512207 46 16 10 10 10 2.4951045476027107 40.07848091819628 0.0 3 0.961844251681162 6.297841361832507 22669.0 33.3507680317322 0.0 - - - - - - - 774.4285714285714 45 7 ALOX15B arachidonate 15-lipoxygenase, type B 1201 155 A20140416_SF113_02 A20140416_SF113_02 TB495455.[MT7]-STGIGIEGFSELIQR.3y6_1.heavy 584.32 / 745.42 102723.0 38.2942008972168 50 20 10 10 10 12.355467660768301 8.093582755877788 0.0 3 0.9948739797218417 17.230049231620807 102723.0 190.65541256511318 0.0 - - - - - - - 348.0 205 2 ALOX15B arachidonate 15-lipoxygenase, type B 1203 155 A20140416_SF113_02 A20140416_SF113_02 TB495455.[MT7]-STGIGIEGFSELIQR.3b4_1.heavy 584.32 / 503.295 58616.0 38.2942008972168 50 20 10 10 10 12.355467660768301 8.093582755877788 0.0 3 0.9948739797218417 17.230049231620807 58616.0 45.57039032419257 0.0 - - - - - - - 1823.857142857143 117 7 ALOX15B arachidonate 15-lipoxygenase, type B 1205 155 A20140416_SF113_02 A20140416_SF113_02 TB495455.[MT7]-STGIGIEGFSELIQR.3b5_1.heavy 584.32 / 560.316 211018.0 38.2942008972168 50 20 10 10 10 12.355467660768301 8.093582755877788 0.0 3 0.9948739797218417 17.230049231620807 211018.0 191.13236162385272 0.0 - - - - - - - 812.4 422 5 ALOX15B arachidonate 15-lipoxygenase, type B 1207 155 A20140416_SF113_02 A20140416_SF113_02 TB495455.[MT7]-STGIGIEGFSELIQR.3y8_1.heavy 584.32 / 949.51 44804.0 38.2942008972168 50 20 10 10 10 12.355467660768301 8.093582755877788 0.0 3 0.9948739797218417 17.230049231620807 44804.0 169.20227301634435 0.0 - - - - - - - 221.45454545454547 89 11 ALOX15B arachidonate 15-lipoxygenase, type B 1209 156 A20140416_SF113_02 A20140416_SF113_02 TB495520.[MT7]-GLTVDSILQTDDATLGK[MT7].3b6_1.heavy 679.044 / 717.39 130781.0 36.35609817504883 43 13 10 10 10 0.9989927633435394 62.10490298298953 0.0 3 0.9179921592065154 4.279776199786512 130781.0 140.7448082443872 0.0 - - - - - - - 1259.5 261 10 NTHL1 nth endonuclease III-like 1 (E. coli) 1211 156 A20140416_SF113_02 A20140416_SF113_02 TB495520.[MT7]-GLTVDSILQTDDATLGK[MT7].3b5_1.heavy 679.044 / 630.358 85953.0 36.35609817504883 43 13 10 10 10 0.9989927633435394 62.10490298298953 0.0 3 0.9179921592065154 4.279776199786512 85953.0 65.76970445344129 0.0 - - - - - - - 2284.5 171 8 NTHL1 nth endonuclease III-like 1 (E. coli) 1213 156 A20140416_SF113_02 A20140416_SF113_02 TB495520.[MT7]-GLTVDSILQTDDATLGK[MT7].3y4_1.heavy 679.044 / 562.368 100154.0 36.35609817504883 43 13 10 10 10 0.9989927633435394 62.10490298298953 0.0 3 0.9179921592065154 4.279776199786512 100154.0 73.29802347312551 0.0 - - - - - - - 823.0 200 3 NTHL1 nth endonuclease III-like 1 (E. coli) 1215 156 A20140416_SF113_02 A20140416_SF113_02 TB495520.[MT7]-GLTVDSILQTDDATLGK[MT7].3b7_1.heavy 679.044 / 830.474 77431.0 36.35609817504883 43 13 10 10 10 0.9989927633435394 62.10490298298953 0.0 3 0.9179921592065154 4.279776199786512 77431.0 102.12943681058388 0.0 - - - - - - - 1181.7142857142858 154 7 NTHL1 nth endonuclease III-like 1 (E. coli) 1217 157 A20140416_SF113_02 A20140416_SF113_02 TB495250.[MT7]-DQVTAGAMQR.2y8_1.heavy 610.812 / 833.43 13333.0 21.358699798583984 50 20 10 10 10 12.856375146193395 7.778242223245071 0.0 3 0.9985033270573963 31.8966251651898 13333.0 32.19665852050776 0.0 - - - - - - - 227.36363636363637 26 11 NTHL1 nth endonuclease III-like 1 (E. coli) 1219 157 A20140416_SF113_02 A20140416_SF113_02 TB495250.[MT7]-DQVTAGAMQR.2y9_1.heavy 610.812 / 961.488 21944.0 21.358699798583984 50 20 10 10 10 12.856375146193395 7.778242223245071 0.0 3 0.9985033270573963 31.8966251651898 21944.0 27.90066114710823 0.0 - - - - - - - 727.5714285714286 43 7 NTHL1 nth endonuclease III-like 1 (E. coli) 1221 157 A20140416_SF113_02 A20140416_SF113_02 TB495250.[MT7]-DQVTAGAMQR.2y6_1.heavy 610.812 / 633.314 11759.0 21.358699798583984 50 20 10 10 10 12.856375146193395 7.778242223245071 0.0 3 0.9985033270573963 31.8966251651898 11759.0 42.887303680198414 0.0 - - - - - - - 661.4285714285714 23 7 NTHL1 nth endonuclease III-like 1 (E. coli) 1223 157 A20140416_SF113_02 A20140416_SF113_02 TB495250.[MT7]-DQVTAGAMQR.2y7_1.heavy 610.812 / 734.361 41851.0 21.358699798583984 50 20 10 10 10 12.856375146193395 7.778242223245071 0.0 3 0.9985033270573963 31.8966251651898 41851.0 252.4853008944196 0.0 - - - - - - - 277.75 83 12 NTHL1 nth endonuclease III-like 1 (E. coli) 1225 158 A20140416_SF113_02 A20140416_SF113_02 TB236029.[MT7]-NVLELTLYDK[MT7].3y3_1.heavy 499.292 / 569.305 255058.0 35.92179870605469 44 14 10 10 10 2.5104986713848794 29.764414694193576 0.0 3 0.9410224737531809 5.056629850299389 255058.0 256.9790903211 0.0 - - - - - - - 461.25 510 4 PLA2G4F phospholipase A2, group IVF 1227 158 A20140416_SF113_02 A20140416_SF113_02 TB236029.[MT7]-NVLELTLYDK[MT7].3b4_1.heavy 499.292 / 600.347 168685.0 35.92179870605469 44 14 10 10 10 2.5104986713848794 29.764414694193576 0.0 3 0.9410224737531809 5.056629850299389 168685.0 179.49038029237977 0.0 - - - - - - - 779.0 337 9 PLA2G4F phospholipase A2, group IVF 1229 158 A20140416_SF113_02 A20140416_SF113_02 TB236029.[MT7]-NVLELTLYDK[MT7].3b5_1.heavy 499.292 / 713.431 54260.0 35.92179870605469 44 14 10 10 10 2.5104986713848794 29.764414694193576 0.0 3 0.9410224737531809 5.056629850299389 54260.0 104.19264421215641 0.0 - - - - - - - 830.25 108 8 PLA2G4F phospholipase A2, group IVF 1231 158 A20140416_SF113_02 A20140416_SF113_02 TB236029.[MT7]-NVLELTLYDK[MT7].3y4_1.heavy 499.292 / 682.389 48231.0 35.92179870605469 44 14 10 10 10 2.5104986713848794 29.764414694193576 0.0 3 0.9410224737531809 5.056629850299389 48231.0 218.34063192904657 0.0 - - - - - - - 316.2857142857143 96 7 PLA2G4F phospholipase A2, group IVF 1233 159 A20140416_SF113_02 A20140416_SF113_02 TB495628.[MT7]-LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR.4y5_1.heavy 1160.9 / 622.331 3084.0 47.63309860229492 48 18 10 10 10 2.7722754121866195 24.938497886538215 0.0 3 0.9819867405267447 9.181468150487172 3084.0 2.2601585483205784 0.0 - - - - - - - 122.66666666666667 6 24 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1235 159 A20140416_SF113_02 A20140416_SF113_02 TB495628.[MT7]-LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR.4b7_1.heavy 1160.9 / 871.5 3227.0 47.63309860229492 48 18 10 10 10 2.7722754121866195 24.938497886538215 0.0 3 0.9819867405267447 9.181468150487172 3227.0 9.388631763795464 0.0 - - - - - - - 151.16666666666666 6 24 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1237 159 A20140416_SF113_02 A20140416_SF113_02 TB495628.[MT7]-LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR.4y10_1.heavy 1160.9 / 1163.64 914.0 47.63309860229492 48 18 10 10 10 2.7722754121866195 24.938497886538215 0.0 3 0.9819867405267447 9.181468150487172 914.0 3.1388089617388983 0.0 - - - - - - - 0.0 1 0 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1239 159 A20140416_SF113_02 A20140416_SF113_02 TB495628.[MT7]-LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR.4b4_1.heavy 1160.9 / 600.347 4141.0 47.63309860229492 48 18 10 10 10 2.7722754121866195 24.938497886538215 0.0 3 0.9819867405267447 9.181468150487172 4141.0 5.725268413559962 0.0 - - - - - - - 182.08333333333334 8 24 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1241 160 A20140416_SF113_02 A20140416_SF113_02 TB495459.[MT7]-ESAALSEVLAGPLAQR.3y7_1.heavy 585.996 / 712.41 132641.0 36.61764907836914 38 13 10 5 10 4.928824488506882 20.288813333317453 0.04010009765625 3 0.9224432362593602 4.402555828976664 132641.0 121.52399606572394 0.0 - - - - - - - 493.0 265 2 ARHGAP4 Rho GTPase activating protein 4 1243 160 A20140416_SF113_02 A20140416_SF113_02 TB495459.[MT7]-ESAALSEVLAGPLAQR.3y6_1.heavy 585.996 / 641.373 166664.0 36.61764907836914 38 13 10 5 10 4.928824488506882 20.288813333317453 0.04010009765625 3 0.9224432362593602 4.402555828976664 166664.0 165.14577015015337 0.0 - - - - - - - 821.6666666666666 333 3 ARHGAP4 Rho GTPase activating protein 4 1245 160 A20140416_SF113_02 A20140416_SF113_02 TB495459.[MT7]-ESAALSEVLAGPLAQR.3b4_1.heavy 585.996 / 503.258 74210.0 36.61764907836914 38 13 10 5 10 4.928824488506882 20.288813333317453 0.04010009765625 3 0.9224432362593602 4.402555828976664 74210.0 47.90396822768623 0.0 - - - - - - - 863.0 148 1 ARHGAP4 Rho GTPase activating protein 4 1247 160 A20140416_SF113_02 A20140416_SF113_02 TB495459.[MT7]-ESAALSEVLAGPLAQR.3b7_1.heavy 585.996 / 832.417 88756.0 36.61764907836914 38 13 10 5 10 4.928824488506882 20.288813333317453 0.04010009765625 3 0.9224432362593602 4.402555828976664 88756.0 245.77762670238218 0.0 - - - - - - - 339.25 177 4 ARHGAP4 Rho GTPase activating protein 4 1249 161 A20140416_SF113_02 A20140416_SF113_02 TB373642.[MT7]-ATLQALLEVVASDDGDVLDSFQTSPSTESLK[MT7].4b8_1.heavy 881.958 / 984.585 10006.0 47.028099060058594 43 13 10 10 10 1.3677828013423405 57.85264297734483 0.0 3 0.9249838340656542 4.477461731373365 10006.0 52.82678030449773 0.0 - - - - - - - 281.9375 20 16 ARHGAP4 Rho GTPase activating protein 4 1251 161 A20140416_SF113_02 A20140416_SF113_02 TB373642.[MT7]-ATLQALLEVVASDDGDVLDSFQTSPSTESLK[MT7].4b7_1.heavy 881.958 / 855.542 3888.0 47.028099060058594 43 13 10 10 10 1.3677828013423405 57.85264297734483 0.0 3 0.9249838340656542 4.477461731373365 3888.0 14.05100590800031 1.0 - - - - - - - 295.0 8 16 ARHGAP4 Rho GTPase activating protein 4 1253 161 A20140416_SF113_02 A20140416_SF113_02 TB373642.[MT7]-ATLQALLEVVASDDGDVLDSFQTSPSTESLK[MT7].4b4_1.heavy 881.958 / 558.337 5081.0 47.028099060058594 43 13 10 10 10 1.3677828013423405 57.85264297734483 0.0 3 0.9249838340656542 4.477461731373365 5081.0 19.473262697090615 0.0 - - - - - - - 282.27777777777777 10 18 ARHGAP4 Rho GTPase activating protein 4 1255 161 A20140416_SF113_02 A20140416_SF113_02 TB373642.[MT7]-ATLQALLEVVASDDGDVLDSFQTSPSTESLK[MT7].4b6_1.heavy 881.958 / 742.458 14724.0 47.028099060058594 43 13 10 10 10 1.3677828013423405 57.85264297734483 0.0 3 0.9249838340656542 4.477461731373365 14724.0 68.19464743917756 0.0 - - - - - - - 720.7 29 10 ARHGAP4 Rho GTPase activating protein 4 1257 162 A20140416_SF113_02 A20140416_SF113_02 TB372898.[MT7]-FISELAR.2y5_1.heavy 490.288 / 575.315 66766.0 31.13960075378418 39 13 8 10 8 1.6201447400684506 51.627029362535055 0.0 4 0.9188773841427409 4.303390965652378 66766.0 27.8693683640374 1.0 - - - - - - - 630.0 274 1 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1259 162 A20140416_SF113_02 A20140416_SF113_02 TB372898.[MT7]-FISELAR.2b4_1.heavy 490.288 / 621.336 35021.0 31.13960075378418 39 13 8 10 8 1.6201447400684506 51.627029362535055 0.0 4 0.9188773841427409 4.303390965652378 35021.0 31.16948412698413 0.0 - - - - - - - 252.0 70 2 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1261 162 A20140416_SF113_02 A20140416_SF113_02 TB372898.[MT7]-FISELAR.2y6_1.heavy 490.288 / 688.399 97000.0 31.13960075378418 39 13 8 10 8 1.6201447400684506 51.627029362535055 0.0 4 0.9188773841427409 4.303390965652378 97000.0 121.22500515357657 0.0 - - - - - - - 1170.0 194 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1263 162 A20140416_SF113_02 A20140416_SF113_02 TB372898.[MT7]-FISELAR.2b5_1.heavy 490.288 / 734.42 18896.0 31.13960075378418 39 13 8 10 8 1.6201447400684506 51.627029362535055 0.0 4 0.9188773841427409 4.303390965652378 18896.0 9.303185294278078 2.0 - - - - - - - 672.0 73 12 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1265 163 A20140416_SF113_02 A20140416_SF113_02 TB495258.[MT7]-AALEEWLPR.2y4_1.heavy 614.844 / 571.335 36548.0 36.21675109863281 46 20 10 6 10 11.46116632828543 8.725115501832162 0.038299560546875 3 0.9978521136996638 26.62434673325043 36548.0 9.1073022751896 1.0 - - - - - - - 861.0 73 1 NTHL1 nth endonuclease III-like 1 (E. coli) 1267 163 A20140416_SF113_02 A20140416_SF113_02 TB495258.[MT7]-AALEEWLPR.2y8_1.heavy 614.844 / 1013.54 58945.0 36.21675109863281 46 20 10 6 10 11.46116632828543 8.725115501832162 0.038299560546875 3 0.9978521136996638 26.62434673325043 58945.0 226.92569879984512 0.0 - - - - - - - 298.7142857142857 117 7 NTHL1 nth endonuclease III-like 1 (E. coli) 1269 163 A20140416_SF113_02 A20140416_SF113_02 TB495258.[MT7]-AALEEWLPR.2y6_1.heavy 614.844 / 829.42 32611.0 36.21675109863281 46 20 10 6 10 11.46116632828543 8.725115501832162 0.038299560546875 3 0.9978521136996638 26.62434673325043 32611.0 22.72204644400252 0.0 - - - - - - - 430.5 65 2 NTHL1 nth endonuclease III-like 1 (E. coli) 1271 163 A20140416_SF113_02 A20140416_SF113_02 TB495258.[MT7]-AALEEWLPR.2b5_1.heavy 614.844 / 658.353 39010.0 36.21675109863281 46 20 10 6 10 11.46116632828543 8.725115501832162 0.038299560546875 3 0.9978521136996638 26.62434673325043 39010.0 31.361473930639356 0.0 - - - - - - - 1292.5 78 6 NTHL1 nth endonuclease III-like 1 (E. coli) 1273 164 A20140416_SF113_02 A20140416_SF113_02 TB373092.[MT7]-RIWEAEK[MT7].3y3_1.heavy 407.239 / 491.295 284976.0 24.606300354003906 44 14 10 10 10 2.044770395608564 48.90524638598263 0.0 3 0.9495971114877213 5.4738566683167305 284976.0 161.6866003665304 0.0 - - - - - - - 1214.0 569 2 SRRD SRR1 domain containing 1275 164 A20140416_SF113_02 A20140416_SF113_02 TB373092.[MT7]-RIWEAEK[MT7].3b4_1.heavy 407.239 / 729.416 47411.0 24.606300354003906 44 14 10 10 10 2.044770395608564 48.90524638598263 0.0 3 0.9495971114877213 5.4738566683167305 47411.0 154.58508609131326 0.0 - - - - - - - 712.1428571428571 94 7 SRRD SRR1 domain containing 1277 164 A20140416_SF113_02 A20140416_SF113_02 TB373092.[MT7]-RIWEAEK[MT7].3b3_1.heavy 407.239 / 600.374 39616.0 24.606300354003906 44 14 10 10 10 2.044770395608564 48.90524638598263 0.0 3 0.9495971114877213 5.4738566683167305 39616.0 29.279972494806962 0.0 - - - - - - - 2245.4285714285716 79 7 SRRD SRR1 domain containing 1279 164 A20140416_SF113_02 A20140416_SF113_02 TB373092.[MT7]-RIWEAEK[MT7].3b4_2.heavy 407.239 / 365.212 227981.0 24.606300354003906 44 14 10 10 10 2.044770395608564 48.90524638598263 0.0 3 0.9495971114877213 5.4738566683167305 227981.0 72.64614937184767 0.0 - - - - - - - 1789.0 455 1 SRRD SRR1 domain containing 1281 165 A20140416_SF113_02 A20140416_SF113_02 TB373099.[MT7]-DFDWNLK[MT7].2y4_1.heavy 613.326 / 704.421 15616.0 32.836299896240234 48 20 10 10 8 35.588600885327494 2.8098884899189196 0.0 4 0.9997434353868618 77.04681778610237 15616.0 18.573419243335866 0.0 - - - - - - - 1204.6666666666667 31 9 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 1283 165 A20140416_SF113_02 A20140416_SF113_02 TB373099.[MT7]-DFDWNLK[MT7].2b3_1.heavy 613.326 / 522.232 27619.0 32.836299896240234 48 20 10 10 8 35.588600885327494 2.8098884899189196 0.0 4 0.9997434353868618 77.04681778610237 27619.0 23.70144079324738 0.0 - - - - - - - 129.0 55 1 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 1285 165 A20140416_SF113_02 A20140416_SF113_02 TB373099.[MT7]-DFDWNLK[MT7].2y3_1.heavy 613.326 / 518.342 8131.0 32.836299896240234 48 20 10 10 8 35.588600885327494 2.8098884899189196 0.0 4 0.9997434353868618 77.04681778610237 8131.0 4.829346000446043 3.0 - - - - - - - 903.0 23 1 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 1287 165 A20140416_SF113_02 A20140416_SF113_02 TB373099.[MT7]-DFDWNLK[MT7].2y6_1.heavy 613.326 / 966.516 5033.0 32.836299896240234 48 20 10 10 8 35.588600885327494 2.8098884899189196 0.0 4 0.9997434353868618 77.04681778610237 5033.0 10.924341085271317 1.0 - - - - - - - 709.5 10 8 YTHDF3;YTHDF2 YTH domain family, member 3;YTH domain family, member 2 1289 166 A20140416_SF113_02 A20140416_SF113_02 TB373501.[MT7]-AALTFLQDENMVSFIK[MT7].2y4_1.heavy 1058.07 / 638.399 7490.0 40.74479961395264 36 10 10 6 10 1.8950807925260782 42.11517744578715 0.037998199462890625 3 0.8275252655947746 2.9278595217979957 7490.0 27.40750049475559 0.0 - - - - - - - 237.5625 14 16 TTC39A tetratricopeptide repeat domain 39A 1291 166 A20140416_SF113_02 A20140416_SF113_02 TB373501.[MT7]-AALTFLQDENMVSFIK[MT7].2y8_1.heavy 1058.07 / 1111.59 3908.0 40.74479961395264 36 10 10 6 10 1.8950807925260782 42.11517744578715 0.037998199462890625 3 0.8275252655947746 2.9278595217979957 3908.0 16.97120070113935 0.0 - - - - - - - 217.33333333333334 7 18 TTC39A tetratricopeptide repeat domain 39A 1293 166 A20140416_SF113_02 A20140416_SF113_02 TB373501.[MT7]-AALTFLQDENMVSFIK[MT7].2y5_1.heavy 1058.07 / 737.468 1303.0 40.74479961395264 36 10 10 6 10 1.8950807925260782 42.11517744578715 0.037998199462890625 3 0.8275252655947746 2.9278595217979957 1303.0 8.36788990825688 1.0 - - - - - - - 188.46666666666667 3 15 TTC39A tetratricopeptide repeat domain 39A 1295 166 A20140416_SF113_02 A20140416_SF113_02 TB373501.[MT7]-AALTFLQDENMVSFIK[MT7].2y3_1.heavy 1058.07 / 551.367 4016.0 40.74479961395264 36 10 10 6 10 1.8950807925260782 42.11517744578715 0.037998199462890625 3 0.8275252655947746 2.9278595217979957 4016.0 47.21979283811778 0.0 - - - - - - - 208.25 8 12 TTC39A tetratricopeptide repeat domain 39A 1297 167 A20140416_SF113_02 A20140416_SF113_02 TB373225.[MT7]-GVEDIPGYYYR.2b4_1.heavy 738.368 / 545.269 33504.0 31.006399154663086 47 17 10 10 10 2.6393837397833426 37.887632060735754 0.0 3 0.9727071646831315 7.453243359092533 33504.0 10.33110987066221 3.0 - - - - - - - 189.0 67 2 ALOX15B arachidonate 15-lipoxygenase, type B 1299 167 A20140416_SF113_02 A20140416_SF113_02 TB373225.[MT7]-GVEDIPGYYYR.2y6_1.heavy 738.368 / 818.383 20908.0 31.006399154663086 47 17 10 10 10 2.6393837397833426 37.887632060735754 0.0 3 0.9727071646831315 7.453243359092533 20908.0 53.14709297052154 0.0 - - - - - - - 684.0 41 7 ALOX15B arachidonate 15-lipoxygenase, type B 1301 167 A20140416_SF113_02 A20140416_SF113_02 TB373225.[MT7]-GVEDIPGYYYR.2b5_1.heavy 738.368 / 658.353 16374.0 31.006399154663086 47 17 10 10 10 2.6393837397833426 37.887632060735754 0.0 3 0.9727071646831315 7.453243359092533 16374.0 29.480625850340132 0.0 - - - - - - - 700.0 32 9 ALOX15B arachidonate 15-lipoxygenase, type B 1303 167 A20140416_SF113_02 A20140416_SF113_02 TB373225.[MT7]-GVEDIPGYYYR.2y7_1.heavy 738.368 / 931.467 13099.0 31.006399154663086 47 17 10 10 10 2.6393837397833426 37.887632060735754 0.0 3 0.9727071646831315 7.453243359092533 13099.0 34.54947883597883 0.0 - - - - - - - 594.0 26 7 ALOX15B arachidonate 15-lipoxygenase, type B 1305 168 A20140416_SF113_02 A20140416_SF113_02 TB373227.[MT7]-TILEMTQILK[MT7].2y8_1.heavy 739.449 / 1119.66 7666.0 38.47100067138672 48 18 10 10 10 3.569678973007891 23.374991944342547 0.0 3 0.9820528903708067 9.198424257147957 7666.0 16.610276173351437 0.0 - - - - - - - 228.66666666666666 15 9 FBXO25 F-box protein 25 1307 168 A20140416_SF113_02 A20140416_SF113_02 TB373227.[MT7]-TILEMTQILK[MT7].2b4_1.heavy 739.449 / 601.368 14874.0 38.47100067138672 48 18 10 10 10 3.569678973007891 23.374991944342547 0.0 3 0.9820528903708067 9.198424257147957 14874.0 21.051476929184354 0.0 - - - - - - - 686.625 29 8 FBXO25 F-box protein 25 1309 168 A20140416_SF113_02 A20140416_SF113_02 TB373227.[MT7]-TILEMTQILK[MT7].2y3_1.heavy 739.449 / 517.383 6293.0 38.47100067138672 48 18 10 10 10 3.569678973007891 23.374991944342547 0.0 3 0.9820528903708067 9.198424257147957 6293.0 5.300683394872906 2.0 - - - - - - - 829.375 12 8 FBXO25 F-box protein 25 1311 168 A20140416_SF113_02 A20140416_SF113_02 TB373227.[MT7]-TILEMTQILK[MT7].2y7_1.heavy 739.449 / 1006.57 9726.0 38.47100067138672 48 18 10 10 10 3.569678973007891 23.374991944342547 0.0 3 0.9820528903708067 9.198424257147957 9726.0 20.104710244390624 0.0 - - - - - - - 305.0 19 9 FBXO25 F-box protein 25 1313 169 A20140416_SF113_02 A20140416_SF113_02 TB373122.[MT7]-DQLEEVLK[MT7].2b3_1.heavy 631.366 / 501.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAGE1 cancer antigen 1 1315 169 A20140416_SF113_02 A20140416_SF113_02 TB373122.[MT7]-DQLEEVLK[MT7].2b4_1.heavy 631.366 / 630.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAGE1 cancer antigen 1 1317 169 A20140416_SF113_02 A20140416_SF113_02 TB373122.[MT7]-DQLEEVLK[MT7].2y3_1.heavy 631.366 / 503.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAGE1 cancer antigen 1 1319 169 A20140416_SF113_02 A20140416_SF113_02 TB373122.[MT7]-DQLEEVLK[MT7].2b5_1.heavy 631.366 / 759.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAGE1 cancer antigen 1 1321 170 A20140416_SF113_02 A20140416_SF113_02 TB373128.[MT7]-YAAPELEIAR.2y8_1.heavy 638.854 / 898.499 5905.0 30.687599182128906 29 18 0 5 6 5.7469988596615655 17.400386261063026 0.043399810791015625 5 0.9876356529761008 11.087363303909946 5905.0 20.98859416445623 0.0 - - - - - - - 282.6666666666667 11 12 SERINC5 serine incorporator 5 1323 170 A20140416_SF113_02 A20140416_SF113_02 TB373128.[MT7]-YAAPELEIAR.2y5_1.heavy 638.854 / 601.367 9046.0 30.687599182128906 29 18 0 5 6 5.7469988596615655 17.400386261063026 0.043399810791015625 5 0.9876356529761008 11.087363303909946 9046.0 2.8343646556255164 3.0 - - - - - - - 1382.0 254 1 SERINC5 serine incorporator 5 1325 170 A20140416_SF113_02 A20140416_SF113_02 TB373128.[MT7]-YAAPELEIAR.2y9_1.heavy 638.854 / 969.536 14448.0 30.687599182128906 29 18 0 5 6 5.7469988596615655 17.400386261063026 0.043399810791015625 5 0.9876356529761008 11.087363303909946 14448.0 45.92912922465209 0.0 - - - - - - - 628.2857142857143 28 7 SERINC5 serine incorporator 5 1327 170 A20140416_SF113_02 A20140416_SF113_02 TB373128.[MT7]-YAAPELEIAR.2y7_1.heavy 638.854 / 827.462 22866.0 30.687599182128906 29 18 0 5 6 5.7469988596615655 17.400386261063026 0.043399810791015625 5 0.9876356529761008 11.087363303909946 22866.0 29.066135951542023 0.0 - - - - - - - 706.625 45 8 SERINC5 serine incorporator 5 1329 171 A20140416_SF113_02 A20140416_SF113_02 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 556478.0 35.92179870605469 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 556478.0 211.79328848413232 0.0 - - - - - - - 286.0 1112 3 1331 171 A20140416_SF113_02 A20140416_SF113_02 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 1043240.0 35.92179870605469 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1043240.0 189.43456499559537 0.0 - - - - - - - 919.0 2086 2 1333 171 A20140416_SF113_02 A20140416_SF113_02 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 1277690.0 35.92179870605469 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1277690.0 205.23431046786737 0.0 - - - - - - - 245.0 2555 1 1335 172 A20140416_SF113_02 A20140416_SF113_02 TB373129.[MT7]-RFDEATQLR.2b3_1.heavy 640.347 / 563.306 7162.0 24.166200637817383 50 20 10 10 10 8.445831363919696 11.840160629680176 0.0 3 0.9938615389905142 15.743823422073392 7162.0 19.86939117533604 0.0 - - - - - - - 738.5 14 8 PFKL phosphofructokinase, liver 1337 172 A20140416_SF113_02 A20140416_SF113_02 TB373129.[MT7]-RFDEATQLR.2y8_1.heavy 640.347 / 979.484 5152.0 24.166200637817383 50 20 10 10 10 8.445831363919696 11.840160629680176 0.0 3 0.9938615389905142 15.743823422073392 5152.0 37.24251105216622 0.0 - - - - - - - 213.8 10 10 PFKL phosphofructokinase, liver 1339 172 A20140416_SF113_02 A20140416_SF113_02 TB373129.[MT7]-RFDEATQLR.2y6_1.heavy 640.347 / 717.389 7539.0 24.166200637817383 50 20 10 10 10 8.445831363919696 11.840160629680176 0.0 3 0.9938615389905142 15.743823422073392 7539.0 17.003477081890217 0.0 - - - - - - - 646.2857142857143 15 7 PFKL phosphofructokinase, liver 1341 172 A20140416_SF113_02 A20140416_SF113_02 TB373129.[MT7]-RFDEATQLR.2b7_1.heavy 640.347 / 992.492 5277.0 24.166200637817383 50 20 10 10 10 8.445831363919696 11.840160629680176 0.0 3 0.9938615389905142 15.743823422073392 5277.0 9.098275862068965 0.0 - - - - - - - 222.3846153846154 10 13 PFKL phosphofructokinase, liver 1343 173 A20140416_SF113_02 A20140416_SF113_02 TB495229.[MT7]-EAQMLC[CAM]QR.2y4_1.heavy 590.29 / 576.292 18158.0 23.590900421142578 47 17 10 10 10 4.31376631611966 23.181598786730866 0.0 3 0.973808259641245 7.6090019567704665 18158.0 16.027817632929775 0.0 - - - - - - - 968.0 36 1 TTC39A tetratricopeptide repeat domain 39A 1345 173 A20140416_SF113_02 A20140416_SF113_02 TB495229.[MT7]-EAQMLC[CAM]QR.2y5_1.heavy 590.29 / 707.333 14042.0 23.590900421142578 47 17 10 10 10 4.31376631611966 23.181598786730866 0.0 3 0.973808259641245 7.6090019567704665 14042.0 31.043264462809915 0.0 - - - - - - - 336.1111111111111 28 9 TTC39A tetratricopeptide repeat domain 39A 1347 173 A20140416_SF113_02 A20140416_SF113_02 TB495229.[MT7]-EAQMLC[CAM]QR.2b4_1.heavy 590.29 / 604.288 10774.0 23.590900421142578 47 17 10 10 10 4.31376631611966 23.181598786730866 0.0 3 0.973808259641245 7.6090019567704665 10774.0 25.56757969303424 0.0 - - - - - - - 328.42857142857144 21 7 TTC39A tetratricopeptide repeat domain 39A 1349 173 A20140416_SF113_02 A20140416_SF113_02 TB495229.[MT7]-EAQMLC[CAM]QR.2y7_1.heavy 590.29 / 906.428 32563.0 23.590900421142578 47 17 10 10 10 4.31376631611966 23.181598786730866 0.0 3 0.973808259641245 7.6090019567704665 32563.0 51.89067881434735 0.0 - - - - - - - 363.0 65 9 TTC39A tetratricopeptide repeat domain 39A 1351 174 A20140416_SF113_02 A20140416_SF113_02 TB495227.[MT7]-ITDVALEK[MT7].2y4_1.heavy 588.858 / 604.379 27736.0 28.334150314331055 42 18 10 6 8 4.813740405870732 20.773866384245025 0.038700103759765625 4 0.9833248156003415 9.543808108071609 27736.0 32.03166130760986 1.0 - - - - - - - 1830.2857142857142 55 7 FBXL5 F-box and leucine-rich repeat protein 5 1353 174 A20140416_SF113_02 A20140416_SF113_02 TB495227.[MT7]-ITDVALEK[MT7].2b4_1.heavy 588.858 / 573.336 22637.0 28.334150314331055 42 18 10 6 8 4.813740405870732 20.773866384245025 0.038700103759765625 4 0.9833248156003415 9.543808108071609 22637.0 5.87020616095279 2.0 - - - - - - - 2239.0 51 1 FBXL5 F-box and leucine-rich repeat protein 5 1355 174 A20140416_SF113_02 A20140416_SF113_02 TB495227.[MT7]-ITDVALEK[MT7].2y3_1.heavy 588.858 / 533.341 14925.0 28.334150314331055 42 18 10 6 8 4.813740405870732 20.773866384245025 0.038700103759765625 4 0.9833248156003415 9.543808108071609 14925.0 7.678823136389935 2.0 - - - - - - - 1119.0 31 1 FBXL5 F-box and leucine-rich repeat protein 5 1357 174 A20140416_SF113_02 A20140416_SF113_02 TB495227.[MT7]-ITDVALEK[MT7].2y7_1.heavy 588.858 / 919.522 28358.0 28.334150314331055 42 18 10 6 8 4.813740405870732 20.773866384245025 0.038700103759765625 4 0.9833248156003415 9.543808108071609 28358.0 98.83485254691689 0.0 - - - - - - - 233.125 56 8 FBXL5 F-box and leucine-rich repeat protein 5 1359 175 A20140416_SF113_02 A20140416_SF113_02 TB236032.[MT7]-LLEFVGFSGNK[MT7].3y6_1.heavy 500.288 / 753.401 8988.0 37.91830062866211 41 17 6 10 8 3.1818224412997145 31.428529355381592 0.0 4 0.9768901588009946 8.102591607130169 8988.0 107.70038076372839 0.0 - - - - - - - 243.08333333333334 17 12 TTC39A tetratricopeptide repeat domain 39A 1361 175 A20140416_SF113_02 A20140416_SF113_02 TB236032.[MT7]-LLEFVGFSGNK[MT7].3b6_1.heavy 500.288 / 803.478 13190.0 37.91830062866211 41 17 6 10 8 3.1818224412997145 31.428529355381592 0.0 4 0.9768901588009946 8.102591607130169 13190.0 161.4481933898243 1.0 - - - - - - - 272.25 26 12 TTC39A tetratricopeptide repeat domain 39A 1363 175 A20140416_SF113_02 A20140416_SF113_02 TB236032.[MT7]-LLEFVGFSGNK[MT7].3b4_1.heavy 500.288 / 647.388 27315.0 37.91830062866211 41 17 6 10 8 3.1818224412997145 31.428529355381592 0.0 4 0.9768901588009946 8.102591607130169 27315.0 54.02602956963932 0.0 - - - - - - - 729.625 54 8 TTC39A tetratricopeptide repeat domain 39A 1365 175 A20140416_SF113_02 A20140416_SF113_02 TB236032.[MT7]-LLEFVGFSGNK[MT7].3y4_1.heavy 500.288 / 549.311 24863.0 37.91830062866211 41 17 6 10 8 3.1818224412997145 31.428529355381592 0.0 4 0.9768901588009946 8.102591607130169 24863.0 45.22963679684102 1.0 - - - - - - - 788.0 84 8 TTC39A tetratricopeptide repeat domain 39A 1367 176 A20140416_SF113_02 A20140416_SF113_02 TB373121.[MT7]-EQWWLSLR.2b3_1.heavy 631.344 / 588.29 8705.0 37.797298431396484 42 14 10 10 8 2.1306100962394927 37.599985657557184 0.0 4 0.9474359439873964 5.359163114390825 8705.0 6.9084112697313715 0.0 - - - - - - - 1728.111111111111 17 9 PFKL phosphofructokinase, liver 1369 176 A20140416_SF113_02 A20140416_SF113_02 TB373121.[MT7]-EQWWLSLR.2y5_1.heavy 631.344 / 674.398 12071.0 37.797298431396484 42 14 10 10 8 2.1306100962394927 37.599985657557184 0.0 4 0.9474359439873964 5.359163114390825 12071.0 12.682801196945686 0.0 - - - - - - - 290.0 24 2 PFKL phosphofructokinase, liver 1371 176 A20140416_SF113_02 A20140416_SF113_02 TB373121.[MT7]-EQWWLSLR.2y6_1.heavy 631.344 / 860.478 13116.0 37.797298431396484 42 14 10 10 8 2.1306100962394927 37.599985657557184 0.0 4 0.9474359439873964 5.359163114390825 13116.0 17.346864138168407 2.0 - - - - - - - 301.6 27 10 PFKL phosphofructokinase, liver 1373 176 A20140416_SF113_02 A20140416_SF113_02 TB373121.[MT7]-EQWWLSLR.2y7_1.heavy 631.344 / 988.536 20893.0 37.797298431396484 42 14 10 10 8 2.1306100962394927 37.599985657557184 0.0 4 0.9474359439873964 5.359163114390825 20893.0 78.22009852216748 0.0 - - - - - - - 255.2 41 10 PFKL phosphofructokinase, liver 1375 177 A20140416_SF113_02 A20140416_SF113_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 866478.0 32.18579864501953 25 -3 10 10 8 null 0.0 0.0 4 0.0 0.0 866478.0 815.71390037155 0.0 - - - - - - - 744.2 1732 5 1377 177 A20140416_SF113_02 A20140416_SF113_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 152039.0 32.18579864501953 25 -3 10 10 8 null 0.0 0.0 4 0.0 0.0 152039.0 189.55511688311688 1.0 - - - - - - - 1154.5714285714287 545 7 1379 177 A20140416_SF113_02 A20140416_SF113_02 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 110982.0 32.18579864501953 25 -3 10 10 8 null 0.0 0.0 4 0.0 0.0 110982.0 63.770173491936205 0.0 - - - - - - - 642.0 221 1 1381 178 A20140416_SF113_02 A20140416_SF113_02 TB495123.[MT7]-YILLC[CAM]R.2b3_1.heavy 491.287 / 534.341 37011.0 32.007999420166016 44 20 6 10 8 20.04326583607835 4.98920688962762 0.0 4 0.9973782786873754 24.097621495543404 37011.0 15.692425152337714 0.0 - - - - - - - 1701.5714285714287 74 7 DEFB125 defensin, beta 125 1383 178 A20140416_SF113_02 A20140416_SF113_02 TB495123.[MT7]-YILLC[CAM]R.2y4_1.heavy 491.287 / 561.318 52891.0 32.007999420166016 44 20 6 10 8 20.04326583607835 4.98920688962762 0.0 4 0.9973782786873754 24.097621495543404 52891.0 46.37865679570692 0.0 - - - - - - - 742.4 105 5 DEFB125 defensin, beta 125 1385 178 A20140416_SF113_02 A20140416_SF113_02 TB495123.[MT7]-YILLC[CAM]R.2y5_1.heavy 491.287 / 674.402 94897.0 32.007999420166016 44 20 6 10 8 20.04326583607835 4.98920688962762 0.0 4 0.9973782786873754 24.097621495543404 94897.0 145.8063202487712 1.0 - - - - - - - 384.0 291 1 DEFB125 defensin, beta 125 1387 178 A20140416_SF113_02 A20140416_SF113_02 TB495123.[MT7]-YILLC[CAM]R.2b4_1.heavy 491.287 / 647.425 13831.0 32.007999420166016 44 20 6 10 8 20.04326583607835 4.98920688962762 0.0 4 0.9973782786873754 24.097621495543404 13831.0 11.493852758413553 0.0 - - - - - - - 713.1428571428571 27 7 DEFB125 defensin, beta 125 1389 179 A20140416_SF113_02 A20140416_SF113_02 TB373614.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7].4b7_1.heavy 740.651 / 1001.51 4444.0 47.42340087890625 37 7 10 10 10 0.5438425678681376 97.95524321334958 0.0 3 0.7486310466595099 2.408010024287994 4444.0 19.12980132450331 0.0 - - - - - - - 186.95238095238096 8 21 ARHGAP4 Rho GTPase activating protein 4 1391 179 A20140416_SF113_02 A20140416_SF113_02 TB373614.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7].4b12_2.heavy 740.651 / 800.408 37792.0 47.42340087890625 37 7 10 10 10 0.5438425678681376 97.95524321334958 0.0 3 0.7486310466595099 2.408010024287994 37792.0 138.45096842307322 0.0 - - - - - - - 231.47368421052633 75 19 ARHGAP4 Rho GTPase activating protein 4 1393 179 A20140416_SF113_02 A20140416_SF113_02 TB373614.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7].4b14_2.heavy 740.651 / 921.472 33866.0 47.42340087890625 37 7 10 10 10 0.5438425678681376 97.95524321334958 0.0 3 0.7486310466595099 2.408010024287994 33866.0 123.08796852201786 0.0 - - - - - - - 192.0 67 22 ARHGAP4 Rho GTPase activating protein 4 1395 179 A20140416_SF113_02 A20140416_SF113_02 TB373614.[MT7]-SRDLEQQLQDELLEVVSELQTAK[MT7].4b10_2.heavy 740.651 / 679.345 13719.0 47.42340087890625 37 7 10 10 10 0.5438425678681376 97.95524321334958 0.0 3 0.7486310466595099 2.408010024287994 13719.0 42.939983878281026 0.0 - - - - - - - 684.875 27 8 ARHGAP4 Rho GTPase activating protein 4 1397 180 A20140416_SF113_02 A20140416_SF113_02 TB373119.[MT7]-SPGWSWIK[MT7].2y4_1.heavy 624.853 / 677.41 23349.0 34.00332546234131 41 15 10 6 10 4.26537613228505 23.444591261973404 0.039699554443359375 3 0.9545389906775323 5.766119743561627 23349.0 15.252701791404304 0.0 - - - - - - - 728.2 46 5 FBXO25 F-box protein 25 1399 180 A20140416_SF113_02 A20140416_SF113_02 TB373119.[MT7]-SPGWSWIK[MT7].2y3_1.heavy 624.853 / 590.378 12051.0 34.00332546234131 41 15 10 6 10 4.26537613228505 23.444591261973404 0.039699554443359375 3 0.9545389906775323 5.766119743561627 12051.0 4.514424681085314 1.0 - - - - - - - 753.3333333333334 24 3 FBXO25 F-box protein 25 1401 180 A20140416_SF113_02 A20140416_SF113_02 TB373119.[MT7]-SPGWSWIK[MT7].2y6_1.heavy 624.853 / 920.511 5649.0 34.00332546234131 41 15 10 6 10 4.26537613228505 23.444591261973404 0.039699554443359375 3 0.9545389906775323 5.766119743561627 5649.0 8.653319724708913 1.0 - - - - - - - 674.75 16 8 FBXO25 F-box protein 25 1403 180 A20140416_SF113_02 A20140416_SF113_02 TB373119.[MT7]-SPGWSWIK[MT7].2y7_1.heavy 624.853 / 1017.56 62390.0 34.00332546234131 41 15 10 6 10 4.26537613228505 23.444591261973404 0.039699554443359375 3 0.9545389906775323 5.766119743561627 62390.0 190.825657878042 0.0 - - - - - - - 596.25 124 8 FBXO25 F-box protein 25 1405 181 A20140416_SF113_02 A20140416_SF113_02 TB495130.[MT7]-QTAEEK[MT7].2y4_1.heavy 497.276 / 620.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1407 181 A20140416_SF113_02 A20140416_SF113_02 TB495130.[MT7]-QTAEEK[MT7].2y5_1.heavy 497.276 / 721.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1409 181 A20140416_SF113_02 A20140416_SF113_02 TB495130.[MT7]-QTAEEK[MT7].2y3_1.heavy 497.276 / 549.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1411 181 A20140416_SF113_02 A20140416_SF113_02 TB495130.[MT7]-QTAEEK[MT7].2b5_1.heavy 497.276 / 703.338 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1413 182 A20140416_SF113_02 A20140416_SF113_02 TB495505.[MT7]-DILGSDQLSLLLFDLR.3b6_1.heavy 654.706 / 745.385 23113.0 46.958274841308594 39 13 10 6 10 2.105228993153371 37.92713089694479 0.0399017333984375 3 0.9087991463883135 4.055137937500287 23113.0 82.4184496124031 0.0 - - - - - - - 206.36363636363637 46 11 PLA2G4F phospholipase A2, group IVF 1415 182 A20140416_SF113_02 A20140416_SF113_02 TB495505.[MT7]-DILGSDQLSLLLFDLR.3y8_1.heavy 654.706 / 976.583 29097.0 46.958274841308594 39 13 10 6 10 2.105228993153371 37.92713089694479 0.0399017333984375 3 0.9087991463883135 4.055137937500287 29097.0 83.16062214042573 0.0 - - - - - - - 292.5 58 12 PLA2G4F phospholipase A2, group IVF 1417 182 A20140416_SF113_02 A20140416_SF113_02 TB495505.[MT7]-DILGSDQLSLLLFDLR.3y5_1.heavy 654.706 / 663.382 56268.0 46.958274841308594 39 13 10 6 10 2.105228993153371 37.92713089694479 0.0399017333984375 3 0.9087991463883135 4.055137937500287 56268.0 56.29897687095911 0.0 - - - - - - - 286.6666666666667 112 12 PLA2G4F phospholipase A2, group IVF 1419 182 A20140416_SF113_02 A20140416_SF113_02 TB495505.[MT7]-DILGSDQLSLLLFDLR.3b7_1.heavy 654.706 / 873.443 31436.0 46.958274841308594 39 13 10 6 10 2.105228993153371 37.92713089694479 0.0399017333984375 3 0.9087991463883135 4.055137937500287 31436.0 137.2306568005638 0.0 - - - - - - - 206.5 62 10 PLA2G4F phospholipase A2, group IVF 1421 183 A20140416_SF113_02 A20140416_SF113_02 TB495339.[MT7]-LIY[MT7]PVGFWR.3y6_1.heavy 480.286 / 761.409 69404.0 35.162200927734375 37 9 10 10 8 0.7154921289572542 74.5315167675059 0.0 4 0.8027864487380816 2.732017884949598 69404.0 298.35236281255993 1.0 - - - - - - - 259.5 184 8 NTHL1 nth endonuclease III-like 1 (E. coli) 1423 183 A20140416_SF113_02 A20140416_SF113_02 TB495339.[MT7]-LIY[MT7]PVGFWR.3y7_2.heavy 480.286 / 534.791 98486.0 35.162200927734375 37 9 10 10 8 0.7154921289572542 74.5315167675059 0.0 4 0.8027864487380816 2.732017884949598 98486.0 246.01518623032248 0.0 - - - - - - - 342.4 196 5 NTHL1 nth endonuclease III-like 1 (E. coli) 1425 183 A20140416_SF113_02 A20140416_SF113_02 TB495339.[MT7]-LIY[MT7]PVGFWR.3y4_1.heavy 480.286 / 565.288 34458.0 35.162200927734375 37 9 10 10 8 0.7154921289572542 74.5315167675059 0.0 4 0.8027864487380816 2.732017884949598 34458.0 64.4567188283208 0.0 - - - - - - - 720.9 68 10 NTHL1 nth endonuclease III-like 1 (E. coli) 1427 183 A20140416_SF113_02 A20140416_SF113_02 TB495339.[MT7]-LIY[MT7]PVGFWR.3y5_1.heavy 480.286 / 664.357 13441.0 35.162200927734375 37 9 10 10 8 0.7154921289572542 74.5315167675059 0.0 4 0.8027864487380816 2.732017884949598 13441.0 18.574618062788275 1.0 - - - - - - - 244.28571428571428 38 7 NTHL1 nth endonuclease III-like 1 (E. coli) 1429 184 A20140416_SF113_02 A20140416_SF113_02 TB495503.[MT7]-IEQLSPFPFDLLLK[MT7].3y3_1.heavy 650.051 / 517.383 3007.0 43.65919876098633 39 9 10 10 10 1.9534853032642037 51.19055660818313 0.0 3 0.8074064499999575 2.7657393628507885 3007.0 9.793999940863394 5.0 - - - - - - - 733.7272727272727 9 11 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1431 184 A20140416_SF113_02 A20140416_SF113_02 TB495503.[MT7]-IEQLSPFPFDLLLK[MT7].3b4_1.heavy 650.051 / 628.379 5935.0 43.65919876098633 39 9 10 10 10 1.9534853032642037 51.19055660818313 0.0 3 0.8074064499999575 2.7657393628507885 5935.0 5.562399540192135 1.0 - - - - - - - 689.5714285714286 12 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1433 184 A20140416_SF113_02 A20140416_SF113_02 TB495503.[MT7]-IEQLSPFPFDLLLK[MT7].3b5_1.heavy 650.051 / 715.411 9971.0 43.65919876098633 39 9 10 10 10 1.9534853032642037 51.19055660818313 0.0 3 0.8074064499999575 2.7657393628507885 9971.0 30.935454997043166 0.0 - - - - - - - 306.06666666666666 19 15 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1435 184 A20140416_SF113_02 A20140416_SF113_02 TB495503.[MT7]-IEQLSPFPFDLLLK[MT7].3b3_1.heavy 650.051 / 515.295 101767.0 43.65919876098633 39 9 10 10 10 1.9534853032642037 51.19055660818313 0.0 3 0.8074064499999575 2.7657393628507885 101767.0 183.11810915860988 0.0 - - - - - - - 376.0 203 4 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1437 185 A20140416_SF113_02 A20140416_SF113_02 TB495435.[MT7]-LLDTAFDLDVFK[MT7].3y3_1.heavy 562.318 / 537.352 25198.0 42.39889907836914 44 14 10 10 10 3.542032877407456 22.61652159562255 0.0 3 0.9460816568735378 5.29082198637045 25198.0 84.14456148427499 0.0 - - - - - - - 233.9090909090909 50 11 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1439 185 A20140416_SF113_02 A20140416_SF113_02 TB495435.[MT7]-LLDTAFDLDVFK[MT7].3b5_1.heavy 562.318 / 658.389 28181.0 42.39889907836914 44 14 10 10 10 3.542032877407456 22.61652159562255 0.0 3 0.9460816568735378 5.29082198637045 28181.0 111.15785176290584 0.0 - - - - - - - 205.8181818181818 56 11 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1441 185 A20140416_SF113_02 A20140416_SF113_02 TB495435.[MT7]-LLDTAFDLDVFK[MT7].3y4_1.heavy 562.318 / 652.379 28284.0 42.39889907836914 44 14 10 10 10 3.542032877407456 22.61652159562255 0.0 3 0.9460816568735378 5.29082198637045 28284.0 52.00135855429608 0.0 - - - - - - - 163.08333333333334 56 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1443 185 A20140416_SF113_02 A20140416_SF113_02 TB495435.[MT7]-LLDTAFDLDVFK[MT7].3b7_1.heavy 562.318 / 920.485 13576.0 42.39889907836914 44 14 10 10 10 3.542032877407456 22.61652159562255 0.0 3 0.9460816568735378 5.29082198637045 13576.0 125.8745631067961 0.0 - - - - - - - 137.33333333333334 27 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1445 186 A20140416_SF113_02 A20140416_SF113_02 TB495232.[MT7]-LTSLPLGALR.2b4_1.heavy 592.878 / 559.357 54575.0 35.59980010986328 44 14 10 10 10 1.8332022570209792 46.43656274121795 0.0 3 0.9453498948022404 5.254953712514353 54575.0 15.852251782231466 0.0 - - - - - - - 2212.0 109 1 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1447 186 A20140416_SF113_02 A20140416_SF113_02 TB495232.[MT7]-LTSLPLGALR.2y9_1.heavy 592.878 / 927.562 105708.0 35.59980010986328 44 14 10 10 10 1.8332022570209792 46.43656274121795 0.0 3 0.9453498948022404 5.254953712514353 105708.0 132.28881223696862 0.0 - - - - - - - 344.4 211 5 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1449 186 A20140416_SF113_02 A20140416_SF113_02 TB495232.[MT7]-LTSLPLGALR.2y6_1.heavy 592.878 / 626.398 147254.0 35.59980010986328 44 14 10 10 10 1.8332022570209792 46.43656274121795 0.0 3 0.9453498948022404 5.254953712514353 147254.0 200.14247427815775 0.0 - - - - - - - 901.0 294 3 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1451 186 A20140416_SF113_02 A20140416_SF113_02 TB495232.[MT7]-LTSLPLGALR.2y7_1.heavy 592.878 / 739.482 23477.0 35.59980010986328 44 14 10 10 10 1.8332022570209792 46.43656274121795 0.0 3 0.9453498948022404 5.254953712514353 23477.0 40.33119349005425 0.0 - - - - - - - 328.0 46 6 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1453 187 A20140416_SF113_02 A20140416_SF113_02 TB373112.[MT7]-LSHIAEDVGR.2y8_1.heavy 620.842 / 896.458 9734.0 25.627700805664062 44 20 4 10 10 6.659105607329017 15.017031700164047 0.0 3 0.9910302157529769 13.021056063500744 9734.0 26.267060938823423 0.0 - - - - - - - 274.1111111111111 19 9 ARHGAP4 Rho GTPase activating protein 4 1455 187 A20140416_SF113_02 A20140416_SF113_02 TB373112.[MT7]-LSHIAEDVGR.2y9_1.heavy 620.842 / 983.49 N/A 25.627700805664062 44 20 4 10 10 6.659105607329017 15.017031700164047 0.0 3 0.9910302157529769 13.021056063500744 25698.0 19.542664632878395 1.0 - - - - - - - 324.25 91 4 ARHGAP4 Rho GTPase activating protein 4 1457 187 A20140416_SF113_02 A20140416_SF113_02 TB373112.[MT7]-LSHIAEDVGR.2y6_1.heavy 620.842 / 646.315 26607.0 25.627700805664062 44 20 4 10 10 6.659105607329017 15.017031700164047 0.0 3 0.9910302157529769 13.021056063500744 26607.0 41.24944670937683 0.0 - - - - - - - 315.14285714285717 53 7 ARHGAP4 Rho GTPase activating protein 4 1459 187 A20140416_SF113_02 A20140416_SF113_02 TB373112.[MT7]-LSHIAEDVGR.2y7_1.heavy 620.842 / 759.399 15185.0 25.627700805664062 44 20 4 10 10 6.659105607329017 15.017031700164047 0.0 3 0.9910302157529769 13.021056063500744 15185.0 17.82361600886116 0.0 - - - - - - - 324.375 30 8 ARHGAP4 Rho GTPase activating protein 4 1461 188 A20140416_SF113_02 A20140416_SF113_02 TB495239.[MT7]-TFVLEVMGR.2y8_1.heavy 598.335 / 950.513 6905.0 38.082698822021484 47 17 10 10 10 3.0054029805386127 26.436466406605184 0.0 3 0.9779611261903227 8.29787359522215 6905.0 62.22087912087912 0.0 - - - - - - - 202.0909090909091 13 11 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 1463 188 A20140416_SF113_02 A20140416_SF113_02 TB495239.[MT7]-TFVLEVMGR.2y5_1.heavy 598.335 / 591.292 4798.0 38.082698822021484 47 17 10 10 10 3.0054029805386127 26.436466406605184 0.0 3 0.9779611261903227 8.29787359522215 4798.0 4.679631547509246 0.0 - - - - - - - 678.6 9 5 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 1465 188 A20140416_SF113_02 A20140416_SF113_02 TB495239.[MT7]-TFVLEVMGR.2y6_1.heavy 598.335 / 704.376 8426.0 38.082698822021484 47 17 10 10 10 3.0054029805386127 26.436466406605184 0.0 3 0.9779611261903227 8.29787359522215 8426.0 10.455069033530572 0.0 - - - - - - - 741.0 16 9 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 1467 188 A20140416_SF113_02 A20140416_SF113_02 TB495239.[MT7]-TFVLEVMGR.2y7_1.heavy 598.335 / 803.444 4564.0 38.082698822021484 47 17 10 10 10 3.0054029805386127 26.436466406605184 0.0 3 0.9779611261903227 8.29787359522215 4564.0 15.13531623931624 1.0 - - - - - - - 275.7857142857143 9 14 PFKL;PFKM;PFKP phosphofructokinase, liver;phosphofructokinase, muscle;phosphofructokinase, platelet 1469 189 A20140416_SF113_02 A20140416_SF113_02 TB373621.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4y8_1.heavy 747.917 / 1192.71 3640.0 47.26070022583008 43 13 10 10 10 1.323008255575068 59.73386320339773 0.0 3 0.9221367297985095 4.393766487001801 3640.0 47.18923976608187 0.0 - - - - - - - 123.05 7 20 ARHGAP4 Rho GTPase activating protein 4 1471 189 A20140416_SF113_02 A20140416_SF113_02 TB373621.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4y8_2.heavy 747.917 / 596.861 11630.0 47.26070022583008 43 13 10 10 10 1.323008255575068 59.73386320339773 0.0 3 0.9221367297985095 4.393766487001801 11630.0 141.96034027667355 0.0 - - - - - - - 226.95 23 20 ARHGAP4 Rho GTPase activating protein 4 1473 189 A20140416_SF113_02 A20140416_SF113_02 TB373621.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4b5_1.heavy 747.917 / 758.38 12811.0 47.26070022583008 43 13 10 10 10 1.323008255575068 59.73386320339773 0.0 3 0.9221367297985095 4.393766487001801 12811.0 60.93316007154036 0.0 - - - - - - - 745.7777777777778 25 9 ARHGAP4 Rho GTPase activating protein 4 1475 189 A20140416_SF113_02 A20140416_SF113_02 TB373621.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7]K[MT7].4b6_1.heavy 747.917 / 871.464 6902.0 47.26070022583008 43 13 10 10 10 1.323008255575068 59.73386320339773 0.0 3 0.9221367297985095 4.393766487001801 6902.0 50.47872895912058 0.0 - - - - - - - 241.61111111111111 13 18 ARHGAP4 Rho GTPase activating protein 4 1477 190 A20140416_SF113_02 A20140416_SF113_02 TB373110.[MT7]-LLQLQPEPR.2y8_1.heavy 619.373 / 980.552 48111.0 31.006399154663086 50 20 10 10 10 5.256554829694185 19.023867007931084 0.0 3 0.9906087721420275 12.72508565215407 48111.0 69.97389987810877 0.0 - - - - - - - 678.75 96 8 PLA2G4F phospholipase A2, group IVF 1479 190 A20140416_SF113_02 A20140416_SF113_02 TB373110.[MT7]-LLQLQPEPR.2y5_1.heavy 619.373 / 626.326 25887.0 31.006399154663086 50 20 10 10 10 5.256554829694185 19.023867007931084 0.0 3 0.9906087721420275 12.72508565215407 25887.0 32.76659199976355 0.0 - - - - - - - 631.4285714285714 51 7 PLA2G4F phospholipase A2, group IVF 1481 190 A20140416_SF113_02 A20140416_SF113_02 TB373110.[MT7]-LLQLQPEPR.2y6_1.heavy 619.373 / 739.41 30433.0 31.006399154663086 50 20 10 10 10 5.256554829694185 19.023867007931084 0.0 3 0.9906087721420275 12.72508565215407 30433.0 46.4798255678509 0.0 - - - - - - - 715.5555555555555 60 9 PLA2G4F phospholipase A2, group IVF 1483 190 A20140416_SF113_02 A20140416_SF113_02 TB373110.[MT7]-LLQLQPEPR.2y7_1.heavy 619.373 / 867.468 32706.0 31.006399154663086 50 20 10 10 10 5.256554829694185 19.023867007931084 0.0 3 0.9906087721420275 12.72508565215407 32706.0 327.70379193366 0.0 - - - - - - - 252.55555555555554 65 9 PLA2G4F phospholipase A2, group IVF 1485 191 A20140416_SF113_02 A20140416_SF113_02 TB236048.[MT7]-LADQIFAYYK[MT7].3b6_1.heavy 507.285 / 832.469 4061.0 36.597599029541016 48 18 10 10 10 7.171778247167228 13.94354322646533 0.0 3 0.9894327891306036 11.99496540173473 4061.0 9.902891510864567 0.0 - - - - - - - 246.0 8 11 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1487 191 A20140416_SF113_02 A20140416_SF113_02 TB236048.[MT7]-LADQIFAYYK[MT7].3b4_1.heavy 507.285 / 572.316 61783.0 36.597599029541016 48 18 10 10 10 7.171778247167228 13.94354322646533 0.0 3 0.9894327891306036 11.99496540173473 61783.0 44.99754423021042 1.0 - - - - - - - 1195.857142857143 143 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1489 191 A20140416_SF113_02 A20140416_SF113_02 TB236048.[MT7]-LADQIFAYYK[MT7].3b5_1.heavy 507.285 / 685.4 39630.0 36.597599029541016 48 18 10 10 10 7.171778247167228 13.94354322646533 0.0 3 0.9894327891306036 11.99496540173473 39630.0 78.03185503557344 0.0 - - - - - - - 703.1428571428571 79 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1491 191 A20140416_SF113_02 A20140416_SF113_02 TB236048.[MT7]-LADQIFAYYK[MT7].3y4_1.heavy 507.285 / 688.379 31138.0 36.597599029541016 48 18 10 10 10 7.171778247167228 13.94354322646533 0.0 3 0.9894327891306036 11.99496540173473 31138.0 41.00369858090424 0.0 - - - - - - - 369.0 62 3 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1493 192 A20140416_SF113_02 A20140416_SF113_02 TB236040.[MT7]-ENVEELIEDK[MT7].3y3_1.heavy 502.603 / 535.284 168050.0 32.53810119628906 40 12 10 10 8 1.5413797578026371 51.05749993290242 0.0 4 0.8985439989830684 3.841328180529205 168050.0 67.45504935659139 0.0 - - - - - - - 1288.0 336 3 CAGE1 cancer antigen 1 1495 192 A20140416_SF113_02 A20140416_SF113_02 TB236040.[MT7]-ENVEELIEDK[MT7].3b4_1.heavy 502.603 / 616.306 57175.0 32.53810119628906 40 12 10 10 8 1.5413797578026371 51.05749993290242 0.0 4 0.8985439989830684 3.841328180529205 57175.0 29.127230553163084 2.0 - - - - - - - 1288.0 121 1 CAGE1 cancer antigen 1 1497 192 A20140416_SF113_02 A20140416_SF113_02 TB236040.[MT7]-ENVEELIEDK[MT7].3b5_1.heavy 502.603 / 745.349 117184.0 32.53810119628906 40 12 10 10 8 1.5413797578026371 51.05749993290242 0.0 4 0.8985439989830684 3.841328180529205 117184.0 79.6954739766147 0.0 - - - - - - - 729.8333333333334 234 6 CAGE1 cancer antigen 1 1499 192 A20140416_SF113_02 A20140416_SF113_02 TB236040.[MT7]-ENVEELIEDK[MT7].3y4_1.heavy 502.603 / 648.369 47002.0 32.53810119628906 40 12 10 10 8 1.5413797578026371 51.05749993290242 0.0 4 0.8985439989830684 3.841328180529205 47002.0 35.147574943364 0.0 - - - - - - - 386.0 94 1 CAGE1 cancer antigen 1 1501 193 A20140416_SF113_02 A20140416_SF113_02 TB373627.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.4b7_1.heavy 756.422 / 854.522 21017.0 44.16304969787598 35 9 10 6 10 0.6572131034736491 78.39168343359424 0.03659820556640625 3 0.8059253613020635 2.754799483207889 21017.0 52.17082062659812 0.0 - - - - - - - 337.3333333333333 42 6 PLA2G4F phospholipase A2, group IVF 1503 193 A20140416_SF113_02 A20140416_SF113_02 TB373627.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.4y13_1.heavy 756.422 / 1169.66 15477.0 44.16304969787598 35 9 10 6 10 0.6572131034736491 78.39168343359424 0.03659820556640625 3 0.8059253613020635 2.754799483207889 15477.0 99.21330844709897 0.0 - - - - - - - 215.11111111111111 30 9 PLA2G4F phospholipase A2, group IVF 1505 193 A20140416_SF113_02 A20140416_SF113_02 TB373627.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.4y7_1.heavy 756.422 / 591.284 59446.0 44.16304969787598 35 9 10 6 10 0.6572131034736491 78.39168343359424 0.03659820556640625 3 0.8059253613020635 2.754799483207889 59446.0 121.24685808105122 0.0 - - - - - - - 264.0 118 3 PLA2G4F phospholipase A2, group IVF 1507 193 A20140416_SF113_02 A20140416_SF113_02 TB373627.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.4b6_1.heavy 756.422 / 797.5 15477.0 44.16304969787598 35 9 10 6 10 0.6572131034736491 78.39168343359424 0.03659820556640625 3 0.8059253613020635 2.754799483207889 15477.0 48.29234375 0.0 - - - - - - - 653.4285714285714 30 7 PLA2G4F phospholipase A2, group IVF 1509 194 A20140416_SF113_02 A20140416_SF113_02 TB373626.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.3b6_1.heavy 1008.23 / 797.5 18569.0 44.17219924926758 48 18 10 10 10 2.7173056997152436 28.41719652845171 0.0 3 0.9804361315985504 8.80895537719599 18569.0 82.82196022727273 0.0 - - - - - - - 249.33333333333334 37 12 PLA2G4F phospholipase A2, group IVF 1511 194 A20140416_SF113_02 A20140416_SF113_02 TB373626.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.3b8_1.heavy 1008.23 / 967.606 11705.0 44.17219924926758 48 18 10 10 10 2.7173056997152436 28.41719652845171 0.0 3 0.9804361315985504 8.80895537719599 11705.0 60.96354166666667 0.0 - - - - - - - 216.0 23 11 PLA2G4F phospholipase A2, group IVF 1513 194 A20140416_SF113_02 A20140416_SF113_02 TB373626.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.3b7_1.heavy 1008.23 / 854.522 12673.0 44.17219924926758 48 18 10 10 10 2.7173056997152436 28.41719652845171 0.0 3 0.9804361315985504 8.80895537719599 12673.0 88.80700757575757 0.0 - - - - - - - 182.28571428571428 25 14 PLA2G4F phospholipase A2, group IVF 1515 194 A20140416_SF113_02 A20140416_SF113_02 TB373626.[MT7]-ALQQVLGLSEALDSGQVPVVAVLGSGGGTR.3y13_1.heavy 1008.23 / 1169.66 35643.0 44.17219924926758 48 18 10 10 10 2.7173056997152436 28.41719652845171 0.0 3 0.9804361315985504 8.80895537719599 35643.0 156.1584066985646 0.0 - - - - - - - 289.14285714285717 71 7 PLA2G4F phospholipase A2, group IVF 1517 195 A20140416_SF113_02 A20140416_SF113_02 TB373069.[MT7]-WFQLTPPR.2b3_1.heavy 594.836 / 606.316 10679.0 35.61032485961914 38 17 10 5 6 3.8289745298385465 26.116653224177135 0.0420989990234375 6 0.9771582734380297 8.150190355091883 10679.0 8.593200325730141 1.0 - - - - - - - 1282.111111111111 26 9 ALOX15B arachidonate 15-lipoxygenase, type B 1519 195 A20140416_SF113_02 A20140416_SF113_02 TB373069.[MT7]-WFQLTPPR.2y5_1.heavy 594.836 / 583.356 11539.0 35.61032485961914 38 17 10 5 6 3.8289745298385465 26.116653224177135 0.0420989990234375 6 0.9771582734380297 8.150190355091883 11539.0 5.080084491247008 2.0 - - - - - - - 307.0 51 2 ALOX15B arachidonate 15-lipoxygenase, type B 1521 195 A20140416_SF113_02 A20140416_SF113_02 TB373069.[MT7]-WFQLTPPR.2y6_1.heavy 594.836 / 711.415 11907.0 35.61032485961914 38 17 10 5 6 3.8289745298385465 26.116653224177135 0.0420989990234375 6 0.9771582734380297 8.150190355091883 11907.0 4.991641974844058 1.0 - - - - - - - 774.4615384615385 24 13 ALOX15B arachidonate 15-lipoxygenase, type B 1523 195 A20140416_SF113_02 A20140416_SF113_02 TB373069.[MT7]-WFQLTPPR.2y7_1.heavy 594.836 / 858.483 22586.0 35.61032485961914 38 17 10 5 6 3.8289745298385465 26.116653224177135 0.0420989990234375 6 0.9771582734380297 8.150190355091883 22586.0 43.426800099247366 1.0 - - - - - - - 314.6875 48 16 ALOX15B arachidonate 15-lipoxygenase, type B 1525 196 A20140416_SF113_02 A20140416_SF113_02 TB495087.[MT7]-ISETTAR.2b3_1.heavy 461.26 / 474.268 11538.0 19.324424266815186 44 20 10 6 8 11.838374851550155 8.447105388532758 0.03669929504394531 4 0.9984705584377096 31.55299277141118 11538.0 10.51011682760161 1.0 - - - - - - - 1331.875 64 8 PFKL phosphofructokinase, liver 1527 196 A20140416_SF113_02 A20140416_SF113_02 TB495087.[MT7]-ISETTAR.2y5_1.heavy 461.26 / 577.294 8009.0 19.324424266815186 44 20 10 6 8 11.838374851550155 8.447105388532758 0.03669929504394531 4 0.9984705584377096 31.55299277141118 8009.0 7.149086315789473 0.0 - - - - - - - 1163.5714285714287 16 7 PFKL phosphofructokinase, liver 1529 196 A20140416_SF113_02 A20140416_SF113_02 TB495087.[MT7]-ISETTAR.2y6_1.heavy 461.26 / 664.326 95967.0 19.324424266815186 44 20 10 6 8 11.838374851550155 8.447105388532758 0.03669929504394531 4 0.9984705584377096 31.55299277141118 95967.0 68.21816382480876 0.0 - - - - - - - 769.3333333333334 191 3 PFKL phosphofructokinase, liver 1531 196 A20140416_SF113_02 A20140416_SF113_02 TB495087.[MT7]-ISETTAR.2b5_1.heavy 461.26 / 676.363 6787.0 19.324424266815186 44 20 10 6 8 11.838374851550155 8.447105388532758 0.03669929504394531 4 0.9984705584377096 31.55299277141118 6787.0 6.487877262153253 2.0 - - - - - - - 814.4444444444445 89 9 PFKL phosphofructokinase, liver 1533 197 A20140416_SF113_02 A20140416_SF113_02 TB372784.[MT7]-LVALSR.2y4_1.heavy 401.767 / 446.272 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1535 197 A20140416_SF113_02 A20140416_SF113_02 TB372784.[MT7]-LVALSR.2b3_1.heavy 401.767 / 428.299 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1537 197 A20140416_SF113_02 A20140416_SF113_02 TB372784.[MT7]-LVALSR.2y5_1.heavy 401.767 / 545.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1539 197 A20140416_SF113_02 A20140416_SF113_02 TB372784.[MT7]-LVALSR.2b5_1.heavy 401.767 / 628.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLA2G4F phospholipase A2, group IVF 1541 198 A20140416_SF113_02 A20140416_SF113_02 TB373482.[MT7]-IMEVIDAITTTAQSHQR.3b6_1.heavy 686.697 / 845.456 14872.0 40.75429916381836 50 20 10 10 10 9.077669202767147 11.016043630397656 0.0 3 0.9970771826547362 22.822104769648398 14872.0 29.076198853791816 0.0 - - - - - - - 751.0 29 7 PFKL phosphofructokinase, liver 1543 198 A20140416_SF113_02 A20140416_SF113_02 TB373482.[MT7]-IMEVIDAITTTAQSHQR.3b4_1.heavy 686.697 / 617.345 18897.0 40.75429916381836 50 20 10 10 10 9.077669202767147 11.016043630397656 0.0 3 0.9970771826547362 22.822104769648398 18897.0 32.625193970346075 0.0 - - - - - - - 633.6666666666666 37 9 PFKL phosphofructokinase, liver 1545 198 A20140416_SF113_02 A20140416_SF113_02 TB373482.[MT7]-IMEVIDAITTTAQSHQR.3b3_1.heavy 686.697 / 518.276 11070.0 40.75429916381836 50 20 10 10 10 9.077669202767147 11.016043630397656 0.0 3 0.9970771826547362 22.822104769648398 11070.0 20.824137931034482 0.0 - - - - - - - 715.8 22 10 PFKL phosphofructokinase, liver 1547 198 A20140416_SF113_02 A20140416_SF113_02 TB373482.[MT7]-IMEVIDAITTTAQSHQR.3y8_1.heavy 686.697 / 928.459 9057.0 40.75429916381836 50 20 10 10 10 9.077669202767147 11.016043630397656 0.0 3 0.9970771826547362 22.822104769648398 9057.0 29.649928443649372 0.0 - - - - - - - 629.0 18 8 PFKL phosphofructokinase, liver 1549 199 A20140416_SF113_02 A20140416_SF113_02 TB495345.[MT7]-STRFEEFLQR.3y6_1.heavy 486.26 / 821.415 5150.0 30.261600494384766 43 13 10 10 10 1.8536458170309487 53.947738603145666 0.0 3 0.9178852456839977 4.276949862678481 5150.0 10.988853503184712 1.0 - - - - - - - 288.8 21 10 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1551 199 A20140416_SF113_02 A20140416_SF113_02 TB495345.[MT7]-STRFEEFLQR.3b6_1.heavy 486.26 / 894.444 8165.0 30.261600494384766 43 13 10 10 10 1.8536458170309487 53.947738603145666 0.0 3 0.9178852456839977 4.276949862678481 8165.0 35.647399262366974 0.0 - - - - - - - 195.55555555555554 16 9 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1553 199 A20140416_SF113_02 A20140416_SF113_02 TB495345.[MT7]-STRFEEFLQR.3y4_1.heavy 486.26 / 563.33 27760.0 30.261600494384766 43 13 10 10 10 1.8536458170309487 53.947738603145666 0.0 3 0.9178852456839977 4.276949862678481 27760.0 23.675556826946405 0.0 - - - - - - - 712.0 55 3 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1555 199 A20140416_SF113_02 A20140416_SF113_02 TB495345.[MT7]-STRFEEFLQR.3y5_1.heavy 486.26 / 692.373 16581.0 30.261600494384766 43 13 10 10 10 1.8536458170309487 53.947738603145666 0.0 3 0.9178852456839977 4.276949862678481 16581.0 23.164418791602024 0.0 - - - - - - - 753.5 33 10 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1557 200 A20140416_SF113_02 A20140416_SF113_02 TB235993.[MT7]-LNVLANVIRK[MT7].3y7_1.heavy 476.648 / 957.633 5070.0 33.20330047607422 35 5 10 10 10 0.9333386653249083 69.53832854519828 0.0 3 0.6595909837849384 2.052068629098738 5070.0 52.410310816411105 0.0 - - - - - - - 169.22222222222223 10 9 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1559 200 A20140416_SF113_02 A20140416_SF113_02 TB235993.[MT7]-LNVLANVIRK[MT7].3y6_1.heavy 476.648 / 844.549 12802.0 33.20330047607422 35 5 10 10 10 0.9333386653249083 69.53832854519828 0.0 3 0.6595909837849384 2.052068629098738 12802.0 60.37153684210526 0.0 - - - - - - - 185.46153846153845 25 13 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1561 200 A20140416_SF113_02 A20140416_SF113_02 TB235993.[MT7]-LNVLANVIRK[MT7].3b4_1.heavy 476.648 / 584.389 9380.0 33.20330047607422 35 5 10 10 10 0.9333386653249083 69.53832854519828 0.0 3 0.6595909837849384 2.052068629098738 9380.0 8.11903050543919 0.0 - - - - - - - 1339.857142857143 18 7 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1563 200 A20140416_SF113_02 A20140416_SF113_02 TB235993.[MT7]-LNVLANVIRK[MT7].3y9_2.heavy 476.648 / 585.876 44745.0 33.20330047607422 35 5 10 10 10 0.9333386653249083 69.53832854519828 0.0 3 0.6595909837849384 2.052068629098738 44745.0 33.440825497941866 0.0 - - - - - - - 1211.2222222222222 89 9 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1565 201 A20140416_SF113_02 A20140416_SF113_02 TB495344.[MT7]-GLSLWNHAEER.3b6_1.heavy 485.92 / 815.453 55727.0 29.441299438476562 48 18 10 10 10 5.214677852658132 19.176640019867378 0.0 3 0.9889223440861717 11.714849231849039 55727.0 75.26349063031242 0.0 - - - - - - - 286.14285714285717 111 7 FBXL5 F-box and leucine-rich repeat protein 5 1567 201 A20140416_SF113_02 A20140416_SF113_02 TB495344.[MT7]-GLSLWNHAEER.3y6_1.heavy 485.92 / 755.343 60736.0 29.441299438476562 48 18 10 10 10 5.214677852658132 19.176640019867378 0.0 3 0.9889223440861717 11.714849231849039 60736.0 59.82212437810371 0.0 - - - - - - - 1158.375 121 8 FBXL5 F-box and leucine-rich repeat protein 5 1569 201 A20140416_SF113_02 A20140416_SF113_02 TB495344.[MT7]-GLSLWNHAEER.3b4_1.heavy 485.92 / 515.331 145642.0 29.441299438476562 48 18 10 10 10 5.214677852658132 19.176640019867378 0.0 3 0.9889223440861717 11.714849231849039 145642.0 60.16747724959778 0.0 - - - - - - - 1628.0 291 1 FBXL5 F-box and leucine-rich repeat protein 5 1571 201 A20140416_SF113_02 A20140416_SF113_02 TB495344.[MT7]-GLSLWNHAEER.3y4_1.heavy 485.92 / 504.241 252212.0 29.441299438476562 48 18 10 10 10 5.214677852658132 19.176640019867378 0.0 3 0.9889223440861717 11.714849231849039 252212.0 77.30007275282657 0.0 - - - - - - - 1753.0 504 4 FBXL5 F-box and leucine-rich repeat protein 5 1573 202 A20140416_SF113_02 A20140416_SF113_02 TB495084.[MT7]-DYFGIR.2b3_1.heavy 457.746 / 570.268 21372.0 30.6658992767334 45 17 10 10 8 3.894580282512521 25.676707821127962 0.0 4 0.9729905795231331 7.492424176878433 21372.0 8.495396932994426 1.0 - - - - - - - 1243.111111111111 44 9 FRMD3;FRMD5 FERM domain containing 3;FERM domain containing 5 1575 202 A20140416_SF113_02 A20140416_SF113_02 TB495084.[MT7]-DYFGIR.2y4_1.heavy 457.746 / 492.293 41236.0 30.6658992767334 45 17 10 10 8 3.894580282512521 25.676707821127962 0.0 4 0.9729905795231331 7.492424176878433 41236.0 14.721952701288572 2.0 - - - - - - - 880.0 186 1 FRMD3;FRMD5 FERM domain containing 3;FERM domain containing 5 1577 202 A20140416_SF113_02 A20140416_SF113_02 TB495084.[MT7]-DYFGIR.2y5_1.heavy 457.746 / 655.356 138543.0 30.6658992767334 45 17 10 10 8 3.894580282512521 25.676707821127962 0.0 4 0.9729905795231331 7.492424176878433 138543.0 120.30879666360322 0.0 - - - - - - - 188.5 277 2 FRMD3;FRMD5 FERM domain containing 3;FERM domain containing 5 1579 202 A20140416_SF113_02 A20140416_SF113_02 TB495084.[MT7]-DYFGIR.2b4_1.heavy 457.746 / 627.289 103970.0 30.6658992767334 45 17 10 10 8 3.894580282512521 25.676707821127962 0.0 4 0.9729905795231331 7.492424176878433 103970.0 85.4237002759867 0.0 - - - - - - - 377.0 207 1 FRMD3;FRMD5 FERM domain containing 3;FERM domain containing 5 1581 203 A20140416_SF113_02 A20140416_SF113_02 TB372787.[MT7]-DIVGLR.2y4_1.heavy 408.757 / 444.293 58962.0 26.971500396728516 47 17 10 10 10 3.2655256198900147 30.622941492453542 0.0 3 0.9731350036736954 7.512627849702934 58962.0 19.470337758199474 0.0 - - - - - - - 1255.0 117 1 FBXL5 F-box and leucine-rich repeat protein 5 1583 203 A20140416_SF113_02 A20140416_SF113_02 TB372787.[MT7]-DIVGLR.2y5_1.heavy 408.757 / 557.377 89196.0 26.971500396728516 47 17 10 10 10 3.2655256198900147 30.622941492453542 0.0 3 0.9731350036736954 7.512627849702934 89196.0 8.90589721995255 0.0 - - - - - - - 878.0 178 2 FBXL5 F-box and leucine-rich repeat protein 5 1585 203 A20140416_SF113_02 A20140416_SF113_02 TB372787.[MT7]-DIVGLR.2b4_1.heavy 408.757 / 529.31 68246.0 26.971500396728516 47 17 10 10 10 3.2655256198900147 30.622941492453542 0.0 3 0.9731350036736954 7.512627849702934 68246.0 15.630055624209948 0.0 - - - - - - - 1317.5 136 2 FBXL5 F-box and leucine-rich repeat protein 5 1587 203 A20140416_SF113_02 A20140416_SF113_02 TB372787.[MT7]-DIVGLR.2y3_1.heavy 408.757 / 345.224 43532.0 26.971500396728516 47 17 10 10 10 3.2655256198900147 30.622941492453542 0.0 3 0.9731350036736954 7.512627849702934 43532.0 17.656561275503968 1.0 - - - - - - - 2258.5 87 2 FBXL5 F-box and leucine-rich repeat protein 5 1589 204 A20140416_SF113_02 A20140416_SF113_02 TB373483.[MT7]-GRVFANAPDSAC[CAM]VIGLK[MT7].3b9_1.heavy 688.382 / 1072.57 2895.0 30.503299713134766 40 10 10 10 10 0.5884022919089075 79.5435627091043 0.0 3 0.8210156508788466 2.8724566549502466 2895.0 13.785714285714285 0.0 - - - - - - - 207.0 5 14 PFKL phosphofructokinase, liver 1591 204 A20140416_SF113_02 A20140416_SF113_02 TB373483.[MT7]-GRVFANAPDSAC[CAM]VIGLK[MT7].3b6_1.heavy 688.382 / 789.449 4908.0 30.503299713134766 40 10 10 10 10 0.5884022919089075 79.5435627091043 0.0 3 0.8210156508788466 2.8724566549502466 4908.0 0.9641884222474462 1.0 - - - - - - - 1025.0 13 7 PFKL phosphofructokinase, liver 1593 204 A20140416_SF113_02 A20140416_SF113_02 TB373483.[MT7]-GRVFANAPDSAC[CAM]VIGLK[MT7].3y4_1.heavy 688.382 / 574.404 29198.0 30.503299713134766 40 10 10 10 10 0.5884022919089075 79.5435627091043 0.0 3 0.8210156508788466 2.8724566549502466 29198.0 9.382041881170737 0.0 - - - - - - - 1217.0 58 3 PFKL phosphofructokinase, liver 1595 204 A20140416_SF113_02 A20140416_SF113_02 TB373483.[MT7]-GRVFANAPDSAC[CAM]VIGLK[MT7].3b7_1.heavy 688.382 / 860.486 8306.0 30.503299713134766 40 10 10 10 10 0.5884022919089075 79.5435627091043 0.0 3 0.8210156508788466 2.8724566549502466 8306.0 14.328645457586196 0.0 - - - - - - - 723.5 16 16 PFKL phosphofructokinase, liver 1597 205 A20140416_SF113_02 A20140416_SF113_02 TB373533.[MT7]-MHEQIENEYIIGLLQQR.3y7_1.heavy 753.396 / 827.51 74219.0 36.83209991455078 43 13 10 10 10 2.5191706672100476 39.695603518100995 0.0 3 0.9205120468465067 4.348025499346121 74219.0 110.28277342725139 0.0 - - - - - - - 815.9090909090909 148 11 FBXL5 F-box and leucine-rich repeat protein 5 1599 205 A20140416_SF113_02 A20140416_SF113_02 TB373533.[MT7]-MHEQIENEYIIGLLQQR.3b4_1.heavy 753.396 / 670.31 29833.0 36.83209991455078 43 13 10 10 10 2.5191706672100476 39.695603518100995 0.0 3 0.9205120468465067 4.348025499346121 29833.0 41.203470121790566 0.0 - - - - - - - 776.1 59 10 FBXL5 F-box and leucine-rich repeat protein 5 1601 205 A20140416_SF113_02 A20140416_SF113_02 TB373533.[MT7]-MHEQIENEYIIGLLQQR.3b3_1.heavy 753.396 / 542.251 14189.0 36.83209991455078 43 13 10 10 10 2.5191706672100476 39.695603518100995 0.0 3 0.9205120468465067 4.348025499346121 14189.0 20.96924512018042 0.0 - - - - - - - 808.6666666666666 28 9 FBXL5 F-box and leucine-rich repeat protein 5 1603 205 A20140416_SF113_02 A20140416_SF113_02 TB373533.[MT7]-MHEQIENEYIIGLLQQR.3b8_1.heavy 753.396 / 1155.52 19040.0 36.83209991455078 43 13 10 10 10 2.5191706672100476 39.695603518100995 0.0 3 0.9205120468465067 4.348025499346121 19040.0 54.31024747937671 0.0 - - - - - - - 251.35714285714286 38 14 FBXL5 F-box and leucine-rich repeat protein 5 1605 206 A20140416_SF113_02 A20140416_SF113_02 TB373280.[MT7]-RRAEVELEYSR.3y6_1.heavy 517.95 / 796.384 6015.0 22.548500061035156 44 14 10 10 10 1.529653415688743 46.861982689203344 0.0 3 0.947736590613894 5.374692673339643 6015.0 9.253846153846153 1.0 - - - - - - - 274.15384615384613 12 13 ARHGAP4 Rho GTPase activating protein 4 1607 206 A20140416_SF113_02 A20140416_SF113_02 TB373280.[MT7]-RRAEVELEYSR.3y4_1.heavy 517.95 / 554.257 9914.0 22.548500061035156 44 14 10 10 10 1.529653415688743 46.861982689203344 0.0 3 0.947736590613894 5.374692673339643 9914.0 5.9645025360586255 0.0 - - - - - - - 795.7142857142857 19 7 ARHGAP4 Rho GTPase activating protein 4 1609 206 A20140416_SF113_02 A20140416_SF113_02 TB373280.[MT7]-RRAEVELEYSR.3y5_1.heavy 517.95 / 667.341 14481.0 22.548500061035156 44 14 10 10 10 1.529653415688743 46.861982689203344 0.0 3 0.947736590613894 5.374692673339643 14481.0 16.117379892682912 0.0 - - - - - - - 334.1666666666667 28 6 ARHGAP4 Rho GTPase activating protein 4 1611 206 A20140416_SF113_02 A20140416_SF113_02 TB373280.[MT7]-RRAEVELEYSR.3b8_2.heavy 517.95 / 564.318 17600.0 22.548500061035156 44 14 10 10 10 1.529653415688743 46.861982689203344 0.0 3 0.947736590613894 5.374692673339643 17600.0 17.2065053310082 0.0 - - - - - - - 446.0 35 3 ARHGAP4 Rho GTPase activating protein 4 1613 207 A20140416_SF113_02 A20140416_SF113_02 TB495208.[MT7]-VSTGEAFGAGTWDK[MT7].3y3_1.heavy 571.961 / 592.321 174330.0 30.75189971923828 46 16 10 10 10 2.4029711412868195 35.33088739089757 0.0 3 0.9659197658051063 6.66607046474142 174330.0 89.45582853466807 0.0 - - - - - - - 2285.0 348 7 ALOX15B arachidonate 15-lipoxygenase, type B 1615 207 A20140416_SF113_02 A20140416_SF113_02 TB495208.[MT7]-VSTGEAFGAGTWDK[MT7].3b6_1.heavy 571.961 / 689.359 331782.0 30.75189971923828 46 16 10 10 10 2.4029711412868195 35.33088739089757 0.0 3 0.9659197658051063 6.66607046474142 331782.0 129.43386674181554 0.0 - - - - - - - 1234.8 663 5 ALOX15B arachidonate 15-lipoxygenase, type B 1617 207 A20140416_SF113_02 A20140416_SF113_02 TB495208.[MT7]-VSTGEAFGAGTWDK[MT7].3b5_1.heavy 571.961 / 618.321 224085.0 30.75189971923828 46 16 10 10 10 2.4029711412868195 35.33088739089757 0.0 3 0.9659197658051063 6.66607046474142 224085.0 68.36701413247027 0.0 - - - - - - - 1386.0 448 1 ALOX15B arachidonate 15-lipoxygenase, type B 1619 207 A20140416_SF113_02 A20140416_SF113_02 TB495208.[MT7]-VSTGEAFGAGTWDK[MT7].3y5_1.heavy 571.961 / 750.39 116514.0 30.75189971923828 46 16 10 10 10 2.4029711412868195 35.33088739089757 0.0 3 0.9659197658051063 6.66607046474142 116514.0 62.56716159056635 0.0 - - - - - - - 756.0 233 1 ALOX15B arachidonate 15-lipoxygenase, type B 1621 208 A20140416_SF113_02 A20140416_SF113_02 TB373535.[MT7]-HWLDSPWPGFFTLDGQPR.3y7_1.heavy 767.384 / 786.41 12069.0 40.91560077667236 39 13 10 6 10 1.288056182907307 46.21831014810462 0.037998199462890625 3 0.9130985560687367 4.155779180121878 12069.0 30.07238726916696 0.0 - - - - - - - 695.8571428571429 24 7 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1623 208 A20140416_SF113_02 A20140416_SF113_02 TB373535.[MT7]-HWLDSPWPGFFTLDGQPR.3y11_1.heavy 767.384 / 1234.62 5315.0 40.91560077667236 39 13 10 6 10 1.288056182907307 46.21831014810462 0.037998199462890625 3 0.9130985560687367 4.155779180121878 5315.0 66.17587746117158 0.0 - - - - - - - 193.75 10 8 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1625 208 A20140416_SF113_02 A20140416_SF113_02 TB373535.[MT7]-HWLDSPWPGFFTLDGQPR.3b4_1.heavy 767.384 / 696.359 8637.0 40.91560077667236 39 13 10 6 10 1.288056182907307 46.21831014810462 0.037998199462890625 3 0.9130985560687367 4.155779180121878 8637.0 12.900807361281178 0.0 - - - - - - - 332.0 17 9 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1627 208 A20140416_SF113_02 A20140416_SF113_02 TB373535.[MT7]-HWLDSPWPGFFTLDGQPR.3y10_1.heavy 767.384 / 1137.57 4429.0 40.91560077667236 39 13 10 6 10 1.288056182907307 46.21831014810462 0.037998199462890625 3 0.9130985560687367 4.155779180121878 4429.0 44.30008326015546 0.0 - - - - - - - 221.33333333333334 8 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 1629 209 A20140416_SF113_02 A20140416_SF113_02 TB373282.[MT7]-FAFVEVIAMIK[MT7].3b4_1.heavy 519.31 / 609.352 7531.0 45.208099365234375 38 13 10 5 10 0.8803179976839336 68.59049749793846 0.040802001953125 3 0.9065129427056093 4.0044574637664265 7531.0 31.97997069346713 1.0 - - - - - - - 250.33333333333334 29 9 CYFIP2 cytoplasmic FMR1 interacting protein 2 1631 209 A20140416_SF113_02 A20140416_SF113_02 TB373282.[MT7]-FAFVEVIAMIK[MT7].3b5_1.heavy 519.31 / 738.394 17392.0 45.208099365234375 38 13 10 5 10 0.8803179976839336 68.59049749793846 0.040802001953125 3 0.9065129427056093 4.0044574637664265 17392.0 278.84126572677053 0.0 - - - - - - - 288.57142857142856 34 7 CYFIP2 cytoplasmic FMR1 interacting protein 2 1633 209 A20140416_SF113_02 A20140416_SF113_02 TB373282.[MT7]-FAFVEVIAMIK[MT7].3y4_1.heavy 519.31 / 606.377 19333.0 45.208099365234375 38 13 10 5 10 0.8803179976839336 68.59049749793846 0.040802001953125 3 0.9065129427056093 4.0044574637664265 19333.0 141.47251733776534 0.0 - - - - - - - 233.0 38 7 CYFIP2 cytoplasmic FMR1 interacting protein 2 1635 209 A20140416_SF113_02 A20140416_SF113_02 TB373282.[MT7]-FAFVEVIAMIK[MT7].3b3_1.heavy 519.31 / 510.283 9007.0 45.208099365234375 38 13 10 5 10 0.8803179976839336 68.59049749793846 0.040802001953125 3 0.9065129427056093 4.0044574637664265 9007.0 45.10274236506906 0.0 - - - - - - - 274.53333333333336 18 15 CYFIP2 cytoplasmic FMR1 interacting protein 2 1637 210 A20140416_SF113_02 A20140416_SF113_02 TB373536.[MT7]-IYTSPTWSAFVTDSSWSAR.3y6_1.heavy 769.378 / 693.331 16352.0 39.38669967651367 48 18 10 10 10 5.3432214499995325 18.715301421768462 0.0 3 0.9881797022567751 11.340166752997211 16352.0 33.0732690117069 0.0 - - - - - - - 304.8333333333333 32 6 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1639 210 A20140416_SF113_02 A20140416_SF113_02 TB373536.[MT7]-IYTSPTWSAFVTDSSWSAR.3b4_1.heavy 769.378 / 609.336 17496.0 39.38669967651367 48 18 10 10 10 5.3432214499995325 18.715301421768462 0.0 3 0.9881797022567751 11.340166752997211 17496.0 34.715183916083916 0.0 - - - - - - - 671.875 34 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1641 210 A20140416_SF113_02 A20140416_SF113_02 TB373536.[MT7]-IYTSPTWSAFVTDSSWSAR.3y8_1.heavy 769.378 / 909.406 31904.0 39.38669967651367 48 18 10 10 10 5.3432214499995325 18.715301421768462 0.0 3 0.9881797022567751 11.340166752997211 31904.0 59.79768951048951 0.0 - - - - - - - 294.0 63 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1643 210 A20140416_SF113_02 A20140416_SF113_02 TB373536.[MT7]-IYTSPTWSAFVTDSSWSAR.3y10_1.heavy 769.378 / 1155.54 11664.0 39.38669967651367 48 18 10 10 10 5.3432214499995325 18.715301421768462 0.0 3 0.9881797022567751 11.340166752997211 11664.0 28.032139815669225 0.0 - - - - - - - 244.92857142857142 23 14 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1645 211 A20140416_SF113_02 A20140416_SF113_02 TB235719.[MT7]-GTDLLSK[MT7].2y4_1.heavy 511.31 / 604.415 34137.0 25.8031005859375 46 18 10 10 8 5.396565271267723 18.530304920505245 0.0 4 0.988145838472829 11.323925345570231 34137.0 26.062570682915748 0.0 - - - - - - - 703.0 68 2 PLA2G4F phospholipase A2, group IVF 1647 211 A20140416_SF113_02 A20140416_SF113_02 TB235719.[MT7]-GTDLLSK[MT7].2y5_1.heavy 511.31 / 719.442 5753.0 25.8031005859375 46 18 10 10 8 5.396565271267723 18.530304920505245 0.0 4 0.988145838472829 11.323925345570231 5753.0 5.48834232867342 1.0 - - - - - - - 1207.7777777777778 30 9 PLA2G4F phospholipase A2, group IVF 1649 211 A20140416_SF113_02 A20140416_SF113_02 TB235719.[MT7]-GTDLLSK[MT7].2b4_1.heavy 511.31 / 531.289 N/A 25.8031005859375 46 18 10 10 8 5.396565271267723 18.530304920505245 0.0 4 0.988145838472829 11.323925345570231 15470.0 2.332275520786042 2.0 - - - - - - - 1406.0 50 2 PLA2G4F phospholipase A2, group IVF 1651 211 A20140416_SF113_02 A20140416_SF113_02 TB235719.[MT7]-GTDLLSK[MT7].2b5_1.heavy 511.31 / 644.374 8566.0 25.8031005859375 46 18 10 10 8 5.396565271267723 18.530304920505245 0.0 4 0.988145838472829 11.323925345570231 8566.0 2.1854583837295167 1.0 - - - - - - - 1197.2727272727273 19 11 PLA2G4F phospholipase A2, group IVF 1653 212 A20140416_SF113_02 A20140416_SF113_02 TB373347.[MT7]-GLNLTEDTYK[MT7]PR.3y6_1.heavy 565.649 / 923.507 28688.0 27.134700775146484 43 13 10 10 10 2.515440366313234 31.314898866130463 0.0 3 0.9230620677264093 4.4204604342727745 28688.0 30.582724706310902 0.0 - - - - - - - 650.0 57 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1655 212 A20140416_SF113_02 A20140416_SF113_02 TB373347.[MT7]-GLNLTEDTYK[MT7]PR.3b4_1.heavy 565.649 / 542.342 66601.0 27.134700775146484 43 13 10 10 10 2.515440366313234 31.314898866130463 0.0 3 0.9230620677264093 4.4204604342727745 66601.0 34.196974941658624 2.0 - - - - - - - 1896.0 133 2 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1657 212 A20140416_SF113_02 A20140416_SF113_02 TB373347.[MT7]-GLNLTEDTYK[MT7]PR.3b7_1.heavy 565.649 / 887.459 41578.0 27.134700775146484 43 13 10 10 10 2.515440366313234 31.314898866130463 0.0 3 0.9230620677264093 4.4204604342727745 41578.0 76.76834786756704 0.0 - - - - - - - 1119.142857142857 83 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1659 212 A20140416_SF113_02 A20140416_SF113_02 TB373347.[MT7]-GLNLTEDTYK[MT7]PR.3y5_1.heavy 565.649 / 808.48 25276.0 27.134700775146484 43 13 10 10 10 2.515440366313234 31.314898866130463 0.0 3 0.9230620677264093 4.4204604342727745 25276.0 44.17720953417422 0.0 - - - - - - - 663.6666666666666 50 12 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1661 213 A20140416_SF113_02 A20140416_SF113_02 TB235715.[MT7]-GLQVLMGR.2y5_1.heavy 509.303 / 575.333 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1663 213 A20140416_SF113_02 A20140416_SF113_02 TB235715.[MT7]-GLQVLMGR.2b4_1.heavy 509.303 / 542.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1665 213 A20140416_SF113_02 A20140416_SF113_02 TB235715.[MT7]-GLQVLMGR.2y6_1.heavy 509.303 / 703.392 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1667 213 A20140416_SF113_02 A20140416_SF113_02 TB235715.[MT7]-GLQVLMGR.2y7_1.heavy 509.303 / 816.476 N/A N/A - - - - - - - - - 0.0 - - - - - - - CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1669 214 A20140416_SF113_02 A20140416_SF113_02 TB495200.[MT7]-EAAAEARK[MT7].2y6_1.heavy 567.329 / 789.47 758.0 16.37980016072591 42 20 10 6 6 11.19862335716729 8.929669014718533 0.03899955749511719 5 0.997365435978717 24.03878965560572 758.0 6.164407002631046 1.0 - - - - - - - 0.0 1 0 NTHL1 nth endonuclease III-like 1 (E. coli) 1671 214 A20140416_SF113_02 A20140416_SF113_02 TB495200.[MT7]-EAAAEARK[MT7].2b7_1.heavy 567.329 / 843.444 622.0 16.37980016072591 42 20 10 6 6 11.19862335716729 8.929669014718533 0.03899955749511719 5 0.997365435978717 24.03878965560572 622.0 10.366666666666667 2.0 - - - - - - - 0.0 1 0 NTHL1 nth endonuclease III-like 1 (E. coli) 1673 214 A20140416_SF113_02 A20140416_SF113_02 TB495200.[MT7]-EAAAEARK[MT7].2y3_1.heavy 567.329 / 518.353 N/A 16.37980016072591 42 20 10 6 6 11.19862335716729 8.929669014718533 0.03899955749511719 5 0.997365435978717 24.03878965560572 2706.0 4.090450013466272 3.0 - - - - - - - 659.1818181818181 5 11 NTHL1 nth endonuclease III-like 1 (E. coli) 1675 214 A20140416_SF113_02 A20140416_SF113_02 TB495200.[MT7]-EAAAEARK[MT7].2y7_1.heavy 567.329 / 860.507 2002.0 16.37980016072591 42 20 10 6 6 11.19862335716729 8.929669014718533 0.03899955749511719 5 0.997365435978717 24.03878965560572 2002.0 46.66037037037037 0.0 - - - - - - - 95.95 4 20 NTHL1 nth endonuclease III-like 1 (E. coli) 1677 215 A20140416_SF113_02 A20140416_SF113_02 TB495484.[MT7]-QLNYSLLC[CAM]LPEDIR.3y7_1.heavy 626.669 / 902.44 48123.0 38.92919921875 43 13 10 10 10 3.6009914576145494 27.77012974816782 0.0 3 0.9183004655100905 4.287957394978325 48123.0 49.64373572507819 0.0 - - - - - - - 753.0 96 7 ALOX15B arachidonate 15-lipoxygenase, type B 1679 215 A20140416_SF113_02 A20140416_SF113_02 TB495484.[MT7]-QLNYSLLC[CAM]LPEDIR.3b5_1.heavy 626.669 / 750.39 48466.0 38.92919921875 43 13 10 10 10 3.6009914576145494 27.77012974816782 0.0 3 0.9183004655100905 4.287957394978325 48466.0 55.357826772729936 0.0 - - - - - - - 372.25 96 4 ALOX15B arachidonate 15-lipoxygenase, type B 1681 215 A20140416_SF113_02 A20140416_SF113_02 TB495484.[MT7]-QLNYSLLC[CAM]LPEDIR.3b3_1.heavy 626.669 / 500.295 36436.0 38.92919921875 43 13 10 10 10 3.6009914576145494 27.77012974816782 0.0 3 0.9183004655100905 4.287957394978325 36436.0 45.853505899758865 0.0 - - - - - - - 720.1428571428571 72 7 ALOX15B arachidonate 15-lipoxygenase, type B 1683 215 A20140416_SF113_02 A20140416_SF113_02 TB495484.[MT7]-QLNYSLLC[CAM]LPEDIR.3y5_1.heavy 626.669 / 629.325 151930.0 38.92919921875 43 13 10 10 10 3.6009914576145494 27.77012974816782 0.0 3 0.9183004655100905 4.287957394978325 151930.0 83.23541490666196 0.0 - - - - - - - 344.0 303 1 ALOX15B arachidonate 15-lipoxygenase, type B 1685 216 A20140416_SF113_02 A20140416_SF113_02 TB235712.[MT7]-SLNEMK[MT7].2y4_1.heavy 505.283 / 665.341 10208.0 23.167800903320312 46 16 10 10 10 2.419030498172375 28.313042622480793 0.0 3 0.9618218015798387 6.295977468980329 10208.0 15.15766317588323 0.0 - - - - - - - 1297.0 20 10 ALOX15B arachidonate 15-lipoxygenase, type B 1687 216 A20140416_SF113_02 A20140416_SF113_02 TB235712.[MT7]-SLNEMK[MT7].2y5_1.heavy 505.283 / 778.425 9608.0 23.167800903320312 46 16 10 10 10 2.419030498172375 28.313042622480793 0.0 3 0.9618218015798387 6.295977468980329 9608.0 24.19046451612903 0.0 - - - - - - - 735.5 19 8 ALOX15B arachidonate 15-lipoxygenase, type B 1689 216 A20140416_SF113_02 A20140416_SF113_02 TB235712.[MT7]-SLNEMK[MT7].2b4_1.heavy 505.283 / 588.311 9848.0 23.167800903320312 46 16 10 10 10 2.419030498172375 28.313042622480793 0.0 3 0.9618218015798387 6.295977468980329 9848.0 6.528893000308356 0.0 - - - - - - - 1321.0 19 7 ALOX15B arachidonate 15-lipoxygenase, type B 1691 216 A20140416_SF113_02 A20140416_SF113_02 TB235712.[MT7]-SLNEMK[MT7].2y3_1.heavy 505.283 / 551.298 8167.0 23.167800903320312 46 16 10 10 10 2.419030498172375 28.313042622480793 0.0 3 0.9618218015798387 6.295977468980329 8167.0 4.324565544785708 0.0 - - - - - - - 240.0 16 1 ALOX15B arachidonate 15-lipoxygenase, type B 1693 217 A20140416_SF113_02 A20140416_SF113_02 TB373344.[MT7]-SQTIYNVHSDNK[MT7].3b6_1.heavy 565.296 / 851.438 22764.0 21.799400329589844 47 17 10 10 10 5.876021919550248 17.018316365922274 0.0 3 0.973138742478114 7.5131530350524525 22764.0 45.1090675828268 0.0 - - - - - - - 248.66666666666666 45 9 FBXL5 F-box and leucine-rich repeat protein 5 1695 217 A20140416_SF113_02 A20140416_SF113_02 TB373344.[MT7]-SQTIYNVHSDNK[MT7].3b4_1.heavy 565.296 / 574.332 25099.0 21.799400329589844 47 17 10 10 10 5.876021919550248 17.018316365922274 0.0 3 0.973138742478114 7.5131530350524525 25099.0 32.68896290887851 0.0 - - - - - - - 364.75 50 4 FBXL5 F-box and leucine-rich repeat protein 5 1697 217 A20140416_SF113_02 A20140416_SF113_02 TB373344.[MT7]-SQTIYNVHSDNK[MT7].3y4_1.heavy 565.296 / 607.317 54868.0 21.799400329589844 47 17 10 10 10 5.876021919550248 17.018316365922274 0.0 3 0.973138742478114 7.5131530350524525 54868.0 104.51100560125874 0.0 - - - - - - - 486.0 109 5 FBXL5 F-box and leucine-rich repeat protein 5 1699 217 A20140416_SF113_02 A20140416_SF113_02 TB373344.[MT7]-SQTIYNVHSDNK[MT7].3y5_1.heavy 565.296 / 744.376 23056.0 21.799400329589844 47 17 10 10 10 5.876021919550248 17.018316365922274 0.0 3 0.973138742478114 7.5131530350524525 23056.0 31.776246506885116 0.0 - - - - - - - 802.75 46 8 FBXL5 F-box and leucine-rich repeat protein 5 1701 218 A20140416_SF113_02 A20140416_SF113_02 TB495498.[MT7]-SVPTTTAGATEAGPLRK[MT7].4y5_1.heavy 487.029 / 714.474 40253.0 24.47719955444336 35 5 10 10 10 0.7626997118654184 90.06549879921062 0.0 3 0.6988611311670582 2.1898946883015835 40253.0 31.01978972425957 0.0 - - - - - - - 1247.7142857142858 80 7 ARHGAP4 Rho GTPase activating protein 4 1703 218 A20140416_SF113_02 A20140416_SF113_02 TB495498.[MT7]-SVPTTTAGATEAGPLRK[MT7].4y8_2.heavy 487.029 / 508.305 161390.0 24.47719955444336 35 5 10 10 10 0.7626997118654184 90.06549879921062 0.0 3 0.6988611311670582 2.1898946883015835 161390.0 53.62939781497006 0.0 - - - - - - - 886.0 322 1 ARHGAP4 Rho GTPase activating protein 4 1705 218 A20140416_SF113_02 A20140416_SF113_02 TB495498.[MT7]-SVPTTTAGATEAGPLRK[MT7].4y10_2.heavy 487.029 / 572.334 391007.0 24.47719955444336 35 5 10 10 10 0.7626997118654184 90.06549879921062 0.0 3 0.6988611311670582 2.1898946883015835 391007.0 69.27137525665044 0.0 - - - - - - - 3165.0 782 1 ARHGAP4 Rho GTPase activating protein 4 1707 218 A20140416_SF113_02 A20140416_SF113_02 TB495498.[MT7]-SVPTTTAGATEAGPLRK[MT7].4y6_1.heavy 487.029 / 785.511 29114.0 24.47719955444336 35 5 10 10 10 0.7626997118654184 90.06549879921062 0.0 3 0.6988611311670582 2.1898946883015835 29114.0 15.136007272677785 0.0 - - - - - - - 253.5 58 2 ARHGAP4 Rho GTPase activating protein 4 1709 219 A20140416_SF113_02 A20140416_SF113_02 TB236268.[MT7]-AALTFLQDENMVSFIK[MT7].3b6_1.heavy 705.718 / 761.468 43304.0 40.75429916381836 48 18 10 10 10 5.679180184589627 17.60817525588439 0.0 3 0.9872899178972467 10.935209881116304 43304.0 41.4355865195708 0.0 - - - - - - - 1193.7777777777778 86 9 TTC39A tetratricopeptide repeat domain 39A 1711 219 A20140416_SF113_02 A20140416_SF113_02 TB236268.[MT7]-AALTFLQDENMVSFIK[MT7].3b4_1.heavy 705.718 / 501.315 46696.0 40.75429916381836 48 18 10 10 10 5.679180184589627 17.60817525588439 0.0 3 0.9872899178972467 10.935209881116304 46696.0 37.66719065864274 0.0 - - - - - - - 1195.5714285714287 93 7 TTC39A tetratricopeptide repeat domain 39A 1713 219 A20140416_SF113_02 A20140416_SF113_02 TB236268.[MT7]-AALTFLQDENMVSFIK[MT7].3b5_1.heavy 705.718 / 648.384 75753.0 40.75429916381836 48 18 10 10 10 5.679180184589627 17.60817525588439 0.0 3 0.9872899178972467 10.935209881116304 75753.0 58.4395666243619 0.0 - - - - - - - 226.0 151 1 TTC39A tetratricopeptide repeat domain 39A 1715 219 A20140416_SF113_02 A20140416_SF113_02 TB236268.[MT7]-AALTFLQDENMVSFIK[MT7].3y4_1.heavy 705.718 / 638.399 145853.0 40.75429916381836 48 18 10 10 10 5.679180184589627 17.60817525588439 0.0 3 0.9872899178972467 10.935209881116304 145853.0 149.74413481870278 0.0 - - - - - - - 339.0 291 1 TTC39A tetratricopeptide repeat domain 39A 1717 220 A20140416_SF113_02 A20140416_SF113_02 TB495499.[MT7]-SVPTTTAGATEAGPLRK[MT7].3y15_2.heavy 649.037 / 807.95 129714.0 24.47719955444336 35 5 10 10 10 0.5543884445840784 83.55578382938363 0.0 3 0.6648648173044271 2.069191931743443 129714.0 84.3761778305313 0.0 - - - - - - - 379.0 259 1 ARHGAP4 Rho GTPase activating protein 4 1719 220 A20140416_SF113_02 A20140416_SF113_02 TB495499.[MT7]-SVPTTTAGATEAGPLRK[MT7].3y6_1.heavy 649.037 / 785.511 20987.0 24.47719955444336 35 5 10 10 10 0.5543884445840784 83.55578382938363 0.0 3 0.6648648173044271 2.069191931743443 20987.0 92.72901783171363 0.0 - - - - - - - 223.53846153846155 41 13 ARHGAP4 Rho GTPase activating protein 4 1721 220 A20140416_SF113_02 A20140416_SF113_02 TB495499.[MT7]-SVPTTTAGATEAGPLRK[MT7].3y11_1.heavy 649.037 / 1214.7 8091.0 24.47719955444336 35 5 10 10 10 0.5543884445840784 83.55578382938363 0.0 3 0.6648648173044271 2.069191931743443 8091.0 88.81876341050254 0.0 - - - - - - - 180.42857142857142 16 7 ARHGAP4 Rho GTPase activating protein 4 1723 220 A20140416_SF113_02 A20140416_SF113_02 TB495499.[MT7]-SVPTTTAGATEAGPLRK[MT7].3y10_1.heavy 649.037 / 1143.66 23515.0 24.47719955444336 35 5 10 10 10 0.5543884445840784 83.55578382938363 0.0 3 0.6648648173044271 2.069191931743443 23515.0 114.782981530343 0.0 - - - - - - - 227.33333333333334 47 15 ARHGAP4 Rho GTPase activating protein 4 1725 221 A20140416_SF113_02 A20140416_SF113_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 598045.0 38.56159973144531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 598045.0 380.29912127238293 0.0 - - - - - - - 808.0 1196 2 1727 221 A20140416_SF113_02 A20140416_SF113_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 1263350.0 38.56159973144531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1263350.0 473.101702911404 0.0 - - - - - - - 4273.5 2526 2 1729 221 A20140416_SF113_02 A20140416_SF113_02 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 986443.0 38.56159973144531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 986443.0 530.5660396716976 0.0 - - - - - - - 1617.0 1972 1 1731 222 A20140416_SF113_02 A20140416_SF113_02 TB373136.[MT7]-ATASALDLLK[MT7].2y4_1.heavy 645.897 / 632.41 6769.0 33.580101013183594 46 20 10 6 10 6.742133495458513 14.832100264309478 0.03820037841796875 3 0.9939306064652066 15.83324082197299 6769.0 2.19988603988604 2.0 - - - - - - - 1254.0 13 2 CAGE1 cancer antigen 1 1733 222 A20140416_SF113_02 A20140416_SF113_02 TB373136.[MT7]-ATASALDLLK[MT7].2y3_1.heavy 645.897 / 517.383 9903.0 33.580101013183594 46 20 10 6 10 6.742133495458513 14.832100264309478 0.03820037841796875 3 0.9939306064652066 15.83324082197299 9903.0 4.182749294675954 2.0 - - - - - - - 1316.5 19 2 CAGE1 cancer antigen 1 1735 222 A20140416_SF113_02 A20140416_SF113_02 TB373136.[MT7]-ATASALDLLK[MT7].2b7_1.heavy 645.897 / 774.411 11031.0 33.580101013183594 46 20 10 6 10 6.742133495458513 14.832100264309478 0.03820037841796875 3 0.9939306064652066 15.83324082197299 11031.0 10.489938589140554 0.0 - - - - - - - 1110.4285714285713 22 7 CAGE1 cancer antigen 1 1737 222 A20140416_SF113_02 A20140416_SF113_02 TB373136.[MT7]-ATASALDLLK[MT7].2b5_1.heavy 645.897 / 546.3 5390.0 33.580101013183594 46 20 10 6 10 6.742133495458513 14.832100264309478 0.03820037841796875 3 0.9939306064652066 15.83324082197299 5390.0 1.074775672981057 6.0 - - - - - - - 2113.1428571428573 10 7 CAGE1 cancer antigen 1 1739 223 A20140416_SF113_02 A20140416_SF113_02 TB373278.[MT7]-GLGELQELYLK[MT7].3y3_1.heavy 517.639 / 567.362 375845.0 36.47679901123047 45 15 10 10 10 2.792347674076253 35.81215939848227 0.0 3 0.9534444248799278 5.697404456565995 375845.0 227.77843860068754 0.0 - - - - - - - 366.0 751 1 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1741 223 A20140416_SF113_02 A20140416_SF113_02 TB373278.[MT7]-GLGELQELYLK[MT7].3b4_1.heavy 517.639 / 501.279 404128.0 36.47679901123047 45 15 10 10 10 2.792347674076253 35.81215939848227 0.0 3 0.9534444248799278 5.697404456565995 404128.0 244.4466576653692 0.0 - - - - - - - 1280.0 808 2 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1743 223 A20140416_SF113_02 A20140416_SF113_02 TB373278.[MT7]-GLGELQELYLK[MT7].3b5_1.heavy 517.639 / 614.363 180547.0 36.47679901123047 45 15 10 10 10 2.792347674076253 35.81215939848227 0.0 3 0.9534444248799278 5.697404456565995 180547.0 209.25676396187959 0.0 - - - - - - - 366.0 361 6 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1745 223 A20140416_SF113_02 A20140416_SF113_02 TB373278.[MT7]-GLGELQELYLK[MT7].3b7_1.heavy 517.639 / 871.464 112156.0 36.47679901123047 45 15 10 10 10 2.792347674076253 35.81215939848227 0.0 3 0.9534444248799278 5.697404456565995 112156.0 248.87514803401947 0.0 - - - - - - - 696.8571428571429 224 7 GP1BA glycoprotein Ib (platelet), alpha polypeptide 1747 224 A20140416_SF113_02 A20140416_SF113_02 TB495358.[MT7]-APPVLPLLGPLAPDAWFC[CAM]R.3y7_1.heavy 745.414 / 951.414 28654.0 46.518150329589844 43 18 10 5 10 4.751539165764478 21.045812001406695 0.041900634765625 3 0.9883248996879517 11.410603539589443 28654.0 131.48800101814697 0.0 - - - - - - - 232.85714285714286 57 7 ALOX15B arachidonate 15-lipoxygenase, type B 1749 224 A20140416_SF113_02 A20140416_SF113_02 TB495358.[MT7]-APPVLPLLGPLAPDAWFC[CAM]R.3b4_1.heavy 745.414 / 509.32 13443.0 46.518150329589844 43 18 10 5 10 4.751539165764478 21.045812001406695 0.041900634765625 3 0.9883248996879517 11.410603539589443 13443.0 79.13235501974641 0.0 - - - - - - - 309.75 26 8 ALOX15B arachidonate 15-lipoxygenase, type B 1751 224 A20140416_SF113_02 A20140416_SF113_02 TB495358.[MT7]-APPVLPLLGPLAPDAWFC[CAM]R.3b5_1.heavy 745.414 / 622.404 37003.0 46.518150329589844 43 18 10 5 10 4.751539165764478 21.045812001406695 0.041900634765625 3 0.9883248996879517 11.410603539589443 37003.0 105.54552742611776 0.0 - - - - - - - 269.0 74 5 ALOX15B arachidonate 15-lipoxygenase, type B 1753 224 A20140416_SF113_02 A20140416_SF113_02 TB495358.[MT7]-APPVLPLLGPLAPDAWFC[CAM]R.3y5_1.heavy 745.414 / 739.334 15565.0 46.518150329589844 43 18 10 5 10 4.751539165764478 21.045812001406695 0.041900634765625 3 0.9883248996879517 11.410603539589443 15565.0 59.49640449438202 0.0 - - - - - - - 165.16666666666666 31 6 ALOX15B arachidonate 15-lipoxygenase, type B 1755 225 A20140416_SF113_02 A20140416_SF113_02 TB495355.[MT7]-ELLIVPGQVVDR.3y7_1.heavy 494.632 / 770.416 277037.0 34.56340026855469 46 16 10 10 10 2.221669761113323 35.88346272659779 0.0 3 0.965036437490609 6.580834477231863 277037.0 1129.342087431694 0.0 - - - - - - - 244.0 554 8 ALOX15B arachidonate 15-lipoxygenase, type B 1757 225 A20140416_SF113_02 A20140416_SF113_02 TB495355.[MT7]-ELLIVPGQVVDR.3y6_1.heavy 494.632 / 673.363 173545.0 34.56340026855469 46 16 10 10 10 2.221669761113323 35.88346272659779 0.0 3 0.965036437490609 6.580834477231863 173545.0 279.742144645499 0.0 - - - - - - - 732.0 347 8 ALOX15B arachidonate 15-lipoxygenase, type B 1759 225 A20140416_SF113_02 A20140416_SF113_02 TB495355.[MT7]-ELLIVPGQVVDR.3b4_1.heavy 494.632 / 613.404 307548.0 34.56340026855469 46 16 10 10 10 2.221669761113323 35.88346272659779 0.0 3 0.965036437490609 6.580834477231863 307548.0 136.83001544034178 0.0 - - - - - - - 366.0 615 3 ALOX15B arachidonate 15-lipoxygenase, type B 1761 225 A20140416_SF113_02 A20140416_SF113_02 TB495355.[MT7]-ELLIVPGQVVDR.3b3_1.heavy 494.632 / 500.32 461810.0 34.56340026855469 46 16 10 10 10 2.221669761113323 35.88346272659779 0.0 3 0.965036437490609 6.580834477231863 461810.0 325.6889931127196 0.0 - - - - - - - 488.0 923 1 ALOX15B arachidonate 15-lipoxygenase, type B 1763 226 A20140416_SF113_02 A20140416_SF113_02 TB495095.[MT7]-AVSPEER.2y4_1.heavy 466.252 / 530.257 N/A N/A - - - - - - - - - 0.0 - - - - - - - AQP8 aquaporin 8 1765 226 A20140416_SF113_02 A20140416_SF113_02 TB495095.[MT7]-AVSPEER.2y5_1.heavy 466.252 / 617.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - AQP8 aquaporin 8 1767 226 A20140416_SF113_02 A20140416_SF113_02 TB495095.[MT7]-AVSPEER.2b6_1.heavy 466.252 / 757.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - AQP8 aquaporin 8 1769 226 A20140416_SF113_02 A20140416_SF113_02 TB495095.[MT7]-AVSPEER.2y6_1.heavy 466.252 / 716.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - AQP8 aquaporin 8 1771 227 A20140416_SF113_02 A20140416_SF113_02 TB235699.[MT7]-LLIPHTR.2y6_1.heavy 497.32 / 736.446 23605.0 26.76409912109375 44 20 4 10 10 16.441780238299938 6.082066452089977 0.0 3 0.9981901280087014 29.005003150997343 23605.0 27.06576749531101 0.0 - - - - - - - 771.2857142857143 47 7 ALOX12B;ALOX15B arachidonate 12-lipoxygenase, 12R type;arachidonate 15-lipoxygenase, type B 1773 227 A20140416_SF113_02 A20140416_SF113_02 TB235699.[MT7]-LLIPHTR.2y4_1.heavy 497.32 / 510.278 34780.0 26.76409912109375 44 20 4 10 10 16.441780238299938 6.082066452089977 0.0 3 0.9981901280087014 29.005003150997343 34780.0 23.822472312958716 0.0 - - - - - - - 1192.875 69 8 ALOX12B;ALOX15B arachidonate 12-lipoxygenase, 12R type;arachidonate 15-lipoxygenase, type B 1775 227 A20140416_SF113_02 A20140416_SF113_02 TB235699.[MT7]-LLIPHTR.2y5_1.heavy 497.32 / 623.362 11300.0 26.76409912109375 44 20 4 10 10 16.441780238299938 6.082066452089977 0.0 3 0.9981901280087014 29.005003150997343 11300.0 8.022959849708782 0.0 - - - - - - - 690.5 22 2 ALOX12B;ALOX15B arachidonate 12-lipoxygenase, 12R type;arachidonate 15-lipoxygenase, type B 1777 227 A20140416_SF113_02 A20140416_SF113_02 TB235699.[MT7]-LLIPHTR.2b4_2.heavy 497.32 / 291.211 N/A 26.76409912109375 44 20 4 10 10 16.441780238299938 6.082066452089977 0.0 3 0.9981901280087014 29.005003150997343 16072.0 1.3458458406156057 28.0 - - - - - - - 9731.0 137 2 ALOX12B;ALOX15B arachidonate 12-lipoxygenase, 12R type;arachidonate 15-lipoxygenase, type B 1779 228 A20140416_SF113_02 A20140416_SF113_02 TB495356.[MT7]-LSEMLSLFEK[MT7].3b6_1.heavy 495.614 / 805.425 26811.0 41.8651008605957 48 18 10 10 10 8.120332338224813 12.314766912835616 0.0 3 0.9898484257426564 12.238482986853644 26811.0 450.1296330275229 0.0 - - - - - - - 181.11111111111111 53 9 FBXL5 F-box and leucine-rich repeat protein 5 1781 228 A20140416_SF113_02 A20140416_SF113_02 TB495356.[MT7]-LSEMLSLFEK[MT7].3y3_1.heavy 495.614 / 567.326 192344.0 41.8651008605957 48 18 10 10 10 8.120332338224813 12.314766912835616 0.0 3 0.9898484257426564 12.238482986853644 192344.0 1701.845529953917 0.0 - - - - - - - 186.28571428571428 384 7 FBXL5 F-box and leucine-rich repeat protein 5 1783 228 A20140416_SF113_02 A20140416_SF113_02 TB495356.[MT7]-LSEMLSLFEK[MT7].3b4_1.heavy 495.614 / 605.308 125479.0 41.8651008605957 48 18 10 10 10 8.120332338224813 12.314766912835616 0.0 3 0.9898484257426564 12.238482986853644 125479.0 757.2976216785056 0.0 - - - - - - - 217.11111111111111 250 9 FBXL5 F-box and leucine-rich repeat protein 5 1785 228 A20140416_SF113_02 A20140416_SF113_02 TB495356.[MT7]-LSEMLSLFEK[MT7].3b5_1.heavy 495.614 / 718.393 39945.0 41.8651008605957 48 18 10 10 10 8.120332338224813 12.314766912835616 0.0 3 0.9898484257426564 12.238482986853644 39945.0 346.0672811059908 0.0 - - - - - - - 199.25 79 12 FBXL5 F-box and leucine-rich repeat protein 5 1787 229 A20140416_SF113_02 A20140416_SF113_02 TB495350.[MT7]-TVEDLELNIK[MT7].2y4_1.heavy 731.424 / 631.426 18499.0 32.53810119628906 48 18 10 10 10 8.347723727386036 11.9793135548957 0.0 3 0.9879597719207079 11.235911177981587 18499.0 12.438358309958108 0.0 - - - - - - - 385.0 36 1 ALOX15B arachidonate 15-lipoxygenase, type B 1789 229 A20140416_SF113_02 A20140416_SF113_02 TB495350.[MT7]-TVEDLELNIK[MT7].2b4_1.heavy 731.424 / 589.295 38541.0 32.53810119628906 48 18 10 10 10 8.347723727386036 11.9793135548957 0.0 3 0.9879597719207079 11.235911177981587 38541.0 26.74688696104144 0.0 - - - - - - - 257.0 77 1 ALOX15B arachidonate 15-lipoxygenase, type B 1791 229 A20140416_SF113_02 A20140416_SF113_02 TB495350.[MT7]-TVEDLELNIK[MT7].2y3_1.heavy 731.424 / 518.342 19399.0 32.53810119628906 48 18 10 10 10 8.347723727386036 11.9793135548957 0.0 3 0.9879597719207079 11.235911177981587 19399.0 17.747017031630172 0.0 - - - - - - - 321.0 38 2 ALOX15B arachidonate 15-lipoxygenase, type B 1793 229 A20140416_SF113_02 A20140416_SF113_02 TB495350.[MT7]-TVEDLELNIK[MT7].2b6_1.heavy 731.424 / 831.422 19013.0 32.53810119628906 48 18 10 10 10 8.347723727386036 11.9793135548957 0.0 3 0.9879597719207079 11.235911177981587 19013.0 23.180570687418935 0.0 - - - - - - - 756.4444444444445 38 9 ALOX15B arachidonate 15-lipoxygenase, type B 1795 230 A20140416_SF113_02 A20140416_SF113_02 TB495219.[MT7]-ERLEAFTR.2b4_1.heavy 583.326 / 672.38 11400.0 25.12980079650879 42 20 4 10 8 8.003068824094644 12.495206801037677 0.0 4 0.9942897532013762 16.324055131356506 11400.0 23.50385887541345 0.0 - - - - - - - 748.5555555555555 22 9 FBXL5 F-box and leucine-rich repeat protein 5 1797 230 A20140416_SF113_02 A20140416_SF113_02 TB495219.[MT7]-ERLEAFTR.2b6_1.heavy 583.326 / 890.485 4534.0 25.12980079650879 42 20 4 10 8 8.003068824094644 12.495206801037677 0.0 4 0.9942897532013762 16.324055131356506 4534.0 25.41840926640927 1.0 - - - - - - - 227.0 39 8 FBXL5 F-box and leucine-rich repeat protein 5 1799 230 A20140416_SF113_02 A20140416_SF113_02 TB495219.[MT7]-ERLEAFTR.2y6_1.heavy 583.326 / 736.399 11270.0 25.12980079650879 42 20 4 10 8 8.003068824094644 12.495206801037677 0.0 4 0.9942897532013762 16.324055131356506 11270.0 5.591681766878267 1.0 - - - - - - - 324.0 22 4 FBXL5 F-box and leucine-rich repeat protein 5 1801 230 A20140416_SF113_02 A20140416_SF113_02 TB495219.[MT7]-ERLEAFTR.2b5_1.heavy 583.326 / 743.417 4404.0 25.12980079650879 42 20 4 10 8 8.003068824094644 12.495206801037677 0.0 4 0.9942897532013762 16.324055131356506 4404.0 7.354169884169885 2.0 - - - - - - - 744.875 8 8 FBXL5 F-box and leucine-rich repeat protein 5 1803 231 A20140416_SF113_02 A20140416_SF113_02 TB495352.[MT7]-TVDWALAEYMAFGSLLK[MT7].3b6_1.heavy 735.062 / 830.453 8028.0 47.3752498626709 42 16 10 6 10 2.868783616013274 34.857979333753036 0.032100677490234375 3 0.9622958451520705 6.335686420180295 8028.0 26.964058016587394 0.0 - - - - - - - 253.6315789473684 16 19 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1805 231 A20140416_SF113_02 A20140416_SF113_02 TB495352.[MT7]-TVDWALAEYMAFGSLLK[MT7].3b4_1.heavy 735.062 / 646.332 3273.0 47.3752498626709 42 16 10 6 10 2.868783616013274 34.857979333753036 0.032100677490234375 3 0.9622958451520705 6.335686420180295 3273.0 7.63773616734143 0.0 - - - - - - - 231.6875 6 16 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1807 231 A20140416_SF113_02 A20140416_SF113_02 TB495352.[MT7]-TVDWALAEYMAFGSLLK[MT7].3b5_1.heavy 735.062 / 717.369 10313.0 47.3752498626709 42 16 10 6 10 2.868783616013274 34.857979333753036 0.032100677490234375 3 0.9622958451520705 6.335686420180295 10313.0 9.605785697080531 0.0 - - - - - - - 829.2857142857143 20 7 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1809 231 A20140416_SF113_02 A20140416_SF113_02 TB495352.[MT7]-TVDWALAEYMAFGSLLK[MT7].3b8_1.heavy 735.062 / 1030.53 8708.0 47.3752498626709 42 16 10 6 10 2.868783616013274 34.857979333753036 0.032100677490234375 3 0.9622958451520705 6.335686420180295 8708.0 44.42137651821862 0.0 - - - - - - - 208.54166666666666 17 24 OGDH;OGDHL oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide);oxoglutarate dehydrogenase-like 1811 232 A20140416_SF113_02 A20140416_SF113_02 TB235985.[MT7]-C[CAM]LELQGELRR.2b3_1.heavy 709.389 / 547.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 1813 232 A20140416_SF113_02 A20140416_SF113_02 TB235985.[MT7]-C[CAM]LELQGELRR.2y5_1.heavy 709.389 / 630.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 1815 232 A20140416_SF113_02 A20140416_SF113_02 TB235985.[MT7]-C[CAM]LELQGELRR.2b4_1.heavy 709.389 / 660.351 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 1817 232 A20140416_SF113_02 A20140416_SF113_02 TB235985.[MT7]-C[CAM]LELQGELRR.2b7_1.heavy 709.389 / 974.473 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 1819 233 A20140416_SF113_02 A20140416_SF113_02 TB235800.[MT7]-SLYATFK[MT7].2y4_1.heavy 559.328 / 610.368 52879.0 30.503299713134766 40 18 2 10 10 5.490388905152132 18.213646014430942 0.0 3 0.9889102993468133 11.708473840673284 52879.0 45.651173069108864 0.0 - - - - - - - 881.0 105 1 FBXL5 F-box and leucine-rich repeat protein 5 1821 233 A20140416_SF113_02 A20140416_SF113_02 TB235800.[MT7]-SLYATFK[MT7].2y5_1.heavy 559.328 / 773.431 35378.0 30.503299713134766 40 18 2 10 10 5.490388905152132 18.213646014430942 0.0 3 0.9889102993468133 11.708473840673284 35378.0 46.890355001417916 0.0 - - - - - - - 1151.0 70 7 FBXL5 F-box and leucine-rich repeat protein 5 1823 233 A20140416_SF113_02 A20140416_SF113_02 TB235800.[MT7]-SLYATFK[MT7].2b4_1.heavy 559.328 / 579.326 N/A 30.503299713134766 40 18 2 10 10 5.490388905152132 18.213646014430942 0.0 3 0.9889102993468133 11.708473840673284 25684.0 3.586652018602734 2.0 - - - - - - - 1857.5 230 4 FBXL5 F-box and leucine-rich repeat protein 5 1825 233 A20140416_SF113_02 A20140416_SF113_02 TB235800.[MT7]-SLYATFK[MT7].2y3_1.heavy 559.328 / 539.331 45577.0 30.503299713134766 40 18 2 10 10 5.490388905152132 18.213646014430942 0.0 3 0.9889102993468133 11.708473840673284 45577.0 19.321261538905983 0.0 - - - - - - - 1511.0 91 1 FBXL5 F-box and leucine-rich repeat protein 5 1827 234 A20140416_SF113_02 A20140416_SF113_02 TB373272.[MT7]-SPIVLHFPLVNR.3y6_1.heavy 512.644 / 745.435 36836.0 35.78260040283203 46 20 10 6 10 9.140783296881287 10.939981482125134 0.03980255126953125 3 0.9978728655128641 26.753948191539266 36836.0 100.42714506986924 0.0 - - - - - - - 724.0 73 7 PLA2G4F phospholipase A2, group IVF 1829 234 A20140416_SF113_02 A20140416_SF113_02 TB373272.[MT7]-SPIVLHFPLVNR.3b4_1.heavy 512.644 / 541.347 65638.0 35.78260040283203 46 20 10 6 10 9.140783296881287 10.939981482125134 0.03980255126953125 3 0.9978728655128641 26.753948191539266 65638.0 71.9462341624554 0.0 - - - - - - - 742.0 131 2 PLA2G4F phospholipase A2, group IVF 1831 234 A20140416_SF113_02 A20140416_SF113_02 TB373272.[MT7]-SPIVLHFPLVNR.3b5_1.heavy 512.644 / 654.431 68852.0 35.78260040283203 46 20 10 6 10 9.140783296881287 10.939981482125134 0.03980255126953125 3 0.9978728655128641 26.753948191539266 68852.0 125.13814424073615 0.0 - - - - - - - 900.5714285714286 137 7 PLA2G4F phospholipase A2, group IVF 1833 234 A20140416_SF113_02 A20140416_SF113_02 TB373272.[MT7]-SPIVLHFPLVNR.3y5_1.heavy 512.644 / 598.367 151424.0 35.78260040283203 46 20 10 6 10 9.140783296881287 10.939981482125134 0.03980255126953125 3 0.9978728655128641 26.753948191539266 151424.0 187.94030333670372 0.0 - - - - - - - 865.3333333333334 302 6 PLA2G4F phospholipase A2, group IVF 1835 235 A20140416_SF113_02 A20140416_SF113_02 TB373541.[MT7]-EFTAGAEEDFQVTLPEDVGR.3b9_1.heavy 785.38 / 1094.48 20514.0 35.59980010986328 41 11 10 10 10 1.6837475171768446 52.15659105543153 0.0 3 0.8544108715830533 3.1943484295627487 20514.0 19.762471675756213 1.0 - - - - - - - 244.0 44 4 ALOX15B arachidonate 15-lipoxygenase, type B 1837 235 A20140416_SF113_02 A20140416_SF113_02 TB373541.[MT7]-EFTAGAEEDFQVTLPEDVGR.3b6_1.heavy 785.38 / 721.364 21979.0 35.59980010986328 41 11 10 10 10 1.6837475171768446 52.15659105543153 0.0 3 0.8544108715830533 3.1943484295627487 21979.0 19.700337024329873 0.0 - - - - - - - 733.0 43 4 ALOX15B arachidonate 15-lipoxygenase, type B 1839 235 A20140416_SF113_02 A20140416_SF113_02 TB373541.[MT7]-EFTAGAEEDFQVTLPEDVGR.3y6_1.heavy 785.38 / 672.331 58856.0 35.59980010986328 41 11 10 10 10 1.6837475171768446 52.15659105543153 0.0 3 0.8544108715830533 3.1943484295627487 58856.0 21.035972490213716 0.0 - - - - - - - 1954.0 117 1 ALOX15B arachidonate 15-lipoxygenase, type B 1841 235 A20140416_SF113_02 A20140416_SF113_02 TB373541.[MT7]-EFTAGAEEDFQVTLPEDVGR.3b5_1.heavy 785.38 / 650.327 12455.0 35.59980010986328 41 11 10 10 10 1.6837475171768446 52.15659105543153 0.0 3 0.8544108715830533 3.1943484295627487 12455.0 8.136096698439012 0.0 - - - - - - - 447.3333333333333 24 3 ALOX15B arachidonate 15-lipoxygenase, type B 1843 236 A20140416_SF113_02 A20140416_SF113_02 TB495490.[MT7]-TLQNLEEVLANTQK[MT7].3b6_1.heavy 630.358 / 843.469 36688.0 37.125301361083984 47 17 10 10 10 3.0893865403343437 25.696620120334494 0.0 3 0.9775310302874701 8.217774892761799 36688.0 66.5133313414168 0.0 - - - - - - - 394.0 73 9 CAGE1 cancer antigen 1 1845 236 A20140416_SF113_02 A20140416_SF113_02 TB495490.[MT7]-TLQNLEEVLANTQK[MT7].3b4_1.heavy 630.358 / 601.343 74355.0 37.125301361083984 47 17 10 10 10 3.0893865403343437 25.696620120334494 0.0 3 0.9775310302874701 8.217774892761799 74355.0 74.9913433526641 0.0 - - - - - - - 978.0 148 2 CAGE1 cancer antigen 1 1847 236 A20140416_SF113_02 A20140416_SF113_02 TB495490.[MT7]-TLQNLEEVLANTQK[MT7].3b5_1.heavy 630.358 / 714.427 53687.0 37.125301361083984 47 17 10 10 10 3.0893865403343437 25.696620120334494 0.0 3 0.9775310302874701 8.217774892761799 53687.0 40.39716937086401 0.0 - - - - - - - 815.3333333333334 107 3 CAGE1 cancer antigen 1 1849 236 A20140416_SF113_02 A20140416_SF113_02 TB495490.[MT7]-TLQNLEEVLANTQK[MT7].3b7_1.heavy 630.358 / 972.512 79736.0 37.125301361083984 47 17 10 10 10 3.0893865403343437 25.696620120334494 0.0 3 0.9775310302874701 8.217774892761799 79736.0 165.912055369988 0.0 - - - - - - - 275.1666666666667 159 12 CAGE1 cancer antigen 1 1851 237 A20140416_SF113_02 A20140416_SF113_02 TB373335.[MT7]-HNYGVVESFTVQR.2y6_1.heavy 840.435 / 737.394 1742.0 28.82487440109253 39 14 10 5 10 1.2299725879173684 58.77948093100507 0.04129981994628906 3 0.9318571964543261 4.700616269570567 1742.0 4.619224996500749 2.0 - - - - - - - 323.4 3 15 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1853 237 A20140416_SF113_02 A20140416_SF113_02 TB373335.[MT7]-HNYGVVESFTVQR.2b3_1.heavy 840.435 / 559.274 3110.0 28.82487440109253 39 14 10 5 10 1.2299725879173684 58.77948093100507 0.04129981994628906 3 0.9318571964543261 4.700616269570567 3110.0 7.9849598163031 0.0 - - - - - - - 210.3846153846154 6 13 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1855 237 A20140416_SF113_02 A20140416_SF113_02 TB373335.[MT7]-HNYGVVESFTVQR.2y8_1.heavy 840.435 / 965.505 3359.0 28.82487440109253 39 14 10 5 10 1.2299725879173684 58.77948093100507 0.04129981994628906 3 0.9318571964543261 4.700616269570567 3359.0 18.8859437751004 0.0 - - - - - - - 230.92857142857142 6 14 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1857 237 A20140416_SF113_02 A20140416_SF113_02 TB373335.[MT7]-HNYGVVESFTVQR.2y10_1.heavy 840.435 / 1121.59 1991.0 28.82487440109253 39 14 10 5 10 1.2299725879173684 58.77948093100507 0.04129981994628906 3 0.9318571964543261 4.700616269570567 1991.0 20.217354060364954 0.0 - - - - - - - 269.4166666666667 3 12 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1859 238 A20140416_SF113_02 A20140416_SF113_02 TB373336.[MT7]-HNYGVVESFTVQR.3y7_1.heavy 560.626 / 866.437 49516.0 28.8351993560791 46 16 10 10 10 2.194006486596428 36.50996151305641 0.0 3 0.965682384439678 6.642842148799443 49516.0 230.54447167193243 0.0 - - - - - - - 782.0 99 7 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1861 238 A20140416_SF113_02 A20140416_SF113_02 TB373336.[MT7]-HNYGVVESFTVQR.3y6_1.heavy 560.626 / 737.394 79002.0 28.8351993560791 46 16 10 10 10 2.194006486596428 36.50996151305641 0.0 3 0.965682384439678 6.642842148799443 79002.0 67.02633544499291 0.0 - - - - - - - 331.6666666666667 158 3 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1863 238 A20140416_SF113_02 A20140416_SF113_02 TB373336.[MT7]-HNYGVVESFTVQR.3b4_1.heavy 560.626 / 616.296 81242.0 28.8351993560791 46 16 10 10 10 2.194006486596428 36.50996151305641 0.0 3 0.965682384439678 6.642842148799443 81242.0 36.788831426769114 0.0 - - - - - - - 498.0 162 1 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1865 238 A20140416_SF113_02 A20140416_SF113_02 TB373336.[MT7]-HNYGVVESFTVQR.3b5_1.heavy 560.626 / 715.364 93559.0 28.8351993560791 46 16 10 10 10 2.194006486596428 36.50996151305641 0.0 3 0.965682384439678 6.642842148799443 93559.0 52.81802958559966 0.0 - - - - - - - 373.0 187 1 LOC100294276;LOC100510495;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1 1867 239 A20140416_SF113_02 A20140416_SF113_02 TB373334.[MT7]-ELLQELAEFMRR.3y11_2.heavy 560.307 / 703.385 34663.0 42.93159866333008 42 12 10 10 10 0.8103270239415727 70.94709703073332 0.0 3 0.8840958006733379 3.589434043608148 34663.0 136.75799919646443 0.0 - - - - - - - 204.58333333333334 69 12 ARHGAP4 Rho GTPase activating protein 4 1869 239 A20140416_SF113_02 A20140416_SF113_02 TB373334.[MT7]-ELLQELAEFMRR.3b4_1.heavy 560.307 / 628.379 21014.0 42.93159866333008 42 12 10 10 10 0.8103270239415727 70.94709703073332 0.0 3 0.8840958006733379 3.589434043608148 21014.0 77.23200126449112 0.0 - - - - - - - 232.0 42 11 ARHGAP4 Rho GTPase activating protein 4 1871 239 A20140416_SF113_02 A20140416_SF113_02 TB373334.[MT7]-ELLQELAEFMRR.3b5_1.heavy 560.307 / 757.421 30931.0 42.93159866333008 42 12 10 10 10 0.8103270239415727 70.94709703073332 0.0 3 0.8840958006733379 3.589434043608148 30931.0 381.5714922172259 0.0 - - - - - - - 253.58333333333334 61 12 ARHGAP4 Rho GTPase activating protein 4 1873 239 A20140416_SF113_02 A20140416_SF113_02 TB373334.[MT7]-ELLQELAEFMRR.3b3_1.heavy 560.307 / 500.32 25727.0 42.93159866333008 42 12 10 10 10 0.8103270239415727 70.94709703073332 0.0 3 0.8840958006733379 3.589434043608148 25727.0 95.54340076335878 0.0 - - - - - - - 699.625 51 8 ARHGAP4 Rho GTPase activating protein 4 1875 240 A20140416_SF113_02 A20140416_SF113_02 TB235597.[MT7]-VSGAQLR.2y5_1.heavy 437.765 / 544.32 7413.0 21.23940086364746 46 20 10 10 6 3.385305861345244 21.456235892250856 0.0 6 0.9929674987173616 14.70796596593988 7413.0 7.441960088691796 2.0 - - - - - - - 385.0 14 1 ARHGAP4 Rho GTPase activating protein 4 1877 240 A20140416_SF113_02 A20140416_SF113_02 TB235597.[MT7]-VSGAQLR.2b4_1.heavy 437.765 / 459.268 9723.0 21.23940086364746 46 20 10 10 6 3.385305861345244 21.456235892250856 0.0 6 0.9929674987173616 14.70796596593988 9723.0 3.995951627868977 5.0 - - - - - - - 1348.0 31 1 ARHGAP4 Rho GTPase activating protein 4 1879 240 A20140416_SF113_02 A20140416_SF113_02 TB235597.[MT7]-VSGAQLR.2y6_1.heavy 437.765 / 631.352 80191.0 21.23940086364746 46 20 10 10 6 3.385305861345244 21.456235892250856 0.0 6 0.9929674987173616 14.70796596593988 80191.0 103.4252946773254 0.0 - - - - - - - 1210.0 160 7 ARHGAP4 Rho GTPase activating protein 4 1881 240 A20140416_SF113_02 A20140416_SF113_02 TB235597.[MT7]-VSGAQLR.2b5_1.heavy 437.765 / 587.327 11071.0 21.23940086364746 46 20 10 10 6 3.385305861345244 21.456235892250856 0.0 6 0.9929674987173616 14.70796596593988 11071.0 6.392035081691378 3.0 - - - - - - - 1299.5 24 8 ARHGAP4 Rho GTPase activating protein 4 1883 241 A20140416_SF113_02 A20140416_SF113_02 TB373053.[MT7]-ERLEAFTR.3y6_1.heavy 389.22 / 736.399 69451.0 25.12980079650879 43 13 10 10 10 1.4293524594228593 60.08204919929126 0.0 3 0.9052632210003638 3.97752821676453 69451.0 347.9691491002571 0.0 - - - - - - - 269.6923076923077 138 13 FBXL5 F-box and leucine-rich repeat protein 5 1885 241 A20140416_SF113_02 A20140416_SF113_02 TB373053.[MT7]-ERLEAFTR.3y3_1.heavy 389.22 / 423.235 357252.0 25.12980079650879 43 13 10 10 10 1.4293524594228593 60.08204919929126 0.0 3 0.9052632210003638 3.97752821676453 357252.0 106.88802496742086 0.0 - - - - - - - 1752.5 714 2 FBXL5 F-box and leucine-rich repeat protein 5 1887 241 A20140416_SF113_02 A20140416_SF113_02 TB373053.[MT7]-ERLEAFTR.3b4_1.heavy 389.22 / 672.38 74254.0 25.12980079650879 43 13 10 10 10 1.4293524594228593 60.08204919929126 0.0 3 0.9052632210003638 3.97752821676453 74254.0 126.2356137647663 0.0 - - - - - - - 276.0 148 8 FBXL5 F-box and leucine-rich repeat protein 5 1889 241 A20140416_SF113_02 A20140416_SF113_02 TB373053.[MT7]-ERLEAFTR.3y5_1.heavy 389.22 / 623.315 144095.0 25.12980079650879 43 13 10 10 10 1.4293524594228593 60.08204919929126 0.0 3 0.9052632210003638 3.97752821676453 144095.0 134.35837508310973 0.0 - - - - - - - 665.25 288 8 FBXL5 F-box and leucine-rich repeat protein 5 1891 242 A20140416_SF113_02 A20140416_SF113_02 TB373166.[MT7]-AVDTWSWGER.2y8_1.heavy 675.832 / 1036.45 29660.0 32.45119857788086 44 17 9 10 8 4.488884645497803 22.27724878167599 0.0 4 0.9791318098617495 8.52828737180801 29660.0 80.60043431977857 1.0 - - - - - - - 272.75 85 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1893 242 A20140416_SF113_02 A20140416_SF113_02 TB373166.[MT7]-AVDTWSWGER.2y9_1.heavy 675.832 / 1135.52 31458.0 32.45119857788086 44 17 9 10 8 4.488884645497803 22.27724878167599 0.0 4 0.9791318098617495 8.52828737180801 31458.0 137.81017120622568 0.0 - - - - - - - 605.4285714285714 62 7 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1895 242 A20140416_SF113_02 A20140416_SF113_02 TB373166.[MT7]-AVDTWSWGER.2y6_1.heavy 675.832 / 820.374 14252.0 32.45119857788086 44 17 9 10 8 4.488884645497803 22.27724878167599 0.0 4 0.9791318098617495 8.52828737180801 14252.0 14.797663854639845 0.0 - - - - - - - 282.4 28 5 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1897 242 A20140416_SF113_02 A20140416_SF113_02 TB373166.[MT7]-AVDTWSWGER.2y7_1.heavy 675.832 / 921.421 37878.0 32.45119857788086 44 17 9 10 8 4.488884645497803 22.27724878167599 0.0 4 0.9791318098617495 8.52828737180801 37878.0 52.14787587203352 1.0 - - - - - - - 626.125 75 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1899 243 A20140416_SF113_02 A20140416_SF113_02 TB495617.[MT7]-TQPLQHHNLLVC[CAM]SVSGFYPGSIEVR.4b8_2.heavy 746.39 / 550.789 13882.0 34.56340026855469 43 13 10 10 10 1.6977017763852325 47.83809624006393 0.0 3 0.9083252226241298 4.044477293832493 13882.0 24.541996991817975 1.0 - - - - - - - 277.6 28 5 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 1901 243 A20140416_SF113_02 A20140416_SF113_02 TB495617.[MT7]-TQPLQHHNLLVC[CAM]SVSGFYPGSIEVR.4b5_1.heavy 746.39 / 712.411 5300.0 34.56340026855469 43 13 10 10 10 1.6977017763852325 47.83809624006393 0.0 3 0.9083252226241298 4.044477293832493 5300.0 5.359289922572394 0.0 - - - - - - - 1192.0 10 9 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 1903 243 A20140416_SF113_02 A20140416_SF113_02 TB495617.[MT7]-TQPLQHHNLLVC[CAM]SVSGFYPGSIEVR.4y7_1.heavy 746.39 / 757.42 96038.0 34.56340026855469 43 13 10 10 10 1.6977017763852325 47.83809624006393 0.0 3 0.9083252226241298 4.044477293832493 96038.0 57.754112121322265 0.0 - - - - - - - 694.0 192 2 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 1905 243 A20140416_SF113_02 A20140416_SF113_02 TB495617.[MT7]-TQPLQHHNLLVC[CAM]SVSGFYPGSIEVR.4b9_2.heavy 746.39 / 607.331 24735.0 34.56340026855469 43 13 10 10 10 1.6977017763852325 47.83809624006393 0.0 3 0.9083252226241298 4.044477293832493 24735.0 36.66202146722899 0.0 - - - - - - - 725.5 49 8 LOC100290966;LOC100294036;LOC100294276;LOC100294468;LOC100507709;LOC100507714;LOC100510495;LOC100510687;HLA-DRB1;HLA-DRB3 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;HLA class II histocompatibility antigen, DRB1-9 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DRB1-7 beta chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;HLA class II histocompatibility antigen, DR beta 3 chain-like;major histocompatibility complex, class II, DR beta 1;major histocompatibility complex, class II, DR beta 3 1907 244 A20140416_SF113_02 A20140416_SF113_02 TB495061.[MT7]-DLVVQR.2y4_1.heavy 437.267 / 501.314 54811.0 23.034700393676758 46 18 10 10 8 5.13735378579536 19.46527417996736 0.0 4 0.9853854654624938 10.196227929735333 54811.0 14.999743446366082 1.0 - - - - - - - 1218.0 114 1 PFKL phosphofructokinase, liver 1909 244 A20140416_SF113_02 A20140416_SF113_02 TB495061.[MT7]-DLVVQR.2b3_1.heavy 437.267 / 472.289 80268.0 23.034700393676758 46 18 10 10 8 5.13735378579536 19.46527417996736 0.0 4 0.9853854654624938 10.196227929735333 80268.0 29.684689533012524 0.0 - - - - - - - 1279.0 160 2 PFKL phosphofructokinase, liver 1911 244 A20140416_SF113_02 A20140416_SF113_02 TB495061.[MT7]-DLVVQR.2y5_1.heavy 437.267 / 614.398 105115.0 23.034700393676758 46 18 10 10 8 5.13735378579536 19.46527417996736 0.0 4 0.9853854654624938 10.196227929735333 105115.0 82.78474022264705 0.0 - - - - - - - 122.0 210 1 PFKL phosphofructokinase, liver 1913 244 A20140416_SF113_02 A20140416_SF113_02 TB495061.[MT7]-DLVVQR.2b4_1.heavy 437.267 / 571.357 41291.0 23.034700393676758 46 18 10 10 8 5.13735378579536 19.46527417996736 0.0 4 0.9853854654624938 10.196227929735333 41291.0 35.408014853209394 0.0 - - - - - - - 304.5 82 2 PFKL phosphofructokinase, liver 1915 245 A20140416_SF113_02 A20140416_SF113_02 TB495060.[MT7]-AVPGLK[MT7].2y4_1.heavy 436.794 / 558.373 291787.0 24.78030014038086 46 18 10 10 8 1.0845754946473676 51.78361987831854 0.0 4 0.9861730603598898 10.483291191899497 291787.0 157.96087051983451 0.0 - - - - - - - 1821.0 583 1 TTC39A;TAS1R1 tetratricopeptide repeat domain 39A;taste receptor, type 1, member 1 1917 245 A20140416_SF113_02 A20140416_SF113_02 TB495060.[MT7]-AVPGLK[MT7].2y5_1.heavy 436.794 / 657.442 40457.0 24.78030014038086 46 18 10 10 8 1.0845754946473676 51.78361987831854 0.0 4 0.9861730603598898 10.483291191899497 40457.0 45.138166035030345 0.0 - - - - - - - 390.0 80 2 TTC39A;TAS1R1 tetratricopeptide repeat domain 39A;taste receptor, type 1, member 1 1919 245 A20140416_SF113_02 A20140416_SF113_02 TB495060.[MT7]-AVPGLK[MT7].2b4_1.heavy 436.794 / 469.289 6895.0 24.78030014038086 46 18 10 10 8 1.0845754946473676 51.78361987831854 0.0 4 0.9861730603598898 10.483291191899497 6895.0 2.147411553395587 9.0 - - - - - - - 1951.0 79 1 TTC39A;TAS1R1 tetratricopeptide repeat domain 39A;taste receptor, type 1, member 1 1921 245 A20140416_SF113_02 A20140416_SF113_02 TB495060.[MT7]-AVPGLK[MT7].2y3_1.heavy 436.794 / 461.32 19643.0 24.78030014038086 46 18 10 10 8 1.0845754946473676 51.78361987831854 0.0 4 0.9861730603598898 10.483291191899497 19643.0 9.565746714846087 1.0 - - - - - - - 1821.0 56 3 TTC39A;TAS1R1 tetratricopeptide repeat domain 39A;taste receptor, type 1, member 1 1923 246 A20140416_SF113_02 A20140416_SF113_02 TB495366.[MT7]-LTDGILEIITK[MT7].3y3_1.heavy 501.979 / 505.347 329641.0 40.63959884643555 43 13 10 10 10 1.0145929233999453 65.70779780649735 0.0 3 0.9078053813493165 4.0328779093393665 329641.0 194.36210611916107 0.0 - - - - - - - 420.42857142857144 659 7 TTC39A tetratricopeptide repeat domain 39A 1925 246 A20140416_SF113_02 A20140416_SF113_02 TB495366.[MT7]-LTDGILEIITK[MT7].3b4_1.heavy 501.979 / 531.289 180494.0 40.63959884643555 43 13 10 10 10 1.0145929233999453 65.70779780649735 0.0 3 0.9078053813493165 4.0328779093393665 180494.0 224.81730609116315 0.0 - - - - - - - 759.7142857142857 360 7 TTC39A tetratricopeptide repeat domain 39A 1927 246 A20140416_SF113_02 A20140416_SF113_02 TB495366.[MT7]-LTDGILEIITK[MT7].3b5_1.heavy 501.979 / 644.374 297503.0 40.63959884643555 43 13 10 10 10 1.0145929233999453 65.70779780649735 0.0 3 0.9078053813493165 4.0328779093393665 297503.0 313.41742555339846 0.0 - - - - - - - 226.0 595 2 TTC39A tetratricopeptide repeat domain 39A 1929 246 A20140416_SF113_02 A20140416_SF113_02 TB495366.[MT7]-LTDGILEIITK[MT7].3b7_1.heavy 501.979 / 886.5 113049.0 40.63959884643555 43 13 10 10 10 1.0145929233999453 65.70779780649735 0.0 3 0.9078053813493165 4.0328779093393665 113049.0 264.0664772727273 0.0 - - - - - - - 679.0 226 8 TTC39A tetratricopeptide repeat domain 39A 1931 247 A20140416_SF113_02 A20140416_SF113_02 TB495062.[MT7]-LLTQVR.2y4_1.heavy 437.286 / 503.294 35131.0 27.213600158691406 38 20 2 10 6 12.881424721395343 7.763116438036971 0.0 5 0.9976024624774654 25.19955405963693 35131.0 14.961630015841436 0.0 - - - - - - - 3363.6666666666665 70 3 CAGE1 cancer antigen 1 1933 247 A20140416_SF113_02 A20140416_SF113_02 TB495062.[MT7]-LLTQVR.2y5_1.heavy 437.286 / 616.378 90069.0 27.213600158691406 38 20 2 10 6 12.881424721395343 7.763116438036971 0.0 5 0.9976024624774654 25.19955405963693 90069.0 42.35025208355391 1.0 - - - - - - - 1619.0 422 1 CAGE1 cancer antigen 1 1935 247 A20140416_SF113_02 A20140416_SF113_02 TB495062.[MT7]-LLTQVR.2b4_1.heavy 437.286 / 600.384 19808.0 27.213600158691406 38 20 2 10 6 12.881424721395343 7.763116438036971 0.0 5 0.9976024624774654 25.19955405963693 19808.0 19.031657514178853 1.0 - - - - - - - 498.0 44 1 CAGE1 cancer antigen 1 1937 247 A20140416_SF113_02 A20140416_SF113_02 TB495062.[MT7]-LLTQVR.2y3_1.heavy 437.286 / 402.246 11710.0 27.213600158691406 38 20 2 10 6 12.881424721395343 7.763116438036971 0.0 5 0.9976024624774654 25.19955405963693 11710.0 0.8418955512572535 18.0 - - - - - - - 6727.0 67 1 CAGE1 cancer antigen 1 1939 248 A20140416_SF113_02 A20140416_SF113_02 TB373266.[MT7]-ELLQELAEFMR.2y8_1.heavy 761.906 / 1023.49 30787.0 45.41360092163086 41 11 10 10 10 0.9920367175061935 60.38771903531212 0.0 3 0.876728232485833 3.4782821524836613 30787.0 215.68392613636362 0.0 - - - - - - - 229.33333333333334 61 15 ARHGAP4 Rho GTPase activating protein 4 1941 248 A20140416_SF113_02 A20140416_SF113_02 TB373266.[MT7]-ELLQELAEFMR.2y9_1.heavy 761.906 / 1136.58 14474.0 45.41360092163086 41 11 10 10 10 0.9920367175061935 60.38771903531212 0.0 3 0.876728232485833 3.4782821524836613 14474.0 119.41049999999998 0.0 - - - - - - - 135.0 28 16 ARHGAP4 Rho GTPase activating protein 4 1943 248 A20140416_SF113_02 A20140416_SF113_02 TB373266.[MT7]-ELLQELAEFMR.2y10_1.heavy 761.906 / 1249.66 7677.0 45.41360092163086 41 11 10 10 10 0.9920367175061935 60.38771903531212 0.0 3 0.876728232485833 3.4782821524836613 7677.0 123.151875 0.0 - - - - - - - 114.28571428571429 15 7 ARHGAP4 Rho GTPase activating protein 4 1945 248 A20140416_SF113_02 A20140416_SF113_02 TB373266.[MT7]-ELLQELAEFMR.2y7_1.heavy 761.906 / 895.434 10316.0 45.41360092163086 41 11 10 10 10 0.9920367175061935 60.38771903531212 0.0 3 0.876728232485833 3.4782821524836613 10316.0 23.064403438965467 1.0 - - - - - - - 254.54545454545453 28 11 ARHGAP4 Rho GTPase activating protein 4 1947 249 A20140416_SF113_02 A20140416_SF113_02 TB236272.[MT7]-GLYADYLFNAIAGNWER.2y9_1.heavy 1059.03 / 1030.51 7825.0 45.208099365234375 43 20 10 5 8 16.78982233347327 5.955989170929675 0.040802001953125 4 0.9921893397149735 13.955179027768875 7825.0 48.49203215134035 0.0 - - - - - - - 190.6 15 15 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 1949 249 A20140416_SF113_02 A20140416_SF113_02 TB236272.[MT7]-GLYADYLFNAIAGNWER.2b6_1.heavy 1059.03 / 827.406 7825.0 45.208099365234375 43 20 10 5 8 16.78982233347327 5.955989170929675 0.040802001953125 4 0.9921893397149735 13.955179027768875 7825.0 12.587781824004503 1.0 - - - - - - - 177.55555555555554 16 9 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 1951 249 A20140416_SF113_02 A20140416_SF113_02 TB236272.[MT7]-GLYADYLFNAIAGNWER.2y10_1.heavy 1059.03 / 1177.57 7068.0 45.208099365234375 43 20 10 5 8 16.78982233347327 5.955989170929675 0.040802001953125 4 0.9921893397149735 13.955179027768875 7068.0 86.81944891903349 0.0 - - - - - - - 180.28571428571428 14 7 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 1953 249 A20140416_SF113_02 A20140416_SF113_02 TB236272.[MT7]-GLYADYLFNAIAGNWER.2b5_1.heavy 1059.03 / 664.342 29703.0 45.208099365234375 43 20 10 5 8 16.78982233347327 5.955989170929675 0.040802001953125 4 0.9921893397149735 13.955179027768875 29703.0 131.39065402810175 0.0 - - - - - - - 183.36363636363637 59 11 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 1955 250 A20140416_SF113_02 A20140416_SF113_02 TB235979.[MT7]-TMLESLIADK[MT7].3y3_1.heavy 470.27 / 477.279 94174.0 37.27619934082031 46 16 10 10 10 3.0327121040493985 27.659202729268138 0.0 3 0.9626358666960602 6.364632038364643 94174.0 92.35539594835703 0.0 - - - - - - - 717.3 188 10 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1957 250 A20140416_SF113_02 A20140416_SF113_02 TB235979.[MT7]-TMLESLIADK[MT7].3b4_1.heavy 470.27 / 619.324 22349.0 37.27619934082031 46 16 10 10 10 3.0327121040493985 27.659202729268138 0.0 3 0.9626358666960602 6.364632038364643 22349.0 19.757081858169723 0.0 - - - - - - - 328.875 44 8 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1959 250 A20140416_SF113_02 A20140416_SF113_02 TB235979.[MT7]-TMLESLIADK[MT7].3b5_1.heavy 470.27 / 706.356 31670.0 37.27619934082031 46 16 10 10 10 3.0327121040493985 27.659202729268138 0.0 3 0.9626358666960602 6.364632038364643 31670.0 170.93849372384938 0.0 - - - - - - - 271.8181818181818 63 11 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1961 250 A20140416_SF113_02 A20140416_SF113_02 TB235979.[MT7]-TMLESLIADK[MT7].3b3_1.heavy 470.27 / 490.282 18883.0 37.27619934082031 46 16 10 10 10 3.0327121040493985 27.659202729268138 0.0 3 0.9626358666960602 6.364632038364643 18883.0 32.94886134607782 0.0 - - - - - - - 222.28571428571428 37 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1963 251 A20140416_SF113_02 A20140416_SF113_02 TB373262.[MT7]-LADQIFAYYK[MT7].2y4_1.heavy 760.424 / 688.379 2326.0 38.093149185180664 19 0 10 5 4 0.2534948603825947 151.36033370969773 0.04180145263671875 9 0.3604617870672095 1.451980647443542 2326.0 2.001677559912854 11.0 - - - - - - - 722.1 7 10 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1965 251 A20140416_SF113_02 A20140416_SF113_02 TB373262.[MT7]-LADQIFAYYK[MT7].2y5_1.heavy 760.424 / 835.447 40391.0 38.093149185180664 19 0 10 5 4 0.2534948603825947 151.36033370969773 0.04180145263671875 9 0.3604617870672095 1.451980647443542 40391.0 101.3152444471149 0.0 - - - - - - - 322.6363636363636 80 11 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1967 251 A20140416_SF113_02 A20140416_SF113_02 TB373262.[MT7]-LADQIFAYYK[MT7].2b4_1.heavy 760.424 / 572.316 2081.0 38.093149185180664 19 0 10 5 4 0.2534948603825947 151.36033370969773 0.04180145263671875 9 0.3604617870672095 1.451980647443542 2081.0 1.7330308529945553 19.0 - - - - - - - 1652.375 9 8 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1969 251 A20140416_SF113_02 A20140416_SF113_02 TB373262.[MT7]-LADQIFAYYK[MT7].2b5_1.heavy 760.424 / 685.4 10771.0 38.093149185180664 19 0 10 5 4 0.2534948603825947 151.36033370969773 0.04180145263671875 9 0.3604617870672095 1.451980647443542 10771.0 11.614985599262019 0.0 - - - - - - - 785.25 21 12 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 1971 252 A20140416_SF113_02 A20140416_SF113_02 TB373552.[MT7]-RLLHGLIHNVLPYVGTSVK[MT7].4y5_1.heavy 601.866 / 635.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL5 F-box and leucine-rich repeat protein 5 1973 252 A20140416_SF113_02 A20140416_SF113_02 TB373552.[MT7]-RLLHGLIHNVLPYVGTSVK[MT7].4b8_2.heavy 601.866 / 542.847 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL5 F-box and leucine-rich repeat protein 5 1975 252 A20140416_SF113_02 A20140416_SF113_02 TB373552.[MT7]-RLLHGLIHNVLPYVGTSVK[MT7].4b7_1.heavy 601.866 / 947.627 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL5 F-box and leucine-rich repeat protein 5 1977 252 A20140416_SF113_02 A20140416_SF113_02 TB373552.[MT7]-RLLHGLIHNVLPYVGTSVK[MT7].4b9_2.heavy 601.866 / 599.868 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL5 F-box and leucine-rich repeat protein 5 1979 253 A20140416_SF113_02 A20140416_SF113_02 TB495360.[MT7]-ALGFENATQALGR.2y8_1.heavy 746.405 / 830.448 30583.0 32.1416015625 48 18 10 10 10 5.273884229312461 18.961356687391046 0.0 3 0.9830642946612045 9.46991083172135 30583.0 85.77575781250002 0.0 - - - - - - - 652.8 61 10 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1981 253 A20140416_SF113_02 A20140416_SF113_02 TB495360.[MT7]-ALGFENATQALGR.2y9_1.heavy 746.405 / 959.49 42484.0 32.1416015625 48 18 10 10 10 5.273884229312461 18.961356687391046 0.0 3 0.9830642946612045 9.46991083172135 42484.0 80.94824652777777 0.0 - - - - - - - 672.0 84 8 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1983 253 A20140416_SF113_02 A20140416_SF113_02 TB495360.[MT7]-ALGFENATQALGR.2y10_1.heavy 746.405 / 1106.56 27128.0 32.1416015625 48 18 10 10 10 5.273884229312461 18.961356687391046 0.0 3 0.9830642946612045 9.46991083172135 27128.0 125.89087500000001 0.0 - - - - - - - 243.2 54 10 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1985 253 A20140416_SF113_02 A20140416_SF113_02 TB495360.[MT7]-ALGFENATQALGR.2y11_1.heavy 746.405 / 1163.58 57199.0 32.1416015625 48 18 10 10 10 5.273884229312461 18.961356687391046 0.0 3 0.9830642946612045 9.46991083172135 57199.0 187.01391796874998 0.0 - - - - - - - 170.66666666666666 114 9 LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 1987 254 A20140416_SF113_02 A20140416_SF113_02 TB373553.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.3b6_1.heavy 802.406 / 881.394 27257.0 37.67390060424805 43 13 10 10 10 1.9713695607092114 39.7801410220182 0.0 3 0.9288507125299991 4.5990470343105745 27257.0 60.15337931034482 0.0 - - - - - - - 261.0 54 8 PLA2G4F phospholipase A2, group IVF 1989 254 A20140416_SF113_02 A20140416_SF113_02 TB373553.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.3y11_1.heavy 802.406 / 1112.57 55327.0 37.67390060424805 43 13 10 10 10 1.9713695607092114 39.7801410220182 0.0 3 0.9288507125299991 4.5990470343105745 55327.0 146.42576724137933 0.0 - - - - - - - 322.22222222222223 110 9 PLA2G4F phospholipase A2, group IVF 1991 254 A20140416_SF113_02 A20140416_SF113_02 TB373553.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.3b4_1.heavy 802.406 / 654.267 17862.0 37.67390060424805 43 13 10 10 10 1.9713695607092114 39.7801410220182 0.0 3 0.9288507125299991 4.5990470343105745 17862.0 23.642275862068963 0.0 - - - - - - - 745.7142857142857 35 7 PLA2G4F phospholipase A2, group IVF 1993 254 A20140416_SF113_02 A20140416_SF113_02 TB373553.[MT7]-ADC[CAM]YVQLWLPTASPSPAQTR.3b5_1.heavy 802.406 / 753.336 16122.0 37.67390060424805 43 13 10 10 10 1.9713695607092114 39.7801410220182 0.0 3 0.9288507125299991 4.5990470343105745 16122.0 5.492236513975004 1.0 - - - - - - - 792.6666666666666 35 6 PLA2G4F phospholipase A2, group IVF 1995 255 A20140416_SF113_02 A20140416_SF113_02 TB372912.[MT7]-GLLDRK[MT7].2y4_1.heavy 495.321 / 675.427 3881.0 22.62042474746704 40 20 10 6 4 3.1384476655779174 24.062194474064952 0.03989982604980469 7 0.9932165371698048 14.975827788697528 3881.0 3.8853165442373645 2.0 - - - - - - - 1764.2857142857142 22 7 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 1997 255 A20140416_SF113_02 A20140416_SF113_02 TB372912.[MT7]-GLLDRK[MT7].2y5_1.heavy 495.321 / 788.511 3528.0 22.62042474746704 40 20 10 6 4 3.1384476655779174 24.062194474064952 0.03989982604980469 7 0.9932165371698048 14.975827788697528 3528.0 6.0 3.0 - - - - - - - 1205.375 7 8 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 1999 255 A20140416_SF113_02 A20140416_SF113_02 TB372912.[MT7]-GLLDRK[MT7].2b4_1.heavy 495.321 / 543.326 13995.0 22.62042474746704 40 20 10 6 4 3.1384476655779174 24.062194474064952 0.03989982604980469 7 0.9932165371698048 14.975827788697528 13995.0 9.696776254233605 0.0 - - - - - - - 2285.285714285714 27 7 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 2001 255 A20140416_SF113_02 A20140416_SF113_02 TB372912.[MT7]-GLLDRK[MT7].2b5_1.heavy 495.321 / 699.427 3646.0 22.62042474746704 40 20 10 6 4 3.1384476655779174 24.062194474064952 0.03989982604980469 7 0.9932165371698048 14.975827788697528 3646.0 2.4802721088435375 4.0 - - - - - - - 470.0 11 2 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 2003 256 A20140416_SF113_02 A20140416_SF113_02 TB236074.[MT7]-NEYEQLNYAK[MT7].3y3_1.heavy 520.603 / 525.315 101698.0 26.456499099731445 46 16 10 10 10 1.7613267364846905 40.444238628289554 0.0 3 0.9645547940215261 6.535704292172766 101698.0 24.799254941713126 1.0 - - - - - - - 764.0 203 1 FBXL5 F-box and leucine-rich repeat protein 5 2005 256 A20140416_SF113_02 A20140416_SF113_02 TB236074.[MT7]-NEYEQLNYAK[MT7].3b4_1.heavy 520.603 / 680.301 74841.0 26.456499099731445 46 16 10 10 10 1.7613267364846905 40.444238628289554 0.0 3 0.9645547940215261 6.535704292172766 74841.0 23.34412522810106 1.0 - - - - - - - 382.0 167 1 FBXL5 F-box and leucine-rich repeat protein 5 2007 256 A20140416_SF113_02 A20140416_SF113_02 TB236074.[MT7]-NEYEQLNYAK[MT7].3b5_1.heavy 520.603 / 808.359 70641.0 26.456499099731445 46 16 10 10 10 1.7613267364846905 40.444238628289554 0.0 3 0.9645547940215261 6.535704292172766 70641.0 162.3647983764345 0.0 - - - - - - - 712.8 141 10 FBXL5 F-box and leucine-rich repeat protein 5 2009 256 A20140416_SF113_02 A20140416_SF113_02 TB236074.[MT7]-NEYEQLNYAK[MT7].3b3_1.heavy 520.603 / 551.258 84515.0 26.456499099731445 46 16 10 10 10 1.7613267364846905 40.444238628289554 0.0 3 0.9645547940215261 6.535704292172766 84515.0 44.55583861941397 0.0 - - - - - - - 891.0 169 2 FBXL5 F-box and leucine-rich repeat protein 5 2011 257 A20140416_SF113_02 A20140416_SF113_02 TB495361.[MT7]-NVLELTLYDK[MT7].2y5_1.heavy 748.434 / 783.437 27330.0 35.92179870605469 48 18 10 10 10 5.633144752521853 17.752073556290537 0.0 3 0.9896977189815086 12.148484824057732 27330.0 55.764135185005344 0.0 - - - - - - - 772.1 54 10 PLA2G4F phospholipase A2, group IVF 2013 257 A20140416_SF113_02 A20140416_SF113_02 TB495361.[MT7]-NVLELTLYDK[MT7].2b4_1.heavy 748.434 / 600.347 43630.0 35.92179870605469 48 18 10 10 10 5.633144752521853 17.752073556290537 0.0 3 0.9896977189815086 12.148484824057732 43630.0 26.851879931527847 0.0 - - - - - - - 1208.142857142857 87 7 PLA2G4F phospholipase A2, group IVF 2015 257 A20140416_SF113_02 A20140416_SF113_02 TB495361.[MT7]-NVLELTLYDK[MT7].2y3_1.heavy 748.434 / 569.305 27943.0 35.92179870605469 48 18 10 10 10 5.633144752521853 17.752073556290537 0.0 3 0.9896977189815086 12.148484824057732 27943.0 31.093842729970326 0.0 - - - - - - - 1315.6 55 15 PLA2G4F phospholipase A2, group IVF 2017 257 A20140416_SF113_02 A20140416_SF113_02 TB495361.[MT7]-NVLELTLYDK[MT7].2y6_1.heavy 748.434 / 896.521 21938.0 35.92179870605469 48 18 10 10 10 5.633144752521853 17.752073556290537 0.0 3 0.9896977189815086 12.148484824057732 21938.0 37.8800573939557 0.0 - - - - - - - 802.0 43 11 PLA2G4F phospholipase A2, group IVF 2019 258 A20140416_SF113_02 A20140416_SF113_02 TB373364.[MT7]-DFVSEAYLLTLGK[MT7].2b3_1.heavy 872.492 / 506.273 14036.0 40.792301177978516 44 14 10 10 10 2.4928778140452468 40.11428054619646 0.0 3 0.9460764132363404 5.290562376504984 14036.0 43.82280542986425 0.0 - - - - - - - 265.53333333333336 28 15 CYFIP2 cytoplasmic FMR1 interacting protein 2 2021 258 A20140416_SF113_02 A20140416_SF113_02 TB373364.[MT7]-DFVSEAYLLTLGK[MT7].2b4_1.heavy 872.492 / 593.305 3316.0 40.792301177978516 44 14 10 10 10 2.4928778140452468 40.11428054619646 0.0 3 0.9460764132363404 5.290562376504984 3316.0 12.777347216921985 0.0 - - - - - - - 272.73333333333335 6 15 CYFIP2 cytoplasmic FMR1 interacting protein 2 2023 258 A20140416_SF113_02 A20140416_SF113_02 TB373364.[MT7]-DFVSEAYLLTLGK[MT7].2b5_1.heavy 872.492 / 722.348 5637.0 40.792301177978516 44 14 10 10 10 2.4928778140452468 40.11428054619646 0.0 3 0.9460764132363404 5.290562376504984 5637.0 8.396298728631148 0.0 - - - - - - - 309.8 11 10 CYFIP2 cytoplasmic FMR1 interacting protein 2 2025 258 A20140416_SF113_02 A20140416_SF113_02 TB373364.[MT7]-DFVSEAYLLTLGK[MT7].2y7_1.heavy 872.492 / 951.599 5195.0 40.792301177978516 44 14 10 10 10 2.4928778140452468 40.11428054619646 0.0 3 0.9460764132363404 5.290562376504984 5195.0 17.630090497737555 0.0 - - - - - - - 732.25 10 8 CYFIP2 cytoplasmic FMR1 interacting protein 2 2027 259 A20140416_SF113_02 A20140416_SF113_02 TB373088.[MT7]-FDSDVGEFR.2y4_1.heavy 608.292 / 508.251 5248.0 29.604299545288086 48 18 10 10 10 5.412509581032558 18.475717872248598 0.0 3 0.9816717755641913 9.101995403317375 5248.0 1.4182352392295061 13.0 - - - - - - - 1874.0 16 7 LOC100290966;LOC100293977;LOC100294276;LOC100510212;LOC100510306;LOC100510688;LOC100510689;HLA-DPB1;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;hypothetical protein LOC100510212;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DP beta 1;major histocompatibility complex, class II, DR beta 1 2029 259 A20140416_SF113_02 A20140416_SF113_02 TB373088.[MT7]-FDSDVGEFR.2y8_1.heavy 608.292 / 924.406 13621.0 29.604299545288086 48 18 10 10 10 5.412509581032558 18.475717872248598 0.0 3 0.9816717755641913 9.101995403317375 13621.0 21.080904269277497 0.0 - - - - - - - 750.0 27 7 LOC100290966;LOC100293977;LOC100294276;LOC100510212;LOC100510306;LOC100510688;LOC100510689;HLA-DPB1;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;hypothetical protein LOC100510212;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DP beta 1;major histocompatibility complex, class II, DR beta 1 2031 259 A20140416_SF113_02 A20140416_SF113_02 TB373088.[MT7]-FDSDVGEFR.2y5_1.heavy 608.292 / 607.32 N/A 29.604299545288086 48 18 10 10 10 5.412509581032558 18.475717872248598 0.0 3 0.9816717755641913 9.101995403317375 39237.0 7.979986900960692 0.0 - - - - - - - 3249.0 78 1 LOC100290966;LOC100293977;LOC100294276;LOC100510212;LOC100510306;LOC100510688;LOC100510689;HLA-DPB1;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;hypothetical protein LOC100510212;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DP beta 1;major histocompatibility complex, class II, DR beta 1 2033 259 A20140416_SF113_02 A20140416_SF113_02 TB373088.[MT7]-FDSDVGEFR.2y7_1.heavy 608.292 / 809.379 13621.0 29.604299545288086 48 18 10 10 10 5.412509581032558 18.475717872248598 0.0 3 0.9816717755641913 9.101995403317375 13621.0 26.083133968253968 0.0 - - - - - - - 587.5 27 10 LOC100290966;LOC100293977;LOC100294276;LOC100510212;LOC100510306;LOC100510688;LOC100510689;HLA-DPB1;HLA-DRB1 HLA class II histocompatibility antigen, DRB1-13 beta chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DRB1-3 chain-like;hypothetical protein LOC100510212;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;HLA class II histocompatibility antigen, DQ beta 1 chain-like;major histocompatibility complex, class II, DP beta 1;major histocompatibility complex, class II, DR beta 1 2035 260 A20140416_SF113_02 A20140416_SF113_02 TB373368.[MT7]-YLGRVQEAEENFR.3y7_1.heavy 585.636 / 894.395 10747.0 30.220500946044922 44 14 10 10 10 3.002531040118496 33.30523437188295 0.0 3 0.9474390681999477 5.359323808676104 10747.0 23.18895542857143 0.0 - - - - - - - 600.0 21 10 TTC39A tetratricopeptide repeat domain 39A 2037 260 A20140416_SF113_02 A20140416_SF113_02 TB373368.[MT7]-YLGRVQEAEENFR.3y6_1.heavy 585.636 / 765.353 15995.0 30.220500946044922 44 14 10 10 10 3.002531040118496 33.30523437188295 0.0 3 0.9474390681999477 5.359323808676104 15995.0 24.45457777777778 0.0 - - - - - - - 291.6666666666667 31 6 TTC39A tetratricopeptide repeat domain 39A 2039 260 A20140416_SF113_02 A20140416_SF113_02 TB373368.[MT7]-YLGRVQEAEENFR.3y4_1.heavy 585.636 / 565.273 N/A 30.220500946044922 44 14 10 10 10 3.002531040118496 33.30523437188295 0.0 3 0.9474390681999477 5.359323808676104 17369.0 8.648144393549696 0.0 - - - - - - - 1375.0 34 1 TTC39A tetratricopeptide repeat domain 39A 2041 260 A20140416_SF113_02 A20140416_SF113_02 TB373368.[MT7]-YLGRVQEAEENFR.3y12_2.heavy 585.636 / 724.368 39112.0 30.220500946044922 44 14 10 10 10 3.002531040118496 33.30523437188295 0.0 3 0.9474390681999477 5.359323808676104 39112.0 36.576448934531925 0.0 - - - - - - - 1820.4285714285713 78 7 TTC39A tetratricopeptide repeat domain 39A 2043 261 A20140416_SF113_02 A20140416_SF113_02 TB373162.[MT7]-YTLHINTLAR.2b3_1.heavy 673.389 / 522.304 6973.0 29.243099212646484 42 18 4 10 10 3.04899396323521 27.5533788002104 0.0 3 0.9821576101206622 9.225459293219078 6973.0 8.131844612148955 0.0 - - - - - - - 809.5 13 8 ALOX15B arachidonate 15-lipoxygenase, type B 2045 261 A20140416_SF113_02 A20140416_SF113_02 TB373162.[MT7]-YTLHINTLAR.2y9_1.heavy 673.389 / 1038.61 6849.0 29.243099212646484 42 18 4 10 10 3.04899396323521 27.5533788002104 0.0 3 0.9821576101206622 9.225459293219078 6849.0 17.439226787752894 0.0 - - - - - - - 249.23076923076923 13 13 ALOX15B arachidonate 15-lipoxygenase, type B 2047 261 A20140416_SF113_02 A20140416_SF113_02 TB373162.[MT7]-YTLHINTLAR.2y6_1.heavy 673.389 / 687.415 4857.0 29.243099212646484 42 18 4 10 10 3.04899396323521 27.5533788002104 0.0 3 0.9821576101206622 9.225459293219078 4857.0 6.144397590361446 2.0 - - - - - - - 871.5714285714286 33 7 ALOX15B arachidonate 15-lipoxygenase, type B 2049 261 A20140416_SF113_02 A20140416_SF113_02 TB373162.[MT7]-YTLHINTLAR.2y7_1.heavy 673.389 / 824.474 8592.0 29.243099212646484 42 18 4 10 10 3.04899396323521 27.5533788002104 0.0 3 0.9821576101206622 9.225459293219078 8592.0 16.39036144578313 0.0 - - - - - - - 844.0 17 9 ALOX15B arachidonate 15-lipoxygenase, type B 2051 262 A20140416_SF113_02 A20140416_SF113_02 TB495607.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].4b4_1.heavy 710.367 / 694.371 4063.0 47.69020080566406 40 10 10 10 10 2.330817641963365 42.90339930487439 0.0 3 0.8353721786741177 2.9989154622441445 4063.0 23.588071850841292 0.0 - - - - - - - 171.08 8 25 PLA2G4F phospholipase A2, group IVF 2053 262 A20140416_SF113_02 A20140416_SF113_02 TB495607.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].4y3_1.heavy 710.367 / 551.367 13716.0 47.69020080566406 40 10 10 10 10 2.330817641963365 42.90339930487439 0.0 3 0.8353721786741177 2.9989154622441445 13716.0 38.55027272727273 0.0 - - - - - - - 190.6206896551724 27 29 PLA2G4F phospholipase A2, group IVF 2055 262 A20140416_SF113_02 A20140416_SF113_02 TB495607.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].4b6_1.heavy 710.367 / 879.451 5315.0 47.69020080566406 40 10 10 10 10 2.330817641963365 42.90339930487439 0.0 3 0.8353721786741177 2.9989154622441445 5315.0 11.898200137394092 0.0 - - - - - - - 171.32142857142858 10 28 PLA2G4F phospholipase A2, group IVF 2057 262 A20140416_SF113_02 A20140416_SF113_02 TB495607.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].4b3_1.heavy 710.367 / 581.287 3971.0 47.69020080566406 40 10 10 10 10 2.330817641963365 42.90339930487439 0.0 3 0.8353721786741177 2.9989154622441445 3971.0 -0.19947276425088423 0.0 - - - - - - - 226.76923076923077 7 26 PLA2G4F phospholipase A2, group IVF 2059 263 A20140416_SF113_02 A20140416_SF113_02 TB495606.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].3b6_1.heavy 946.82 / 879.451 3105.0 47.69020080566406 41 11 10 10 10 0.778614164400193 73.65433383263361 0.0 3 0.8531230978550023 3.1799532881992345 3105.0 4.757133155835337 0.0 - - - - - - - 195.46153846153845 6 26 PLA2G4F phospholipase A2, group IVF 2061 263 A20140416_SF113_02 A20140416_SF113_02 TB495606.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].3b4_1.heavy 946.82 / 694.371 3988.0 47.69020080566406 41 11 10 10 10 0.778614164400193 73.65433383263361 0.0 3 0.8531230978550023 3.1799532881992345 3988.0 3.680623787766366 0.0 - - - - - - - 190.9655172413793 7 29 PLA2G4F phospholipase A2, group IVF 2063 263 A20140416_SF113_02 A20140416_SF113_02 TB495606.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].3b3_1.heavy 946.82 / 581.287 2618.0 47.69020080566406 41 11 10 10 10 0.778614164400193 73.65433383263361 0.0 3 0.8531230978550023 3.1799532881992345 2618.0 5.779389199734174 0.0 - - - - - - - 674.1428571428571 5 7 PLA2G4F phospholipase A2, group IVF 2065 263 A20140416_SF113_02 A20140416_SF113_02 TB495606.[MT7]-IC[CAM]YLQGMWGSAFATSLDEIFLK[MT7].3b7_1.heavy 946.82 / 1010.49 7428.0 47.69020080566406 41 11 10 10 10 0.778614164400193 73.65433383263361 0.0 3 0.8531230978550023 3.1799532881992345 7428.0 4.05346112979182 0.0 - - - - - - - 149.74074074074073 14 27 PLA2G4F phospholipase A2, group IVF 2067 264 A20140416_SF113_02 A20140416_SF113_02 TB495604.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].4y4_1.heavy 707.62 / 560.316 32752.0 40.67839813232422 43 13 10 10 10 2.279883883634958 43.86188293088151 0.0 3 0.9048413731770178 3.9685574624092763 32752.0 15.136744088595508 0.0 - - - - - - - 824.5 65 4 ARHGAP4 Rho GTPase activating protein 4 2069 264 A20140416_SF113_02 A20140416_SF113_02 TB495604.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].4y5_1.heavy 707.62 / 657.369 95412.0 40.67839813232422 43 13 10 10 10 2.279883883634958 43.86188293088151 0.0 3 0.9048413731770178 3.9685574624092763 95412.0 69.94758764096225 0.0 - - - - - - - 910.0 190 1 ARHGAP4 Rho GTPase activating protein 4 2071 264 A20140416_SF113_02 A20140416_SF113_02 TB495604.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].4b7_1.heavy 707.62 / 887.47 8415.0 40.67839813232422 43 13 10 10 10 2.279883883634958 43.86188293088151 0.0 3 0.9048413731770178 3.9685574624092763 8415.0 18.05383895980996 0.0 - - - - - - - 241.5 16 8 ARHGAP4 Rho GTPase activating protein 4 2073 264 A20140416_SF113_02 A20140416_SF113_02 TB495604.[MT7]-TQASQVQGLGSLEEAVEALDPPGDK[MT7].4b5_1.heavy 707.62 / 660.343 26270.0 40.67839813232422 43 13 10 10 10 2.279883883634958 43.86188293088151 0.0 3 0.9048413731770178 3.9685574624092763 26270.0 21.157421206306253 0.0 - - - - - - - 114.0 52 1 ARHGAP4 Rho GTPase activating protein 4 2075 265 A20140416_SF113_02 A20140416_SF113_02 TB373352.[MT7]-ETYPYYDLQVK[MT7].3y3_1.heavy 569.634 / 518.342 50036.0 31.699100494384766 46 16 10 10 10 1.4046608471587816 44.10786574728717 0.0 3 0.968760388407998 6.9642191039089125 50036.0 25.903507007631 0.0 - - - - - - - 2274.3333333333335 100 3 PLA2G4F phospholipase A2, group IVF 2077 265 A20140416_SF113_02 A20140416_SF113_02 TB373352.[MT7]-ETYPYYDLQVK[MT7].3b5_1.heavy 569.634 / 798.379 44729.0 31.699100494384766 46 16 10 10 10 1.4046608471587816 44.10786574728717 0.0 3 0.968760388407998 6.9642191039089125 44729.0 81.33146223604737 0.0 - - - - - - - 757.8571428571429 89 7 PLA2G4F phospholipase A2, group IVF 2079 265 A20140416_SF113_02 A20140416_SF113_02 TB373352.[MT7]-ETYPYYDLQVK[MT7].3b3_1.heavy 569.634 / 538.263 118266.0 31.699100494384766 46 16 10 10 10 1.4046608471587816 44.10786574728717 0.0 3 0.968760388407998 6.9642191039089125 118266.0 65.0066143170415 0.0 - - - - - - - 1221.3333333333333 236 3 PLA2G4F phospholipase A2, group IVF 2081 265 A20140416_SF113_02 A20140416_SF113_02 TB373352.[MT7]-ETYPYYDLQVK[MT7].3b7_1.heavy 569.634 / 1076.47 19332.0 31.699100494384766 46 16 10 10 10 1.4046608471587816 44.10786574728717 0.0 3 0.968760388407998 6.9642191039089125 19332.0 58.424240506329106 0.0 - - - - - - - 216.57142857142858 38 7 PLA2G4F phospholipase A2, group IVF 2083 266 A20140416_SF113_02 A20140416_SF113_02 TB495376.[MT7]-TLPPGLLTPTPK[MT7].3b6_1.heavy 508.32 / 723.452 180973.0 31.785600662231445 44 14 10 10 10 1.3325142892558468 50.030733031686424 0.0 3 0.9406609053424648 5.041045365759921 180973.0 251.38264960896115 0.0 - - - - - - - 321.0 361 2 GP1BA glycoprotein Ib (platelet), alpha polypeptide 2085 266 A20140416_SF113_02 A20140416_SF113_02 TB495376.[MT7]-TLPPGLLTPTPK[MT7].3b5_1.heavy 508.32 / 610.368 155303.0 31.785600662231445 44 14 10 10 10 1.3325142892558468 50.030733031686424 0.0 3 0.9406609053424648 5.041045365759921 155303.0 10.808137958990997 1.0 - - - - - - - 577.5 323 2 GP1BA glycoprotein Ib (platelet), alpha polypeptide 2087 266 A20140416_SF113_02 A20140416_SF113_02 TB495376.[MT7]-TLPPGLLTPTPK[MT7].3y4_1.heavy 508.32 / 586.368 182256.0 31.785600662231445 44 14 10 10 10 1.3325142892558468 50.030733031686424 0.0 3 0.9406609053424648 5.041045365759921 182256.0 75.4271029181937 0.0 - - - - - - - 1732.75 364 4 GP1BA glycoprotein Ib (platelet), alpha polypeptide 2089 266 A20140416_SF113_02 A20140416_SF113_02 TB495376.[MT7]-TLPPGLLTPTPK[MT7].3b7_1.heavy 508.32 / 836.536 23873.0 31.785600662231445 44 14 10 10 10 1.3325142892558468 50.030733031686424 0.0 3 0.9406609053424648 5.041045365759921 23873.0 64.57631177504597 0.0 - - - - - - - 256.6666666666667 47 3 GP1BA glycoprotein Ib (platelet), alpha polypeptide 2091 267 A20140416_SF113_02 A20140416_SF113_02 TB495073.[MT7]-GVFDC[CAM]R.2y4_1.heavy 449.222 / 597.245 10893.0 24.736600875854492 44 14 10 10 10 6.0738873478129 16.463920760072746 0.0 3 0.9344382954413762 4.793309235857025 10893.0 22.04597448348091 0.0 - - - - - - - 691.5555555555555 21 9 PFKL;PFKP phosphofructokinase, liver;phosphofructokinase, platelet 2093 267 A20140416_SF113_02 A20140416_SF113_02 TB495073.[MT7]-GVFDC[CAM]R.2b5_2.heavy 449.222 / 362.166 5447.0 24.736600875854492 44 14 10 10 10 6.0738873478129 16.463920760072746 0.0 3 0.9344382954413762 4.793309235857025 5447.0 1.239958725797365 30.0 - - - - - - - 2594.0 102 1 PFKL;PFKP phosphofructokinase, liver;phosphofructokinase, platelet 2095 267 A20140416_SF113_02 A20140416_SF113_02 TB495073.[MT7]-GVFDC[CAM]R.2y5_1.heavy 449.222 / 696.313 8559.0 24.736600875854492 44 14 10 10 10 6.0738873478129 16.463920760072746 0.0 3 0.9344382954413762 4.793309235857025 8559.0 11.973279838821732 1.0 - - - - - - - 734.7777777777778 19 9 PFKL;PFKP phosphofructokinase, liver;phosphofructokinase, platelet 2097 267 A20140416_SF113_02 A20140416_SF113_02 TB495073.[MT7]-GVFDC[CAM]R.2b4_1.heavy 449.222 / 563.295 151986.0 24.736600875854492 44 14 10 10 10 6.0738873478129 16.463920760072746 0.0 3 0.9344382954413762 4.793309235857025 151986.0 88.34003616552064 0.0 - - - - - - - 908.0 303 3 PFKL;PFKP phosphofructokinase, liver;phosphofructokinase, platelet 2099 268 A20140416_SF113_02 A20140416_SF113_02 TB495379.[MT7]-TVEVLEPEVTK[MT7].3b4_1.heavy 511.299 / 573.336 369198.0 29.482099533081055 50 20 10 10 10 30.040664223453778 3.328821202359652 0.0 3 0.9953256074630273 18.043902126185834 369198.0 231.82930227242957 0.0 - - - - - - - 1257.0 738 1 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 2101 268 A20140416_SF113_02 A20140416_SF113_02 TB495379.[MT7]-TVEVLEPEVTK[MT7].3b5_1.heavy 511.299 / 686.42 137192.0 29.482099533081055 50 20 10 10 10 30.040664223453778 3.328821202359652 0.0 3 0.9953256074630273 18.043902126185834 137192.0 153.60230881378396 0.0 - - - - - - - 736.4285714285714 274 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 2103 268 A20140416_SF113_02 A20140416_SF113_02 TB495379.[MT7]-TVEVLEPEVTK[MT7].3y4_1.heavy 511.299 / 620.374 106006.0 29.482099533081055 50 20 10 10 10 30.040664223453778 3.328821202359652 0.0 3 0.9953256074630273 18.043902126185834 106006.0 122.31395010877554 0.0 - - - - - - - 1778.142857142857 212 7 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 2105 268 A20140416_SF113_02 A20140416_SF113_02 TB495379.[MT7]-TVEVLEPEVTK[MT7].3y5_1.heavy 511.299 / 717.426 175545.0 29.482099533081055 50 20 10 10 10 30.040664223453778 3.328821202359652 0.0 3 0.9953256074630273 18.043902126185834 175545.0 275.7711082678243 0.0 - - - - - - - 707.125 351 8 CYFIP1;CYFIP2 cytoplasmic FMR1 interacting protein 1;cytoplasmic FMR1 interacting protein 2 2107 269 A20140416_SF113_02 A20140416_SF113_02 TB495601.[MT7]-VHK[MT7]APPVLPLLGPLAPDAWFC[CAM]R.4y5_1.heavy 686.393 / 739.334 24297.0 41.283199310302734 41 11 10 10 10 0.9308342301946079 65.5297606737155 0.0 3 0.868432153531129 3.3643926948167278 24297.0 38.733395595086826 0.0 - - - - - - - 299.6666666666667 48 3 ALOX15B arachidonate 15-lipoxygenase, type B 2109 269 A20140416_SF113_02 A20140416_SF113_02 TB495601.[MT7]-VHK[MT7]APPVLPLLGPLAPDAWFC[CAM]R.4b8_2.heavy 686.393 / 565.868 62316.0 41.283199310302734 41 11 10 10 10 0.9308342301946079 65.5297606737155 0.0 3 0.868432153531129 3.3643926948167278 62316.0 23.056919999999998 1.0 - - - - - - - 224.5 124 2 ALOX15B arachidonate 15-lipoxygenase, type B 2111 269 A20140416_SF113_02 A20140416_SF113_02 TB495601.[MT7]-VHK[MT7]APPVLPLLGPLAPDAWFC[CAM]R.4b4_1.heavy 686.393 / 724.471 16310.0 41.283199310302734 41 11 10 10 10 0.9308342301946079 65.5297606737155 0.0 3 0.868432153531129 3.3643926948167278 16310.0 16.59619120286822 1.0 - - - - - - - 337.3333333333333 32 6 ALOX15B arachidonate 15-lipoxygenase, type B 2113 269 A20140416_SF113_02 A20140416_SF113_02 TB495601.[MT7]-VHK[MT7]APPVLPLLGPLAPDAWFC[CAM]R.4y7_1.heavy 686.393 / 951.414 48706.0 41.283199310302734 41 11 10 10 10 0.9308342301946079 65.5297606737155 0.0 3 0.868432153531129 3.3643926948167278 48706.0 12.212926242569617 1.0 - - - - - - - 365.5 97 4 ALOX15B arachidonate 15-lipoxygenase, type B 2115 270 A20140416_SF113_02 A20140416_SF113_02 TB373254.[MT7]-VWDFIPDNSK[MT7].3b4_1.heavy 503.604 / 692.352 138951.0 35.51340103149414 48 18 10 10 10 3.7767824068479734 26.47756455830824 0.0 3 0.9842682270217604 9.826583149405302 138951.0 197.3036476113662 0.0 - - - - - - - 428.0 277 2 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 2117 270 A20140416_SF113_02 A20140416_SF113_02 TB373254.[MT7]-VWDFIPDNSK[MT7].3y4_1.heavy 503.604 / 607.317 81218.0 35.51340103149414 48 18 10 10 10 3.7767824068479734 26.47756455830824 0.0 3 0.9842682270217604 9.826583149405302 81218.0 90.83101474375724 0.0 - - - - - - - 428.0 162 2 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 2119 270 A20140416_SF113_02 A20140416_SF113_02 TB373254.[MT7]-VWDFIPDNSK[MT7].3b3_1.heavy 503.604 / 545.284 232156.0 35.51340103149414 48 18 10 10 10 3.7767824068479734 26.47756455830824 0.0 3 0.9842682270217604 9.826583149405302 232156.0 164.15919185832843 0.0 - - - - - - - 367.0 464 1 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 2121 270 A20140416_SF113_02 A20140416_SF113_02 TB373254.[MT7]-VWDFIPDNSK[MT7].3y5_1.heavy 503.604 / 704.37 148859.0 35.51340103149414 48 18 10 10 10 3.7767824068479734 26.47756455830824 0.0 3 0.9842682270217604 9.826583149405302 148859.0 129.04911455212056 0.0 - - - - - - - 326.3333333333333 297 3 C2orf89;LOC388630 chromosome 2 open reading frame 89;UPF0632 protein A 2123 271 A20140416_SF113_02 A20140416_SF113_02 TB495600.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7].4b5_1.heavy 679.868 / 758.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 2125 271 A20140416_SF113_02 A20140416_SF113_02 TB495600.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7].4b9_1.heavy 679.868 / 1243.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 2127 271 A20140416_SF113_02 A20140416_SF113_02 TB495600.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7].4b6_1.heavy 679.868 / 871.464 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 2129 271 A20140416_SF113_02 A20140416_SF113_02 TB495600.[MT7]-DLEQQLQDELLEVVSELQTAK[MT7].4b4_1.heavy 679.868 / 630.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGAP4 Rho GTPase activating protein 4 2131 272 A20140416_SF113_02 A20140416_SF113_02 TB373253.[MT7]-ENVEELIEDK[MT7].2b4_1.heavy 753.401 / 616.306 3979.0 32.53810119628906 44 14 10 10 10 1.7765390723977754 47.260210587606686 0.0 3 0.9409666375114554 5.0542138588100745 3979.0 7.37234632034632 0.0 - - - - - - - 654.5 7 10 CAGE1 cancer antigen 1 2133 272 A20140416_SF113_02 A20140416_SF113_02 TB373253.[MT7]-ENVEELIEDK[MT7].2b6_1.heavy 753.401 / 858.432 3979.0 32.53810119628906 44 14 10 10 10 1.7765390723977754 47.260210587606686 0.0 3 0.9409666375114554 5.0542138588100745 3979.0 2.9126535692824644 2.0 - - - - - - - 722.0 8 8 CAGE1 cancer antigen 1 2135 272 A20140416_SF113_02 A20140416_SF113_02 TB373253.[MT7]-ENVEELIEDK[MT7].2b5_1.heavy 753.401 / 745.349 N/A 32.53810119628906 44 14 10 10 10 1.7765390723977754 47.260210587606686 0.0 3 0.9409666375114554 5.0542138588100745 5391.0 5.174664070107108 1.0 - - - - - - - 1796.875 10 8 CAGE1 cancer antigen 1 2137 272 A20140416_SF113_02 A20140416_SF113_02 TB373253.[MT7]-ENVEELIEDK[MT7].2y7_1.heavy 753.401 / 1019.54 3081.0 32.53810119628906 44 14 10 10 10 1.7765390723977754 47.260210587606686 0.0 3 0.9409666375114554 5.0542138588100745 3081.0 13.770973714849617 0.0 - - - - - - - 299.55555555555554 6 9 CAGE1 cancer antigen 1 2139 273 A20140416_SF113_02 A20140416_SF113_02 TB235824.[MT7]-VTVLGHVQR.3y3_1.heavy 384.904 / 402.246 501748.0 24.649200439453125 50 20 10 10 10 4.6280461882609885 18.237674385157188 0.0 3 0.9913529259755017 13.26216222579538 501748.0 89.21305467914952 0.0 - - - - - - - 2927.0 1003 2 PFKL;PFKM phosphofructokinase, liver;phosphofructokinase, muscle 2141 273 A20140416_SF113_02 A20140416_SF113_02 TB235824.[MT7]-VTVLGHVQR.3b5_1.heavy 384.904 / 614.399 154024.0 24.649200439453125 50 20 10 10 10 4.6280461882609885 18.237674385157188 0.0 3 0.9913529259755017 13.26216222579538 154024.0 244.1748971955205 0.0 - - - - - - - 1203.5 308 8 PFKL;PFKM phosphofructokinase, liver;phosphofructokinase, muscle 2143 273 A20140416_SF113_02 A20140416_SF113_02 TB235824.[MT7]-VTVLGHVQR.3b3_1.heavy 384.904 / 444.294 326650.0 24.649200439453125 50 20 10 10 10 4.6280461882609885 18.237674385157188 0.0 3 0.9913529259755017 13.26216222579538 326650.0 161.57623588523535 0.0 - - - - - - - 2472.0 653 2 PFKL;PFKM phosphofructokinase, liver;phosphofructokinase, muscle 2145 273 A20140416_SF113_02 A20140416_SF113_02 TB235824.[MT7]-VTVLGHVQR.3y5_1.heavy 384.904 / 596.326 259135.0 24.649200439453125 50 20 10 10 10 4.6280461882609885 18.237674385157188 0.0 3 0.9913529259755017 13.26216222579538 259135.0 273.92719699099064 0.0 - - - - - - - 809.6666666666666 518 9 PFKL;PFKM phosphofructokinase, liver;phosphofructokinase, muscle 2147 274 A20140416_SF113_02 A20140416_SF113_02 TB373250.[MT7]-LTDGILEIITK[MT7].2b4_1.heavy 752.465 / 531.289 14830.0 40.62989902496338 40 14 10 6 10 2.0654492181002646 38.765369079743216 0.038799285888671875 3 0.949036169547243 5.443389567783254 14830.0 11.303094555873926 0.0 - - - - - - - 839.3 29 10 TTC39A tetratricopeptide repeat domain 39A 2149 274 A20140416_SF113_02 A20140416_SF113_02 TB373250.[MT7]-LTDGILEIITK[MT7].2y3_1.heavy 752.465 / 505.347 14721.0 40.62989902496338 40 14 10 6 10 2.0654492181002646 38.765369079743216 0.038799285888671875 3 0.949036169547243 5.443389567783254 14721.0 14.661940508940852 0.0 - - - - - - - 747.4285714285714 29 7 TTC39A tetratricopeptide repeat domain 39A 2151 274 A20140416_SF113_02 A20140416_SF113_02 TB373250.[MT7]-LTDGILEIITK[MT7].2b7_1.heavy 752.465 / 886.5 10796.0 40.62989902496338 40 14 10 6 10 2.0654492181002646 38.765369079743216 0.038799285888671875 3 0.949036169547243 5.443389567783254 10796.0 37.88504587155963 0.0 - - - - - - - 348.8 21 10 TTC39A tetratricopeptide repeat domain 39A 2153 274 A20140416_SF113_02 A20140416_SF113_02 TB373250.[MT7]-LTDGILEIITK[MT7].2b5_1.heavy 752.465 / 644.374 20610.0 40.62989902496338 40 14 10 6 10 2.0654492181002646 38.765369079743216 0.038799285888671875 3 0.949036169547243 5.443389567783254 20610.0 27.647230619594644 0.0 - - - - - - - 747.4285714285714 41 7 TTC39A tetratricopeptide repeat domain 39A 2155 275 A20140416_SF113_02 A20140416_SF113_02 TB235967.[MT7]-AVIQHFQEK[MT7].3y3_1.heavy 463.269 / 548.316 31702.0 24.21150016784668 46 18 10 10 8 10.998584484380554 9.092079089087623 0.0 4 0.9843358543825954 9.847828448097545 31702.0 20.50899452045223 0.0 - - - - - - - 1108.0 63 3 APP amyloid beta (A4) precursor protein 2157 275 A20140416_SF113_02 A20140416_SF113_02 TB235967.[MT7]-AVIQHFQEK[MT7].3b4_1.heavy 463.269 / 556.357 51899.0 24.21150016784668 46 18 10 10 8 10.998584484380554 9.092079089087623 0.0 4 0.9843358543825954 9.847828448097545 51899.0 24.763775997479115 0.0 - - - - - - - 895.0 103 1 APP amyloid beta (A4) precursor protein 2159 275 A20140416_SF113_02 A20140416_SF113_02 TB235967.[MT7]-AVIQHFQEK[MT7].3y4_1.heavy 463.269 / 695.385 33875.0 24.21150016784668 46 18 10 10 8 10.998584484380554 9.092079089087623 0.0 4 0.9843358543825954 9.847828448097545 33875.0 56.04324996902235 1.0 - - - - - - - 668.5384615384615 70 13 APP amyloid beta (A4) precursor protein 2161 275 A20140416_SF113_02 A20140416_SF113_02 TB235967.[MT7]-AVIQHFQEK[MT7].3y5_1.heavy 463.269 / 832.443 2429.0 24.21150016784668 46 18 10 10 8 10.998584484380554 9.092079089087623 0.0 4 0.9843358543825954 9.847828448097545 2429.0 7.390625 2.0 - - - - - - - 255.7 4 10 APP amyloid beta (A4) precursor protein 2163 276 A20140416_SF113_02 A20140416_SF113_02 TB495371.[MT7]-LQYYTQELGVR.2b3_1.heavy 757.41 / 549.315 12005.0 33.16270065307617 48 18 10 10 10 5.2347378376208535 19.103153415119102 0.0 3 0.988612501124773 11.554075624227446 12005.0 29.811457207269637 0.0 - - - - - - - 587.8888888888889 24 9 PLA2G4F phospholipase A2, group IVF 2165 276 A20140416_SF113_02 A20140416_SF113_02 TB495371.[MT7]-LQYYTQELGVR.2y8_1.heavy 757.41 / 965.505 12393.0 33.16270065307617 48 18 10 10 10 5.2347378376208535 19.103153415119102 0.0 3 0.988612501124773 11.554075624227446 12393.0 57.765135830417776 0.0 - - - - - - - 204.25 24 12 PLA2G4F phospholipase A2, group IVF 2167 276 A20140416_SF113_02 A20140416_SF113_02 TB495371.[MT7]-LQYYTQELGVR.2y9_1.heavy 757.41 / 1128.57 17685.0 33.16270065307617 48 18 10 10 10 5.2347378376208535 19.103153415119102 0.0 3 0.988612501124773 11.554075624227446 17685.0 54.83720930232559 0.0 - - - - - - - 270.9 35 10 PLA2G4F phospholipase A2, group IVF 2169 276 A20140416_SF113_02 A20140416_SF113_02 TB495371.[MT7]-LQYYTQELGVR.2y7_1.heavy 757.41 / 802.442 11618.0 33.16270065307617 48 18 10 10 10 5.2347378376208535 19.103153415119102 0.0 3 0.988612501124773 11.554075624227446 11618.0 27.1648318745277 0.0 - - - - - - - 301.0 23 9 PLA2G4F phospholipase A2, group IVF 2171 277 A20140416_SF113_02 A20140416_SF113_02 TB373457.[MT7]-RFGLEGC[CAM]EVLIPALK[MT7].3b9_1.heavy 664.051 / 1192.59 4576.0 35.88202476501465 36 13 10 3 10 0.9285835087943829 66.97158175054514 0.079498291015625 3 0.9083528267454913 4.0450959762742835 4576.0 17.414736842105263 1.0 - - - - - - - 175.33333333333334 9 12 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2173 277 A20140416_SF113_02 A20140416_SF113_02 TB373457.[MT7]-RFGLEGC[CAM]EVLIPALK[MT7].3y4_1.heavy 664.051 / 572.389 102277.0 35.88202476501465 36 13 10 3 10 0.9285835087943829 66.97158175054514 0.079498291015625 3 0.9083528267454913 4.0450959762742835 102277.0 68.12173474348396 0.0 - - - - - - - 1391.25 204 4 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2175 277 A20140416_SF113_02 A20140416_SF113_02 TB373457.[MT7]-RFGLEGC[CAM]EVLIPALK[MT7].3b8_1.heavy 664.051 / 1093.52 9894.0 35.88202476501465 36 13 10 3 10 0.9285835087943829 66.97158175054514 0.079498291015625 3 0.9083528267454913 4.0450959762742835 9894.0 23.1402813069975 0.0 - - - - - - - 206.11111111111111 19 9 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2177 277 A20140416_SF113_02 A20140416_SF113_02 TB373457.[MT7]-RFGLEGC[CAM]EVLIPALK[MT7].3b8_2.heavy 664.051 / 547.265 49840.0 35.88202476501465 36 13 10 3 10 0.9285835087943829 66.97158175054514 0.079498291015625 3 0.9083528267454913 4.0450959762742835 49840.0 43.67200904798665 0.0 - - - - - - - 247.0 99 1 OGDH oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 2179 278 A20140416_SF113_02 A20140416_SF113_02 TB372901.[MT7]-IIASYK[MT7].2y4_1.heavy 491.812 / 612.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - YTHDF2 YTH domain family, member 2 2181 278 A20140416_SF113_02 A20140416_SF113_02 TB372901.[MT7]-IIASYK[MT7].2y5_1.heavy 491.812 / 725.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - YTHDF2 YTH domain family, member 2 2183 278 A20140416_SF113_02 A20140416_SF113_02 TB372901.[MT7]-IIASYK[MT7].2y3_1.heavy 491.812 / 541.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - YTHDF2 YTH domain family, member 2 2185 278 A20140416_SF113_02 A20140416_SF113_02 TB372901.[MT7]-IIASYK[MT7].2b5_1.heavy 491.812 / 692.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - YTHDF2 YTH domain family, member 2 2187 279 A20140416_SF113_02 A20140416_SF113_02 TB495375.[MT7]-ELLQELAEFMR.3b4_1.heavy 508.273 / 628.379 27701.0 45.41360092163086 50 20 10 10 10 8.079293128190594 12.377320442932808 0.0 3 0.9961799883800736 19.961431374096243 27701.0 248.85458924497556 0.0 - - - - - - - 157.9 55 10 ARHGAP4 Rho GTPase activating protein 4 2189 279 A20140416_SF113_02 A20140416_SF113_02 TB495375.[MT7]-ELLQELAEFMR.3b5_1.heavy 508.273 / 757.421 36467.0 45.41360092163086 50 20 10 10 10 8.079293128190594 12.377320442932808 0.0 3 0.9961799883800736 19.961431374096243 36467.0 204.02948498675903 1.0 - - - - - - - 175.4 78 5 ARHGAP4 Rho GTPase activating protein 4 2191 279 A20140416_SF113_02 A20140416_SF113_02 TB495375.[MT7]-ELLQELAEFMR.3b3_1.heavy 508.273 / 500.32 47074.0 45.41360092163086 50 20 10 10 10 8.079293128190594 12.377320442932808 0.0 3 0.9961799883800736 19.961431374096243 47074.0 650.3155445480445 0.0 - - - - - - - 243.55555555555554 94 9 ARHGAP4 Rho GTPase activating protein 4 2193 279 A20140416_SF113_02 A20140416_SF113_02 TB495375.[MT7]-ELLQELAEFMR.3y5_1.heavy 508.273 / 653.308 56191.0 45.41360092163086 50 20 10 10 10 8.079293128190594 12.377320442932808 0.0 3 0.9961799883800736 19.961431374096243 56191.0 954.8273918831169 0.0 - - - - - - - 162.85714285714286 112 7 ARHGAP4 Rho GTPase activating protein 4 2195 280 A20140416_SF113_02 A20140416_SF113_02 TB235577.[MT7]-LAQISR.2y4_1.heavy 416.262 / 503.294 30428.0 23.445600509643555 50 20 10 10 10 6.104549164628293 16.38122608290747 0.0 3 0.9940739276672677 16.02375110898061 30428.0 14.480006743618596 0.0 - - - - - - - 1127.0 60 2 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 2197 280 A20140416_SF113_02 A20140416_SF113_02 TB235577.[MT7]-LAQISR.2b3_1.heavy 416.262 / 457.289 51591.0 23.445600509643555 50 20 10 10 10 6.104549164628293 16.38122608290747 0.0 3 0.9940739276672677 16.02375110898061 51591.0 16.637998551496864 0.0 - - - - - - - 1377.0 103 1 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 2199 280 A20140416_SF113_02 A20140416_SF113_02 TB235577.[MT7]-LAQISR.2y5_1.heavy 416.262 / 574.331 181193.0 23.445600509643555 50 20 10 10 10 6.104549164628293 16.38122608290747 0.0 3 0.9940739276672677 16.02375110898061 181193.0 60.564543910640225 0.0 - - - - - - - 2379.0 362 1 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 2201 280 A20140416_SF113_02 A20140416_SF113_02 TB235577.[MT7]-LAQISR.2b4_1.heavy 416.262 / 570.373 26672.0 23.445600509643555 50 20 10 10 10 6.104549164628293 16.38122608290747 0.0 3 0.9940739276672677 16.02375110898061 26672.0 21.749185944897178 0.0 - - - - - - - 782.75 53 4 ALOX15B;ALOXE3 arachidonate 15-lipoxygenase, type B;arachidonate lipoxygenase 3 2203 281 A20140416_SF113_02 A20140416_SF113_02 TB236088.[MT7]-MLPLLGAVLLQK[MT7].2b4_1.heavy 792.512 / 599.371 6059.0 44.2630500793457 46 20 10 6 10 6.079996189797699 16.447378728263203 0.03569793701171875 3 0.9931919376052295 14.948716511819638 6059.0 31.657664037741284 0.0 - - - - - - - 267.15384615384613 12 13 PLA2G4F phospholipase A2, group IVF 2205 281 A20140416_SF113_02 A20140416_SF113_02 TB236088.[MT7]-MLPLLGAVLLQK[MT7].2y3_1.heavy 792.512 / 532.357 5613.0 44.2630500793457 46 20 10 6 10 6.079996189797699 16.447378728263203 0.03569793701171875 3 0.9931919376052295 14.948716511819638 5613.0 0.0 0.0 - - - - - - - 287.0 11 9 PLA2G4F phospholipase A2, group IVF 2207 281 A20140416_SF113_02 A20140416_SF113_02 TB236088.[MT7]-MLPLLGAVLLQK[MT7].2y10_1.heavy 792.512 / 1195.79 11940.0 44.2630500793457 46 20 10 6 10 6.079996189797699 16.447378728263203 0.03569793701171875 3 0.9931919376052295 14.948716511819638 11940.0 165.68426966292134 0.0 - - - - - - - 244.875 23 8 PLA2G4F phospholipase A2, group IVF 2209 281 A20140416_SF113_02 A20140416_SF113_02 TB236088.[MT7]-MLPLLGAVLLQK[MT7].2y7_1.heavy 792.512 / 872.569 8554.0 44.2630500793457 46 20 10 6 10 6.079996189797699 16.447378728263203 0.03569793701171875 3 0.9931919376052295 14.948716511819638 8554.0 9.375080812934769 0.0 - - - - - - - 203.42857142857142 17 7 PLA2G4F phospholipase A2, group IVF 2211 282 A20140416_SF113_02 A20140416_SF113_02 TB373357.[MT7]-NQLTFLLLLLEK[MT7].3y3_1.heavy 578.365 / 533.341 36742.0 47.543701171875 42 12 10 10 10 0.9841463958011234 60.27142334860933 0.0 3 0.8892659671663388 3.673924922826386 36742.0 153.71959104697214 0.0 - - - - - - - 228.28 73 25 SRRD SRR1 domain containing 2213 282 A20140416_SF113_02 A20140416_SF113_02 TB373357.[MT7]-NQLTFLLLLLEK[MT7].3b6_1.heavy 578.365 / 861.495 14873.0 47.543701171875 42 12 10 10 10 0.9841463958011234 60.27142334860933 0.0 3 0.8892659671663388 3.673924922826386 14873.0 151.6577745269518 0.0 - - - - - - - 124.55555555555556 29 18 SRRD SRR1 domain containing 2215 282 A20140416_SF113_02 A20140416_SF113_02 TB373357.[MT7]-NQLTFLLLLLEK[MT7].3b5_1.heavy 578.365 / 748.411 15756.0 47.543701171875 42 12 10 10 10 0.9841463958011234 60.27142334860933 0.0 3 0.8892659671663388 3.673924922826386 15756.0 138.2883914010378 0.0 - - - - - - - 127.65217391304348 31 23 SRRD SRR1 domain containing 2217 282 A20140416_SF113_02 A20140416_SF113_02 TB373357.[MT7]-NQLTFLLLLLEK[MT7].3y4_1.heavy 578.365 / 646.426 18560.0 47.543701171875 42 12 10 10 10 0.9841463958011234 60.27142334860933 0.0 3 0.8892659671663388 3.673924922826386 18560.0 211.8294729775092 0.0 - - - - - - - 121.95454545454545 37 22 SRRD SRR1 domain containing 2219 283 A20140416_SF113_02 A20140416_SF113_02 TB373071.[MT7]-LSDQQEAVR.2y8_1.heavy 595.318 / 932.443 33648.0 21.47559928894043 46 18 10 10 8 4.846436800361969 20.633715886387137 0.0 4 0.9826401036551651 9.353163390592314 33648.0 244.20704951148122 0.0 - - - - - - - 175.92307692307693 67 13 PLA2G4F phospholipase A2, group IVF 2221 283 A20140416_SF113_02 A20140416_SF113_02 TB373071.[MT7]-LSDQQEAVR.2b4_1.heavy 595.318 / 588.311 3813.0 21.47559928894043 46 18 10 10 8 4.846436800361969 20.633715886387137 0.0 4 0.9826401036551651 9.353163390592314 3813.0 11.308057522452923 0.0 - - - - - - - 750.625 7 8 PLA2G4F phospholipase A2, group IVF 2223 283 A20140416_SF113_02 A20140416_SF113_02 TB373071.[MT7]-LSDQQEAVR.2y6_1.heavy 595.318 / 730.384 21638.0 21.47559928894043 46 18 10 10 8 4.846436800361969 20.633715886387137 0.0 4 0.9826401036551651 9.353163390592314 21638.0 95.45808778619653 0.0 - - - - - - - 313.2142857142857 43 14 PLA2G4F phospholipase A2, group IVF 2225 283 A20140416_SF113_02 A20140416_SF113_02 TB373071.[MT7]-LSDQQEAVR.2b5_1.heavy 595.318 / 716.37 4099.0 21.47559928894043 46 18 10 10 8 4.846436800361969 20.633715886387137 0.0 4 0.9826401036551651 9.353163390592314 4099.0 15.379813244931169 1.0 - - - - - - - 306.35714285714283 8 14 PLA2G4F phospholipase A2, group IVF